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Abstract 
 
Polarity is an important prerequisite for cell differentiation. The development of cellular asymmetry 
and cell polarity can be achieved by either selectively transporting key intracellular proteins or 
vectorial trafficking mRNAs to a subcellular location for local translation. The “A2RE-mRNA 
trafficking pathway” fits in the latter category, renowned for moving the myelin basic protein 
(MBP) RNA molecules from the nucleus to cytoplasmic myelin compartment of oligodendrocytes. 
This prominent pathway is named after a 11-nucleotide cis-acting sequence of “A2 response 
element (A2RE)”, which is necessary and sufficient for mRNA localization. The universally 
expressed protein hnRNP A2 was the first identified trans-acting factor bound to the A2RE cis-
element directing the A2RE-containing transcripts to their subcellular locations along cytoskeletal 
components.  
 
In addition to hnRNP A2, hnRNP A3 is the second abundant proteins pulled down by the A2RE-
sequence. At the beginning of this project, hnRNP A3 had just been identified as a novel key 
component along with other A2RE-binding proteins. A lot of structural and functional questions 
arising from the discovery of hnRNP A3 in the A2RE-context await answers. 
 
The detailed structural knowledge of hnRNP A3 among the A2RE-binding proteins was essential 
prior to the investigation of its biological involvement in the A2RE-trafficking pathway. Therefore, 
the overall aim of this project was to characterize the structure of hnRNP A3 isoforms which were 
purified by binding to the A2RE-sequence. At the same time, the structural comparison with other 
A2RE-binding proteins was also carried out, aiming to find out any similar or distinct features 
between these proteins when they were associated together with the same A2RE-sequence. The 
investigations in this project were established from aspects of genomics, proteomics and cellular 
location to characterize the hnRNP A3 isoforms. The experimental data, presented in this thesis, 
were collected reproducibly and comprise all above aspects.  
 
From the genomic aspect, the two splicing forms of hnRNP A3 in rat brain were exclusively 
identified through the extensive PCR screening. At the protein level, the masses of the intact A2RE-
binding proteins were measured by liquid chromatography mass spectrometry (LC/MS) and 
analyzed. Next, the rat brain A2RE-binding proteins were successfully separated by two-
dimensional gel electrophoresis (2-DE), showing a more complicated profile of hnRNP A/B 
isoforms in the A2RE-context. Each binding components were identified by mass spectrometry 
(MS) based peptide mass fingerprinting.  
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Targeting the complexity of hnRNP A3 inside the A2RE-proteome, the post-translational 
modifications (PTMs) of hnRNP A3 were investigated. Phospho-proteins of the A2RE proteome 
were detected by blotting and staining. Moreover, the pattern of protein phosphorylation was 
observed to be isoform-specific between the alternatively spliced isoform pairs.  In terms of Arg 
modifications, the methylation of A3 was confirmed, and six asymmetric dimethylated residues of 
A3 were successfully identified in the protein Gly-rich region by the bottom-up tandem MS 
proteomics. The same MS/MS proteomic method also invalidated the occurrence of citrullinated 
Arg residues in A3.  
 
In the developmental study, the uneven levels between two alternatively spliced HNRPA3 
transcripts were discovered. From the observation, the truncated A3b transcripts always maintain a 
stable higher level than the full-length A3a transcripts. The subcellular distribution patterns of the 
A3 isoforms were also explored by transfecting GFP-tagged A3 vectors into neuronal cells, in 
comparison with its endogenous cellular pattern detected by the specific immunostaining method.  
 
In summary, the investigations of hnRNP A3 in this project expanded from its encoding gene to its 
final cellular location. With more results acquired, the hnRNP A3 isoforms became more significant 
along with the other key A2RE-binding components A1 and A2/B1. The clarified 2-D profile of the 
A2RE proteome and unambiguously identified methylated residues of A3 provide insight into the 
functionally interweaved hnRNP A/B paralogs. Although the conclusions deduced from this project 
only represent the hnRNP A3 isoforms inside the A2RE-context, the characterization of A3 
isoforms under such specific circumstance still provide valuable information for studies of hnRNP 
A/B paralogs in other fields, opening up a window for studying downstream mechanisms of mRNA 
biogenesis and metabolism.  
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Chapter 1. Introduction 
1.1 Cellular polarity and mRNA localization 
 
Polarity is an important prerequisite for cell specialization and differentiation. The mechanisms that 
establish cell polarity are complicated and remain mostly unknown. Cell asymmetry can be 
developed either by selectively transporting key intracellular proteins to a subcellular location, or by 
delivery of distinct types of RNA transcripts to defined cytoplasmic regions, followed by local 
translation. The molecular mechanism of subcellular RNA transport is of particular interest for this 
project and will be elaborated on further in this introduction.  
 
1.1.1 Advantages of localizing RNA molecules 
 
The discovery of unevenly distributed actin transcripts in cytoplasm of the ascidian (Styela) embryo 
was the first evidence for cytoplasmic RNA localization (Jeffery, Tomlinson, & Brodeur, 1983). 
Soon after, increasing numbers of mRNAs were reported to localize in various developing and 
differentiated cells. To date, the number has jumped to more than seventy, spanning mRNA species 
from yeast to mammalian cells. It is clear that vectorial targeting of mRNA to a subcellular location 
represents a common mechanism. Such a mechanism is believed to provide a variety of advantages 
over post-translational protein sorting to establish and maintain cellular asymmetry.  
 
First, mRNA localization is more energy-efficient than protein transport. A single transcript can be 
translated into many protein molecules, reducing the transport cost. Secondly, localized mRNAs 
make it possible to establish and maintain protein gradients of cell fate determinants during early 
development. In Drosophila (Ephrussi & St Johnston, 2004; Hachet & Ephrussi, 2004) (Hachet & 
Ephrussi, 2001), Xenopus (M. L. King, Messitt, & Mowry, 2005; Rand & Yisraeli, 2001), zebrafish 
(Conway, Margoliath, Wong-Madden, Roberts, & Gilbert, 1997) oocytes and early embryos, 
localized RNAs have been discovered to generate cell polarity and develop correct body plans. 
Thirdly, mRNA localization provides an effective way to temporally and spatially control protein 
synthesis. In order to meet the time limitation, local mRNA translation is the only operative solution 
for neurons when high local protein concentrations are rapidly required in response to signals at 
postsynaptic sites (Dahm, Kiebler, & Macchi, 2007). Regarding spatial control, local synthesis of 
myelin basic protein (MBP) contributes a good example. MBP is a key component of the myelin 
 22 
sheath of oligodendrocytes that wraps around axons of neurons. The synthesis of MBP is spatially 
limited to the myelin compartment of oligodendrocytes. Due to its high positive charge, MBP easily 
sticks to the cytosolic surfaces of membranes (Homchaudhuri, Polverini, Gao, Harauz, & Boggs, 
2009) and interacts with cytoskeleton and a number of polyanionic proteins including actin, tubulin, 
Ca2+-calmodulin, and clathrin (Boggs & Rangaraj, 2000). To prevent ectopic protein synthesis, 
specifically MBP mRNA trafficking followed by local translation is necessary: this also avoids 
adhesion of MBP to surfaces other than myelin layers (Boggs, 2006; Smith, 2004).  
 
In addition, specific mRNA sorting and localization could facilitate the accurate segregation of 
closely related protein isoforms. For instance, the isoforms of actin partition into discrete 
subcellular locations: β-actin message accumulates at the periphery of myoblasts (Kislauskis, Zhu, 
& Singer, 1997), whereas α- and γ-actin mRNAs are concentrated in the perinuclear region (Hill & 
Gunning, 1993). Given that all actin isoforms are very similar in structure, the distinct filament 
arrays have to be achieved by the local translation of precisely segregated alternatively spliced 
mRNAs, in order to properly form the cytoskeleton.  
 
1.1.2 Patterns of RNA localization 
 
Based on the cell origin, the RNA localization patterns can be placed into three categories: oocytes, 
early embryos and somatic cells. Table 1-1 summarizes the typical RNA localization patterns of 
various cell types. As the model system for each category, Xenopus oocytes, Drosophila embryos 
and neural cells will be illustrated in cell-type specific RNA localization during development.  
 
1.1.2.1 mRNA localization in Xenopus oocytes 
 
The Xenopus oocyte has been intensively studied as a model for vertebrate development over many 
years. During Xenopus development, localization of mRNAs in oocytes determines the embryonic 
body plan (reviewed in (Kloc et al., 2001; Y. Zhou & King, 2004)). Several mRNAs are localized to 
the vegetal/animal pole or hemisphere of the oocyte, and the cellular asymmetry arising from this 
region will eventually be inherited by its own embryo if fertilized.  
 
In the Xenopus oocyte, both the early pathway and the late pathway regulate vegetal RNA 
localization (M. L. King et al., 2005). During the early pathway, mRNAs, such as Xcat-2, Xwnt-11 
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and Xlsirts, are sorted to the vegetal pole inside a structure called the mitochondrial cloud, a large, 
dense mass composed of clumps of mitochondria, rough endoplasmic reticulum (RER), Golgi 
apparatus and dense granules. There are three distinct steps in the early pathway (Kloc & Etkin, 
1995): movement from the germinal vesicle to the mitochondrial cloud, sorting within a region 
known as METRO (messenger transport organizer) inside the mitochondrial cloud, and 
translocation and anchoring to vegetal cortex. Most of these mRNAs are incorporated into the germ 
plasm and encode proteins that are required for germ cell development.  
 
On the other hand, the late pathway sorts mRNAs to either the animal or the vegetal hemisphere. 
The late pathway relies on intact microtubules but correlates with the dispersion of the 
mitochondrial cloud. Vg1 mRNA (which encodes a growth factor) and An1 transcripts (which 
encode a zinc-finger protein) are established examples of the late pathway. Vg1 RNA localization 
starts from an even distribution in the oocyte cytoplasm with exclusion from the mitochondrial 
cloud. As development continues, Vg1 transcripts migrate in a wedge-like pattern towards the 
vegetal pole until tightly anchored at the cortex of the entire vegetal hemisphere upon maturation 
(Melton, 1987). Heading in the opposite direction, An1 mRNA is enriched at the animal hemisphere 
via the late pathway (M. L. King et al., 2005). Therefore, the mature Xenopus oocyte demonstrates a 
clear pattern along the animal-vegetal axes with the specifically localized RNAs: Xcat-2, Xwnt-11 
and Xlsirts RNAs are localized at the tip of the vegetal pole, while the Vg1 RNA is distributed 
throughout the vegetal cortex and An1 RNA accumulates about four-fold in the animal pole. 
 
1.1.2.2 mRNA localization in Drosophila embryos 
 
In Drosophila oocytes and early embryos, there are at least 20 different maternal mRNAs localized 
to the distinct subcellular regions. The asymmetric intracellular localization of RNA, which is 
strictly regulated in a temporally and spatially-dependent manner, establishes the germline and 
embryonic axes in oogenesis and early embryo development, ultimately determining the embryo 
body plan (Wolpert, 1969). 
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Localized bicoid and nanos mRNAs are among the best-characterized examples in forming 
anterior/posterior axis of the oocyte (Ephrussi & St Johnston, 2004). The transcription factor 
Bicoid, encoded by bicoid gene, initiates the series of transcriptional events that are responsible for 
the formation of the anterior body segment. Bicoid mRNA is transported during oogenesis to the 
anterior tip of the oocyte where it is anchored. After fertilization, translation of bicoid results in a 
decreasing gradient of Bicoid protein extending from the anterior to posterior poles in the embryo. 
It allows Bicoid to enter the nuclei in the anterior region and to switch on its target genes (Driever 
& Nusslein-Volhard, 1988). Accurate targeting of bicoid mRNA is particularly important because 
all bicoid mutants lead to defects in embryonic patterning (Ephrussi & St Johnston, 2004). Nanos, 
on the other hand, encodes an RNA-binding protein considered to be a determinant of posterior cell 
fate (C. Wang & Lehmann, 1991). It assists the formation of the posterior body plan by inhibiting 
hunchback mRNA translation, which is induced by the bicoid cascade (Crucs, Chatterjee, & Gavis, 
2000). Thus, the distinct position of these antagonistic pairs establishes the anterior/posterior axis in 
Drosophila embryo. 
 
A third localized mRNA, gurken, defines the dorso/ventral axis of the embryo (Nilson & 
Schupbach, 1999). Gurken encodes a signaling protein, transforming growth factor α (TGFα). 
During late oocyte development, a two-step mechanism directs gurken to the anteriodorsal corner of 
the oocyte adjacent to the cell nucleus. The local translation of gurken mRNA at the anteriodorsal 
corner triggers a secondary signal in the adjacent follicle cells, eventually forming the dorso/ventral 
axis of the oocyte. 
 
In addition to inducing the formation of intracellular protein gradients, localized mRNAs also 
facilitate the formation of extracellular signal gradients. In the Drosophila embryo wg mRNAs, 
encoding a secreted glycoprotein wingless (wg), localize just below the surface of the apical 
membrane. Wg determines the segmentation of the ventral epidermis (Klingensmith & Nusse, 
1994). Improper localization of wg mRNA to the basal cell membrane leads to a wg function-loss 
phenotype in embryo (Simmonds, dosSantos, Livne-Bar, & Krause, 2001). This suggests that 
mRNA localization to the apical side of the cell is necessary for proper secretion and extracellular 
gradient formation. 
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1.1.2.3 mRNA localization in neurons 
 
Neurons are highly differentiated somatic cells. A large axon, protruding form the cell body and 
terminating at a synapse, and the numerous dendrites facilitate the transmission of electrical signals. 
This unique morphology of neurons gives rise to their cellular asymmetry, which is imperative in 
establishing and maintaining synaptic plasticity. With the techniques of in situ hybridization, a large 
number of localized mRNAs have been revealed in dendritic layers of the hippocampus and at 
postsynaptic densities of hippocampal neurons in vivo and in vitro. The mRNA encoding the 
microtubule-associated protein 2 (MAP2) was first identified in neuron dendritic localization, and is 
generally considered as the marker for the dendritic cytoskeleton. Proteins encoded by other 
dendritically localized mRNAs include the α-subunit of Ca2+/calmodulin-dependent protein kinase 
II (CaMKIIα), brain-derived neurotrophic factor (BDNF), activity-regulated cytoskeleton-
associated protein (Arc), tyrosine-related kinase B (TrkB) receptor, IP3 receptor, the atypical protein 
kinase M, the NMDA receptor (NMDAR) NR1 subunit and glycine receptor α subunit (reviewed in 
(Steward & Schuman, 2003)).  
 
Some dendritic mRNA localizations are only activated in early stages of development or triggered 
by certain cellular events. mRNAs are localized to dendritic growth cones in developing neurons, 
but the localizations disappear when neurons mature (Crino & Eberwine, 1996). For other mRNAs, 
the dendritic localization is a response to cellular activities (Link et al., 1995): synaptic activity 
induces the transcription of Arc mRNA as well as its dendrite targeting (Lyford et al., 1995); while 
neuronal activity elevates the dendritic localization of BDNF and trkB mRNAs (Tongiorgi et al., 
2004).  
 
Localized mRNAs are also found in glial cells, e.g. astrocyte processes are enriched for glial 
fibrillary acidic protein (GFAP) mRNA and glial intermediate filament mRNA (Landry, Watson, 
Kashima, & Campagnoni, 1994); mRNAs of specific isoforms of myelin-
associated/oligodendrocytic basic proteins (MOBP) are localized to the myelinating periphery of 
oligodendrocytes (Gould, Freund, & Barbarese, 1999); mRNAs encoding MBP, tau and carbonic 
anhydrase localize to the distal processes in Schwann cells and oligodendrocytes (Ghandour & 
Skoff, 1991; LoPresti, Szuchet, Papasozomenos, Zinkowski, & Binder, 1995; Rao & Steward, 
1993). In particular, the RNA trafficking pathway will be illustrated in Section 1.3.2, using the 
localization pattern of MBP mRNA in oligodendrocytes as an example.  
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1.2 Heterogeneous nuclear ribonucleoproteins 
 
In eukaryotic cells, gene expression is extensively regulated after transcription. RNAs are 
transcribed in the nucleus by RNA polymerase II. Due to the marked differences in size and nuclear 
location, newly synthesized RNAs (pre-mRNAs) are termed heterogeneous nuclear RNAs 
(hnRNAs). From the time transcription initiates, hnRNAs are found to associate with a large 
number of proteins, forming heterogeneous nuclear ribonucleoprotein (hnRNP) particles. hnRNP 
particles are defined as “complexes of RNA and protein present in the cell nucleus during gene 
transcription and subsequent post-transcriptional modification” (Watson, 2008).  
 
Inside the hnRNP particles, proteins are generally classified into three groups: the most abundant 
hnRNP proteins; the less abundant stable components of other classes of ribonucleoprotein 
complexes such as small nuclear RNPs (snRNPs); and numerous other enzymes and regulatory 
factors involved in RNA processing (Dreyfuss, Swanson, & Pinol-Roma, 1988; Pinol-Roma, Choi, 
Matunis, & Dreyfuss, 1988). Throughout all stages of RNA biogenesis from synthesis to maturation 
in the nucleus, RNAs are present in dynamic hnRNA-hnRNP-snRNP complexes, rather than naked, 
in a pattern like “beads-on-a-string” under electron microscopy (Reed & Magni, 2001). The “beads” 
of hnRNP particles are assembled along the “string” of the hnRNA transcript, which turns into the 
major nuclear structure. In the following sections, hnRNP protein characteristics and functions in 
relation to RNA metabolism will be discussed.  
 
1.2.1 General features of hnRNP proteins 
 
hnRNP proteins collectively refer to a group of RNA-binding proteins ranging from 30 kDa to 120 
kDa that are the most abundant proteins in the nucleus,. Decades ago, hnRNPs were first isolated as 
large particles and characterized by density-gradient sedimentation (Martin et al., 1974) and 
immunoprecipitation from the nucleoplasm (Pinol-Roma et al., 1988), and at least 20 major nuclear 
proteins were identified and shown to be in direct contact with hnRNA in vivo by UV-induced 
RNA-protein crosslinking (Mayrand & Pederson, 1981). Though hnRNPs are not uniform in size 
and nuclear location, most hnRNPs share a modular structure, cooperatively assisting and 
regulating RNAs undergoing complicated modification processes. Therefore, these hnRNPs are 
assigned to a subfamily of hnRNP proteins from hnRNP A to U, based on their common structural 
features.  
 
 28 
From the structural viewpoint, the hnRNP proteins typically include one or more RNA-binding 
domains and other auxiliary domains. The RNA recognition motif (RRM), arginine-glycine-glycine 
(RGG) box and K-Homology (KH) motif are the major RNA-binding modules identified in 
hnRNPs. The knowledge of these motifs helps to predict the nucleic acid interactions of unknown 
proteins containing these characteristic modules.  
 
RRM 
 
RRMs are around 90 aa in length, and have been well characterized structurally and functionally. 
They are sometimes referred to as RNA-binding domains (RBD) or ribonucleoprotein domains 
(RNP). The RRM is evolutionarily conserved in most pre-mRNA-binding proteins from most 
animals, plants, fungi and cyanobacteria. RRM-containing proteins are localized to the nucleus, the 
nucleolus, the cytoplasm, and to cytoplasmic organelles associated with many types of RNAs, i.e. 
pre-mRNA, pre-rRNA, snRNA, and mRNA (reviewed in (Dreyfuss, Matunis, Pinol-Roma, & Burd, 
1993)). With such diversity in number, location, RNA-binding molecule and possible function, 
RRM proteins form the largest RNA-binding protein family. 
 	  	  
 
Figure	  1-­‐1:	  Amino	  acid	  sequence	  alignment	  of	  RRM	  1	  and	  RRM	  2	  of	  hnRNP	  A1.	  The	  sequences	  of	  RRM	  1	  (84	  aa)	  and	  RRM	  2	  (80	  aa)	  of	  human	  hnRNP	  A1	  are	  aligned	  by	  ClustalW	  program.	   Inside	  the	  each	   RRM,	   the	   highly	   conserved	   region	   of	   RNP	   1	   and	   RNP	   2	   are	   shaded	   in	   gray.	   The	   identity	   and	  similarity	  between	  aligned	  sequences	  are	   indicated	  by	  ClustalW	  consensus	  symbols:	   “*”	   for	   identical	  matching;	  “:”	  for	  conserved	  substitutions;	  and	  “.”	  for	  semi-­‐conserved	  substitutions.	  
 
The entire sequence of RRMs is moderately conserved. However, the signature octamer RNP 1 and 
hexamer RNP 2 are highly conserved inside the motif, as illustrated in Figure 1-1, with around 30 
residues apart (Dreyfuss et al., 1988). The RNP 2 is rich in aromatic and aliphatic residues and less 
conserved compared with the RNP 1. The best-conserved RNP 1 is preceded by the least-conserved 
region within the domain. The sequence similarity first became noticeable from the comparison 
between hnRNP A1 and mRNA poly(A)-binding protein (Adam, Nakagawa, Swanson, Woodruff, 
& Dreyfuss, 1986). RNP consensus sequences are RNA-binding sites for several snRNP proteins 
and hnRNP proteins (Gorlach, Wittekind, Beckman, Mueller, & Dreyfuss, 1992; Lutz-Freyermuth, 
Query, & Keene, 1990). A few exceptions, such as hnRNPs I, L, and M, contain multiple copies of 
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non-canonical RRMs. Their overall domain is similar to the canonical RRM but the RNP 1 and 
RNP 2 regions are less alike (Dreyfuss et al., 1993).  
 
The three-dimensional (3-D) structure of an RRM was determined by multi-dimensional nuclear 
magnetic resonance (NMR) spectroscopy (Hoffman, Query, Golden, White, & Keene, 1991). As 
depicted in Figure 1-2, the backbone of the single RRM of hnRNP C1/C2 folds into a β1-α1-β2-β3-
α2-β4 arrangement, in which the four-stranded anti-parallel β-sheet is packed against two 
perpendicular α-helices (Wittekind, Gorlach, Friedrichs, Dreyfuss, & Mueller, 1992). The RNP 1 
and RNP 2 consensus sequences are positioned in the two inner adjacent β strands (i.e. β3 and β1) 
respectively. The β-α-β sandwich exhibits a right-handed twist. Also β-bulges in β1 and β4 are 
common in many RRMs. The side chains of highly conserved aromatic residues in the RNP 1 C-
terminus, in conjunction with the critical perpendicular topology between two α-helices, are 
believed to be the most important factors affecting the overall RRM scaffold structure. 
 
 
Figure	  1-­‐2:	  The	  secondary	  structure	  of	  the	  RRM	  from	  residue	  2-­‐94	  in	  hnRNP	  C.	  The	  structure	  is	  depicted	   from	  residue	  2-­‐94	  of	  hnRNP	  C,	   in	  which	   the	  arrows	   represent	   the	  orientation	  of	   four	  anti-­‐parallel	  β-­‐sheets,	   and	   the	  cylinders	   symbolize	   the	   two	  α-­‐helices.	  The	  order	  of	  α-­‐helix	  and	  β-­‐sheet	   is	  labeled	  on	  the	  primary	  sequence.	  The	  consensus	  sequences	  of	  RNP	  1	  and	  RNP	  2,	  highlighted	   in	  grey	  boxes,	  locate	  inside	  the	  central	  anti-­‐parallel	  strands	  of	  β3	  and	  β1	  respectively.	  	  
 
Early UV-crosslinking experiments, mutational analysis, and peptide-binding studies identified the 
four-stranded β-sheet as the RNA binding spot (Gorlach et al., 1992), with dissociation constants 
varying from 10-11 to 10-7 M (Gorlach, Burd, & Dreyfuss, 1994). The binding site may extend over 
more than the canonical 90 residues of the RRM domain (Query, Bentley, & Keene, 1989). 
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Furthermore, a large number of residues of the four-stranded β-sheet in the adjacent N- and C-
terminal regions are responsible for RNA contacts (Gorlach et al., 1992), which provide a spacious 
“platform” for binding of RNA substrates. NMR spectroscopy showed that the overall conformation 
of the RRM did not change upon binding to RNA. In addition, the annealing of complementary 
RNAs was increased for ssRNA ligand when bound (Portman & Dreyfuss, 1994). The result also 
proved that the RNA-RRM association promotes RNA ligand exposure to other RNAs or RNA-
binding proteins.  
 
While hnRNP C has only a single RRM, many other hnRNPs contain multiple tandemly arrayed 
RRMs, permitting these proteins to bind more than one RNA sequence at the same time. The 
multiple RRMs showed less identity between them by sequence comparison analysis, however 
multiple RRMs within hnRNP proteins containing two tandem RRMs and followed by a glycine-
rich region, i.e. 2×RRM-GRD proteins, are thought to be derived from a unique ancestor. The 
independent evolution of each internal RRM renders the individual RNA-binding domain capable 
of binding specific RNAs, making it possible for the host protein to undertake multi-tasking in 
RNA processing.  
 
RGG box 
 
The RGG box is a domain consisting of a few arginine-glycine-glycine repeats separated by 
aromatic residues. The individual repeats are typically 20 to 25 residues The RGG repeats inside the 
domain are closely spaced, but the number of RGG (or GRG or RRG) repeats are variable. Since 
the RGG box is normally found in hnRNPs in tandem with RRMs (Casas-Finet, Karpel, Maki, 
Kumar, & Wilson, 1991), the domain used to be regarded in facilitating the binding of neighboring 
RRMs. However, deletion analysis of hnRNP U showed that the RGG box is the only sequence-
specific RNA binding domain (Kiledjian & Dreyfuss, 1992) in the peptide context without an 
RRM. The characteristic spacing of RGG repeats in hnRNP U shows a similar pattern to the RGG 
box next to RRM, thus the RGG box may indicate a minimal motif in specific RNA-binding (Burd 
& Dreyfuss, 1994).  
 
The RGG box-containing proteins have recently been related to some human disorders and 
malignancies. Even though the specific roles of RGG box proteins are yet to be clarified, their 
participation in RNA metabolism was inferred from the common RNA-binding features. The 
mRNA-carrying fragile X mental retardation 1 protein (FMR-1), responsible for the fragile X 
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syndrome, contains one RGG box and two KH domains (Verkerk et al., 1991). An RGG box is also 
found in the Epstein-Barr virus nuclear antigen-1 (EBNA-1) (Baer et al., 1984), a pathogenic 
protein of Epstein-Barr virus. Two closely related genes, EWS (Delattre et al., 1992) and TLS 
(Crozat, Aman, Mandahl, & Ron, 1993), which have been identified in Ewing’s sarcoma and 
myxoid liposarcoma respectively, both encode proteins with an RRM and three RGG boxes.  
 
Inside the RGG box, the arginine residues are of particular interest. The strong positive charge (+3 
~ +9) of these domains is mostly attributable to these residues, which are crucial for interaction with 
negatively charged ssRNA. Besides, the arginines in RGG box provide a few hotspots for post-
translational modification (i.e. phosphorylation, methylation, etc.), which are prevalent in hnRNPs. 
The post-translational modification of hnRNPs will be addressed in more detail in later sections.  
 
KH motif 
 
The KH motif is first identified in human hnRNP K (Matunis, Michael, & Dreyfuss, 1992). It is 
near 70 residues long with a characteristic sequence (VIGXXGXXI, where X denotes any amino 
acid) flanked by a few conserved residues (H. Siomi, Matunis, Michael, & Dreyfuss, 1993). hnRNP 
K contains three KH domains, which are highly conserved between species. However no other 
hnRNPs show obvious resemblance to this sequence. On the other hand, the KH motif is present in 
a broad range of RNA-associated proteins of different origins (i.e. archaeal and eukaryotic exosome 
subunits (Oddone et al., 2007), bacterial and organelle PNPases (Matus-Ortega et al., 2007), 
eukaryotic and prokaryotic ribosomal S3 protein (H. Siomi et al., 1993), and human onconeural 
ventral antigen-1 (NOVA-1) (H. A. Lewis et al., 1999)). These proteins undertake a myriad of 
different biological roles.  
 
The KH motif functions in RNA or ssDNA recognition (Garcia-Mayoral et al., 2007). With few 
exceptions, the KH motif usually appears in form of repeats within the protein and each single motif 
could function independently or cooperatively (Braddock, Louis, Baber, Levens, & Clore, 2002) 
(Beuth, Pennell, Arnvig, Martin, & Taylor, 2005). There are two versions of folds revealed by 
NMR spectroscopy (Grishin, 2001), termed type I and type II KH folds. Type I domains, folding 
into the order of β1-α1-α2-β2-β’-α’, are found in multiple copies in eukaryotic proteins; while type 
II KH domains, with the folding of α’-β’-β1-α1-α2-β2, are typically found as single copy in 
prokaryotic proteins. The identical linear part of β1-α1-α2-β2 is regarded as the KH minimal motif. 
Interestingly, in eukaryotic proteins with multiple type I KH domains, the KH1 domains is always 
more similar to other KH1 domain in different proteins than to the KH2 or KH3 domains in the 
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same protein. Similar situations are found in KH2 and KH3 domains—they are more similar to 
other KH2 and KH3 domains, respectively, than they are to each other within the protein (Valverde, 
Edwards, & Regan, 2008). A few hypotheses have been proposed based on this observation, 
however the implication of the KH domain origin and evolution is yet to be determined.  
 
 
Figure	  1-­‐3:	  Type	  I	  and	  type	  II	  KH	  domains.	  Panel	  A	  and	  A'	  depict	  the	  secondary	  structure	  in	  linear	  and	  folding	  patterns	  of	  type	  I	  KH	  domain;	  panel	  B	  and	  B'	  depict	  the	  patterns	  of	  type	  II	  KH	  domain.	  The	  arrows	  represent	  the	  orientation	  of	  β-­‐sheets	  and	  the	  cylinders	  symbolize	  the	  α-­‐helices	  The	  common	  structure	  of	  “the	  KH	  minimal	  motif”,	  shared	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In contrast to the “platform” pattern in the RRM binding region, the typical binding surface of KH 
motifs is a flexible cleft which could only pair with the specific CCCT/U tetra-nucleotide 
(Braddock, Baber, Levens, & Clore, 2002). With such a strict nucleic acid recognition mode, higher 
affinity and specificity binding could be achieved by either increasing the number of KH motif 
repeats or by including neighboring structural motifs in the protein (Braddock, Baber, et al., 2002). 
The nucleic acid-binding activity of KH domain is essential to many cellular processes, such as 
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fragile X mental retardation syndrome and paraneoplastic disease are related to the functional 
failure of a particular KH domain (H. A. Lewis et al., 2000). Therefore, KH domains represent 
motifs well balanced between functional diversity and specificity.  
 
Auxiliary domains 
 
The general modular structure of hnRNPs not only contains RNA-binding domains in the N-
terminus, but also includes auxiliary domains in the C-terminus. Unlike RNA-binding domains, 
these domains are unstructured, and have diverse sequences, making their classification difficult.  
 
The glycine-rich domain (GRD) found in hnRNPs A1 and A2/B1 from divergent organisms is the 
most prevalent type of auxiliary domain. The GRD confers many activities to hnRNP A1, such as 
protein-protein interactions, mediating the RNA-binding properties, and nucleo-cytoplasmic 
shuttling.  
 
The protein-protein interactions are important for the formation of hnRNP complexes. The GRD of 
hnRNP A1 is required for protein-protein contacts (Cartegni et al., 1996). Deletion analysis 
indicated that protein-binding determinants are distributed over the entire length of the domain. The 
periodic recurrence of aromatic residues makes the hydrophobic protein-protein interaction 
possible. A hybrid protein consisting of the GRD fused to GST was used to indicate direct protein–
protein interaction in vitro. Not only hnRNP A1 itself, but also other hnRNPs such A2/B1 and C are 
efficiently recognized by the GRD fusion protein in the absence of RNA (Cobianchi, Biamonti, 
Maconi, & Riva, 1994). However, hnRNP A1 lacking the GRD region failed to bind in vivo. The 
similar protein-protein interactions are obtained using the yeast two-hybrid system (Cartegni et al., 
1996). Therefore, the specific GRD-mediated homotypic and heterotypic protein-protein 
interactions imply a selective mode in assembly of specific multi-protein complexes.  
 
The GRD of hnRNP A1 is shown to bind RNA in a less specific manner through a 36 aa sequence 
analogous to an RGG box, yet this binding is weak compared to that of the glycine-rich RGG box 
region of hnRNP U (Kiledjian & Dreyfuss, 1992). Furthermore, the association of the hnRNP A1 
GRD with nucleic acid promotes complementary nucleic acid annealing in vitro (Cobianchi, Calvio, 
Stoppini, Buvoli, & Riva, 1993; Idriss et al., 1994). It may be the consequence from both the RNA-
binding and protein-protein interaction.  
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The signals that mediate nucleo-cytoplasmic shuttling of hnRNP A1 have been ascribed to a ~38 aa 
sequence, termed M9, located inside the GRD. M9 shows no sequence similarity to classical protein 
nuclear localization signals (NLS) such as that of SV-40 large T antigen or nucleoplasmin 
(Dingwall & Laskey, 1991). On the contrary, M9 alone is sufficient to direct both nuclear export 
and import of hnRNP A1 in cultured somatic cells (H. Siomi & Dreyfuss, 1995). Mutagenesis 
experiments indicate that the signals for nuclear export and import activities are either identical or 
overlapping in M9, because mutant M9 import signal eliminates the export activity (Michael, Choi, 
& Dreyfuss, 1995). It is possible that the same receptor recognizes M9 either in the nucleus or in 
the cytoplasm. Later, transportin was found to interact with the M9 domain and mediates import to 
the nucleus, rather than importin α or β in the classical NLS-import pathway (Pollard et al., 1996). 
Moreover, M9 recognition is required but not sufficient for mRNA export (Izaurralde et al., 1997). 
These results suggested that M9 participates distinctive pathways to direct hnRNP shuttling and 
mRNA export.  
 
Besides GRD, the auxiliary domains of several hnRNPs possess clusters rich in one or a few 
particular residues, reminiscent of eukaryotic transcription factors. The proline-rich region, found in 
hnRNPs K, L and the poly(A)-binding proteins, resembles the CCAAT-binding transcription factor 
(CTF), and the glutamine-rich region in hnRNP U is similar to the activation domain of the 
transcription factor SP1 (Dreyfuss et al., 1993). These regions also mediate protein-protein 
interactions (Ren, Mayer, Cicchetti, & Baltimore, 1993) (Parry & Steinert, 1992), indicating the 
significance of the auxiliary domains in transcriptional regulation.  
 
1.2.2 Functions of hnRNP proteins 
 
Due to their modular structure, intricate relationship to RNA, diversity in cellular distribution and 
high abundance, hnRNP proteins are involved in the entire process of mRNA biogenesis. The 
diverse functions performed by these proteins are based on their dual ability to recognize RNA 
through RNA-binding domains and to interact with other proteins utilizing specialized auxiliary 
domains (Dreyfuss et al., 1993; Gorlach, Burd, Portman, & Dreyfuss, 1993). The identified roles of 
hnRNP proteins comprise chromatin remodelling, transcriptional regulation, mRNA splicing, 
localization and translation.  
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1.2.2.1 Association with chromatin and telomeres 
 
Chromatin packs DNA into a small volume and undergoes structural changes during the cell cycle 
(Fedor, 1992). In the interphase, the chromatin structure is in extended form, optimized to allow 
easy access of transcription and DNA repair factors in the nucleus; while the metaphase structure of 
chromatin is condensed and optimized for physical strength and manageability, forming the classic 
chromosome structure (Dame, 2005). Histone is the major scaffold protein of chromatin, and many 
other proteins dynamically associate with chromatin to switch it between condensed and extended 
forms in DNA packing (Voss & Hager, 2008). hnRNP U, also called scaffold attachment factor A 
(SAF-A), was first identified to bind nuclear matrix with high affinity in the vertebrate genome 
(Romig, Fackelmayer, Renz, Ramsperger, & Richter, 1992). Later, hnRNP K was found to interact 
with a chromatin remodeling factor polycomb group (PcG) protein EEd, both in vivo and in vitro 
(Bomsztyk, Van Seuningen, Suzuki, Denisenko, & Ostrowski, 1997), followed by the discovery of 
hnRNP K aggregated at transcribed gene loci (Ostrowski, Kawata, Schullery, Denisenko, & 
Bomsztyk, 2003). Recently, hnRNP C1/C2 was found in another chromatin-remodeling complex to 
provide a specific DNA recognition element for regulatory locus control regions (LCRs) (M. C. 
Mahajan, Narlikar, Boyapaty, Kingston, & Weissman, 2005).  
  
Telomeres are regions of repetitive DNA at the end of chromosomes, that protect the termini from 
destruction. Telomeric DNA is composed of a duplex telomeric tract followed by a 3’ G-rich 
single-stranded overhang, and is packed with proteins (Neumann & Reddel, 2002). Telomeres are 
maintained by telomerases, minimally composed of a functional RNA template and a catalytic 
protein containing conserved reverse transcriptase motifs. Telomerase synthesizes specific DNA 
repeat, TTAGGG in vertebrates, to preserve the 3’ overhang structure (Greider & Blackburn, 1985). 
hnRNPs A1, A2/B1, A3, D, E, K and I have been demonstrated to specifically associate with the ss 
telomeric repeats in the 3’ overhang. Subsequent studies showed that hnRNP A1 protect the G-rich 
overhang region from degradation (Dallaire, Dupuis, Fiset, & Chabot, 2000), while hnRNPs D, K 
and E prefer the hnRNPrich telomeric sequence (Bandiera et al., 2003; Marsich, Bandiera, Tell, 
Scaloni, & Manzini, 2001). hnRNP D and its isoforms not only bind to ss oligonucleotides but also 
disrupt G-G pairing, facilitating telomerase access (Eversole & Maizels, 2000). On the other hand, 
hnRNP C binds to the U-rich sequence just 5’ to the RNA template of telomerase (Ford, Suh, 
Wright, & Shay, 2000), and hnRNP A1 promotes telomerase activity in vivo (LaBranche et al., 
1998). Therefore, the hnRNP proteins inclusively participate in telomere biogenesis by maintaining 
the telomere overhang structure, assisting telomerase access for telomere elongation. 
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1.2.2.2 Transcription 
 
hnRNP proteins influence transcription by altering the folding of promoter DNA, by recruiting or 
inhibiting other transcriptional factors or by interacting with the RNA pol II complexes. hnRNP F 
interacts with the RNA pol II holoenzyme (Yoshida, Kokura, Makino, Ossipow, & Tamura, 1999), 
while hnRNP U is associated with the phosphorylated C-terminal domain of Pol II, regulating the 
initial phases of transcription (Kukalev, Nord, Palmberg, Bergman, & Percipalle, 2005). hnRNPs 
A1 and K play multiple roles in transcription, usually accomplished through direct DNA binding or 
interaction with other proteins.  
 
In the Apolipoprotein E (APOE) promoter, the polymorphic 219T/G variations monitor the basal 
transcriptional activity. hnRNP A1 specifically interacts with the T-allelic form of APOE promoter 
at 219T region, altering the conformation of the DNA-protein complex in favor of transcription. 
Furthermore, high-level expression of hnRNP A1 results in the high activity of the allelic T form 
rather than G form, indicating a positive role as a transcription factor (Campillos et al., 2003). 
Contrary to enhancing transcription, hnRNP A1 suppresses it by direct binding to an “ATTT” 
sequence in the human thymidine kinase promoter (J. S. Lau et al., 2000). Over-expressed hnRNP 
A1 down-regulates basal γ-fibrinogen transcription (Xia, 2005). These data suggest that hnRNP A1 
acts either as an enhancer or as a repressor in specific transcription regulation. 
 
hnRNP K affects transcription by binding to a CT-element (Bomsztyk, Denisenko, & Ostrowski, 
2004). The CT element is a positively acting homo-pyrimidine tract upstream of the c-myc gene, to 
which hnRNP K binds both in vivo and in vitro (Ostrowski et al., 2003; Takimoto et al., 1993). 
hnRNP K stimulates the c-myc gene promoter in cooperation with TATA box-binding protein 
(TBP) (Michelotti, Michelotti, Aronsohn, & Levens, 1996), and activates the c-src promoter 
partnered with the transcription factor Sp1 (Ritchie et al., 2003). Still, through the CT motif hnRNP 
K represses transcription of the thymidine kinase gene (Hsieh et al., 1998) and the neuronal 
nicotinic acetylcholine receptor β4 subunit (W. Du, Thanos, & Maniatis, 1993), due to prevention 
of the binding of transcriptional enhancers. Apart from the CT motif, hnRNP K is transiently 
recruited to multiple sites within an inducible locus, implying its possible action on steps 
downstream of transcription initiation, such as elongation and termination vitro (Ostrowski et al., 
2003).  
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1.2.2.3 Pre-mRNA processing  
 
In eukaryotic cells, nascent RNA transcripts are assembled with a large number of proteins and 
undergo substantial remodelling processes in RNP complexes, until becoming mature mRNAs. Pre-
mRNA processing is complicated with multiple steps, but there are three main modifications 
applying to most primary transcripts: i.e. 5’ capping, 3’ polyadenylation, and splicing. Many 
hnRNP proteins are reported to take an active part in these post-transcriptional events, acting as a 
subset of the trans-acting transcription factors. The functional mechanism is only partially 
understood. 
 
The functions of hnRNP proteins in pre-mRNA processing are summarized in Table 1-2. In general, 
the abundant hnRNP proteins actively bind to numerous RNAs and function in a range of processes 
in mRNA maturation. Interestingly, some hnRNP proteins, such as F, H and I, act as enhancers for 
some genes but as a silencer for others. The binding of a certain hnRNP protein to mRNA will lead 
to two kinds of consequences on other trans-acting factors: either attracting more factors to the 
binding site via protein-protein interactions in a cooperative manner; or obstructing the access point 
for other factors in a competitive way, leading to distinct RNA fates. 
 
1.2.2.4 mRNA stability 
 
After binding to hnRNP proteins, pre-mRNAs are stimulated in annealing activities. It was first 
discovered in hnRNP A1-RNA interactions, and has been verified in vitro (Munroe & Dong, 1992). 
Many other hnRNP proteins have the significant annealing-promotion property, suggesting that the 
pre-mRNA sequences or structures are stabilized by hnRNP proteins for easier access (Portman & 
Dreyfuss, 1994). Moreover, NMR studies have revealed that the annealing-promotion activity can 
be attributed to the single RRM of hnRNP C alone (Gorlach et al., 1992). With multiple RRMs, 
hnRNP proteins may bring together different RNA sequences, being elevated in accessibility for the 
complementary strand or future trans-regulating factors. This chaperone activity of hnRNP proteins 
not only makes up the local constellation of RNA-protein structures, but also impacts profoundly on 
pre-mRNA processing (Portman & Dreyfuss, 1994). 
 
Pre-mRNAs are structurally stabilized by binding to hnRNP proteins, while the intracellular mRNA 
level is controlled by the balance between RNA pol II synthesis and ribonuclease degradation. The 
information determining the half-life of a particular mRNA is generally situated in the 3’UTR of its 
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own transcript (Garneau, Wilusz, & Wilusz, 2007). Until now, only a handful of regulatory factors 
(e.g. hnRNPs D and C) have been found to control a large cohort of target mRNAs. Therefore, 
those proteins regulate the rate of mRNA turnover with strict mRNA decay mechanisms, otherwise 
aberrations in RNA stability (e.g. abnormal stabilization of oncogenic transcripts) directly lead to 
oncogenesis and tumor development (Benjamin & Moroni, 2007).  
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Adenylate-uridylate rich elements (ARE) in the 3' UTR of target mRNAs are the destabilizing cis-
elements for rapid degradation (Shaw & Kamen, 1986). hnRNP D (also named AUF1) was the first 
and best characterized ARE-binding protein in promoting mRNA degradation (G. Brewer, 1991). 
Four alternatively spliced hnRNP D isoforms differ in ARE-binding capacity and stability control, 
but the rate of the target RNA turnover is determined by the overall equilibrium of individual 
isoform level (Raineri, Wegmueller, Gross, Certa, & Moroni, 2004). hnRNP A2 is also a mRNA 
destabilizer by binding to ARE in glucose transportin-1 (Glut1) 3' UTR (Hamilton et al., 1999).  
Conversely, hnRNP A1 positively modulates mRNA stability by associating with an ARE in the 3' 
UTR of the β-adrenergic receptor transcript with high affinity (Pende et al., 2008). In fibroblasts, 
hnRNPs A1, E1, and K increase RNA stability by interacting with the ARE consensus of collagen 
genes COL1A1, 1A2, and 3A1, respectively (Thiele et al., 2004). mRNA stability is regulated by the 
antagonistic effects of hnRNP proteins, so that cells always maintain a steady mRNA level for gene 
expression in response to intracellular and extracellular stimuli.     
 
1.2.2.5 Translation 
 
mRNA stability is tightly coupled to translation, which is regulated by numerous proteins mainly 
targeting the initiation step. Two distinct mechanisms account for translation initiation in eukaryotic 
cells: cap-dependent scanning and internal ribosome entry.  
 
In the cap-dependent mechanism, the eukaryotic initiation factor 4E (eIF-4E) specifically 
recognizes the cap structure in the 5' UTR of mRNA, unfolds the secondary structure, and recruits 
the 40S ribosomal subunit to initiate scanning for the start codon (Sonenberg & Gingras, 1998). The 
ribosome binding at 5' UTR cap structure is promoted by hnRNPs A1 and I, resulting in 
translational inhibition of uncapped mRNAs (Svitkin, Ovchinnikov, Dreyfuss, & Sonenberg, 1996). 
hnRNP A 2 enhances cap-dependent translation by binding to the A2RE sequence in the 3' UTR 
(Kwon, Barbarese, & Carson, 1999), whereas hnRNP C1/C2 effectively regulates the translation 
initiation of p27 mRNA when associated with a U-rich element in the 5' UTR (Millard, Vidal, 
Markus, & Koff, 2000). 
 
A complex RNA structural element in the 5' UTR, the internal ribosome entry segment (IRES), is 
essential for translations occurring via an internal initiation mechanism (Hellen & Sarnow, 2001). 
This less common mechanism of translation initiation is considered to alternatively maintain the 
polypeptide synthesis level when the cap-dependent translation is compromised (Pelletier & 
 42 
Sonenberg, 1988). A number of RNA-binding proteins have been identified to bind IRES in the 
IRES-driven translation, known as IRES trans-acting factors (ITAFs). Many ITAFs are hnRNP 
proteins, including hnRNPs A1, C, D, I, E1/E2, K and L. Although the mechanisms of ITAFs in 
IRES-initiation are not fully understood to date, these ITAFs hnRNP proteins are generally 
presumed to enhance the binding between IRESs and components of the translational apparatus (i.e. 
canonical initiation factors and ribosomes) at a considerable distance from the cap structure (H. A. 
King, Cobbold, & Willis, 2010). For BAG-1 mRNA, the IRES activity is promoted by the 
association with hnRNPs I and K. Mutational analysis of IRES-binding site reveals that hnRNP K 
remodels the RNA structure, enabling the internal access of the ribosomal complex, while hnRNP I 
is critical to form the pre-initiation complex (Pickering, Mitchell, Spriggs, Stoneley, & Willis, 
2004). In human breast tumour cells, hnRNP C competes with HuR protein for the 5' UTR binding 
site of the type I insulin-like growth factor receptor (IGF-IR) mRNA, eventually enhances IRES-
mediated translation initiation in a concentration-dependent manner (Meng et al., 2008). hnRNPs D 
and L promote IRES translation initiation of hepatitis C virus (HCV) RNA in different manners: 
hnRNP L specifically interacts with the 3' border of the HCV IRES in the core-coding sequence to 
improve translational efficiency (Hahm, Kim, Kim, Kim, & Jang, 1998), while hnRNP D interacts 
with the 5' border of IRES (stem-loop II) and up-regulates HCV mRNA translation (Paek, Kim, 
Park, Kim, & Jang, 2008). Interestingly, as an ITAF hnRNP A1 enhances the IRES-mediated 
expression the fibroblast growth factor 2 mRNA (Bonnal et al., 2005), cyclin D1 and c-myc mRNA 
(Jo et al., 2008) on one hand; but negatively regulates IRES-mediated X-linked inhibitor of 
apoptosis (XIAP) translation on the other hand (S. M. Lewis et al., 2007).  
 
1.2.2.6 Nucleo-cytoplasmic Shuttling 
 
Although most hnRNP proteins are restricted to the nucleus, several hnRNP proteins shuttle 
between the nucleus and cytoplasm, raising the possibility that hnRNP proteins could regulate gene 
expression in both compartments of the cell. hnRNPs C and U are mainly confined in the nucleus so 
that they dissociate from the RNP complex before it migrates out of the nucleus. On the other hand, 
hnRNPs A1, E and K keep company with RNAs all the way to the cytoplasm and shortly afterwards 
return to the nucleus (Gorlich & Kutay, 1999; Mili, Shu, Zhao, & Pinol-Roma, 2001).  
 
The co-localization of hnRNP A1 with poly(A)+ RNA in both the nucleus and cytoplasm indicates 
that hnRNP A1 and mRNAs are in the same cargo from the nucleus to the cytoplasm (Pinol-Roma 
& Dreyfuss, 1992). hrp 36, the hnRNP A1 ortholog in Chironomus tentans, has also been observed 
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to shuttle with mRNA through the nuclear pore to polysomes (Visa et al., 1996). Since mRNA is 
transported through nuclear pores as a RNP complex, the shuttling of hnRNP proteins is consistent 
with the role of mRNA carrier to the cytoplasm.  
 
A few factors are required to assist hnRNP proteins shuttle between nucleus and cytoplasm. Among 
them, transportin 1 (Trn1) and transportin 2 (Trn2) have been identified as the key regulators for 
hnRNP A/B protein shuttling (Rebane, Aab, & Steitz, 2004). In the cytoplasm, newly synthesized 
hnRNP A/B protein binds to transportin, and is recruited into the nucleus through the interaction of 
transportin with nucleoporin. Inside the nucleus, the subsequent association of transportin with Ras-
related nuclear protein (Ran)GTP disrupts the structure of the transportin-hnRNP A/B complex and 
releases hnRNP A/B proteins free for the upcoming nuclear functions. After importing hnRNP A/B 
proteins to the nucleus, transportin returns to the cytoplasm via the (Ran)GTPase system through 
the nuclear pore complex, preparing for the next import cycle.  
 
Given that many ITAFs are hnRNP proteins that shuttle between nucleus and cytoplasm, the 
subcellular localization of these hnRNP factors turns out to be crucial for their roles in regulation of 
IRES-dependent translation. The cytoplasmic localization of hnRNP A1 determines the intensity of 
the negative regulation on XIAP IRES translation. In osmotic shock when hnRNP A1 accumulates 
in the cytoplasm in responding to this cellular stress, XIAP levels decrease substantially, and 
knocking down hnRNP A1 abrogates the XIAP expression (S. M. Lewis et al., 2007).  More 
evidence comes from the cytoplasmic hnRNP A1-mediated IRES translations of the human 
rhinovirus-2 and the human apoptotic peptidase activating factor 1 (apaf-1) mRNAs. Cytoplasmic 
redistribution of hnRNP A1 after rhinovirus infection enhances rhinovirus IRES-mediated 
translation, whereas shortwave ultraviolet (UV-C) irradiation caused the cytoplasmic accumulation 
of hnRNP A1, limiting the UV-triggered translational activation of the apaf-1 IRES (Cammas et al., 
2007). In addition, the c-myc ITAF hnRNP C1/C2 translocates from the nucleus to the cytoplasm 
during the G2/M phase of the cell cycle, promoting the IRES-dependent translation of c-myc 
protein (J. H. Kim et al., 2003).  
 
It appears that the nuclear history of mRNAs affects their cytoplasmic future, which highlights a 
new concept in regulation of gene expression through the subcellular trans-localization of a nuclear 
mRNA-binding protein. Recent reports of hnRNP proteins have related the nucleo-cytoplasmic 
shuttling to the post-translational modification in response stress stimuli (Allemand et al., 2005), 
and suggested these post-translational modifications are dependent on the activation of signaling 
pathways (van der Houven van Oordt et al., 2000). Therefore, future experiments delineating the 
 44 
signaling pathways that direct modifications and shuttling behaviors of hnRNP proteins will 
provide a better understanding of the mechanisms not only in gene regulation but also in cellular 
survival during stress.  
 
1.3 hnRNP A/B subfamily 
 
The hnRNPs A and B were initially isolated and defined as the two abundant low-molecular weight 
proteins (i.e. hnRNPs A1 and A2/B1) from the 40S “core” hnRNP particles of HeLa cells. hnRNPs 
A1 and A2/B1 together make up more than 60% of the total protein mass of hnRNP particles 
(Beyer, Christensen, Walker, & LeStourgeon, 1977). Since more components in the 40S particle 
with sizes around 40 kDa have been identified similar to hnRNPs A1 and A2/B1 in amino acid 
sequence, these proteins are classified into the hnRNP A/B subfamily.   
 
1.3.1 Structural module of hnRNP A/B proteins 
 
Members of hnRNP A/B subfamily are individually encoded by four genes, i.e. HNRPA0, 
HNRPA1, HNRPA2B1, and HNRPA3. Table 1-3 lists the major members with the general 
knowledge of their protein characteristics. The “2×RRM-GRD” domain structure is shared for all 
hnRNP A/B members: a short N-terminus widely differing both in sequence and length; the highly 
conserved tandem RRMs joined by a small short linker; and a glycine-rich auxiliary domain in the 
C-terminus. Because each domain component has affinities for nucleic acids or proteins, the 
common “2×RRM-GRD” structure provides the physical basis for hnRNP A/B members to 
participate in nascent RNA packaging and the subsequent mRNA processing activities.  
 
1.3.2 hnRNP A/B protein isoforms 
 
Alternative splicing is the mechanism in which the exons of the primary transcript are separated and 
reconnected so as to generate alternative ribonucleotide arrangements. Protein isoforms are the 
products when the transcripts of alternative splice-forms are translated. Alternative splicing not only 
expands protein variety from a single gene, but also effectively controls the relative expression of 
each protein isoform by switching between inclusion and exclusion of exon(s) to meet the 
biological demands.  
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In human, hnRNP A/B subfamily genes HNRPA0, HNRPA1, HNRPA2B1 and HNRPA3 are located 
on different chromosomes. Except for HNRPA0, the transcripts of the hnRNP A/B subfamily are 
subject to alternative splicing. HNRPA0 gene is intronless and solely encodes hnRNP A0 in low 
abundance (Myer & Steitz, 1995). There are three alternatively spliced transcripts arising from 
HNRPA1 gene: inclusion or exclusion of exon 7b gives rise to A1b or A1a isoform respectively 
(Buvoli et al., 1990), however ‘the isoform 2’ of hnRNP A1 which is missing the sequence of 203-
307 was only reported by the Mammalian Gene Collection Project Team without experimental 
confirmation (Gerhard et al., 2004). Though hnRNP A1a is the truncated form of full-length A1b, it 
is 20 times more abundant than A1b and participates in many cellular processes.   
 
HNRPA2B1 gene produces four transcripts with alternative combinations of exon 2 and 9 inclusion.  
hnRNP B1 is the canonical full-length form; exon 2 is spliced out in hnRNP A2 (Burd, Swanson, 
Gorlach, & Dreyfuss, 1989); and isoforms of hnRNPs A2b and B1b (also named as hnRNPs B0a 
and B0b ) miss exon 9 from hnRNPs A2 and B1, respectively (Kamma et al., 1999). For the 
HNRPA2B1 gene, the full-length B1 transcripts constitute only 5% of the total A2/B1 transcripts in 
HeLa cells; A2 by far is the most abundant form (Kozu, Henrich, & Schafer, 1995). Other minor 
forms of B0a/b are reported to express in a tissue- and developmental-specific manner (Matsui et al., 
2000). If transcripts of A1 and A2 are aligned according to the position of exons, the alternative 
splicing site of exon 9 in A1 virtually coincides with the position of exon 7b in A2 (Kamma et al., 
1999). However, the relative abundance of A1 and A2 transcripts shows the opposite: A1a excluding 
exon 7b is the majority, whereas A2 including exon 9 is more abundant. Inside the HNRPA2B1 
gene, the functional significance of exon 9 inclusion/exclusion has not yet been determined, but the 
region of 12 residues encoded by exon 2 clearly improves the association of host protein isoforms 
with telomeric ssDNA in vitro (Kamma et al., 2001).  
 
At the beginning of this project, there were two isoforms of hnRNP A3 identified from alternative 
splicing. The full-length A3a isoform contain all 10 coding exons. In the other form, A3b, exon 1 of 
HNRPA3 is spliced out, only leaving a start codon for translation initiation (Ma et al., 2002). The 
isoform study of hnRNP A3 is the major topic of this project.  
 
hnRNP AB was previously classified as a type C hnRNP for its co-migration with hnRNP C2 on 
SDS-PAGE (Celis, Bravo, Arenstorf, & LeStourgeon, 1986), but was later classified into hnRNP 
A/B subfamily because of its hallmark 2×RRM–GRD domain structure (Khan, Jaiswal, & Szer, 
1991). However, sequence-wise, hnRNP AB is more similar to hnRNP D type proteins 
(Akindahunsi, Bandiera, & Manzini, 2005).  The HNRPAB gene encodes four isoforms by 
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alternative splicing. Unlike the other A/B subfamily members, splicing events not only cause 
missing of exon fragment in the isoforms 3 and 4 (P. P. Lau, Zhu, Nakamuta, & Chan, 1997), but 
also made several frame-shifts that result in a 7-residue substitution from the position 26-32 (in 
isoforms 2, 3 and 4) and a replacement of two residues of ‘S’ and ‘P’ into a single residue of ‘A’ at 
the position of 164 (in isoforms 2 and 3) (Khan et al., 1991).  
 
1.3.3 Homology of hnRNPs A1, A2 and A3 
 
In evolutionary biology, homologs exhibit similar characteristics inherited from their common 
genetic ancestry (Fitch, 1970). In genetics, homologs are genes sharing a common genetic origin, 
based on the sequence similarity analyzed using bioinformatic techniques. Homologs are classified 
into two types: orthologs and paralogs, which have distinct and important evolutionary and 
functional connotations (Koonin, 2005). 
 
1.3.3.1 Orthology 
 
Orthologs are defined as “genes derived from a single ancestral gene in the last common ancestor of 
the compared species” (Koonin, 2005). A speciation event separates a single gene into divergent 
copies in individual species in the evolution process, resulting in the orthologs which are similar to 
each other. Even the definition of orthologs does not include its connection to biological function, It 
is essential that orthologs perform equivalent functions in the respective organisms, which is both 
theoretically plausible and empirically supported by considerable evidence(Koonin, 2005). 
 
Orthologous sequences provide useful information in taxonomic classification studies of organisms. 
The shorter evolutionary distance between organisms, the higher the level of similarity between 
ortholog sequences. Based on the crucial notion that one-to-one orthologs are functionally 
equivalent, an initial estimate is normally performed on newly sequenced gene. The functional 
prediction, obtained from comparing with the experimentally characterized one-to-one orthologs 
from model organisms, will be a guide leading to the further functional investigation on this novel 
gene.  
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1.3.3.2 Paralogy 
 
Paralogs are defined as “gene related via duplication” (Koonin, 2005). A gene in an organism is 
duplicated to occupy two or more different positions, and then the resulting derivatives are paralogs 
to each other. Paralogous genes often belong to the same species, but it is not necessary for the 
paralogs to be restricted in the same genome or at the same duplication timeframe leading to the 
emergence of new paralogs. More generally, evolution of paralogs, particularly in the context of 
lineage-specific expansions of paralogous families, may involve both sub-functionalization and 
neo-functionalization. Paralogous sequences provide useful insight to the way genomes evolve, as it 
reveals the root position of a phylogenetic tree (Holland, 1999). 
 
The definition of paralogy does not refer to biological function, but there are major functional 
connotations distinct from those of orthology. The general themes for paralogy are functional 
diversification and specialization, sometimes mechanically related. It could be explained that the 
selective constraints affect evolution of paralogs immediately after duplication in the sub-
functionalization mode; or the lack of original selective pressure allows the duplicated copy to 
mutate and accidentally hit on a new function in the neo-functionalization mode. In some rare cases, 
paralogs may retain the same ancestral function fixed in the genome due to the gene dosage effects. 
 
Collectively, it makes a more complex subject in bioinformatics: when homologous genes have 
been found from the genomes of different species, the functions could not be arbitrarily concluded, 
as they could be paralogs with sub- or neo-functional differentiations. 
 
1.3.3.3 hnRNPs A1, A2/B1 and A3 are paralogs 
 
The HNRPA1, HNRPA2B1 and HNRPA3 genes occupy different genomic locations. In Homo 
sapiens, their loci are 12q13.1, 7p15 and 2q31.2, respectively. As the most abundant members in 
hnRNP A/B subfamily, they not only share the typical structural modules, but also exhibit 
homology in protein identity. Table 1-4 collects data from ClustalW comparisons of the protein 
sequences of human hnRNPs A1, A2/B1 and A3.  
 
Inside the typical modules, it is obvious that the RRM 2 is a homologous region. Both RRMs of the 
hnRNP A3 have high amino acid identity (over 85%) with A1, however its GRD shares more 
resemblance with that of A2. After analyzing the exon structure and diversity of hnRNP A2, 
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Biamonti et. al. found that the intron/exon organization of the genes of HNRPA1 and HNRPA2B1 
are identical over the entire length. Therefore, it was proposed that the genes of the hnRNP A/B 
subfamily proteins are the consequence of a number of gene duplications (including the 
rearrangement of the tandem repeats) of an ancestral gene coding for a RNA-binding domain 
(Biamonti, Ruggiu, Saccone, Della Valle, & Riva, 1994). Later, the phylogenetic analysis of 
tandem RRMs of the 10 human proteins in the hnRNP A/B subfamily strongly supports this 
intragenic duplication theory. The results from unrooted consensus neighbor-joining tree agrees that 
hnRNPs A3 is evolutionarily closer to hnRNP A1, rather than hnRNP A2 (Akindahunsi et al., 
2005).  
	  
Table	  1-­‐4:	  Percentage	  of	  amino	  acid	  identity	  between	  hnRNPs	  A1,	  A2/B1	  and	  A3	  (%)	  
Region A1	  vs.	  A2/B1 A1	  vs.	  A3 A2/B1	  vs.	  A3 
Full-­‐length 65 72 69 
RRM1 77 89 76 
RRM2 85 86 82 
GRD 57 63 67 
 
  
In addition, the discovery of a pseudogene in the hnRNP A/B subfamily further supports the theory 
of gene duplication. With more and more pseudogenes being reported, has become a common 
phenomenon in the hnRNP A/B subfamily. As a non-functional replica, pseudogene shares the 
common ancestry with its functional counterpart followed by evolutionary divergence into separate 
genetic entities. There is a selective mechanism underlying gene duplication and loss. The duplicate 
genes with ‘successful’ functions are selected, fixed and maintained in the population. Conversely, 
many ‘unsuccessful’ duplicates remain in the genome as pseudogenes, characterized by an intact 
exon/intron structure and promoter sequence (Korbel et al., 2008). Numerous HNRPA1 
pseudogenes are reported in the human genome (Biamonti et al., 1989; Buvoli et al., 1988; Saccone 
et al., 1992), and HNRPA2B1 pseudogenes are identified in the mouse genome (Hatfield, 
Rothnagel, & Smith, 2002). The HNRPA3 gene has processed pseudogenes both in the mouse and 
human genomes (Makeyev et al., 2005).  
 
Collectively, the theory of gene duplication proposes that the contemporary HNRPA1, HNRPA2B1 
and HNRPA3 genes are vertically duplicated from one origin of the ancient gene and remain in the 
genome after evolutionary divergence. Matching perfectly with the concept of paralogy, HNRPA1, 
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HNRPA2B1 and HNRPA3 are paralogs to each other, however the percentage identities between 
them are not identical. The paralogy in genomic structure of HNRPA1, HNRPA2B1 and HNRPA3 
provide a lot of valuable information for unveiling the mystery of the newly-discovered hnRNP A3.    
 	  
 
Figure	   1-­‐4:	   	   Alignment	   between	   paralogs	   of	   hnRNPs	   A1,	   A2/B1	   and	   A3.	   For	   each	   protein,	   the	  exons	  of	  the	  coding	  region	  are	  aligned	  based	  on	  the	  actual	  length	  and	  the	  bar	  aside	  denotes	  the	  length	  of	  100	  bp.	  hnRNPs	  A1,	  A2/B1	  and	  A3	  are	  compared	   in	  their	   full-­‐length	   forms.	  Exons	  are	  depicted	   in	  boxes	  with	  numbers	  labeled	  underneath.	  Introns,	  3'-­‐	  and	  5’-­‐UTR	  regions	  are	  ignored.	  The	  dark	  green	  boxes	   represent	   the	   alternative	   splicing	   sites.	   In	   the	   background,	   the	   derived	   the	   protein	   domain	  shared	  by	  all	  three	  proteins	  are	  highlighted	  into	  colour	  rectangular	  boxes:	  RRMs	  in	  pink;	  GRDs	  in	  light	  green;	   and	   linkers	   between	   domains	   in	   yellow.	   ClustalW	   alignment	   of	   two	  RRM	   sequences	   of	   three	  paralogs	   demonstrates	   that	   they	   are	   highly	   homologous	   in	   RNA-­‐binding	   domains.	   The	   consistent	  intron/exon	  arrangements,	  the	  similar	  size	  of	  corresponding	  exons,	  and	  the	  matching	  RRM	  sequences	  all	  evidently	  supporting	  the	  gene	  duplication	  theory.   	  
 
1.4 hnRNP A2/B1 and the  “cis-trans” determinant 
 
In vertebrates, hnRNP A2/B1 is distributed in a wide range of tissues and cell lines, with especially 
high abundance in brain and testis (Hoek, Kidd, Carson, & Smith, 1998; Kamma et al., 1999). 
Different expression patterns are detected between hnRNP A2/B1 isoforms: isoform hnRNP A2 is 
expressed abundantly in the adrenal medulla and testis, while the hnRNP B1 is mainly observed in 
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skin (Kamma et al., 1999). In addition, this predominantly nuclear protein is also found in the 
cytoplasm as a component of RNP particles in oligodendrocytes and neurons (Dreyfuss, Kim, & 
Kataoka, 2002; Ma et al., 2002).  
 
Many intracellular events involving hnRNP A2/B1 have been reported. Among them, the most 
prominent role of hnRNP A2 is in RNA localization as a carrier of mRNA to the cytoplasm. In 
oligodendrocytes, hnRNP A2 has been intensively studied for cytoplasmic trafficking MBP 
mRNAs. During myelination in rat spinal cords, MBP mRNAs are specifically recruited to the 
cytoplasmic compartment to improve the local expression level of myelin proteins, resulting in the 
successful differentiation of oligodendrocytes into MBP-positive cells (Maggipinto et al., 2004). 
This specific mRNA localization is achieved by the “cis-trans ” determinant.  
 
A 21-nt segment (GCCAAGGAGCCAGAGAGCAUG) inside the 3' UTR of the MBP transcript, 
named hnRNP A2 response element (A2RE), was originally identified as the cis-acting element. It 
is necessary and sufficient to direct mRNAs to the appropriate cytoplasmic locations (Ainger et al., 
1997). Later, the segment length was reduced to 11-nt (underlined in the 5’ of A2RE sequence 
above) the minimal cis-element, A2RE11 (Munro et al., 1999). The localization pattern of myelin-
associated oligodendrocytic basic protein (MOBP) mRNAs adds further evidence for A2RE acting 
as a cis-element. MOBP has seven alternatively spliced transcripts, of which four contain an A2RE-
like sequence in exon 8b and the other three splice out this exon. The former four A2RE-inclusive 
transcripts are all enriched in the myelin compartment, while the lack of the A2RE-like sequence 
results in the other three splicing variants being retained in the oligodendrocyte soma (Gould et al., 
1999). An essential feature of cis-elements is that they can solely direct localization, independent of 
the adjacent RNA sequence. This also has been verified by the observation that GFP RNAs 
conferred transportability when fused with A2RE-like sequences in cultured oligodendrocytes, as 
effective as that of the native A2RE-containing mRNA controls (Munro et al., 1999). Not only the 
MBP mRNA 3' UTR contains an A2RE sequence, many other transported mRNAs also carry 
A2RE-like sequences, usually located in the 3' UTR, such as protamine 2, MAP2A, neurogranin, 
and glial fibrillary acidic protein (Ainger et al., 1997). It implies that the A2RE represents a general 
cis-element for RNA localization.  
 
When using immobilized A2RE sequence to isolate specifically binding proteins from rat brain, 
hnRNP A2 was found to be abundantly associated with this cis-element. UV cross-linking 
experiments confirmed the specific affinity of rat brain hnRNP A2 with the A2RE sequences in 
vitro. The potential role as a cognate trans-acting factor that hnRNP A2 plays in RNA trafficking 
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has been verified in vivo by the hnRNP A2 knockdown experiment in which cultured 
oligodendrocytes were treated with the anti-sense oligonucleotides of hnRNP A2. The expression 
level of hnRNP A2 drops significantly upon the inhibitory oligonucleotides treatment, 
simultaneously a correlated decrease in transported MBP mRNA to the peripheral myelinating 
processes is also observed in those oligodendrocytes due to the disrupted interactions between 
hnRNP A2 and A2RE (Munro et al., 1999). Furthermore, the specificity of the A2RE-hnRNP A2 
interaction has been validated that neither the single nucleotide mutant nor the randomly-ordered 
A2RE sequence can sustain the effective interaction, so that it abrogates the transport of 
microinjected mRNAs (Munro et al., 1999). Given the finding that many mRNAs containing 
A2RE-like segments are specifically recognized by hnRNP A2 and transported upon recognition, 
the “cis-trans” in particular “A2RE-hnRNP A2” determinant represents a general pathway targeting 
the mRNA to subcellular locations. 
 
However, the RNA trafficking pathway is an elaborate system consisting of many steps and each 
step is strictly controlled by multiple regulating factors. Carson (Carson & Barbarese, 2005) used 
neural cells as an RNA trafficking model to break the entire mRNA journey into five milestone 
stages: nuclear export, granule assembly, transport on microtubules, localization and translation. 
Figure 1-5 was drawn using Adobe Illustrator to portray each major step of the A2RE-mRNA 
trafficking in a schematic neural cell.  
 
1.4.1 Nuclear export 
 
As a major trans-acting factor, hnRNP A2 shuttles between the nucleus and the cytoplasm. In the 
cytoplasm, newly synthesized hnRNP A2 binds to transportin 1, and is imported through the 
nuclear pore into the nucleus (M. C. Siomi et al., 1997). After releasing from transportin inside the 
nucleus, hnRNP A2 specifically recognizes nascent A2RE-containing RNAs and binds to them on 
the transcription site, forming an export-competent mRNP complex (Erkmann & Kutay, 2004). 
Thus, the associated RNAs are designated to localize and the nuclear transport subsystem mediates 
exports of the A2RE-hnRNP A2 mRNP complex out of the nucleus through the nuclear pore. 
During the subsequent cytoplasmic steps, hnRNP A2 remains associated with the transport-
competent RNAs, escorting them to their ultimate destination (Carson & Barbarese, 2005).   
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Figure	   1-­‐5:	   Major	   steps	   of	   A2RE-­‐mRNA	   trafficking.	   The	   solid	   arrow	   line	   shows	   the	   path	   RNA	  molecules	   travel,	   from	  the	   transcription	  site	   inside	   the	  nucleus,	   through	   the	  NPC	  structure,	  over	   the	  microtubules,	  to	  the	  location	  where	  they	  are	  translated.	  The	  dotted	  arrow	  line	  depicts	  the	  sidetrack	  for	  
trans-­‐factors	  (i.e.	  hnRNP	  A2)	  returning	  to	  the	  nucleus,	  where	  the	  trans-­‐factors	  start	  preparing	  for	  the	  next	  round	  of	  mRNA	  trafficking	  cycle.	  Adobe	  Illustrator	  was	  used	  to	  draw	  this	  figure.	  	  
 
1.4.2 Granule assembly 
 
Once exported to the cytoplasm, the primitive A2RE-hnRNP A2 complex aggregates into a large 
intermediate particle, called RNA granule. Although the term of RNA granule defines a large group 
of entities, ranging from neuronal RNA transport granules to specific structures for the storages of 
mRNAs, assembly of RNA granule is in a sequence-dependent manner (Kiebler & Bassell, 2006). 
Assembly of A2RE-RNA granules is mediated by the specific binding of A2RE-hnRNP A2. Since 
many A2RE-RNAs contain several A2RE-like sequences, they are able to associate with multiple 
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hnRNP A2 molecules alone (Barbarese et al., 2013). High concentrations of hnRNP A2 are located 
in the nucleus, with hnRNP A2 molecules possibly present as dimers when bound to A2RE-RNAs 
(Carson, Cui, & Barbarese, 2001). In the cytoplasm, the level of hnRNP A2 is 20-fold lower than in 
the nucleus, which causes the dimer to dissociate and some of the bound hnRNP A2 molecules 
return to the monomer status (Brumwell, Antolik, Carson, & Barbarese, 2002). Thus, the free 
dimerization sites on the bound hnRNP A2 monomers are ready for re-dimerization reactions. 
Through the re-dimerization between the hnRNP A2 monomers bound to different RNA molecules, 
RNA aggregates into large uniform RNA granules (Carson & Barbarese, 2005). The RNA 
aggregation occurs straight after nuclear export, which also physically prevents RNA molecules 
from re-entering the nucleus.  
 
Not only RNA and hnRNP A2 molecules are assembled into the cytoplasmic RNA granule, other 
components are also recruited, such as the translation machinery (e.g. aminoacyl-tRNA synthases, 
elongation factors and ribosomal subunits) (Barbarese et al., 1995), molecular motors (e.g. 
conventional kinesin and cytoplasmic dynein) (Carson, Worboys, Ainger, & Barbarese, 1997), and 
linking molecules (e.g. tumor over-expressed gene protein) (Kosturko, Maggipinto, D'Sa, Carson, 
& Barbarese, 2005).  
	  
1.4.3 Transport on microtubules 
 
The cytoskeleton is required to deliver RNAs to their distal subcellular location in Drosophila and 
Xenopus. In mature oligodendrocytes, microtubules and microfilaments, but not intermediate 
filaments, make up the cytoskeleton network (Wilson & Brophy, 1989). Microtubules extend in 
bundles from the perikaryon to the processes, while microfilaments are present in a fine meshwork 
in the processes and myelin membranes (Kachar, Behar, & Dubois-Dalcq, 1986). For the trafficking 
pathway in the oligodendrocyte cytoplasm, the transport of A2RE-mRNAs occurs along the 
processes, whereas localization completes at the myelin membrane. Intact microtubules, but not 
microfilaments, are essential for transport of A2RE-mRNA granules (Carson et al., 1997).  
	  
Inside RNA granules, the molecular motors are assembled to facilitate the movement of RNA 
molecules. On the microtubule track, dynein and kinesin motors individually move the granules 
towards the minus end or plus end. With the driving forces heading to the opposite orientations, the 
actual movement of RNA granules containing both motors exhibits intricate bi-directional dynamics 
(Song, Carson, Barbarese, Li, & Duncan, 2003). The equilibrium of forces between kinesin and 
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dynein determines the overall direction of movement. For A2RE-RNA granules, the ultimate 
trafficking direction is from the perikaryon area towards the plus ends of microtubules in the cell 
periphery (Lunn, Baas, & Duncan, 1997). Given the fact that both motor molecules are observed in 
the granule, it evidently indicates kinesin overpowers dynein in controlling the movement (Carson 
et al., 2001). 
	  
The polarity of microtubules in mature oligodendrocytes is uniformly oriented on the separate end, 
however in neuronal dendrites microtubules have mixed polarity (Rakic, Knyihar-Csillik, & Csillik, 
1996). Therefore, the bi-directional transport of RNA granules turns out to be necessary to flexibly 
adjust the orientation when local circumstances change. Even in different cellular skeleton systems, 
the balance between “push” and “pull” forces from kinesin and dynein activities ensures RNA 
granules are correctly driven in one ultimate direction, heading to the final destination. Collectively, 
the opposite orientation-driven motors in the granule, the mixed polarities of microtubule track and 
the bi-directional nature of granule movement constitute a complicated transport subsystem (Gao, 
Tatavarty, Korza, Levin, & Carson, 2008). On the other hand, such a sophisticated subsystem 
enables the RNA granules to cope with variable conditions on their way to their functional sites, 
which might imply a universal mechanism not limited to neurons.  
	  
1.4.4 Localization and translation  
 
Although equipped with translation machinery, RNA molecules in the trafficking granule are 
translationally inactive throughout the transport stages. In oligodendrocytes and neurons, hnRNP 
E1, which is recruited into the trafficking granule through binding to hnRNP A2, suppresses 
translation of A2RE-mRNAs in transit (Kosturko et al., 2006). How hnRNP E1 suppresses 
translation inside A2RE-RNA granules is not clear, but hnRNP E1 inhibits translation of 
lipoxygenase RNA by blocking recruitment of the 60S ribosomal subunit in the erythrocyte system 
(Ostareck et al., 1997). In oligodendrocytes, this translational suppression mechanism ensures the 
synthesis of MBP only at the target myelination sites. The introduction of translational suppressor 
hnRNP E1 to trafficking granules regulates A2RE-RNA granules to be either transport-competent 
or translation-competent.  
 
On reaching their target destination, the RNA granules anchor on the microtubule end where they 
release the shuttling factors and become active for local translation. Only one or at most a few 
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polyribosomes are observed in myelin sites of oligodendrocytes (Barry, Pearson, & Barbarese, 
1996) and dendritic spines in neurons (Steward, Falk, & Torre, 1996) by electron microscopy. Since 
the number of polyribosomes stands for the number of translationally active RNA molecules, it 
suggests that A2RE-RNA complexes have been locally translated one at time (Gao et al., 2008). 
Although the mechanism of the exclusive transition from transport-competent to translation-
competent is not clear it is believed that the initiation of local translation requires highly 
cooperative removal of all translational suppressors (i.e. hnRNP E1) in each granule (Kosturko et 
al., 2006). In the subsequent step, hnRNP A2 itself functions as a specific activator of cap-
dependent translation of A2RE-RNAs (Kwon et al., 1999).   
 
1.5 hnRNP A3 identification 
 
With the recent advances in intensive studies of the core components of the hnRNP complex and 
extensive screening for RNA-binding proteins followed by proteomic techniques, hnRNP proteins 
continue to be discovered and identified. In 1993, the gene encoding hnRNP A3 was first isolated 
using PCR amplification with degenerate primers (Good, Rebbert, & Dawid, 1993). In the Xenopus 
genome, the hnRNP A3 gene encodes two copies of cDNA (accession #L02956 and #L02957), 
which share 94% and 96% identities at the nucleic acid and protein levels, respectively. The 
individual domains of the 2×RRM–GRD structure in Xenopus hnRNP A3 have been located by a 
pair-wise comparison with Xenopus hnRNPs A1 and A2. Closely related to hnRNPs A1 and A2 but 
with distinctive features, hnRNP A3 is classified into the hnRNP A/B subfamily.  
 
Before the protein sequences of hnRNP A3 in human and murine have been officially annotated in 
the Swiss-Prot database, a few reports of the identification of the novel hnRNP A/B members in 
human and murine cells had been published. A new polypeptide clone encoding a protein referring 
to hnRNP A/B family member other than A1 or A2 was identified from a human fetal brain cDNA 
library, and thereafter named Fetal Brain RNP (FBRNP) (Takiguchi et al., 1993). This polypeptide 
clone is the first reported hnRNP A3-like sequence in human. Later, two immunologically related 
protein B2 and mBx were detected in sera of patients with rheumatic autoimmune disease. Both 
proteins were identified to be the new members of hnRNP A/B family (Dangli et al., 1996). The 
mBx protein was subsequently reported to be abundant in murine cells, and the evidences of its 
molecular characterization revealed it as a new gene product, which is closely related to the 
Xenopus RNPA3 gene (Plomaritoglou, Choli-Papadopoulou, & Guialis, 2000). 
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In 2002, the cDNA sequences of hnRNP A3 were identified in rat and human, which revealed two 
hnRNP A3 variants from alternative splicing (Ma et al., 2002). The protein sequences encoded by 
HNRNPA3 are identical in Rattus norvegicus and Mus musculus, and differ by an absent 309G 
residue in Homo sapiens. The sequence of rat hnRNP A3 protein is 379 aa long and the alternative 
splicing of exon 1 in the N-terminus leads to two isoforms with masses of 38 and 41 kDa. These 
two mammalian hnRNP A3 isoforms closely correspond to the two Xenopus hnRNP A3 homologs, 
however the splicing in Xenopus occurs at the 3’ of the mRNAs, generating C-proximal part 
variations. Also reported in human, the predicted 269 aa FBRNP polypeptide matches hnRNP A3 
except for a few residues. The hypothetical FBRNP is a processed pseudogene located on 
chromosome 10, composed from a single exon with canonical start and stop codons and 
polyadenylation signal. However, the FBRNP proteins with predicted mass have never being 
reported, and its experimental evidences are still at transcript level. In contrast, human hnRNP A3 is 
derived from 11 exons spanning over 11 kb on chromosome 2.   
 
Orthologs of the individual hnRNP A/B family member are more conserved in sequence than 
paralogs of the same species (Han et al., 2010). Given the protein sequence similarity, the related 
murine mBx, human FBRNP and Xenopus hnRNP A3 are presumed to be A3 orthologs and their 
evolutionary distance might accounts for the sequence variations.     
 
 
1.5.1 Ambiguity of hnRNP A/B nomenclature 
 
Protein sequences of hnRNP A3 in human and rat have been identified in 2002 (Ma et al., 2002) 
and annotated in Swiss-Prot database since then. However, the A3-related proteins mentioned in the 
previous section were individually named under different nomenclatures, which bring ambiguity in 
protein identification and characterization. In this section, the reported proteins with hnRNP A/B 
characteristics but named under different nomenclatures are clarified with the consistent up-to-date 
hnRNP A/B nomenclature.  
 
When hnRNPs B2 and mBx were first time isolated by 2-D electrophoresis, they were named based 
on gel distances to the well-known hnRNP A1 and A2 of 40S hnRNP complex components (i.e. 
hnRNP B2 migrates close to hnRNP A1b and mBx sits on top of hnRNP A2 with the prefix ‘m’ to 
indicate the murine origin). The monoclonal 9H10 antibody specifically against hnRNP A1 species 
clearly established that hnRNPs B2 and A1b belong to immunologically distinct protein components 
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(Dangli et al., 1996). Through a detailed comparison of the hnRNP A/B proteins in nuclear extracts 
of human and murine origin, the abundant protein species mBx, which is only present in murine but 
not in human, has been verified to be an hnRNP A3 ortholog (Plomaritoglou et al., 2000). Thus, 
mBx and murine hnRNP A3 refer to the same protein entity; while hnRNP B2, as a protein entity 
immunologically distinctive to hnRNP A1b, has not been further defined.  
 
Autoantibody detection closely connects hnRNPs B2 and mBx to the hnRNP A/B subfamily. The 
autoantibody RA33 from sera of rheumatoid arthritis (RA) patients primarily recognizes hnRNP A2 
with mixed weak reactions with protein population corresponding in size to B2 and mBx hnRNP 
polypeptides (Steiner et al., 1992). The autoantibodies from sera of systemic rheumatic disease 
patients also provide evidence on immunological connections between hnRNPs A2, B2 and mBx 
(Dangli et al., 1996). Autoantibody 64b from the serum of a patient with SLE and Sjogren’s 
syndrome (SS) recognizes not only hnRNP A2/B1 isoforms, but also hnRNP B2. However, 
autoantibody 3806 from the serum of a SS patient specifically recognizes hnRNP B2 from HeLa 
cells as well as rat origin. In addition to hnRNP B2 in both cellular systems, autoantibody 4004 
from the serum of a SLE patient strongly reacts with the rat mBx polypeptides. These autoantibody 
detections demonstrated that autoantibody 4004 recognized an auto-epitope shared by the rat B2 
and mBx polypeptides, whereas autoantibody 3806 only targeted to an epitope unique to the B2 
polypeptide.  
 
Given the fact that hnRNP B2 is detected not only by anti-B2/Bx but also by the anti-A2(RA33) 
sera, hnRNP B2 is believed to be the major target autoantigen in human cells recognized by anti-
hnRNP A/B antibodies. Ambiguity exists in the literatures to classify hnRNP B2 as a variant of A1 
(Buvoli et al., 1990) or of A2 (Kamma et al., 1999). The conflict can also be found between the 
public protein databases: the latest NCBI database (http://www.ncbi.nlm.nih.gov, 2015) annotates 
hnRNP B2 as an alternative name under the entry of hnRNP A1, whereas no entry of hnRNP B2 is 
included in Swiss-Prot database (http://www.uniprot.org, 2015) at all.  
 
In the hnRNP A/B family, knowledge of paired protein isoforms hnRNP A1/A1b and hnRNP 
A2/B1 has already been established. For the novel member hnRNP A3, two splicing variants of 
HRNPA3 gene also give rise to the paired isoform hnRNP A3a/A3b. New evidences in the 
differential expression of two hnRNP A3 isoforms present a clearer scenario: the unspliced hnRNP 
A3a which is common to both human and murine; and the spliced hnRNP A3b (mBx) is the major 
isoform, mostly found in rat and mouse (Papadopoulou, Boukakis, Ganou, Patrinou-Georgoula, & 
Guialis, 2012). Hence, historical name of mBx can be accurately updated into hnRNP A3b isoform.  
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1.5.2 hnRNP A3 researches up-to-date 
 
Sharing sequence similarity and 2×RRM–GRD structural module in the hnRNP A/B subfamily, 
hnRNP A3 was initially investigated in comparison with its well-studied paralogs hnRNP A1 and 
A2. Although the structural and functional mysteries of hnRNP A3 are largely unsolved, more and 
more participations of hnRNP A3 in cellular events are revealed by recent studies. 
 
The involvement of hnRNP A3 in cellular functions (summarized in Table 1-5) can be fit in two 
categories: either by direct binding to the target sequences or in association with other hnRNP 
components in a large complex. The repertoire of A3-specific nucleic acid sequences includes 
A2RE in the 3’-UTR of MBP mRNA, AU-rich element (AURE) in the 3’-UTR of COX-2 mRNA 
(Cok, Acton, Sexton, & Morrison, 2004), the G-quartets structure of the single-stranded telomeric 
repeats d(GGCAG) and d(TTAGGG) (Tanaka et al., 2007) or the higher order structure formed by 
d(CGG) triplet repeats (Nakagama et al., 2006), the stem-loop structure in the age-related increase 
element (AIE) RNA (Hamada, Kurachi, & Kurachi, 2010), and GGGGCC repeats in the regulatory 
region of mutant C9orf72 gene (Mori et al., 2013). These sequences differ in nucleotide order and 
secondary or tertiary structure, and their specific affinities to hnRNP A3 reflect the multi-task 
nature of hnRNP A3. Therefore, through the direct binding to DNA/RNA, hnRNP A3 played a 
broad spectrum of regulatory roles, like its paralogs hnRNPs A1 and A2. The direct binding enables 
hnRNP A3 specifically recognise and pickup the target sequences from a pool of transcripts, then 
escort or mediate the sequences at different stages of RNA metabolism, including mRNA 
packaging, splicing, trafficking, stability and degradation. In the review of nuclear functions played 
by hnRNP A/B proteins (He & Smith, 2008), the sequence repertoire of hnRNP A3 is the smallest 
in comparison to A1 and A2. However, it is believed that A3’s repertoire is expanding when more 
specific sequences will be revealed in direct association with A3 in a particular cellular mechanism 
in the near future.  
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Other than the direct binding to the nucleic acid sequence, hnRNP A3 participates in many cellular 
activities as a component in a regulatory complex, such as hnRNP or mRNP complexes. Each 
hnRNP or mRNP complex is a large network of protein-protein interactions, by which the core 
proteins (hnRNPs A/B and C) facilitate the incorporation of the less stably associated hnRNP 
proteins (D–U) into the complex. In particular, the roles of hnRNP A3 are speculated to facilitate 
assembly and stability inside the hnRNP complexes. A few in vitro experiments have provided 
evidences of hnRNP A3’s role in the specific hnRNP/mRNP complexes. Pull-down assays on the 
extracts of mouse embryonic fibroblast cells showed that it was hnRNP A3, neither A1 nor A2/B1, 
interact with HuR in an RNA-independent manner (Papadopoulou, Patrinou-Georgoula, & Guialis, 
2010). HuR is a ubiquitously expressed RNA-binding protein, which specifically binds to mRNA 
containing 3’-UTR ARE elements (Lu & Schneider, 2004). HuR is also reported as a regulatory 
protein in mRNA stability/translation inside hnRNP complexes (Papadopoulou et al., 2010). More 
recent, in vitro assays were carried out by the same group to investigate the interactions of the 
auxiliary domain of hnRNP A3 with endogenous hnRNP proteins (i.e. A1, A2, A3 itself, L and M) 
from nuclear and cytoplasmic fractions (Papadopoulou et al., 2012). The pull-down assays followed 
by Western blotting confirmed the direct protein-protein interactions between hnRNP A3 with the 
testing endogenous hnRNPs in both cellular compartments. Therefore, hnRNP A3 can form both 
homo- and hetero- hnRNP complexes insensitive to RNase digestion. In particular, the associations 
of hnRNP A3 with L and M are more stable than with hnRNP A/B proteins under the stringency 
wash.  
 
A spliceosome is a large complex composed of small nuclear RNAs and a range of associated 
protein factors. The major hnRNP A/B proteins A1, A2, and A3 are among the few hnRNPs 
detected from human spliceosomal complexes at different splicing stages (Gulesserian, 
Engidawork, Fountoulakis, & Lubec, 2003; Z. Zhou, Licklider, Gygi, & Reed, 2002). However, 
incorporation of hnRNP A3 in the spliceosome is limitedly reported in literature due to its low 
abundance or even absence in some spliceosomal complexes at later splicing stages. Till now, there 
is no direct evidence that hnRNP A3 regulating the process of RNA splicing; however, the dynamic 
abundances of A3 appearing in human spliceosome detected by semiquantitative proteomic analysis 
implies its important roles in the complex assembly and stability (Agafonov et al., 2011).  
 
The responses of hnRNP A3 to different cellular stresses, stimuli and carcinogenesis have been 
investigated for more than a decade. In the protein kinase Raf-MEK-ERK pathway, the inhibitor 
PD98059 was found to reduce the expression of hnRNP A3b isoform in proto-oncogene c-JUN-
transformed rat fibroblasts (Bergman et al., 1999). Ethanol exposure during the early CNS 
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differentiation in mouse embryos quickly upregulated the expression of hnRNP A3 homolog ET4, 
resulting in an overexpressed region of the neural tube (X. Du & Hamre, 2003). The treatment of 
anti-proliferative glucocorticoid hormones (GCs) in the rat glioma cell line ST1 doubled the 
expression of hnRNP A3 in the nuclear fraction (Demasi et al., 2007). Recent researches have also 
cast lights on the expression changes of hnRNP A/B proteins during human carcinogenesis. In non-
small cell lung cancer, a parallel analysis was conducted on paired biopsy tumour/non-tumour 
tissues to profile the expression of hnRNP A/B proteins. The resultant tumour-to-normal ratio 
revealed that hnRNP A/B proteins were all regulated with a high frequency of overexpression. 
hnRNP A1 showed highest overexpression ratio (76%), followed by A3 (52%) and A2/B1 (43%) 
(Boukakis, Patrinou-Georgoula, Lekarakou, Valavanis, & Guialis, 2010). This is the first literature 
reporting the overexpression of hnRNP A3 during carcinogenesis. Later, overexpression of hnRNP 
A3 was observed from the late stage of colorectal cancer tissue by a new tool called two-
dimensional difference gel electrophoresis (2D-DIGE). This differential analysis implied a general 
tumour-promoting role of hnRNP A3 which positively regulates the transcription of many 
oncogenes in cancer cells (H. Shi, Hood, Hayes, & Stubbs, 2011). More recently, the transcriptional 
responses of hnRNP A/B proteins to the stresses (i.e. acidosis, hypoxia and serum deprivation) 
generated in a tumour microenvironment were reported (Romero-Garcia, Prado-Garcia, & Lopez-
Gonzalez, 2014). The comparison of transcript profiles between hnRNP A/B proteins showed the 
hnRNP A3 transcript was the least abundant yet the most constant in transcript level under all tested 
stress conditions in different lung tumour cell lines. In contrast, down-regulations were observed for 
hnRNP A0, A1, A2 and B1 in response under the same stresses. Therefore, down-regulation of 
other hnRNP transcripts reflected the stability of hnRNP A3 transcript, which might be regulated in 
a distinct mechanism in response to tumour stresses. 
 
1.5.3 Facts of hnRNP A3 involvement in A2RE-RNA localization 
 
hnRNP A3, with its specificity to A2RE and nucleo-cytoplasmic shuttling ability, participates in the 
canonical A2RE-hnRNP A2 localization pathway.  
 
In vitro pull-down experiments with A2RE immobilized on magnetic particles co-purify hnRNPs 
A1, A2 together with A3, and UV cross-linking electrophoretic mobility shift assays have 
demonstrated that the affinity of hnRNP A3 for the cis-element A2RE is independent of the major 
trans-factor hnRNP A2 (Ma et al., 2002). The A2RE mutational analysis and hnRNP A3 anti-sense 
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oligonucleotides experiments disrupt the association of A2RE with hnRNP A3, so that hnRNP A3 
is also a trans-factor in A2RE-RNA localization. Furthermore, biosensor assays deciphered the 
binding nature of two RRMs working on recombinant hnRNPs A2 and A3. Both proteins comprise 
one A2RE-specific domain with the other domain with less specificity (Shan et al., 2000). In regard 
to the dissociation constants for A2RE, biosensor assays indicate binding of hnRNP A3 is several-
fold higher than that of hnRNP A2. Although hnRNP A3 is more similar in sequence identity to 
hnRNP A1, selective binding of A2RE sequence prefers hnRNPs A2 and A3 to A1.  
 
On the other hand, in vivo observations have demonstrated that hnRNP A3 co-localizes with A2RE-
RNA along the neurites but few A2RE-RNA cargos engaged with both hnRNPs A2 and A3 (Ma et 
al., 2002). It implies that trafficking of A2RE-RNA does not require the interaction between 
hnRNPs A2 and A3, both play an important role in sorting and delivering mRNAs.       
 
1.6 Research Aims 
 
Unlike its most-studied and best-understood paralogs A1 and A2, hnRNP A3 had just been 
identified as a novel key component amongst the A2RE-binding proteins. The knowledge of 
hnRNP A3 is very limited at the time when this project commenced. The emerging of hnRNP A3’s 
involvement in many cellular functions raised a lot of structural and functional questions awaiting 
answers. A comprehensive characterization of hnRNP A3, the theme of this project, became 
essential to understand its roles in many biological mechanisms as well as its biochemical and 
biological relationship to its well-characterized paralogs A1 and A2.  
 
The overall aim of this project is to characterize the hnRNP A3 isoforms from the structure aspects, 
with the investigation of their functional variations, so as to establish the connection from the 
structural alternation to functional diversity between A3 isoforms. Since hnRNP A3 parallels 
hnRNP A2 in many facets, from the tissue distribution pattern to the nucleic acid binding specificity 
(Ma et al., 2002), the characterization of hnRNP A3 isoforms in this project was largely carried out 
by investigating A3 isoforms among the A2RE-binding proteins. Under the same experimental 
conditions, a close comparison of hnRNP A3 with well-characterized hnRNP A2 among the group 
of A2RE-binding proteins might unveil possible roles of A3 isoforms in A2RE-hnRNP A2 
trafficking pathway. In addition, both hnRNPs A2 and A3 are enriched when pulled down by the 
A2RE sequence, which is the only method could provide sufficient protein material for 
characterization. The scope of the project is defined into three parts: 
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1) Identification and characterization the hnRNP A3 isoforms from DNA level and protein 
level 
a. Inclusive PCR screening in search for additional alternatively spliced transcripts 
b. Protein isolation followed by mass spectrometry to identify the variation between 
isoforms 
2) Investigation of post-translational modifications of the hnRNP A3 isoforms 
a. 2-D peptide mass fingerprinting to identify all the A2RE-binding proteins and their 
isoforms 
b. Bottom-up proteomics to investigate phosphorylation, methylation and citrullination 
3) Studies of developmental changes and subcellular localization of the hnRNP A3 isoforms 
a. Real-time PCR to determine the changes of transcripts of hnRNP A3 isoforms in 
brain development 
b. Immunofluorescent staining on cultured neural cells to establish the cellular 
distribution of endogenous hnRNP A3     
c. Transfecting cultured neural cells with GFP-tagged hnRNP A3 constructs to observe 
the impact of exogenous hnRNP A3 in A2RE-RNA trafficking 
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Chapter 2. Experimental Methods 
 
Chemicals and reagents used in this project were at least of analytical grade, and the highest purity 
grade was used if available. The commercial suppliers of chemicals were among BDH Laboratory 
Supplies (Poole, UK), ICN Biomedicals INC (Costa Mesa, CA, USA), Sigma-Aldrich (Sydney, 
Australia), or other companies particularly stated along the method descriptions. Water mentioned 
in this section was fresh deionized H2O with MilliQ plus Ultra-Pure Water System (Millipore, 
Billerica, MA, USA). Sterilized solutions were prepared either by autoclaving for 20 min at 121°C 
at 1 bar or by filtering through a 0.22 µm cartridge filter (Millipore). The reagents and buffers for 
RNA work were made with water containing 0.1% diethyl pyrocarbonate (DEPC). The 
experimental methods described in this chapter were carried out solely by the author, except that the 
MALDI-TOF mass spectrometry system was operated and calibrated by Dr. Amanda Nouwens.  
 
2.1 Molecular biology 
 
The methodology of molecular biology was employed in this project to characterize hnRNP A3 
isoforms at DNA level as well as to construct the recombinant GFP vectors of the HNRPA3 gene. 
The subsequent protein structural studies in vitro and functional investigations in vivo were carried 
out on these constructed HNRPA3 gene products.   
 
2.1.1 RNA extraction 
 
Total RNA was isolated from 100 mg of fresh Wistar brain tissue or cultured cells using TRIzol 
reagent (Invitrogen, Mount Waverley, Australia). Procedures were exactly as described in the 
experimental manual of TRIzol reagent. The aspirated pellet containing RNA was resuspended in 
20 µl DEPC-treated water. RNA purity and concentration were determined by using a NanoDrop 
Spectrophotometer (Thermo Scientific, MA, USA) at the wavelength of 260 nm and by 
electrophoresis on 2% agarose gels.  
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2.1.2 DNA and RNA agarose gel electrophoresis  
 
DNA and RNA samples were separated by electrophoresis on 0.8-2% (w/v) agarose gels with the 
actual concentration adjusted according to the size of samples. Ethidium bromide (0.5 µg/ml) was 
added to the melt agarose gel solution prior to casting. Orange G agarose gel sample buffer (35% 
sucrose and 0.35% orange G sodium salt) was added to the samples and well mixed before loading 
samples on the gel. Electrophoresis was carried out for 20-40 min at 70-95 V. The gels was then 
visualized under an UV transilluminator.   
 
2.1.3 Reverse transcription and polymerase chain reaction 
2.1.3.1 Reverse transcription  
 
First-strand cDNAs were synthesized in the reverse transcriptase-polymerase chain reaction (RT-
PCR) on the MyCycle Thermal Cycler System (Bio-Rad Laboratory, Hercules, CA, USA). The 
reaction was initiated by heating the mixed solution of 2 µg extracted total RNAs, 10 nmol 
deoxynucleotide triphosphates (dNTPs) (Roche Applied Science, Sydney, Australia) and 250 ng 
oligo(dT)15 (Promega, Madison, WI, USA) at 65 °C for 5 min, followed by chilling on ice for more 
than 1 min. Then 200 U of reverse transcriptase from SuperScript III First-Strand Synthesis System 
(Invitrogen, Mount Waverley, Australia), 4 µl 5× first-strand buffer supplied with the transcriptase, 
and 2 µl 0.1 M DTT were added to the chilled reaction mixture and the reaction were resumed at 50 
°C for 1 h and finally terminated by heat-inactivation at 70 °C for 10 min.      
 
2.1.3.2 Primer design  
 
Oligonucleotide primers and probes used in this project were specifically designed for the target 
genes, otherwise directly purchased from commercial suppliers. Customized oligonucleotides were 
synthesized by GeneWorks (GeneWorks Pty Ltd, SA, Australia) and delivered as a lyophilized 
triethylammonium salt.  
 
In order to find possible splicing variations in the HNRPA3 gene, primer pairs were designed to 
screen the entire coding region of HNRPA3 gene through polymerase chain reactions (PCRs). The 
designing strategy is illustrated in Figure 2-1. In addition to primer pairs for screening alternative 
 70 
splicing of HNRPA3 gene, a few more primers were designed for applications of clone construction, 
DNA sequencing reaction and real-time PCR. Detailed primer sequences and the information of 
target amplicons are listed in Appendix 1. 
 	  
 
Figure	   2-­‐1:	   Schematic	   map	   of	   primers	   designed	   for	   alternative	   splicing	   screening.	   Primers	  designed	  to	  screen	  splicing	  variations	  of	  HNRPA3	  are	  indicated	  specifically	  to	  the	  amplification	  region.	  Exons	   of	   HNRPA3	   are	   illustrated	   as	   boxes	   and	   labeled	   with	   numbers	   above.	   The	   length	   of	   exons	  (except	   for	  the	  non-­‐coding	  exon	  11)	  and	  amplicons	   is	  proportional	   to	  the	   length	  of	  100	  bp	  bar	  (top-­‐right).	  The	  orange	  boxes	  represent	  UTRs	  and	  the	  blue	  box	  stands	  for	  the	  identified	  splicing	  fragment	  of	  exon	  1.	  The	   intron	   regions	   are	   simplified	   as	   connecters	  between	  exon	  boxes.	  The	  background	   light-­‐colored	  boxes	  of	  RRM1,	  RRM2	  and	  GRD	  indicate	  the	  corresponding	  regions	  of	  protein	  domains	  when	  
HNRPA3	  is	  translated.	  	  
 
2.1.3.3 PCR 
 
The MyCycle Thermal Cycler System (Bio-Rad Laboratory) was also used for PCR. The 50 µl 
standard PCR mixture included 200 nM forward and reverse primers, 0.2 mM dNTPs, 1.25 U of 
recombinant Taq polymerase (Invitrogen) and supplied Taq reaction buffer in a final 1 × working 
concentration. The required amount of template DNA varied for cDNA (0.5 µl of a RT-PCR 
product mixture), plasmid (0.2-10 ng), and genomic DNA (5-100 ng). Cycling conditions were 
optimized individually with the primer properties, amplicon size and polymerase efficiency. The 
standard PCR was started at a denaturing session for 5 min at 94-96 °C; followed by 20-35 cycles 
of the amplification session of denaturation at 94-95 °C for 15-30 sec, annealing at 55-65 °C for 30 
sec, and extension at 65-72 °C for 1-2 min per kb of the amplicon; and completed by an extension 
session at 65-72 °C for 7 min. 
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2.1.4 Plasmid selection 
 
A few plasmids, as illustrated in Figure 2-2, were selected to clone the HNRPA3 gene into 
prokaryotic and mammalian expression systems. pGEM-T Easy vector system (Promega) was used 
for directly cloning PCR products. The single T overhang at the 3’ insertion site not only efficiently 
improves the ligation to PCR products, but also prevents the vector from self-circularization. The 
pET-30a(+) vector system (Merck Novagen, Darmstadt, Germany) was used for cloning and 
producing protein products of the target gene in a large scale. The recombinant protein products 
feature with His•Tag, which can be easily purified by one-step immobilized metal ion affinity 
chromatography on nickel or cobalt. A pEGFP vector system (BD Biosciences Clontech, NJ, USA), 
including vectors of pEGFP-N1 and pEGFP-C1, was used to fluorescently label clones of target 
gene. When transfected into mammalian cells, the recombinant fusion protein could be located in 
vivo by observing the green fluorescence tag upon expression. The vectors of pEGFP-N1 and 
pEGFP-C1 only differ in the position of a reporter gene, in which pEGFP-N1 fuses the target gene 
to the N-terminus of EGFP in frame, while pEGFP-C1 fuses to the C-terminus. Given that the 
orientation of reporter gene in the fused constructs virtually has no impact on the expression and 
functionality of cloned gene, both constructs should demonstrate the same expression pattern of the 
fusion protein when transfected independently. 
 
2.1.5 Restriction enzyme digestion and ligation  
 
Purified DNAs were digested with an appropriate endonuclease (New England Biolabs, Ipswich, 
MA, USA) at a ratio of 2-5 U/µg of DNA. Double restriction digestions were performed 
simultaneously only if both reaction buffers were compatible, otherwise in a sequential manner. In a 
sequential double digestion, one endonuclease was added at a time for single digestion, followed by 
a DNA precipitation ready for the second digestion under different buffer conditions.   
 
Before ligation, vectors and insert DNAs were checked by agarose gel electrophoresis and purified 
from gels using QIAquick gel extraction kit (QIAGEN, Melbourne, Australia). To prevent self-
ligation, 1-2 U calf intestinal alkaline phosphatase (CIP) and the buffer 3 (New England Biolabs) 
were added to 1-2 µg vectors followed by 1 h incubation at 37 °C. The standard ligation mixture, 
made up of DNA fragments, 1-5 U T4 DNA ligase (Promega), and supplied ligation buffer with 1 × 
working concentration, was incubated for 2 h at room temperature or overnight at 4 °C. The ligation 
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mixture then was ready for the transformation of heat-shock competent cells, or needed to be 
precipitation-purified before electroporation.  
  
  
Figure	   2-­‐2:	   Restriction	   maps	   of	   plasmids	   used	   for	   cloning.	   Restriction	  maps	  with	   the	  MCS	   are	  indicated	  on	  each	  vector.	  Maps	  were	  cited	  from	  the	  experimental	  manuals	  supplied	  with	  the	  vectors.	  
 
2.1.6 Bacterial strain selection and Transformation 
 
Various strains of E. coli were chosen to clone genes with different purposes. Strains of DH5α (Life 
Technologies, Melbourne, Australia) and XL1-Blue (Stratagene, La Jolla, CA, USA) were used as 
hosts for blue/white screening, fast expanding copy number of transformed constructs and easy 
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plasmid extraction. BL21(DE3) (Stratagene, La Jolla, CA, USA) was chosen for high-level protein 
expression of target genes with easy induction. To achieve the optimal expression, BL21(DE3) host 
strains were transformed with T7 promoter-driven constructs (i.e. pET-30a(+) fused with HNRPA3 
clone) to improve the yield of the recombinant hnRNP A3 in this project.  
 
The closed-circular DNA constructs were transformed into competent cells of selected bacterial 
strains by electroporation or heat shock. Competent cells were electroporated with the purified 
plasmid constructs dissolved in water on the Gene Pulser MXcell Electroporation System (Bio-Rad 
Laboratory) at 1.8 kV, 200 Ω, and 25 µF, and immediately transferred to 1 ml SOC medium (2% 
Bacto-Tryptone, 0.5% Bacto-Yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM 
MgSO4, 20 mM glucose) to recover from transformation at 37 °C for 1 h. In the heat-shock 
transformation, the frozen competent cells (e.g. Stbl2 and JM109 cells) in glycerol stockswere 
thawed on ice, mixed with DNA, and incubated on ice for 30 min. Then the cells were heat-shocked 
in a 42 °C water bath for 25 sec for Stbl2 cells or 45 sec for JM109 cells. The heat-shock 
transformation was terminated by chilling competent cells on ice for 2 min, immediately followed 
by transferring those competent cells into 1 ml warm SOC medium with 1 h incubation at 30 °C for 
Stbl2 cells or 37 °C for JM109 cells. When the competent cells were recovered after incubation, 10-
200 µl of transformed cell culture were plated on LB-agar medium with appropriate antibiotics, 
ready for clone screening. 
 
2.1.7 Bacterial culture 
 
All the bacterial culture media were prepared at room temperature and autoclaved before 
inoculation. The liquid medium for culturing bacteria was Luria-Bertani broth (LB)  (1% Bacto-
Tryptone, 0.5% Bacto-Yeast extract, 0.5% NaCl pH 7.0), and the bacteria grew in LB medium at 37 
°C in the rotary shaking incubator Innova 4300 Incubator (New Brunswick Scientific, NJ, USA) 
with the speed at 220-250 rpm. The LB-agar medium (1.5% agar in LB, autoclaved and settled in 
the Petri dish) was routinely used to inoculate bacterial strains by streaking or spreading, and the 
LB-agar plates with inoculated bacterial strains were incubated at 37 °C in Sanyo MIR-series 
incubator (Sanyo Biomedical, IL, USA). Ampicillin and kanamycin, specific for vector screening, 
were added into the culturing media at a final concentration of 100 µg/ml and 30 µg/ml, 
respectively. For long-term storage, E. coli strains containing clones of interest were added into 
glycerol stock to make a final concentration of 15-25% (v/v) glycerol and kept frozen at -80°C.   
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2.1.8 Clone screening and DNA sequencing 
 
Blue/white screening applies to the vectors encoding a lacZ gene with an internal multiple cloning 
site, i.e. pGEM-T easy vector. LB-agar plates were treated with 50 µl X-Gal (20 µg/ml) and 30 µl 
100 mM isopropyl-β-D-thiogalactoside (IPTG) before the transformed competent cells were plated 
and incubated overnight at 37 °C. Then white colonies were selected individually proceeding to 
further clone verifications. For other vectors, a PCR screening was carried out to select the correct 
clones. A few single colonies were picked out from the overnight plates and dipped immediately 
into a PCR reaction mixture without template, followed by the amplification cycling. The PCR 
results were examined with agarose gel electrophoresis to select expected clones. A modified 
method of alkaline lysis was used for a quick screening after the first clone selection. 200 µl lysis 
buffer (0.2 M NaOH, 1% SDS) was added to 200 µl of bacterial culture and neutralized by addition 
of 200 µl 5 M potassium acetate (pH 5.0). The neutralized mixture was centrifuged at 16,000 × g 
for 3 min, followed by the plasmid DNA precipitation with an equal volume of isopropanol. After 2 
min centrifuging at 16,000 ×g, the pellet was aspirated and resuspended in 20 µl water. The 
plasmids of the expected size were determined after agarose gel examination, and the host bacterial 
culture was undergone further plasmid purification by miniprep. The correct clone insert was 
confirmed by DNA sequencing.  
 
The ABI BigDye Terminator Cycle Sequencing Kit (version 3.1)  (Applied Biosystems, CA, USA) 
was utilized for DNA sequencing reaction. Australian Genomic Research Facility (AGRF, 
Brisbane, Australia) provided services for cleaning up and resolving samples of the sequencing 
reaction products. A standard 20 µl sequencing reaction mixture included 2 µl BigDye Terminator 
chemistry, 4 pmol primer, and 5-200 ng of PCR product or 400-600 ng of plasmid DNA. The 
sequencing reaction started at 5 min denaturation at 94 °C, followed by 35 cycles of 96 °C for 10 
sec, 50 °C for 10 sec, and 60 °C for 4 min, and finalized by holding at 4 °C. Then DNAs in the 
reaction mixture were precipitated by adding 75% (v/v) isopropanol and the pellet was ready for 
submission to AGRF.  
 
2.1.9 Real-time PCR   
 
Real-time PCR was used to quantify the transcript level of alternatively spliced HNRPA3 gene 
during brain development. The reaction conditions (i.e. concentration of template DNA and 
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primers, incubation temperature and times, cycle number) were individually optimized prior to the 
quantification reactions.  
 
The template DNA was individually diluted by 1/2, 1/4, 1/8, 1/16, and 1/32. Then reactions using 
this serial of diluted templates were accommodated on a 384-well-plate and carried out 
simultaneously in ABI PRISM 7900HT Real Time PCR System (Applied Biosystems). The 
standard 10 µl reaction mixture was made of 5 µl SYBR Green PCR Master Mix (Applied 
Biosystems, Scoresby, Vic, Australia) or FastStart Universal SYBR Green Master ROX (Roche), 2 
µl diluted template DNA and 1 µl H2O. The PCR program started at the denaturation stage at 95 °C 
for 10 min; followed by 45 cycles of two-step-amplification at 95 °C for 15 sec and 60 °C for 1 
min; terminated by the dissociation stage at 95 °C for 2 min, 60 °C for 15 sec and 95 °C for 15 sec.   
 
When the PCR program was finished, the PCR products were examined by 2% agarose gel 
electrophoresis. The SDS 2.2.2 software (Applied Biosystems) was used to analyze the real-time 
data recorded by the system.  
 
2.2 Proteomics 
 
In order to identify the structural difference between hnRNP A3 isoforms at the protein level, 
proteomic methodology was applied, in particular mass spectrometry (MS) was used in concert 
with the protein separation methods. The “bottom-up” strategy was adopted for this project, in 
which purified proteins were subjected to proteolysis, generating peptide products to be analyzed by 
peptide mass-fingerprinting (PMF). The workflow of the bottom-up approach is illustrated in Figure 
2-3. In addition, the characterization of intact hnRNP A3 protein was carried out through reverse-
phase high-pressure liquid chromatography (HPLC), liquid chromatography mass spectrometry 
(LC/MS), two-dimensional gel electrophoresis (2-DE) and Western blotting.    
	  
2.2.1 Protein extraction 
 
Wistar rat (male or female) brain tissue or monolayer-cultured cells were homogenized in a hand-
held Dounce homogenizer over ice in an equal volume (w/v) of freshly prepared ice-cold protein 
extraction buffer (20 mM HEPES, 0.65 M KCl, 2 mM EGTA, 1 mM MgCl2, 2 M glycerol, 14 mM 
β-mercaptoethanol, 0.5% IGEPAL CA-630, 12 mM deoxycholic acid, 1 mM PMSF, pH 7.4) with 
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the presence of a protease inhibitor cocktail (Sigma-Aldrich) diluted in 1/20 (v/v). The homogenate 
was centrifuged at 13,000 × g for 45 min at 4 °C. The top two layers of supernatant, the aqueous 
phase containing soluble brain proteins, was collected and either used immediately or flash-frozen 
in liquid nitrogen in 1 ml aliquots and stored at -70°C. The protein concentration of the extract was 
determined using the Bradford protein assy. 
	  
 
Figure	  2-­‐3:	  Flow	  Chart	  of	  The	  Bottom-­‐Up	  Proteomics	  
 
  
2.2.2 Affinity purification of RNA-binding proteins 
 
All biotinylated oligoribonucleotides were synthesized by GeneWorks (Adelaide, Australia) and the 
manufacturer specified concentration and purity were checked with the NanoDrop 
Spectrophotometer (Thermo Scientific, MA, USA) at the wavelength of 260 nm. 
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A2RE-binding proteins were isolated from fresh soluble lysates (from rat tissue or cultured cells) by 
affinity purification. In a standard assay, a 50 µl suspension of streptavidin magnetic particles 
(Roche) was washed three times with 700 µl Binding Buffer TEN100 (10 mM Tris-HCl, 1 mM 
EDTA, 100 mM NaCl, pH 7.5) and incubated with 1.5 µg biotin-labeled nucleic acid probe in 250 
µl Binding Buffer TEN100 for 10 min at 4 °C. After the incubation period, the particles were washed 
twice with 700 µl Wash Buffer TEN1000 (10 mM Tris-HCl, 1 mM EDTA, 1 M NaCl, pH 7.5) 
followed by the equilibration in 700 µl RNA-Protein Buffer (10 mM HEPES, 40 mM NaCl, 5% 
glycerol, pH 7.5). Supernatant was removed and 5 mg fresh protein lysates were applied to the 
beads to make 1 ml of binding mixture including 1× RNA-Protein Buffer with 100 mg/ml heparin. 
The binding mixture was incubated on a roller for 30 min at 4 °C, then followed by washing three 
times with 700 µl RNA-Protein Buffer until the supernatant turned clear. The proteins bound to the 
particles were eluted in 100 µl solution of 30% (v/v) acetonitrile (ACN) and 0.1% trifluoroacetic 
acid (TFA) (v/v) by heating for 10 min at 65 °C. 
 
2.2.3 Recombinant protein expression and purification 
 
Single BL21(DE3) colonies containing pET30a+/HNRPA3 constructs were inoculated in 1 ml LB 
broth with 30 µg/ml kanamycin, and incubated overnight at 37°C with shaking at 220-250 rpm. 
After reaching the A600 of 0.6, 50 µl of each culture was added into fresh 1 ml LB broth without 
antibiotics and incubated at 37°C for 2 h, followed by 2 h induction of IPTG at a final concentration 
of 1 mM. The IPTG concentration and induction time were optimized to be HNRPA3 gene-specific. 
Then, the induction was terminated by transferring cultures on ice.  
 
Recombinant protein was expressed as insoluble inclusion bodies, therefore denaturing conditions 
were applied for the purification. Harvesting induced cell culture was carried out by centrifugation 
of 20-25 ml of culture suspension at 1,000-3,000 × g for 15 min at 4 °C, and the pellet was 
resuspended in 2 ml of denaturing Equilibration/Wash Buffer (50 mM sodium phosphate pH 7.0, 6 
M guanidine-HCl, 300 mM NaCl) with gentle agitation until the solution became translucent. Then 
the translucent lysates were centrifuged at 10,000-12,000 × g for 20 min at 4 °C to pellet any 
insoluble material and the clarified supernatant was carefully collected.  
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Cobalt-based immobilized metal affinity chromatography (IMAC) TALON resin (Clontech, CA, 
USA) was used to isolate recombinant protein with a hexahistidine-tag. All procedures using 
TALON resin were performed at 4 °C to maintain protein stability and improve yield. 2 ml TALON 
resin suspension was thoroughly washed and equilibrated by 20 ml Equilibration/Wash Buffer. 
Then above clarified lysate was added to the resin with 20 min gentle agitation to facilitate the 
binding between the histidine-tag and the resin. After the centrifugation of the binding mixture at 
700 × g for 5 min, the resin pellet was washed with 20-40 ml Equilibration/Wash Buffer. The steps 
of centrifugation and pellet wash were repeated to wash off unbound proteins from the resin. Then 
the hexahistidine-tagged protein was eluted by 10 ml of Elution Buffer (45 mM sodium phosphate 
pH 7.0, 5.4 M guanidine-HCl, 270 mM NaCl, 150 mM imidazole). The eluted proteins were 
collected in 500 µl fractions.  
 
2.2.4 One- and two-dimensional electrophoresis 
 
Discontinuous SDS-PAGE was used to separate proteins, in which 5% “stacking gel” (170 µl 30% 
acryl-bisacrylamide mix, 130 µl 1.5 M Tris pH 6.8, 10 µl 10% SDS, 10 µl 10% ammonium 
persulfate, 1 µl TEMED, 680 µl H2O) and a 12% “separating gel” (2 ml 30% acryl-bisacrylamide 
mix, 1.3 ml 1.5 M Tris pH 8.8, 50 µl 10% SDS, 50 µl 10% ammonium persulfate, 2 µl TEMED, 1.6 
ml H2O) were prepared for a standard mini-gel (10 × 8 cm unit). A standard large gel (18 × 16 cm 
unit) with the same polyacrylamide concentration was cast with a three-fold amount of the mini-gel 
ingredient. Sample wells were formed with 1 cm deep in the stacking gel to accommodate up to 40 
µl protein samples. Hoefer SE 250 Mighty Small II (Hoefer Inc., MA, USA) and Bio-Rad Mini 
Protean III (Bio-Rad, CA, USA) units were used for the mini-gel electrophoresis, while the large 
gel electrophoresis was performed on Hoefer SE 600 Series Standard Vertical Electrophoresis Unit 
(Hoefer Inc.).  
 
Protein samples were mixed with 4 × SDS-PAGE sample buffer (62.5 mM Tris-HCl, pH 6.8, 2% 
(w/v) SDS (electrophoresis grade), 72 mM β-mercaptoethanol, 0.12% w/v bromophenol blue, 25% 
(v/v) glycerol) to dilute into 1 × loading concentration and optionally heated to 65°C for 10 min to 
denature proteins prior to loading. Gels were electrophoresed in SDS-PAGE running buffer (25 mM 
Tris-HCl, pH 8.3, 0.1% SDS (electrophoresis grade), 192 mM glycine) either at a constant 140 V 
(for mini-gels) or at a constant 25 mA (for large gels), until the bromophenol blue indicator dye 
reached the gel bottom. Molecular weight markers, Precision Plus Protein All Blue Standards (Bio-
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Rad) or SigmaMarker Wide Range (Sigma-Aldrich), were loaded into the gel along with protein 
samples to estimate the masses of separated protein molecules.  
 
After electrophoresis, gels were incubated in the Coomassie blue staining solution (10% acetic acid 
(v/v), 40% methanol (v/v), 0.1% Coomassie brilliant blue R-250 (w/v), filtered) for 1 h, followed 
by destaining in the Coomassie blue destaining solution (10% acetic acid  (v/v) and 40% methanol 
(v/v)) with freshly changing solution every 0.5-1 hour until the background stain was removed.  
 
Two-dimensional electrophorysis (2-DE) were carried out in two discrete steps: the first-dimension 
step of isoelectric focusing (IEF) to separate proteins according to their isoelectric points (pI); the 
second-dimension step of SDS-PAGE to separate proteins based on their molecular weight. 
 
Spots of bromophenol blue were added to the soluble protein lysis containing 15-30 µg proteins, 
followed by the centrifugation of 12,000 × g for 5 min at 4 °C. The clear protein supernatant was 
mixed well with 125 µl Rehydration Solution (9.5 M urea, 2% CHAPS (w/v), 1% DTT, 0.8%, 
Pharmalytes 6-11 (GE Healthcare)) and loaded into the IEF holder (GE Healthcare) between the 
electrodes. Immobiline 7 cm DryStrip with pH 6-11 (GE Healthcare) was placed in the IEF holders 
facing the protein mixture and then covered with 0.5 ml DryStrip Cover Fluid (GE Healthcare). The 
IEF holder was transferred to the IPGphor (GE Healthcare), with the setting of IEF program as 
described in Table 2-1. The program was continued at 8000 V until the total volt-hour reaching 
8080 Vh. After IEF, the DryStrip was ready for the immediate secondary-dimensional separation or 
stored at -70 °C in a screw-cap tube.   
  
Before separation in the second-dimension, DryStrips were equilibrated at room temperature 
immediately prior to the SDS-PAGE. The equilibration started by a 15 min incubation in 5 ml 
Equilibration Buffer (50 mM Tris-HCl pH 8.8, 6 M urea, 30% glycerol (v/v), 2% SDS, 0.002% 
bromophenol blue) with 10 mg/ml DTT and finished by a 15 min incubation in 5 ml Equilibration 
Buffer with 25 mg/ml iodoacetamide. Briefly rinsed with water, the individual DryStrip was then 
fitted into a 12% polyacrylamide gel, and air bubbles between the gel and DryStrip were removed.  
The DryStrip was stabilized in the sample well by covering with the warm agarose gel sealing 
solution (0.5% agarose (w/v), 0.002% bromophenol blue (w/v), 25 mM Tris-HCl, pH 8.3, 0.1% 
SDS, 192 mM glycine). The normal SDS-PAGE was carried out when the agarose gel sealing 
solution was set. 
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Table	  2-­‐1:	  IEF	  program	  for	  7	  cm	  DryStrip	  on	  the	  IPGphor	  
Voltage Time	   Type	  30	  V	   14	  h	   Sample	  application	  200	  V	   30	  min	   Step-­‐and-­‐hold	  500	  V	   30	  min	   Step-­‐and-­‐hold	  1000	  V	   30	  min	   Step-­‐and-­‐hold	  1000-­‐8000	  V	   30	  min	   Gradient	  8000	  V	   1	  h	  30	  min	   Hold	  
 
 
SYPRO Ruby protein stain (Bio-Rad) was usually applied to gels after 2-DE when proteins were 
separated into small spots that were hard to detect with Coomassie blue staining. After 
electrophoresis, the 2-DE gel was incubated in the fixing solution (40% methanol, 10% 
trichloroacetic acid) for at least 3 h, followed by 10 min washing three times with water. Then the 
2-DE gel was stained with 50 ml (for the mini-gel) or 150 ml (for the large gel) SYPRO Ruby 
protein stain with gently agitation for at least 3 h in the dark for maximal sensitivity. 2-DE gel was 
destained with the solution of 10% methanol and 7% acetic acid for 30-60 min to remove the 
background fluorescence. SYPRO Ruby-stained gels were visualized under a UV transilluminator 
and imaged by Typhoon Multipurpose Gel and Blot Imager (GE Healthcare) with the laser/filter 
setting of 488/550LP. 
 
2.2.5 Western blotting 
 
Protein samples resolved by SDS-PAGE were transferred to Immobilon polyvinylidene difluoride 
(PVDF) FL membrane (Millipore) in the Protein Transfer Buffer (20 mM Tris pH 7.4, 192 mM 
glycine, 10% (v/v) methanol) at 400 mA and 100 V for 1 h at 4 °C. The protein retention on the 
membrane was optionally checked by staining the membrane with Ponceau S staining solution 
(0.1% Ponceau S, 5% (v/v) glacial acetic acid) up to 1 h with gentle agitation and the stain was 
easily removed by washing with water. The transferred membrane was incubated in the blocking 
buffer of 3% (v/v) fish skin gelatin dissolved in phosphate-buffered saline (PBS) (137 mM NaCl, 
10 mM phosphate, 2.7 mM KCl, pH of 7.4) for 1 h at room temperature or overnight at 4 °C on a 
roller. The primary antibody and Tween-20 were added into to the blocking buffer to make the 
correct dilution of antibody and 0.1% (v/v) Tween-20. The incubation with the primary antibody 
lasted 1 h at room temperature, followed by washing with 0.1% Tween-20 in PBS for 5 min 
repeated four times. Then the membrane was incubated with fluorescence-labeled secondary 
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antibody, which was diluted in the fresh blocking buffer with 0.1% Tween-20 and 0.01% SDS, for 
30-60 min at room temperature. The incubation was terminated by washing with 0.1% Tween-20 in 
PBS for 5 min repeated four times. All procedures related to the fluorescence-labeled antibodies 
were performed in dark. Finally, the membrane was briefly rinsed with water to remove residual 
Tween-20 and scanned using an Odyssey infrared imaging system (LI-COR Biosciences, Nebraska, 
USA).     
 
The primary antibodies of Western blotting were the polyclonal antibodies raised in rabbit, 
specifically against peptides unique to human hnRNPs A1, A2/B1 and A3. The sequences of 
peptides synthesized (Minetopes, Melbourne, Australia) to raise antibodies are: SKSESPKEPEQLC 
(anti-A1), GGNFGFGDSRGGC (anti-A2/B1), VKPPPGRPQPDSGRRC (anti-A3 to the N-
terminus), GYDGYNEGGNFC (anti-A3 to the C-terminus), and KTLETVPLERKKRC (anti-B1). 
Antibodies were purified from the collected rabbit antisera by adsorption onto the corresponding 
immobilized antigen. The secondary antibodies of Western blotting were chosen from IRDye 
700DX Conjugated Affinity Purified Goat Anti-Rabbit IgG or IRDye 800 Conjugated Affinity 
Purified Goat Anti-Mouse IgG (Rockland, Gilbertsville, PA, USA) with the dilution factor of 
20,000, ideal for the dual fluorescent channels of the Odyssey system.  
 
2.2.6 Reverse phase-HPLC 
 
A2RE-binding proteins isolated from the brain tissue by affinity purification were further separated 
by reverse phase-HPLC, in which the stationary phase of Vydac 214TP C4 analytical column (250 
mm × 4.6 mM, 5 µm particle size) (Grace Davison, IL, USA) was selected in combination with the 
mobile phase of ACN and TFA solvents. The aqueous solvent A (0.1% TFA in H2O, filtered with a 
0.45 µm HPLC grade membrane) and the organic solvent B (0.1% TFA in ACN, filtered as above) 
were used to generate a linear gradient for chromatography. The method was optimized to separate 
A2RE-binding proteins with a 45% gradient change of solvent B over 60 min, as outlined in Table 
2-2. The absorbance was simultaneously recorded at the wavelengths of 280 and 214 nm.  
 
Prior to loading protein samples, the column had been equilibrated in an isocratic mode with the 
solvent condition of 5% ACN and 0.1% TFA for at least 1 h, followed by a blank preparation run 
with the same gradient method without any sample injection to obtain the starting conditions of the 
chromatography system. 
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Table	  2-­‐2:	  Method	  for	  separating	  A2RE-­‐binding	  proteins	  on	  HPLC	  C4	  analytical	  column	  Flow-­‐rate:	  1	  ml/min	  	  
Time	  (min) Solvent	  A	  (%) Solvent	  B	  (%) 0 95 5 5 95 5 65 50 50 66 0 100 69 0 100 70 95 5 
 
 
Affinity purified A2RE-binding protein sample was reconstituted in the solvent A to make the final 
concentration of 5% ACN and 0.1% TFA, followed by the centrifugation at 13,000 × g for 10 min 
at room temperature. The supernatant containing A2RE-binding proteins was injected into the 
reverse-phase HPLC column. The separated protein fractions were collected according to the 
changes of A214 and the retention time of each fraction was recorded.  
 
2.2.7 LC/MS 
 
LC/MS was used to accurately measure the molecular weights of intact A2RE-binding proteins. 
The liquid chromatography was conducted on Agilent 1100 Series LC and LC/MS System (Agilent 
Technologies, Santa Clara, CA, USA) with the stationary phase of the Zobax 300SB C3 column 2.1 
mm × 150 mm (Agilent Technologies) and the mobile phase of ACN and formic acid solvents (i.e. 
Solvent A: 0.1% formic acid, filtered; Solvent B: 0.1% formic acid in ACN, filtered). MS was 
carried out on API Q-Star Pulsar-I System with an IonSpray Source (Applied Biosystems), which 
was connected to the liquid chromatography instrument. 
 
A2RE-binding protein sample were lyophilized and redissolved in 2.5% formic acid solution. After 
brief centrifugation, 1.5 ml of protein sample supernatant was loaded to the MS system at a 
injection flow-rate of 40 µl/min. Then the acquisition method, as described in Table 2-3, was 
initiated. The running conditions were set up as: sprayer at 5000 V, focusing potential at 250 V, 
maximum pressure of 100 bar, and column temperature at 60 °C. The mass spectrometry data with 
the mass-to-charge (m/z) ratio range of 400-2000 m/z were collected by the Analyst QS software 
and analyzed with BioAnalyst 1.1 (Applied Biosystems).  
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Table	  2-­‐3:	  Acquisition	  method	  of	  LC/MS	  for	  A2RE-­‐binding	  proteins	  	  Flow-­‐rate:	  180	  µl/min	  
Time	  (min) Solvent	  A	  (%) Solvent	  B	  (%) 0 100 0 2 100 0 42 20 80 52 20 80 53 100 0 80 100 0 
 
 
2.2.8 Phospho-protein detection and dephosphorylation 
 
Phosphoproteins were detected in the polyacrylamide gels by staining with Pro-Q Diamond 
Phosphoprotein Gel Stain (Invitrogen). After SDS-PAGE, protein gel was incubated in 100 ml Fix 
Solution (50% methanol and 10% acetic acid) at room temperature with gentle agitation for at least 
30 min, followed by 10 min washing three times with water. In the dark with gentle agitation, the 
gel was stained by incubating in 60 ml Pro-Q Diamond Phosphoprotein Gel Stain for 60-90 min and 
destained in 80-100 ml Destain Solution (20% ACN, 50 mM sodium acetate, pH 4.0) for 1.5 h with 
solution freshly changed every 30 min. After washing twice with water for 5 min, gel with stained 
phosphoprotein was ready to be visualized on an UV transilluminator or be imaged by Typhoon 
Multipurpose Gel and Blot Imager (GE Healthcare). Containing both phosphorylated and 
nonphosphorylated proteins, PeppermintStick Phosphoprotein Molecular Weight Standards 
(Invitrogen) were usually loaded with protein samples on the polyacrylamide gel, serving as 
positive/negative controls for the detection as well as molecular markers.  
 
Calf Intestinal Phosphatase (New England Biolabs) was used to release phosphate groups from 
phosphorylated tyrosine, serine and threonine residues in the proteins. The 50 µl of standard 
reaction mixture of dephosphorylation included 2.5-5 µg proteins (without any phosphatase 
inhibitor), 1 × reaction buffer 3 (New England Biolabs), and 2.5-5 U phosphatase. The mixture was 
incubated at 37 °C for 60 min and then chilled on ice to terminate the reaction. 
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2.2.9 Protease digestion 
2.2.9.1 Tryptic digestion 
 
Proteins resolved by 1-DE or 2-DE were digested in-gel by trypsin. Protein bands/spots were 
excised from gels using a clean razor blade, placed in microcentrifuge tubes, and washed three 
times with 120 µl wash solution (25 mM ammonium bicarbonate pH 7.8 and 50% ACN) at 37˚C for 
5 min each. After washing, 50µl 100% ACN was added to gel pieces, incubated for 1 min, and 
removed. The gel pieces were dried on a SpeedVac system (Thermo Scientific) for 20 min. For 1-
DE protein samples, protein reduction and alkylation were required before tryptic digestion. The 
dried 1-DE gel pieces were incubated in 25 µl reducing solution (fresh 10 mM DTT in 25 mM 
NH4HCO3) at 60 °C for 30 min, and reducing solution was removed after the incubation. Then 40 
µl alkylation solution (fresh 100 mM iodoacetamide in 25 mM NH4HCO3) was added to gel pieces, 
followed by 30 min incubation in the dark. After alkylation solution was removed, the procedures 
of washing and dehydrating were repeated as above. The dried gel pieces were rehydrated in buffer 
containing 10 ng/µl sequencing grade modified trypsin (Promega) and 25 mM NH4HCO3 at 4°C for 
30 min, with the buffer volume just enough to cover the gel pieces. After rehydration, the gel pieces 
were added with the same volume of 25 mM NH4HCO3 and incubated at 37°C for 16 h to allow 
enzymatic digestion.  
 
HPLC-separated proteins were subject to be digested in-solution by trypsin. Proteins purified by 
HPLC were quantified with A280 on a NanoDrop Spectrophotometer before lyophilization. The 
lyophilized proteins were dissolved in 10 µl reducing buffer and incubated at 60 °C for 30 min. The 
protein solution was allowed to cool and subsequently added to 10 µl of alkylation solution, 
followed by 30 min incubation at room temperature in the dark. Then trypsin was added to the 
protein mixture to a final concentration of 10 ng/µl and tryptic digestion followed by incubation at 
37 °C for 16 h. 
  
2.2.9.2 Double protease digestion 
 
Proteins separated by 1-DE or 2-DE were digested in-gel with sequencing grade trypsin and Asp-N 
endoproteinase (Roche) to improve the peptide coverage for MS analysis. To avoid cross-lysis, the 
digestions by two proteases were carried out sequentially. The protein samples were initially 
processed with reduction, alkylation and tryptic digestion as described above, followed by 
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SpeedVac dehydration. The dried gel pieces were subsequently added to 8 µl of digestion buffer 
containing 10 ng/µl Asp-N and 25 mM NH4HCO3 and rehydrated at 4 °C for 30 min. After the 
rehydration, the gel pieces were topped with 22 µl digestion buffer of 25 mM NH4HCO3 and 
incubated at 37°C for at least 5 h. 
 
2.2.10 Peptide mass fingerprinting 
 
After in-gel proteolysis, peptides were extracted from the gel matrix and used for matrix-assisted 
laser-desorption/ionization- (MALDI) time-of-flight (TOF) MS. Firstly, the gel pieces in the 
digestion solution were centrifuged and the supernatant was collected. 8 µl of 50% ACN and 1% 
TFA was added to the gel pellet with sonication for 10min in a water-bath sonicator, followed by 
spinning and collection of supernatant: this was repeated twice to maximize the peptide extraction. 
The collected supernatants were combined and concentrated either by SpeedVac until the desired 
volume was reached or with ZipTipC18 pipette tips (Millipore). For phosphorylation identification, 
the phosphorylated peptides were enriched by loading to the TiO2 tip by pipetting the sample 
solution for 10 cycles. After washing with 50 µl of a solution of 50% ACN and 1% TFA, the 
peptides bound to TiO2 were subsequently eluted with 5 µL of ammonium phosphate (100 mM, pH 
8.5) buffer. Then, 1 µl concentrated peptides or TiO2 tip-enriched peptides were spotted onto a 
MALDI target plate, immediately covered by 1 µl matrix of α-cyano-4-hydroxycinnamic acid 
(CHCA, 10 mg/ml) dissolved in solution of 50% ACN and 1% TFA, and allowed to dry at room 
temperature prior to MS analysis.  
 
MALDI-TOF MS was carried out on a Voyager-DE™ STR Biospectrometry Workstation (Applied 
Biosystems). An external calibration was conducted using purified standards Glu-Fibrinopeptide B 
(peptide sequence: EGVNDNEEGFFSAR, monoisotopic molecular weight 1569.7 Da) and ACTH 
II (peptide sequence: RPVKVYPNGAEDESAEAFPLEF, monoisotopic molecular weight 2464.2 
Da), provided in the Applied Biosystems LC/MS Peptide/Protein Mass Standards Kit.  Mono-
isotopic peak lists within the range of 700-4000 m/z were generated from the calibrated spectra with 
Data Explorer (version 4.2) software (Applied Biosystems) and searched using MASCOT. 
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2.2.11 Citrulline identification 
 
Citrullinated proteins were identified with Anti-Citrulline (modified) Detection Kit (Millipore), 
which was a two-step process of adjusted Western blotting analysis. The first step was the 
modification of citrulline residues of proteins retained on the PVDF membrane, followed by the 
detection of modified citrulline residues. 
 
Modification buffer was freshly prepared by mixing 5 ml Reagent A (0.025% FeCl3, 24.5% H2SO4 
and 17% H3PO4) and 5 ml Reagent B (0.5% 2,3-butanedione monoxime, 0.25% antipyrine, 0.5 M 
acetic acid, supplied with the kit). After protein being transferred to PVDF membrane, the 
membrane was immediately placed into the modification buffer in a lightproof container for 
incubation at 37 °C overnight without agitation, followed by thoroughly washing with water for 4-5 
times. Thus, the citrulline residues were modified to form an ureido group adduct, ensured to be 
detected regardless of neighboring residues. The standard Western blotting procedure was applied 
afterwards. The membrane was blocked in freshly prepared 3% (w/v) nonfat milk in Tris-buffered 
saline (TBS) (25 mM Tris, 150 mM NaCl, 2 mM KCl, pH 7.4) with constant agitation for 30 min at 
room temperature, followed by overnight incubation in the solution of TBS-milk containing the 
primary antibody of anti-modified citrulline (supplied with the kit) diluted by 1:10,000 at 4 °C with 
agitation. After washing twice with water, the PVDF membrane was incubated in the TBS-milk 
solution containing 1:5,000 dilution of goat anti-rabbit HRP-conjugated IgG (supplied with the kit) 
for 1 h with agitation. The membrane was rinsed with water twice after incubation, followed by 
repeated 5 min washing with 0.05% (v/v) Tween-20 dissolved in TBS (TBST) for three times. After 
brief rinse with water, the blotting of modified citrulline residues were examined by enhanced 
chemiluminescence detection.          
 
The samples of the citrulline-rich protein, as positive controls for citrulline detection, were prepared 
from the hairs of Wistar rats.  Ethanol-cleaned hair was shaved off 21-day-old rats, weighed and 
immediately snap-frozen in liquid nitrogen. The frozen hair was finely ground and subsequently 
suspended in water to make the final concentration of 5% (w/v). The ground hair suspension was 
digested with 0.5% (w/w) trypsin at pH 8 and 37 °C for at least 3 h, followed by centrifugation at 
5,000 × g. The insoluble keratin and cell debris were removed, while the supernatant was clarified 
by filtration through a 0.65 µm Millipore filter. The resultant soluble digest contained a complex 
mixture of tryptic polypeptides as well as a citrulline-enriched fraction. 
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2.3 Cell biology 
 
According to the previous studies of A2RE-mRNA trafficking, oligodendrocytes and hippocampal 
neurons were cultured in this project to provide the cell systems to identify the involvement of 
hnRNP A3 in this pathway. The functional differences between hnRNP A3 isoforms were also 
investigated inside these cellular environments, in comparison with hnRNP A2/B1. The subcellular 
data of endogenous hnRNP A3 were collected through immuno-fluorescent detection, and 
transfections with GFP-tagged hnRNP A3 clones into neural cells were conducted to find out 
activities of exogenous hnRNP A3 isoforms. 
 
2.3.1 Primary neural cell isolation and cell culture 
 
In the central nervous system (CNS), the neural stem cells (NSCs) give rise to the three major 
neural lineages, i.e. neurons, astrocytes and oligodendrocytes (Figure 2-4). With the capacity to 
self-renew and to differentiate into the three defined cell types, the neural stem cells were isolated 
from newborn rat brain and manipulated with the genetic and epigenetic factors to specifically 
generate the primary cultures of oligodendrocytes and neurons for this project. With the presence of 
epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF), the populations of 
stem/progenitor cells were expanded and maintained in the form of neurosphere; while the absence 
of these growth factors stimulated the differentiation process into the three major CNS cell types.  
Therefore, the culturing procedures of neural progenitor cells were carried out in the order as: brain 
dissection, progenitor cell isolation, cell plating, proliferation and passage of neurosphere, and cell 
differentiation. 
 
2.3.1.1 Brain tissue dissection  
 
The head of newborn Wistar rat was stabilized on a dry Petri dish lid using straight tweezers on the 
snout of the animal, followed by a shallow cut from back to front in the skull using micro-scissors, 
along the midline to the point between the eyes. Additionally, four shallow cuts were made 
perpendicular to the initial cut. Two of the cuts were at the base of the brain and the others were 
behind the eyes to allow the skull folding back using curved tweezers. Then, the exposed brain was 
placed into a clean dish containing ice-cold DMEM with 15 mM HEPES, followed by the 
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separation of the hemisphere region from the remainder of the brain tissue using micro-scissors and 
fine-tip forceps. The excess white matter was carefully removed, and the meningeal membranes 
were peeled off from the individual hemisphere under a dissection microscope.  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
Figure	  2-­‐4:	   	  Neural	  stem	  cell	  differentiation	  
and	   neurogenesis.	   Neural	   stem	   cells	   (NSCs)	  are	   the	   self-­‐renewable	   and	   multipotent	   cells.	  They	   generate	   three	   major	   lineages	   in	   the	  nervous	   system,	   which	   are	   neurons,	  oligodendrocytes	   and	   astrocytes.	   	   The	   early	  neural	  precursors,	  directly	  derived	   from	  NSCs,	  are	   also	   self-­‐renewable	   and	   can	   be	  differentiated	   into	   lineage	   restricted	  progenitor	  cells.	  FGF	  and	  EGF	  are	  mitogens	  for	  self-­‐renewing	   activities	   of	   NSCs	   and	   neural	  progenitors.	  	  The	  glial	  progenitor	  cells	  give	  rise	  to	   mature	   oligodendrocytes	   and	   astrocytes,	  while	  the	  mature	  neurons	  are	  derived	  from	  the	  neuron	   progenitor	   cells.	   This	   diagram	   is	   cited	  from	   (Lie,	   Song,	   Colamarino,	   Ming,	   &	   Gage,	  2004).	  
 
 
2.3.1.2 Oligodendrocyte progenitor cell isolation and culture 
 
The method for preparing primary oligodendrocyte cultures was adapted from McCarthy and de 
Vellis (McCarthy & de Vellis, 1980), and the solutions and media mentioned in this subsection 
were modified by the Carson group (Song et al., 2003). 
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The meninges-free hemispheres were immediately transferred into Oligodendrocyte Plating 
Medium (DMEM with 5% newborn calf serum and 0.5% gentamicin), and cut into smaller slices 
using the micro-spring scissors. Slices were triturated 30 times using a 9-inch Pasteur pipette with 
the tip fire-polished to an opening of 0.7 to 0.9 mm diameter, avoiding air bubbles. The triturated 
cell suspension was centrifuged at 2000 rpm for 5-7 min, followed by removal of supernatant. The 
resultant cell pellet was resuspended into 5 ml of pre-warmed Oligodendrocyte Maintenance 
Medium (DMEM defined above with 5% newborn calf serum), and the viability and density of the 
cell suspension were measured with a hemocytometer. The culturing dishes had been pre-treated 
with 0.1 mg/ml poly-L-lysine (m.w. 30,000-70,000 from Sigma-Aldrich) solution for 1 h at room 
temperature, followed by washing three times with water and leaving for air-drying. Prior to plating 
the cell suspension, the dishes were moistureized with warm DMEM. Then, the cell suspension was 
plated at the final cell density of 1 × 106 cells per 6-cm-plate or 2 × 106 cells per 10-cm-plate, 
followed by culturing in a humidified 37 °C incubator with 5% CO2. The cell growth was checked 
daily and the medium (10 ml per dish) was changed at 3-4 day intervals.  
 
At the 14th day of cell plating, the primary culture consisted a confluent glial monolayer with the 
sparse distribution of oligodendrocyte progenitors on the top. This mixed brain cell culture was 
gently rinsed with the medium to remove unattached cells and debris, without disturbing cells on 
the surface layer. Then oligodendrocyte progenitors were dissociated from the layer of mixed cell 
types by washing with 0.05% trypsin-EDTA (Invitrogen). The culture was briefly rinsed with 1 ml 
of trypsin followed by vigorously rinsing with 5 ml of trypsin on the culture surface. The washed-
off cell suspension was collected and added with an equal volume of the maintenance medium, 
followed by centrifugation at 2000 rpm for 5-7 min. The supernatant was carefully removed without 
disturbing the invisible cell pellet and the pellet was resuspended in the pre-warmed maintenance 
medium. The cell suspension was plated onto a clean culturing dish not treated with poly-L-lysine. 
After incubation for 24 h, oligodendrocyte progenitors were loosely attached to the untreated poly-
L-lysine surface, so that they occupied the most superficial layer of the culture and were easily 
rinsed off from the growing surface. The washing media were collected and centrifuged at 2000 
rpm for 5-7 min, followed by the removal of supernatant.  
 
The cell pellet, containing a relatively homogeneous population of oligodendrocyte progenitors, 
was resuspended in N2 supplement medium and plated on 10-cm-plates coated with poly-L-lysine. 
The N2 supplement medium was prepared to differentiate the isolated oligodendrocyte progenitors 
and maintain their cytomorphology, which contained 0.01 µM hydrocortisone, 0.015 nM T3 (m.w. 
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673 from Sigma-Aldrich), 0.01 µg/ml biotin, 0.03 µM sodium selenite, 16.5 µg/ml insulin, 0.11 
mg/ml sodium pyruvate, 0.05 mg/ml transferin, 3.55 mg/ml HEPES, 0.5% gentamicin, dissolved 
into the nutrient mixture F-12 (DMEM/F12, Invitrogen) and filter-sterilized. The growth and 
differentiation stages of oligodendrocytes were checked daily and the medium was changed every 
3-4 days. 
  
2.3.1.3 Hippocampal neuron progenitor cell isolation and culture 
 
Brewer established the method for isolating and culturing neurons (G. J. Brewer, 1997) from 
postnatal rats to effectively reproduce and differentiate hippocampal and cortical neurons, 
independent of age. The neuron culture procedures of this project were adapted from his method.  
 
Under a dissecting microscope, twelve brain hemispheres were removed from newborn Wistar rats. 
The meninges were removed, and the hippocampi were dissected out and collected in a 35-mm 
Petri dish containing ice-cold minimum essential media (MEM, Invitrogen). The hippocampal 
tissues were finely diced with a scalpel blade, transferred into a 15-ml-tube, and triturated with 1 ml 
pipette at room temperature. The neural cells were dissociated by adding 3 ml 0.05% trypsin-EDTA 
followed with incubation in a water bath at 37 °C for 20 min. The mild trypsinization was 
terminated by adding 3 ml of 0.05% soybean trypsin inhibitor (Invitrogen) into the solution. The 
solution was centrifuged at 700 rpm for 7 min, and the supernatant was carefully removed without 
disturbing the cell pellet. The cell pellet was resuspended in 1 ml neurosphere medium, which 
included 45% MEM, 45% DMEM/F12 and 5% NeuroCult proliferation supplements (Stemcell 
Technologies, Vancouver, Canada). The cell suspensions was individually triturated 10 times (in 
about 30 sec) with 19- and 22-gauge needles, followed by gentle filtration through 0.4 µm cell 
culture filter (BD Biosciences). The viability and cell density was measured using a 
hemocytometer, and the filtered cell suspension was subsequently plated at the density of 5 × 105 
cells per well for a 6-well-plate. The plates for culturing hippocampal neurons had been coated with 
poly-L-lysine, as previously described. 
 
After the neural culture was incubated at 37 °C for 1 h, the medium was aspirated to remove the 
unattached cells and debris. Fresh, warm neurosphere medium with 20 ng/ml hFGF (Invitrogen) 
was added to the culture and the culture was returned to humidified incubator at 37 °C for overnight 
growing. In the neurosphere medium with hFGF, the NSCs formed characteristic neurospheres in 
suspension cultures, which could be produced over 10 passages with high cell expansion and 
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viability. Within 7 days, approximately 5-10 distinct colonies of cells with a neuronal phenotype 
could be seen in each well, and some cells with glial characteristics were also observed, but not 
appear to proliferate as rapidly as those with a neuronal phenotype). Glial cells adhered to the tissue 
culture dish more strongly than the neuronal precursors. Cells derived from the neurosphere/hFGF 
media produced a higher percentage of neurons at earlier passages, therefore differentiated 
hippocampal neurons were obtained mostly from first three passages of the neurosphere culture by 
gently washing neuronal precursors out with fresh medium.  
 
The almost homogenous neuronal precursor cells were replated into 25cm2 tissue culture flasks and 
allowed to proliferate in the neurosphere/hFGF media. Half of the culture media were changed with 
fresh neurosphere medium containing 20 ng/ml hFGF every 2-3 days. Cells from this source were 
found to maintain their phenotypes for up to six months in tissue culture.  
 
2.3.1.4 Cell line culture  
 
HeLa cells, with unpolarized cell morphology, were used in this project as control samples for 
transfection experiments. They were maintained in Dulbecco’s Modified Eagles Medium (D-MEM, 
Invitrogen) containing 10% newborn calf serum, 100 U/ml penicillin, 100 µg/ml streptomycin, 
HEPES, pH 7.4 at 37 °C in a humidified 5% CO2 atmosphere.  
 
2.3.2 Transfection 
 
Mammalian cell lines were plated with the density of 0.5-2 ×105 per 500 µl in absence of antibiotics 
on the day before transfection, in order to reach 90-95% confluence at the time of transfection. The 
transfection complexes were prepared at room temperature as: first dilute 200-400 ng plasmid DNA 
in 50 µl of Opti-MEM I Medium (Invitrogen) without serum by gentle mixing; then dilute 1.5 µl 
Lipofectamine 2000 (Invitrogen) in 50 µl of Opti-MEM I Medium with gentle mixing and 
incubated for 5 min, followed by combination of diluted DNA with diluted Lipofectamine 2000 to 
make a total volume of 100 µl with gentle mixing and incubation for 20 min. During the incubation, 
overnight growth medium was removed from cell culture and cells were washed twice with warm 
Opti-MEM I Medium prior to transfection. Then 100 µl complexes were applied to cells for each 
transfection sample. After gentle mixing by rocking the plate back and forth, cells were incubated at 
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37°C in a CO2 incubator for 18-48 hours ready for transgene expression. The transfection 
complexes were changed by normal growing medium after 4-6 h.  
 
For the cell-type specific primary culture (e.g. neurons and oligodendrocytes), the transfection was 
adjusted to enhance transfections. Cultured cells were 50-80% confluent at the time of transfection. 
The modified transfection complexes were prepared at room temperature as: first dilute 500 ng 
plasmid DNA in 100 µl of Opti-MEM I Medium without serum by gentle mixing, then 0.5 µl PLUS 
Reagent (Invitrogen) and was added and directly incubated for 5-15 min, followed by adding 1.25 
µl Lipofectamine 2000 with gentle mixing and incubation for 30 min. Then, the cells were washed 
and incubated for transfection as described above. 
 
2.3.3 Immunocytochemistry 
 
Coverslips with cell cultures growing on them were collected, gently washed twice with chilled 
PBS, and applied with 4% paraformaldehyde (PFA) dissolved in PBS for 30 min at room 
temperature to fix cells. Then coverslips with fixed cells were rinsed twice with cold PBS to remove 
the PFA, ready for immediate immuno-staining or storage at 4 °C. PBS containing 0.1% Triton X-
100 was applied to the fixed cells for 10 min permeabilization, followed by two washes with PBS. 
Then PBS containing 50 mM ammonium chloride was applied to cells for 10 min quenching, 
followed by two washes with PBS. After 30 min incubation in the fresh blocking buffer (0.2% BSA 
or 0.2% fish skin gelatin dissolved in PBS), cells were applied with the primary antibody diluted in 
the blocking buffer for 1 h incubation in a humidified chamber at 37 °C, followed by 5 min washing 
thrice with PBS. The secondary antibodies diluted in the blocking buffer were applied to cells with 
30 min incubation in the dark at room temperature, followed by 3x5 min washing with PBS. 
Finally, the coverslips were mounted with Vectashield containing 4’,6-diamidino-2-phenylindole 
hydrochloride (DAPI) (Vector Laboratories, CA, USA) before being visualized.  
 
2.3.4 Microscopy and digital image analysis 
 
Fluorescent images were taken with a ZEISS Axioplan 2 epifluorescence light microscope with a 
high-resolution Axiocam greyscale digital camera fitted with Zeiss HBO 100 mercury arc lamp and 
Zeiss filter sets 1, 10 and 15 and Plan-Apochromat objectives 63x 1.4 oil. Confocal images were 
taken with a Zeiss LSM 510 Meta confocal system fitted with a 1 mW Argon laser (458 nm, 
 93 
477nm, 488nm, 514nm), a 1 mW HeNe laser (543 nm) and a 5 mW HeNe laser (633 nm) using an 
Aixoplan 2 MOT upright optical microscope fitted with Zeiss filter sets 10, 15, 26 and 47 and Plan-
Apochromat objectives 63x and 100x 1.4 oil, DIC, 8/0.17, WD 0.18. Images were extracted using 
the Zeiss software and assembled in Photoshop CS. Co-localization plots were extracted from the 
Zeiss software. 
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Chapter 3. hnRNP A3 Isoforms 
3.1 Introduction 
 
From the Medical Subject Headings thesaurus database (MeSH) provided by U.S. National Library 
of Medicine (NLM), the term “protein isoforms” is defined as “different forms of a protein that may 
be produced from different genes, or from the same gene by alternative splicing”. The diversity of a 
protein consists of dynamically expressed isoforms which originated post-transcriptionally post-
translationally. This chapter is focused on the hnRNP A3 isoforms, targeting to answer the 
following questions: How many protein isoforms of hnRNP A3 are present in rat brain tissue? From 
the proteomic perspective, how different are these hnRNP A3 isoforms? From the genomic 
perspective, how many occurrences of alternative splicing for HNRPA3 gene? Therefore, the 
investigation of hnRNP A3 isoform was divided into three methodologies: isolation of A2RE-
binding proteins; proteomic mapping the A2RE-binding proteins; and transcript screening to search 
for the alternatively spliced HNRPA3 genes. 
 
Protein isolation 
 
hnRNP A2/B1 is over-expressed in many human cancer cell lines, and it is considered as a marker 
for early detection of cancers (Satoh et al., 2000). In this project, cultured HeLa cells containing 
upregulated hnRNP A2, together with rat brain, one of the tissues in which both hnRNPs A2 and 
A3 are abundantly expressed (Ma et al., 2002), were chosen as the sample sources providing protein 
paralogs. A modified rat brain procedure was developed (Friend et al., 2013) and used to pull down 
these proteins from cultured HeLa cells.  
 
The specific affinity of RRM domains for A2RE-containing nucleic acids makes it possible to 
isolate hnRNP A3 from rat brain and HeLa cells. Not only hnRNP A3, but also other hnRNP A/B 
family members containing similar RRM domains were pulled down by the A2RE sequence. After 
pull-down, A2RE-binding proteins from rat brain extracts and HeLa cell extracts were individually 
separated by SDS-PAGE and compared. The gel bands of hnRNPs A2 and A3 were subsequently 
verified by Western blotting. In order to separate hnRNPs A2 and A3, reverse-phase HPLC was 
used to obtain chromatographically separated and concentrated fractions for SDS-PAGE 
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visualization. Liquid Chromatography/Mass Spectrometry (LC/MS) was used to determine the 
masses of the intact A2RE-binding proteins.  
 
Proteomic mapping 
 
Proteomic analysis primarily aims at comprehensiveness and completeness of protein information. 
In this project, the investigation was narrowed down to a small group of A2RE-binding proteins, 
particularly focusing on paralogs of hnRNPs A2 and A3. Here the proteomic methods were carried 
out to achieve two objectives: firstly, mapping all the A2RE-binding proteins onto a two-
dimensional SDS-PAGE (2-DE) gel; secondly, analysing the profiles of hnRNPs A2 and A3 in 2-
DE gels. Hence, samples of total soluble protein extracts and purified A2RE pull-down proteins 
were used for 2-DE separation. The resultant gels containing different population of proteins before 
and after the A2RE affinity purifications were compared, targeting to the 34-40 kDa proteins. The 
identification of hnRNPs A2 and A3 was achieved by 2-DE Western blotting with the specific anti-
A2 and A3 antibodies. 
 
Transcript screening for alternative splicing 
 
All the reported isoforms of three paralogs hnRNPs A1, A2/B1 and A3, are the products of 
alternative splicing, which depicted in details in Figure 3-1. Inclusion or exclusion of exon 8 of the 
HNRPA1 gene gives rise to the isoforms of hnRNP A1b or A1a, respectively. For the HNRPA2B1 
gene, the four isoforms hnRNP A2, B1, A2b (B0a) and B1b (B0b) are encoded by the four 
transcripts alternatively spliced in the regions of exons 2 and 9 (Hatfield et al., 2002). In the 
HNRPA3 gene, exon 1 was the only identified site of alternative splicing (Ma et al., 2002).  
 
Protein isoforms with a variety of post-translational modifications (PTMs) give rise to diversity of 
hnRNP A3. Based on homology studies, a few groups have postulated that the area down to the 3’ 
end of the HNRPA3 coding region, in particular where the position is equivalent to exon 9 in 
HNRPA2B1 or exon 8 in HNRPA1, might contain alternative splicing sites (Makeyev et al., 2005). 
So far, no experimental data have been presented to validate this presumption. Therefore, PCR 
screening of HNRPA3 transcripts was carried out in searching for another conceivable sites of 
alternative splicing. Screening of the entire HNRPA3 cDNAs was necessary to determine the 
occurrences of alternative splicing, so that the number of hnRNP A3 isoforms can finally be 
determined, which will provide a clearer ground for the subsequent PTM studies. 
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Figure	   3-­‐1:	   Alternative	   splicing	   of	   hnRNP	   A/B	   protein	   mRNAs.	   hnRNP A/B protein mRNAs are 
depicted as aligned boxes of exons, labeled with numbers on top. The exon boxes are proportional to the 
actual length (scale bar = 100 bp). Intron Regions, 5'- and 3’-UTR are ignored. The dark green exon boxes 
represent the identified alternative splicing sites. For each of the hnRNP A/B gene, the alternatively spliced 
transcripts are specified with the protein isoforms they encode. In the background, the rectangular shades 
outline the encoded protein domains shared by hnRNP A/B proteins: RRMs in pink; GRDs in light green; 
and linker regions between domains in yellow.	  
 
 
 
3.2 Isolation of the A2RE-binding proteins 
3.2.1 One-dimensional gel electrophoresis of the A2RE-binding proteins 
 
Affinity purification (method described in Section 2.2.2) was used to isolate A2RE-binding proteins 
from rat brain extracts. A2RE11 (sequence: GCC AAG GAG CC) was identified as the necessary 
and sufficient sequence of the full-length 21-nt A2RE (sequence: GCC AAG GAG CCA GAG 
AGC AUG) to bind hnRNP A2 (Munro et al., 1999). In contrast, NS (sequence: CAA GCA CCG 
AAC CCG CAA CUG) was a randomly arranged oligonucleotide fragment with the same 
composition as A2RE. The NS sequence was used in this experiment as a negative control.  
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Figure 3-2 shows a mini SDS-PAGE gel of proteins recovered from the A2RE pull-down 
experiment. Parallel experiments were carried out individually by using each of uncoupled, NS- or 
A2RE11-coupled magnetic particles to isolate the A2RE-binding proteins from rat brain and HeLa 
cells. Only in the experiment with A2RE11, three major proteins were isolated, among which the 
36-kDa-protein (hnRNP A2) was prominent and two other proteins (37 and 39 kDa, hnRNP A3 
isoforms) were less abundant. However, A2RE11 was associated with more proteins when pulled 
down from the HeLa cell extracts. Among the isolated proteins from HeLa cells, the proteins with 
masses of 45 and 55 kDa were the most abundant. In the parallel experiments where proteins 
isolated by uncoupled or NS-coupled magnetic particles, the pulled-down proteins were much less 
abundant, none of which is similar to hnRNPs A1, A2 or A3 in size. For the experiments with 
uncoupled particles, proteins isolated from rat brain tissue and HeLa extracts were alike. These 
proteins bound directly to the magnetic particles in absence of any oligonucleotide, so that the 
binding was not a specific DNA-protein interaction.  	  
	  
Figure	   3-­‐2:	   Mini-­‐gel	   separation	   of	   eluted	   proteins	   from	   parallel	   pull-­‐down	   experiments.	   Rat	  brain	  extracts	  and	  cultured	  HeLa	  cell	  extracts,	  containing	  5mg	  proteins,	  were	   individually	  applied	  to	  the	  uncoupled,	  NS-­‐	  or	  A2RE11-­‐coupled	  magnetic	  beads	  in	  the	  pull-­‐down	  experiments.	  After	  washing,	  proteins	   bound	   to	   immobilized	   oligonucleotides	   were	   eluted	   off	   the	   beads,	   followed	   by	   SDS-­‐PAGE	  separation	  and	  visualization	  by	  Coomassie	  blue	  staining.	  The	  experimental	  conditions	  for	  each	  protein	  lane	  are	  specified	  in	  the	  coupled	  oligonucleotides	  (as	  on	  top	  of	  the	  gel)	  and	  the	  inclusion	  of	  100	  mg/ml	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heparin	  in	  the	  binding	  solution	  (at	  the	  bottom	  of	  the	  gel).	  The	  molecular	  masses	  are	  labelled	  on	  both	  sides	  along	  with	  the	  protein	  standards	  in	  kDa.	  	  
	  
 
On the other hand, NS-binding proteins from brain and HeLa extracts were not identical. Rat brain 
NS-binding proteins were resolved into a few weak protein bands; whereas 45 and 55 kDa proteins 
dominated the NS-binding proteins from HeLa extracts, in a similar pattern when immobilized 
A2RE11 was used. Other results (Dr. Lexie Friend personal communication) verified that the 45 
and 55 kDa proteins bind non-selectively to oligonucleotides, so that they could be pulled down 
with either A2RE11 or NS sequence.   
 
Among the parallel experiments, only immobilized A2RE11 can selectively isolate hnRNPs A2 and 
A3 from rat brain extracts. Although NS is the scrambled version of full-length A2RE, the same 
nucleotide composition cannot render NS the same binding capacity to hnRNPs A2 and A3. 
Therefore, A2RE-recognition takes place in a sequence-dependent manner. In addition, the optimal 
A2RE-specific interaction was only achieved in the presence of heparin. Because of its negatively 
charged nature, heparin minimizes non-specific DNA/RNA-protein interactions in protein isolation. 
In the pull-down experiment without heparin, a large amount of non-specific protein was prone to 
bind oligonucleotides, overshadowing the specific A2RE-binding proteins. 
 
The mini-gel bands in the hnRNPs A2 and A3 region were broad, and it is not certain how many 
proteins were clustered into one thick protein band. Thus, in order to completely separate proteins 
with approximate masses, particularly in the region where hnRNPs A2 and A3 reside, A2RE-
binding proteins were subject to large gel (18 × 16 cm) electrophoresis. Figure 3-3 is a large gel 
image of separated A2RE-binding proteins. 
 
The longer electrophoresis duration of large gels results in a clearer protein composition of A2RE-
binding proteins. Trace amounts of hnRNP A1, barely visible in the mini-gel, migrated apart from 
the prominent A2 band, sitting right below the A2 band in the large gel. Two isoforms of hnRNP 
A3, observed from mini-gel with the approximate masses of 38 and 40 kDa, were resolved into five 
individual bands. The band intensity of the bottom two was stronger than that of the top three. This 
observation leads to a few questions about hnRNP A3: How many protein bands belong to hnRNP 
A3? Among the protein bands of hnRNP A3, what is the cause for the mass variations between 
them? Therefore, Western blotting with A3-specific antibodies was used to clarify the various 
forms hnRNP A3. 
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Figure	  3-­‐3:	  Large	  gel	  separation	  of	  A2RE-­‐binding	  proteins	  from	  pull-­‐down	  assays. Panel	  A	  is	  the	  one-­‐dimensional	  mini-­‐gel	   of	   rat	   brain	  A2RE-­‐binding	   proteins.	   Panel	   B	   is	   the	   large	   gel	   (18	  ×	   16	   cm)	  image	   of	   same	   protein	   sample.	   Both	   gel	   panels	   were	   visualized	   by	   Coomassie	   blue	   staining.	   The	  molecular	  masses	  are	  indicated	  along	  with	  the	  standard	  proteins	  in	  both	  panels. 
 
3.2.2 hnRNP A3 identification by one-dimensional Western blotting 
 
Antibodies used in the project to identify hnRNPs A2 and A3 were previously raised in our 
laboratory. The hnRNP A2 antibody (αA2) was raised against the A2 peptide sequence 
RGGNFGFGDSRGGC, which appears in all four isoforms of hnRNP A2/B1 so that it theoretically 
blots all isoforms of A2 (Ma et al., 2002). The hnRNP A3 C-terminal antibody (αA3C) was against 
a peptide sequence GYDGYNEGGNFC near the C-terminus of A3, which is shared by both 
alternatively spliced isoforms. In contrast to αA3C, the hnRNP A3 N-terminal antibody (αA3N) 
was raised against a peptide sequence SKSESPKEPEQLC inside the alternative splicing region. 
Since this region is missing in the truncated A3 isoform, the αA3N antibody only blots the full-
length isoform, whereas the αA3C antibody detects both. 
 
Western blottings were carried out on one-dimensional gels to identify hnRNPs A2 and A3. In 
panel A of Figure 3-4, the total soluble proteins of brain extracts were separately blotted with αA2, 
αA3C and αA3N antibodies. αA2 blotted not only abundantly expressed hnRNP A2, but also the 
minor amount of hnRNP B1. When blotted with αA3C antibody, two major protein bands were 
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observed, clearly indicating they are the two isoforms of hnRNP A3. However, only one protein 
band was blotted with the αA3N antibody, which appears to be the full-length isoform 1. The 
blotting intensity of both hnRNP A3 isoforms in the total protein extracts is much lower than that of 
hnRNP A2. The identification of hnRNPs A2 and A3 among the group of A2RE-isolated proteins is 
demonstrated in the panel B. Applied with the same antibody, the differences of blots between the 
total protein extracts in the panel A and the A2RE-binding proteins in the panel B will reveal the 
changes of hnRNPs A2 and A3 before and after pull-down experiments. Although hnRNP A3 
isoforms were obviously enriched after purification, the blotting patterns in both panels are 
consistent.  
 
In combination with the A2 or A3 antibodies, each protein lane of gel-separated A2RE-binding 
proteins was double-blotted with the anti-Smith (Sm) antigen autoantibody (Y12) (ab3138, Abcam, 
Cambridge, UK). This antibody, first discovered in sera of patients with autoimmune disease, 
recognizes an epitope on some of the Sm proteins of the snRNP complex (Lerner, Lerner, Janeway, 
& Steitz, 1981).  
	  
Interestingly, the anti-Sm (Y12) autoantibody also appears to cross-react with each of the hnRNPs 
A/B (Friend LR, manuscript in preparation), and therefore has been used as a marker of the hnRNPs 
A/B, in this current study.  The anti-Sm (Y12) blotting on gel-separated A2RE-binding proteins 
indicates all hnRNP A/B proteins bound to A2RE. Moreover, the intensity of the protein blots 
clearly reflects the relative amount of each of the hnRNP A/B proteins when they are 
simultaneously blotted with Y12 under the same circumstances. The bottom image in panel B is the 
Y12 blotting on A2RE-binding proteins, where both hnRNPs A2 and A3 were recognized by Y12 
and the relative amount of blotted proteins is also indicated: A2 is the most abundant, followed by 
the short isoform A3b, and the full-length isoform A3a is the least.  
 
	  
 101 
	  
	  
Figure	  3-­‐4:	  Identification	  of	  hnRNPs	  A2	  
and	  A3	  by	  Western	  blotting.	  An	  Odyssey	  infrared	   imaging	   system	   was	   used	   to	  detect	   antibody	   blottings	   on	   PVDF	  membranes.	   Panel	   A	   shows	   Western	  blotting	   on	   mini-­‐gel-­‐separated	   brain	  extracts.	   Each	   protein	   lane	   was	   blotted	  with	   an	   antibody,	   which	   is	   indicated	   on	  top	   of	   the	   image.	   	   Pre-­‐stained	   protein	  marker	   was	   loaded	   beside	   the	   sample	  lanes,	   and	   their	   masses	   are	   indicated	   in	  kDa.	   Panel	   B	   includes	   three	   images	   of	  double-­‐blotted	   brain	   A2RE-­‐binding	  proteins.	   A2RE-­‐binding	   proteins	   were	  blotted	  with	  two	  different	  antibodies,	  and	  scanned	   with	   the	   red/green	   dual	  channels.	  The	   two	  antibodies	  used	   in	   the	  double-­‐blotting	   are	   indicated	   on	   both	  ends	   of	   the	   corresponding	   protein	   lane	  with	   the	   colours.	   Red	   and	   green	   channel	  scannings	  are	  merged	  in	  the	  top	  image	  of	  panel	   B	   for	   comparison,	   whereas	   the	  single-­‐channel	   scanning	   is	   individually	  presented	   in	   the	   middle	   and	   the	   bottom	  images.	   Pre-­‐stained	   protein	   marker	   was	  detected	  only	  with	  the	  red	  channel.	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3.2.3 HPLC separation of the A2RE-binding proteins 
 
In the previous section, hnRNPs A2 and A3 were separated and visualized by one-dimensional 
SDS-PAGE followed by Western blotting. Although hnRNP A3 isoforms were enriched after pull-
down purifications, the abundance was still low, creating difficulty in the structural investigation. 
Therefore, reverse-phase HPLC was applied to separate hnRNPs A2 and A3 based on 
hydrophobicity, in particular to acquire highly concentrated hnRNP A3.  
 
During the reverse-phase HPLC, the linear gradient method was set up to span 70 min, in which the 
separation period is 45 min with a 5-50% of gradient of solvent B. The recorded chromatogram is 
shown in Figure 3-5.  
 
Figure	   3-­‐5:	   Reverse-­‐phase	   HPLC	   chromatogram	   of	   rat	   brain	   A2RE-­‐binding	   proteins.	   Four	  batches	   of	   A2RE-­‐binding	   proteins	   purified	   from	   rat	   brain	   extracts	   were	   combined,	   lyophilised,	   and	  then	  dissolved	   in	   dH2O.	  An	   aliquot	   of	   dissolved	  protein	  was	   injected	   onto	   a	   reverse-­‐phase	  HPLC	  C4	  analytical	  column,	   followed	  by	  a	   linear	  gradient	  elution.	  The	  solvent	  gradient	   is	   indicated	  by	  a	  green	  line.	  The	  proteins	  were	  detected	  at	  wavelengths	  of	  214	  (blue)	  and	  280	  nm	  (red).	  The	  vertical	  axis	  on	  the	  left	  refers	  to	  the	  scale	  of	  absorbance,	  while	  the	  axis	  on	  the	  right	  indicates	  the	  solvent	  gradient. 
	  
	  
It is obvious that the majority of A2RE-binding proteins were eluted at the timeframe between 50 
and 60 min. All the chromatographic peaks were individually collected, followed by SDS-PAGE 
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analysis. The mini-gel electrophoresis narrowed down the elution period of most hnRNPs A2 and 
A3-like proteins to 50-60 min. Thus, the fractions corresponding to hnRNPs A2 and A3 peaks in 
this duration were analyzed by large gel SDS-PAGE. 
 
Figure 3-6 shows the large gel SDS-PAGE results of the peaks collected during the elution period 
50-60 min. In panel B, the peaks I-IV turned out to be proteins, while the peak V appeared to 
contain no protein component. Unlike peak I and IV showing single protein band after gel 
separation, there are multiple protein components included in fractions of peaks II and III. 
Compared with masses of the protein standards, the protein compositions of peaks II-IV were 
identified as: hnRNP A1 (peak II, the bottom band with mass less than 36 kDa) and A3 isoforms 
(the top three proteins with masses ranging 38-40 kDa in peak II and the top two bands with masses 
between 38-39 kDa in peak III); hnRNP A2 (the bottom band with mass of 36 kDa in peak III and 
the only protein band in peak IV). Although the peaks in the HPLC chromatogram were sharp and 
without obvious overlaps, the gel image demonstrated that the proteins were still not fully 
separated, in particular the hnRNP A2 and A3 proteins in peak III might come from overlapping 
regions of peaks IV and II, respectively. In order to obtain fully separated single-protein fractions 
for hnRNP A3 isoforms, a few modified gradient method was used to improve the resolution. Due 
to the highly homologous region shared between hnRNP A3 isoforms the transcript alteration of 
exon 1 was not enough to change the protein hydrophobicity in HPLC separation, hnRNP A3 
isoforms were always eluted from HPLC with each other.  
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Figure	   3-­‐6:	   Large	   gel	   electrophoresis	   of	   major	   HPLC	   peaks.	   Peaks	   subject	   to	   gel	   analysis	  were	  highlighted	   in	   pink	   and	   labeled	   on	   the	   HPLC	   chromatogram	   (panel	   A).	   The	   corresponding	   protein	  fractions	  were	   collected,	   lyophilised,	   reconstituted	   in	  water,	   and	  electrophoresed	   in	  a	   large	  gel	  unit.	  Panel	  B	   is	   the	  resultant	   image	  of	   these	  protein	   fractions.	  Peak	  numbers	  are	   labeled	  on	  top	  of	   the	  gel	  lane.	  Sizes	  of	  standard	  proteins	  are	  indicated	  on	  the	  right.	  
 
3.2.4 Mass identification of the intact A2RE-binding proteins by LC/MS 
 
HPLC concentrated the rat brain A2RE-binding proteins and gel electrophoresis of the separated 
fractions showed the protein contents with their approximate molecular masses of the HPLC peaks. 
HPLC analysis is based on retention time, peak area and UV spectral character, so that lots of 
extensively metabolised molecules still retain the same retention time and UV spectrum as the 
parent compound. This seems to be the reason that full separation of hnRNP A3 isoforms by HPLC 
is not achieved. Mass spectrometry (MS) complements the limitations of HPLC, because two 
compounds may have similar UV spectra or similar mass spectra, but not have both. When HPLC is 
joined with MS in Liquid Chromatography/Mass Spectrometry (LC/MS), the two orthogonal sets of 
data can be integrated to specifically characterize, confirm, and quantify compounds. Furthermore, 
LC/MS makes it possible to identify components down to trace levels in unresolved 
chromatographic peaks. Therefore, LC/MS became the method of choice to identify intact rat brain 
hnRNP A3 isoforms.  
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An LC/MS system comprising an electrospray ionisation (ESI) source and time-of-flight (TOF) 
mass analyser was used. The mass spectrometer was operated in a scan mode over a mass range 
specifically targeting intact hnRNPs A2 and A3. Acquired through a mass spectrometer by ion 
detection, the MS data of A2RE-binding proteins were plotted in the total ion current (TIC) 
chromatogram (as Panel A of Figure 3-7). Though the TIC chromatogram is not very similar to an 
HPLC trace, the retention time of HPLC-separated proteins determined the relative position of 
peaks in the TIC chromatogram. As a result, after matching with the HPLC profile, the TIC peaks 
of hnRNPs A2 and A3 were easily located. Four major peaks inside this time range (as Panel B of 
Figure 3-7) were further individually analyzed. The molecular weights of protein components 
included in the individual peaks were calculated by internal data system for singly charged 
molecules, resulting in a deconvoluted mass spectrum for each analyzed peak (Figure 3-8).  
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Figure	  3-­‐7:	  Total	   ion	  current	  chromatogram	  of	  A2RE-­‐binding	  proteins.	  Panel	  A	  is	  an	  overall	  TIC	  chromatogram,	   in	   which	   the	   vertical	   axis	   measures	   the	   intensity	   of	   the	   ion	   current	   in	   counts	   per	  second	   (cps)	  and	   the	  horizontal	   axis	   records	   the	   retention	   time	  of	  protein	   compounds	   separated	  by	  HPLC.	   The	   HPLC	   elution	   of	   hnRNPs	   A2	   and	   A3	   is	   defined	   in	   a	   rectangle	   box,	   and	   this	   region	   of	  chromatogram	  is	  magnified	  in	  panel	  B.	  The	  significant	  peaks	  inside	  the	  box	  are	  labeled	  with	  retention	  times.	   In	   panel	   B,	   four	   significant	   peaks,	   as	   highlighted	   in	   yellow,	  were	   deconvoluted	   for	  molecular	  weight	  determination.	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A.	  Mass	  spectrum	  of	  the	  peak	  I	  (Tr=39.065	  -­‐	  39.565	  min)	  
	  
B.	  Mass	  spectrum	  of	  the	  peak	  II	  (Tr=40.498	  -­‐	  40.998	  min)	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C.	  Mass	  spectrum	  of	  the	  peak	  III	  (Tr=41.131	  -­‐	  41.631	  min)	  
	  
	  
D.	  Mass	  spectrum	  of	  the	  peak	  IV	  (Tr=42.664	  -­‐	  43.164	  min)	  
Figure	   3-­‐8:	   Mass	   spectrum	   of	   the	  major	   A2RE-­‐binding	   proteins.	  Masses	   of	   protein	   compounds	  were	   identified	  on	   selected	  LC/MS	  peaks	   I-­‐IV	   (as	  highlighted	   in	  Panel	  B	  of	  Figure	  3-­‐7).	   In	   the	  panel	  from	   A	   to	   D,	   a	   deconvoluted	   mass	   spectrum	   is	   reconstructed	   for	   each	   selected	   peak.	   In	   the	   mass	  spectrum,	   the	  vertical	   axis	  denotes	   the	   relative	   intensity	  of	   ion	   current,	  whereas	   the	  horizontal	   axis	  represents	  mass	  value	  in	  atomic	  mass	  units	  (amu).	  The	  time	  range	  for	  deconvolution	  analysis	  of	  each	  selected	  peaks	  was	  indicated	  as	  retention	  time	  (Tr)	  in	  the	  bracket.	  The	  mass	  values	  of	  the	  major	  peaks	  are	  labeled	  on	  the	  spectra.	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After deconvoluting the raw TIC spectrum, signals in the mass spectra clearly reveal the protein 
identities inside either well or poorly resolved chromatographic peaks from the initial HPLC. 
Furthermore, the relative intensity of mass peaks reflects the quantity of corresponding protein 
components. The major masses from the individual mass spectrum are listed in Table 3-1 along 
with published theoretical and experimental mass values of hnRNP A/B proteins.  
 
Table	  3-­‐1:	  Comparison	  of	  LC/MS-­‐detected	  masses	  with	  published	  masses	  of	  hnRNP	  A/B	  
proteins	  a. LC/MS-­‐detected	  masses	  are	  listed	  from	  the	  deconvoluted	  mass	  spectra	  (Figure	  3-­‐8).	  Masses	  of	  the	  significant	  peaks	  are	  underlined.	  b. For	  comparison,	  theoretical	  mass	  data	  of	  the	  hnRNP	  A/B	  proteins	  refer	  to	  Rattus	  norvegicus.	  	  	  c. Species	  of	  the	  protein	  source	  is	  also	  Rattus	  norvegicus.	  	  	  
 
Peak	   Time	  range	   LC/MS	  detected	  Mass	  a	  (Da)	  ±	  4	  
I	   39.065	  -­‐	  39.565	  min	   37340,	  39125,	  39879,	  39981,	  40102	  
II	   40.498	  -­‐	  40.998	  min	   34253,	  36110,	  37313,	  37391,	  38861	  
III	   41.131	  -­‐	  41.631	  min	   34254,	  36097,	  37317,	  37395,	  37518,	  38858	  
IV	   42.664	  -­‐	  43.164	  min	   36094	  
Published	  masses	  of	  hnRNP	  A/B	  proteins	  
Protein	  
Theoretical	  mass	  b	  	  
(Da)	  
Experimentally	  	  
identified	  mass	  c	  
(Da)	  Average	   Monoisotopic	  hnRNP	  A1	  isoforms	   A1b	   38861	   38822	   	  A1a	   34212	   39191	   	  
hnRNP	  A2	  isoforms	  
B1	   37478	   37454	   	  A2	   36054	   36031	   36076	  (Ma	  et	  al.,	  2002)	  B1b	  (B0b)	   33959	   33938	   	  A2b	  (B0a)	   32536	   32515	   	  hnRNP	  A3	  isoforms	   isoform	  1	  (A3a)	   39652	   39627	   39863	  (Ma	  et	  al.,	  2002)	  isoform	  2	  (A3b)	   37086	   37063	   37297	  (Ma	  et	  al.,	  2002)	  
 
 
In Table 3-1, the published mass data were from two different resources: the experimental values of 
hnRNPs A2 and A3 were identified from LC/MS on intact proteins (Ma et al., 2002); however, all 
the theoretical values in the table were summarized from the online Swiss-Prot Protein 
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Knowledgebase (http://www.uniprot.org) and these values are solely calculated according to the 
putative protein sequences. Therefore, the experimental values are considered more reasonable for 
comparing with the LC/MS-detected raw data.  
 
All analyzed LC/MS peaks, except peak IV, contain multiple components. The single mass detected 
in peak IV is 36094 with the highest intensity. It is straightforward to pinpoint that this high 
intensity mass belongs to hnRNP A2 in the group of rat brain A2RE-binding proteins. However, 
this LC/MS-detected mass did not exactly match the hnRNP A2 mass of 36076 from the published 
experimental results (Ma et al., 2002). The system variation might account for a mass gap of Δ18, 
and this variation was later taken into consideration to adjust masses in comparison. 
 
After allowing for instrument calibration, some of the LC/MS-detected raw data matched perfectly 
with the experimental values of hnRNPs A2 and A3. The majority of protein components inside 
peaks I-IV are revealed: peak I contains hnRNP A3a (major), A2-like and a few unknown proteins; 
peak II contains hnRNP A3b (major) and A1b (minor); peak III contains hnRNPs A2 (major), A3b 
(major) and A1b (minor); peak IV contains hnRNP A2 only. Except that all the significant masses 
were matched, a few detected masses, which are classified as the similar masses in Table 3-2, are 
different from the theoretical values by less than ±50. Since the theoretical masses were calculated 
without considering PTMs, the mass differences might be the consequences of PTMs of these 
proteins.  
 
In the unmatched masses, two mass values, 37391 from peak II and 37395 from peak III, are only 
different by Δ4. It indicates that they might belong to the same protein identity. Detected from the 
two adjacent chromatographic peaks, the mass of 37391/37395 is approximately in the middle 
between hnRNPs B1 (37478 Da) and A3b (37297 Da). Its difference to the theoretical value of B1 
is -Δ87±4 and to the experimental value of A3b is +Δ94±4. It is not certain whether the protein 
identity it referring to is a truncated or degraded form of B1 or a modified form of A3b. If hnRNP 
A3 is post-translationally modified like its paralogs A1 and A2, it is assumed that the additional 
mass of Δ94 on A3b might be made up of a methylation (+Δ14) and a phosphorylation (+Δ80). 
Interestingly, if the same PTMs apply to the full-length isoform A3a, the resultant mass is estimated 
to be 39973, close to another unmatched mass of 39981.  
 
Figure 3-9 shows the gel-separated protein bands corresponding to all the mass values detected with 
LC/MS. The first masses located on protein bands are 34253/34254 of hnRNP A1, 36094/36097 of 
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hnRNP A2, 37313/37317 of hnRNP A3a, and 39879 of hnRNP A3b. Other masses are assigned to 
the rest of protein bands based on the size variations reflected as the relative distance to those 
already located bands. The mass difference between the two alternatively spliced isoforms of 
hnRNP A3 is Δ2566, which matches exactly the difference between masses of 39879 and 37313. 
Except for these two masses, the difference of Δ2566 is not found between any other detected 
masses. It implies that both hnRNP A3 isoforms are not identically modified.  
	  
	  
Table	  3-­‐2:	  Identification	  of	  hnRNP	  A/B	  proteins	  after	  mass	  adjusting	  The	   LC/MS-­‐detected	   raw	   data	   were	   compared	   with	   the	   theoretical	   (tMW)	   or	   experimental	   values	  (eMW),	   and	   then	   classified	   into	   matched	   (±4),	   similar	   (±50)	   or	   otherwise	   unmatched	   masses.	   The	  protein	   identities	   of	   matched	   or	   similar	   masses	   are	   indicated	   in	   brackets.	   The	   experimental	   mass	  values	   are	   adjusted	   by	   adding	   a	   mass	   gap	   of	   Δ18	   due	   to	   the	   system	   difference.	   The	   adjusted	  experimental	  masses	  (adj.	  eMW)	  of	  hnRNPs	  A2	  and	  A3	  are:	   	  adj.	  eMW	  of	  hnRNP	  A2	  =	  36076	  +	  Δ18	  =	  36094	  adj.	  eMW	  of	  hnRNP	  A3a	  =	  39863	  +	  Δ18	  =	  39881	  adj.	  eMW	  of	  hnRNP	  A3b	  =	  37297	  +	  Δ18	  =	  37315	  
	  
Peak	  
Retention	  time	  
(min)	  
Raw	  data	  detected	  
by	  LC/MS	  	  
	  Comparison 
I	   39.065	  -­‐	  39.565	  	   37340,	   39125,	  39879,	   39981,	  40102	  
Matched: 39879 (adj. eMW of hnRNP A3a) 
Similar: 37340 (adj. eMW of hnRNP A3b) 
Unmatched: 39125, 39981, 40102 
II	   40.498	  -­‐	  40.998	  	   34253,	   36110,	  37313,	   37391,	  38861	  
Matched:  
37313 (adj. eMW of hnRNP A3b),  
38861 (tMW of hnRNP A1b) 
Similar:  
34253 (tMW of hnRNP A1a),  
36110 (adj. eMW of hnRNP A2) 
Unmatched: 37391 
III	   41.131	  -­‐	  41.631	  	   34254,	   36097,	  37317,	   37395,	  37518,	  38858	  
Matched:  
36097 (adj. eMW of hnRNP A2),  
37317 (adj. eMW of hnRNP A3b),  
38858 (tMW of hnRNP A1b) 
Similar:  
34254 (tMW of hnRNP A1a),  
37518 (tMW of hnRNP B1) 
Unmatched: 37395 
IV	   42.664	  -­‐	  43.164	  	   36094	   Matched: 36094 (adj. eMW of hnRNP A2) 
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Figure	   3-­‐9:	   Mass	   analysis	   of	   gel-­‐separated	   A2RE-­‐binding	   proteins.	   LC/MS-­‐detected	  masses	   are	  listed	   along	   with	   the	   A2RE-­‐binding	   protein	   bands	   separated	   on	   a	   large	   SDS-­‐PAGE	   gel.	   The	   Roman	  numerals	  in	  the	  brackets	  next	  to	  each	  mass	  indicate	  the	  chromatographic	  peaks	  that	  the	  masses	  were	  from.	  	  	  
 
 
Among the A2RE-binding proteins, the sub-group of proteins ranging from 37 - 40 kDa are present 
in low abundance with many protein varieties. It is clear that both modified forms and isoforms of 
hnRNP A3 are included in this sub-group of proteins. In addition to hnRNP A3 protein forms, this 
sub-group might consist of other forms of hnRNP A1 and B1. Therefore, protein analysis of this 
sub-group will reveal more evidence of PTMs on hnRNPs A1, A2 and A3. 
 
3.3 Proteomic mapping of the A2RE-binding proteins 
 
The genome is the entirety of an organism’s hereditary information, including both the genes and 
the non-coding sequences of the DNA. The proteome is the entire complement of proteins 
expressed by a genome, cell, tissue or organism. In general, the proteome is the set of expressed 
proteins at a given time under defined conditions; specifically, the proteome has been considered as 
the collection of proteins in certain subcellular biological systems. Though the term “proteome” is 
an analogy with “genome”, the proteome is much more complicated than the genome, especially in 
eukaryotes. The genome is a rather constant entity defined by the sequence of nucleotides, whereas 
the proteome fluctuates in response to environmental changes and is unrestricted by the sum of 
protein sequences due to alternative splicing of genes and sometimes massive PTMs.  
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3.3.1 Two-dimensional electrophoresis of the A2RE-binding proteins 
 
Proteomics, the study of the proteome, has largely been practiced through the separation of proteins 
by two-dimensional gel electrophoresis (2-DE). In the first dimension, proteins are separated by 
isoelectric focusing (IEF) on the basis of charge. The second dimension is an SDS-PAGE 
separation of proteins based on size. Each protein is featured by its unique combination of pI and 
MW, in reciprocal, the coordinates of its pI and MW determine the distinct spot that the protein 
itself will locate on a 2-DE gel. By this means, a few proteins with same molecular weights which 
are stacked into a single band on a one-dimensional gel will outspread into a series of spots on a 2-
DE gel due to the charge heterogeneity.  
 
Isoelectric points of hnRNP A/B proteins are within the range pH 8-10, for this reason a narrow 
immobilized pH gradient (IPG) of pH 6-11 was chosen for all the first-dimensional IEFs in this 
project to achieve more detailed distribution profiles of hnRNP A/B proteins. The 2-DE separation 
of total soluble protein samples extracted from cultured HeLa cells and 21-day-old rat brains are 
shown in Figure 3-10.  
 
The both gel images shows that a large numbers of proteins with low pI are excluded from the pH 
6-11 gradient, thus are concentrated at the edge of pH 6. In contrast, proteins with	  pI greater than 
pH 6 are well focused inside this gradient. A region with borders of pH 7-10 and MW 34-42 kDa is 
enlarged on both gels for comparison. This region virtually covers all forms of hnRNPs A2 and A3, 
so that the constellation of protein spots in this region provides preliminary pI and MW values for 
the visible hnRNPs A2 and A3 forms. In addition, the staining intensity and the spot size briefly 
reflects the in vivo expression level of the individual protein. Therefore, the relative proportion of 
the various forms of a protein species can be also observed. The gel image of total soluble protein 
from HeLa cells is in agreement with the 2-DE gel of RNP particle proteins from HeLa cell extracts 
(Beyer et al., 1977), therefore, a string of spots around 36 kDa, as pointed out by the arrows, are 
identified charge isomers of hnRNP A2. There is no published 2-DE gel of rat brain proteins, so the 
hnRNP A2 species are located corresponding to the same position compared with the HeLa protein 
gel (Figure 3-10).  
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On both gels, the protein spots belong to hnRNP A2 share a common trend in that the protein level 
is gradually elevated as the pI increases. However, the composition and isoelectric focusing of the 
hnRNP A2 charge isomers is not identical between the two gels. In the gel of HeLa extracts, the 
isomers with pI 8.23, 8.50, and 8.86 constitute more than 80% of overall A2 species, and the pI 8.86 
isomer is the most abundant. In the gel of rat brain extracts, the size elevations of hnRNP A2 spots 
are moderate until the pI 8.63 isomer peaks the amount. Except that the spots of pI 8.50 and 8.86 
isomers are missing, the position of other isomers matches perfectly with their counterparts in the 
HeLa protein gel. The size of protein spots located above and beneath hnRNP A2 spots suggests 
that they might belong to hnRNPs A1 and A3, but neither of them shows a uniform distribution 
pattern between the two gels. In the context of total soluble proteins, it is not practical to correlate 
those proteins as analogues between two gels merely based on size. For a general comparison of 
HeLa and rat brain total soluble proteins, the overall level of hnRNP A2 in HeLa cells is much 
higher than that in rat brain, which is believed to be the consequence of carcinogenesis; whereas the 
composition of approximate 40 kDa protein in rat brain extracts is more diverse than that in HeLa 
extracts, possibly because of the miscellaneous cell types inside the brain tissue. 
 
The purpose of the total soluble protein 2-DE is to provide a comprehensive map of endogenous 
cellular proteins. The following 2-DE of the purified A2RE-binding proteins (Figure 3-11) intends 
to specify the diversities of hnRNPs A2 and A3 which were enriched by binding to A2RE. The 
comparison between 2-DE profiles of pre- and post-purified proteins would indicate which isoforms 
are in favour of the A2RE sequence, which will deliver more information in structural studies on 
the A2RE-A2 interaction.  
 
As mentioned in the previous section on optimization of A2RE interaction, the A2RE-binding 
proteins from rat brain and HeLa cells contain different protein components, which are clearly 
shown on 2-DE gels. Relatively clean and specific hnRNP A/B proteins dominate the recovered 
proteins after purification from rat brain; while for HeLa cell proteins, almost half of the yield are 
non-specific proteins with MW of 45- and 55- kDa and the other half of the yield mostly are the 
specific hnRNP A/B proteins.  
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Figure	   3-­‐11:	   2-­‐DE	   gels	   of	   the	   A2RE-­‐binding	   proteins.	   The	   A2RE-­‐binding	   proteins	  were	   isolated	  from	   rat	   brain	   by	   affinity	   purification,	   lyophilised	   and	   redissolved	   in	   the	   IPG	   buffer	   (pH	   6-­‐11).	   An	  aliquot	  of	  sample	  was	  used	  for	  one-­‐dimensional	  electrophoresis,	  showing	  as	  the	  right	  lane	  in	  the	  same	  gel	  to	  indicate	  the	  distance	  of	  protein	  migration.	  The	  rest	  of	  the	  sample	  was	  used	  for	  2-­‐DE	  separation,	  as	  previously	  described.	  The	  direction	  of	  pH	  6-­‐11	  gradient	  for	  the	  first	  dimensional	  IEF	  are	  labelled	  on	  top	  of	  the	  gel.	  Both	  gel	  panels	  were	  visualized	  by	  Coomassie	  blue	  staining.	  Proteins	  of	  hnRNPs	  A2	  and	  A3	  are	  pointed	  out	  by	  arrow-­‐lines	  on	  the	  1D	  gel	  lane	  of	  panel	  A.	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Comparing the distribution pattern of A2RE-binding proteins on both gels, the specific hnRNP A/B 
proteins are located in the same IPG range of approximate pH 7-9.5. Furthermore, almost all the 
spots inside this region are mirrored each other between two gels. After the A2RE-affinity 
purification, the specific hnRNP proteins are enriched, in particular the group of protein spots 
between MW 37-40 kDa become noticeable. For the HeLa A2RE-binding proteins, the non-specific 
interactions results in the considerably less hnRNP A/B proteins purified. Therefore, all the hnRNP 
A/B protein spots are in relatively low intensity. In contrast, proteins recovered from the rat brain 
purification are exclusively enriched hnRNP A/B proteins. The intensity of the visible hnRNP A/B 
spots is much higher than those HeLa protein counterparts, so that the protein species could be 
briefly classified according to their vertical positions on the one-dimensional gel lane.  
 
The rat brain A2RE-binding proteins, which were separated into less than eight protein bands in 
one-dimensional electrophoresis, clearly scatter into more than 30 protein spots in two dimensions 
(panel A of Figure 3-11). Typically the charge isomerization of a protein species creates a series of 
protein isomers within a narrow range of MW but clearly different pI values. On the 2-DE gel, the 
most significant spots belong to hnRNP A2 (~36 kDa) isomers, constituting more than 50% of the 
overall A2RE-binding proteins. Spots of the alternatively spliced hnRNP A3 (A3b, ~37 kDa) are 
the second most abundant. The horizontal stretch of the A3b isomers resembles that of the A2 
isomers, which suggest the two parent proteins, A3b and A2, might be processed through the 
similar isomerizations. Other than the significant hnRNPs A2 and A3b isomers, the remaining 
protein spots are smaller and stay at the basic side of IPG. The vertical distribution of these minor 
spots is fitted into three MW ranges, therefore, these minor isomers might be created from the 
isomerizations of three different parent proteins. Thus, the minor spots are referred as 40 kDa 
isomers (relatively intense isomer spots of ~40 kDa proteins), 39 kDa isomers (less intense isomer 
spots of ~38-39 kDa proteins), and 35 kDa isomers (moderately intense isomer spots of ~34-35 kDa 
proteins). Interestingly, 39 kDa and 35 kDa isomers are more alike in the pI disposition, which 
suggests that these protein isomers may have similar charges. Based on the previous one-
dimensional gel identification, either 40 kDa or 39 kDa isomers, if not both, belong to the full-
length hnRNP A3 isoform (A3a). But neither isomers shows any resemblance in the charge 
arrangement to the truncated A3b isoform, which implies that two hnRNP A3 isoforms might 
undergo different modification processes resulting in the two extreme charge isomerizations.  
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3.3.2 Protein pI estimation of the A2RE-binding protein 
 
In a 2-DE gel, the MW identification of 2D-separated protein spots is conducted by comparing their 
vertical migration distance with the protein markers separated by one-dimensional SDS-PAGE on 
the same gel. The size-based migration of protein molecules varies between gels, depending the 
electrophoresis duration and the polyacrylamide gel concentration, so that the apparent MWs of the 
protein molecules is only comparable in the same gel. In the horizontal dimension, the relative 
position of a protein molecule is only determined by the charge it carries. Therefore, the relative 
position of such protein within a given IPG would stay invariable over batches. With the high 
reliability and reproducibility of IEF, the specific protein pI can be estimated by converting the 
horizontal position of a protein spot into a pH value, and the accuracy of the resultant pI value will 
remain the same between 2-DE gels. 
 
The Coomassie-blue-stained 2-DE gel of rat brain A2RE-binding proteins was analyzed using the 
PhotoShop grid (Figure 3-12, A) to define the relative positions of separated proteins spots. The 
calibrated plot (Figure 3-12, B) of the pH gradient against the horizontal gel distance was acquired 
from the product manual of the Immobiline IPG DryStrip  (Amersham, GE Healthcare). After 
calibration, the pI value (i.e. estimated pI) of each labeled spots was listed in Table 3-3.  
 
A picture comprising a 2-D map and 1-D lane (Figure 3-13, Panel A) was drawn to illustrate the 2-
DE and 1-DE separation pattern of hnRNP A/B proteins on the basis of their theoretical values of pI 
and MW. This picture gives a theoretical layout of all isoforms of hnRNP A/B proteins, in which 
each isoform was symbolized as a single molecule without taking into consideration any 
isomerization or modification. In reality, all hnRNP A/B proteins are reported to undergo extensive 
modifications which inevitably have impacts on their pIs and masses. Therefore, the experimental 
2-DE gel image, populated by multiple forms of each protein species, is more intricate than the 
theoretical map. In order to make a close comparison, the theoretical isoelectrical positions of the 
hnRNP A/B proteins are indicated on the experimental 2-DE gel image (Figure 3-13, Panel B). 
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Figure	   3-­‐12:	   Gel	   image	   analysis	   of	   2-­‐DE-­‐separated	   A2RE-­‐binding	   proteins.	  The	  2-­‐DE	  gel	   of	   rat	  brain	  A2RE-­‐binding	  proteins	  was	  stained	  with	  Coomassie	  blue,	  and	  analyzed	  using	  the	  PhotoShop	  grid	  (Panel	   A).	   The	   original	   gel	   image	   was	   cropped	   to	   bring	   the	   hnRNP	   A/B	   proteins	   into	   focus.	   The	  corresponding	  pH	  range	  is	   indicated	  on	  the	  top	  of	  the	   image.	  Panel	  B	   is	  a	  calibrated	  plot	  (cited	  from	  the	  IPG	  strip	  manual)	  of	  pH	  value	  against	  position	  on	  Immobiline	  7	  cm	  DryStrip	  	  (linear	  pH	  6-­‐11	  IPG).	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Table	  3-­‐3:	  List	  of	  estimated	  protein	  pIs	  of	  2-­‐DE-­‐separated	  A2RE-­‐binding	  proteins	  
 
Spot	  
Number 
Estimated	  pI	  
Spot	  
Number 
Estimated	  pI	  
1 7.36 16 8.28 
2 7.78 17 8.55 
3 8.09 18 8.78 
4 8.28 19 8.89 
5 8.43 20 8.13 
6 8.59 21 8.47 
7 8.74 22 8.66 
8 8.93 23 8.82 
9 8.93 24 8.97 
10 9.05 25 9.08 
11 9.05 26 9.20 
12 9.16 27 8.66 
13 7.28 28 8.78 
14 7.63 29 8.93 
15 8.01 30 9.01 
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Figure	   3-­‐13:	   Theoretical	   2-­‐D	   pattern	   of	   A2RE-­‐binding	   proteins. In	   Panel	   A,	   a	   theoretical	  distribution	  map	  of	  hnRNP	  A/B	  molecules	  was	  drawn	  to	  emulate	  the	  separation	  with	  2-­‐DE	  and	  1-­‐DE.	  Both	  horizontal	  (pH)	  and	  vertical	  (kDa)	  dimensions	  were	  drawn	  to	  be	  linear	  (horizontal	  scale	  bar	  =	  pH	  0.1,	   vertical	   scale	  bar	  =	  1	  kDa).	  The	   scaled	  pH	  gradient	  and	  MW	  range	  are	   indicated	  on	   the	   top	  and	  right	   side	   of	   the	   picture,	   respectively.	   Panel	   B	   is	   the	   experimental	   2-­‐DE	   gel	   image.	   The	   theoretical	  positions	  in	  the	  IEF	  dimension	  of	  the	  hnRNP	  A/B	  proteins	  are	  indicated	  with	  arrowed	  lines	  (horizontal	  scale	  bar	  =	  ΔpH	  0.2). 
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A few protein spots are found closely related to one of the hnRNP A/B isoforms when judged with 
pI and mass: for hnRNP A1, spot 26 seems to match hnRNP A1b; for hnRNP A2/B1, spot 19 is 
close to hnRNP B1 and spot 6 matches hnRNP A2; for hnRNP A3, spot 30 is close to hnRNP A3a 
to the left, while spot 17 is the close to hnRNP A3b to the right. Thus, the proteins may be classified 
into the five hnRNP subgroups: spots 1-12 include hnRNP A2; spots 13-19 include hnRNPs A3b 
and B1; spots 20-30 include hnRNPs A1b and A3a. The average mass difference between B1 and 
A3b is Δ392, and the mass gap between A3a and A1b is Δ791. These theoretical mass discrepancies 
make it difficult to vertically separate protein spots of B1, A3b and A1b. Since the modifications 
would alter the pI and mass values of these proteins to some extent, the boundaries between these 
protein species become more obscure. The current knowledge of modifications A3 are very limited, 
therefore, it is difficult to further specify the hnRNP B1 and A3b from spots 13-19 as well as the 
hnRNPs A3a and A1b from spots 20-30.  
	  
	  
3.3.3 Identification of hnRNPs A2 and A3 by two-dimensional Western blotting 
 
After the protein estimation in the previous section, Western blotting was used to identify hnRNPs 
A2 and A3 among the 2-DE-separated A2RE-binding proteins. Once blotted with the specific 
antibodies, all the spots belonging to the same protein species will appear as polymorphism. The 
diversity between the different forms of hnRNPs A2 and A3, in terms of pI and MW, is the clue for 
the further investigation of structural modifications of hnRNP A/B proteins.  
 
For Western blotting, rat brain A2RE-binding proteins were transferred from 2-DE gels onto PVDF 
membranes. Two different antibodies were used to blot a single membrane for the Western blottings 
discussed in this section. To avoid cross-reactions, the antibodies of αA2, αA3C and αA3N were 
not paired with each other. Instead, they were individually partnered with the Y12 antibody in the 
double-blotting. When a membrane containing the 2-DE-separated A2RE-binding proteins is 
double-blotted, two independent sets of blotting are obtained: the overall scenario of hnRNP A/B 
proteins were from the Y12 blottings; whereas the detections of A2 and A3 were achieved by the 
A2- or A3-specific blotting. The double-blotted 2-DE images are shown in Figure 3-14. 
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The Y12 antibody was used in all three double-blottings. The green channel scanner of the Odyssey 
system detected Y12 antibody, and the resultant images clearly illustrate the two-dimensional map 
of the hnRNP A/B proteins. In comparison with the stained 2-DE gels, both layouts of the hnRNP 
A/B proteins are identical. Due to the antibody specificity, the blotted spots of hnRNP A/B proteins 
appear to be more focused than the Coomassie stained spots. The purpose of using the Y12 
antibody in the double-blottings is to provide a background landscape of all the A2RE-binding 
hnRNP A/B species, so that the blots from the other partner antibody can by observed when images 
of both channels are merged.  
 
The αA2, αA3C and αA3N antibodies were paired with the Y12 antibody in double-blotting, and 
their blots were detected by the red channel scanner. In Figure 3-14, the specific antibody blots are 
indicated by the red arrows. Since these antibodies are polyclonal, there still exist some weak cross-
reactions resulting in non-specific blotting. Regarding to the blotting intensity, the non-specific 
blotting are ignorable. In the first row, the image of the αA2 antibody shows that this antibody 
blotted the major spots of 36 kDa protein isomers, leaving few minor spots with relatively higher pI 
and lower MW unblotted. The αA3C antibody, raised against a peptide in the C-terminus of hnRNP 
A3, was used to blot protein species of both isoforms A3a and A3b. In the second row image of the 
αA3C blotting, only the major spots at the left side of the 37 kDa isomer line were blotted, whereas 
the minor spots at the right side of the line were not recognized by the antibody. At the same time, 
the protein spots with the highest MW among the group of A2RE-binding hnRNP A/B proteins 
were blotted. The blotted 37 kDa isomers belong to the A3b species, while the blotted large protein 
molecules are the A3a species. The image of the blotting of the αA3N antibody, shown in the third 
row, confirmed the identity of the A3a spots. The αA3N antibody specifically targets the peptide in 
the N-terminal splicing region, so that the blotted proteins belong to the full-length isoform. 
Therefore, the spots with the highest MW among the group represent full-length hnRNP A3a.     
 
With the results of the two-dimensional Western blotting, hnRNPs A2 and A3 can be identified in a 
2-DE map. As outlined in Figure 3-15, the spots 1-8 turn out to be the hnRNP A2 species, while the 
spots 13-16 and 27-30 belong to the hnRNP A3b and A3a, respectively. The identification of 
hnRNP A2 rules out the spots 9-10 with their identities remaining unknown. According to the 
previous estimations, the species of hnRNPs A3b and B1 might constitute the line of 37 kDa protein 
spots, whereas the cluster of large protein molecules (approximately 39-40 kDa) might be hnRNPs 
A1b and A3a. Therefore, the identification of A3b spots 13-16 suggests that the spots 17-19 might 
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belong to the hnRNP B1 species; and the identification of hnRNP A3a spots 27-30 implies the 
remaining spots 20-26 in the cluster might belong to hnRNP A1b species. 
 	  
 
Figure	  3-­‐15:	   Identification	  of	  2-­‐DE-­‐separated	  hnRNP	  A/B	  proteins.	  Based	  on	  the	  images	  of	  two-­‐dimensional	   Western	   blotting,	   three	   groups	   of	   protein	   spots	   were	   outlined	   on	   a	   2-­‐DE	   gel	   as	   the	  identified	  protein	  species.	  	  
 
 
For identified proteins, the spots distribution shows that hnRNPs A2 and A3 might be modified 
differently so that their isomers carry different charges. The pIs of the A2 spots rang from 7.3-8.9, 
whereas the spots of two isoforms of A3 separately occupy the two extremes of this pI range. The 
number of the A2 spots is greater than that of the each A3 isoform, which suggests that the 
modification processes are far more complicated for hnRNP A2 than for either A3a or A3b. 
Isoforms A3a and A3b, differing by a 22-residue-fragment due to the alternative splicing, 
individually contain approximate four isomers. The pI range of the A3b spots is 7.2-8.3, in contrast 
to a rather narrow range of 8.6-9 for the A3a spots. The spots of both isoforms show a similar 
tendency, in which the predominant forms are the isomers with higher pI and the protein level 
gradually decreases along with the acidity increase of isomers.  
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3.4 Screening for alternative splicing 
 
The complexity of hnRNPs A2 and A3 were identified by two-dimensional Western blotting. At the 
genomic level, the alternative splicing is the major cause for establishing the protein polymorphism. 
And the splicing variation of a certain gene can be identified by PCR techniques. The alternative 
splicing of the HNRPA2B1 gene has been well characterized in Mus musculus (Dr. Jodie Hatfield 
personal communication). Splicing inclusively or exclusively the regions of exons 2 and 9 is 
necessary and sufficient to generate the transcripts of four proteins isoforms, i.e. hnRNPs B1, A2, 
B1b and A2b. For the HNRPA3 gene, other than the only identified splicing site inside exon 1 (Ma 
et al., 2002), a few exons close to the 3’ end were predicted from the bioinformatic analysis to 
contain the possible sites of alternative splicing (Makeyev et al., 2005).  None of the predicted sites 
had been confirmed experimentally. Under such circumstances, it is necessary to verify how many 
sites of alternative splicing and their locations inside the coding region of HNRPA3. Figure 3-16 
shows a schematic structure of the rat HNRPA3 cDNA and the strategy of PCR screenings using the 
HNRPA3 transcript as template.  
 
 
Figure	   3-­‐16:	   Screening	   strategy	   of	   searching	   the	   possible	   splicing	   variation	   on	   the	   HNRPA3	  
cDNA.	  Six	  amplicons	  are	  specified	  with	  size	  and	  relative	  position	  on	  the	  cDNA	  sequence	  of	  HNRPA3.	  The	  small	  arrows	  at	  the	  ends	  of	  amplicons	  represent	  the	  designed	  forward	  and	  reverse	  primers.	  Exons	  of	   the	  HNRPA3	  gene	  are	   illustrated	  as	  boxes.	  Except	   for	  the	  non-­‐coding	  exon	  11,	  exons	  are	  drawn	  to	  scale	  and	  the	  scale	  bar	  in	  the	  top	  right	  corner	  indicates	  the	  length	  of	  a	  100	  bp	  sequence.	  The	  orange	  boxes	  represent	  UTRs.	  The	  identified	  fragment	  of	  alternative	  splicing	  is	  shown	  as	  the	  blue	  box	  in	  exon	  1.	  All	  intron	  regions	  are	  simplified	  as	  connecters	  between	  exons.	  The	  protein	  domains	  of	  RRM1,	  RRM2	  and	  GRD	  as	  well	  as	  two	  linker	  regions	  are	  depicted	  in	  background.	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The HNRPA3 gene spans approximately 11 kb containing 11 exons and 10 introns, among which 
exons 1-10 are translated. The identified region of alternative splicing is a 66-nt long sequence at 3’ 
end of exon 1, which is just downstream from the start codon ATG. Based on the sequence of 
HNRPA3 cDNA, six pairs of primers were designed for screening, aiming to find other sites of 
alternative splicing. As indicated in Figure 3-16, the HNRPA3 cDNA is partitioned into six 
amplicons defined by these primer pairs. The size of each amplicon is shorter than 400 bp. Thus, 
even the minor changes in the length of sequence caused by alternative splicing were expected to be 
noticeable after PCR amplifications. The overlapping of the amplicons ensured that the entire 
coding cDNA sequence was examined. With the knowledge of the splicing variation at exon 1, two 
forward primers were designed to pair with the same reverse primer to differentiate the splicing 
variation: one forward primer starts from 5' UTR but leaves the splicing fragment out, targeting at 
the truncated transcript; while the other starts inside the splicing region, aiming for the full-length 
sequence. 
 
From the homology studies, the organization of a few exon junctions, resulting from the transcript 
splicing, were highly conserved between paralogous genes of HNRPA1, HNRPA2B1 and HNRPA3 
(Figure 3-1). In terms of alternative splicing, the identified splicing variations in exon 9 of 
HNRPA2B1 and exon 8 of HNRPA1 lead to a hypothesis that a region close to the 3’ side of the 
HNRPA3 ORF might be alternatively spliced. In details, a fragment of 183 nt (24 nt from 3’ of the 
exon 6 + 81 nt of the entire exon 7 + 78 nt of 5’ of the exon 8) of HNRPA3 was bioinformatically 
predicted to mirror those identified instances (Makeyev et al., 2005). In this light, the primer pairs 
of amplicons V and VI were specifically designed to verify this predicted region and the possible 
flanking areas, which might be equivalent to the counterparts of HNRPA1 and HNRPA2B1.  
 
Total RNAs were individually extracted from three species: rat (Rattus norvegicus) and mouse 
(Mus musculus) brains, and the cultured human breast cancer MDA-MB-231 cells (Homo sapiens, a 
kind gift from Dr. Juliet French). All RNA samples were checked by PCR immediately after 
extraction to ensure against DNA contamination. The RNAs were subsequently quantified and 
reverse-transcribed into cDNAs using RT-PCR. Starting from the same amount of the extracted 
RNAs, these cDNA templates originated from the three different species were used in PCR 
screenings for the alternative site of splicing. 
 
The preliminary results of PCR screening are shown in Figure 3-17. In comparison with the 
screening results of cDNA templates from the three species, high resemblances are found between 
the PCR products amplified from rat (panel A) and mouse (panel B), except that the band intensity 
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differs. Not only the sizes of the PCR products match perfectly as designed, but also the size 
difference of approximately 20 bp between PCR products is clearly noticeable on the both gels. 
However, neither rat nor mouse cDNAs had more than one template amplified in each screening 
reaction. The single bands on the gel lanes of the amplicons I and II reveal that alternative splicing 
does occur on the exon 1, generating two different HNRPA3 cDNA templates in both species. No 
more than one band was obtained from the amplifications of amplicons III-VI, suggesting that there 
might not exist another site for splicing variation inside the coding region other than exon 1.  
 
In panel C, the screening on cDNAs from human breast cancer cells is shown in low amplification 
efficiency, which is not comparable with the rat and mouse counterparts. No obvious PCR products 
was detected for the amplicons I and V. One PCR product but in low intensity was observed for 
each of the amplicons II-IV. Only the amplicon VI was sufficiently amplified, but accompanied by 
a small number of unexpected products shown as a few obscure bands on the gel. In order to further 
clarify these unexpected PCR products of the amplicon VI, the reactions with two- and four-fold 
diluted cDNA templates were subsequently carried out under the same PCR cycling conditions. 
Figure 3-18 shows the amplification results targeting to the amplicon VI from ½ and ¼ diluted 
human breast cancer cDNA templates. These obscure PCR products became clearer: one major 
product with the size of 357 bp (indicated as the amplicon VI on gel image, Figure 3-18) and one 
minor product (indicated with an asterisk, Figure 3-18) with approximate 210-220 bp in size. 
Consistently, this minor product is faintly visible on the screening PCR gels using undiluted 
templates (indicated with an asterisk in Figure 3-17, C). Considering the size and position, this 
unpredicted shorter fragment differs from the major amplicon VI by 140-150 bp, and resides in the 
area consisting of exons 7-10. Although the size and position are not in agreement with the 
postulated 187 bp fragment (Makeyev et al., 2005), this novel fragment might represent an 
alternatively spliced transcript of HNRPA3.       
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Figure	   3-­‐17:	   PCR	   screenings	   for	   alternative	   splicing	   on	   the	  HNRPA3	   cDNA.	   Panels	   A,	   B	   and	   C	  demonstrate	  the	  PCR	  results	  using	  cDNA	  templates	  from	  rat,	  mouse	  and	  human,	  respectively.	  In	  panel	  D,	  the	  amplifications	  of	  two	  housekeeping	  genes,	  i.e.	  GAPDH	  and	  ACTB,	  serve	  as	  the	  control	  PCRs.	  The	  same	  amounts	  of	  cDNA	  template	  were	  used	  for	  both	  screening	  and	  control	  PCRs.	  Each	  gel	  lane	  of	  PCR	  products	   was	   labeled	   with	   the	   specific	   targeting	   amplicons.	   The	   sizes	   (bp)	   of	   DNA	   ladders	   were	  indicated	  beside	   the	   images.	  A	  possible	   splicing	   variation	  was	  pointed	  out	  by	   an	   asterisk	  on	   the	   gel	  image	  in	  panel	  C. 	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Other amplicons (i.e. I-V) were also checked in PCRs using the diluted templates, but none of them 
were amplified (data not shown). The problem might be associated with the limitation of the 
traditional PCRs that the concentration of the diluted templates was too low to start amplifications. 
Thus, it is not certain that the failure of template amplifications is due to the poor efficiency of the 
traditional PCRs, or the targeting transcripts do not contain the designed amplicons. To overcome 
this problem, the traditional PCRs was replaced by real-time PCRs, in which the high sensitivity 
and specificity allows the amplification to commence with very low copy number of template 
molecules. Rather than the accuracy of quantifying the amount of amplicon production during the 
reactions, the real-time PCR was preferred here for the merit of automated cycles. Therefore, the 
PCR products were still visualized through the agarose gel electrophoresis (Figure 3-19) when the 
real-time cycles finished.  
	  
 
 
Figure	  3-­‐18:	  PCRs	  on	  the	  amplicon	  VI	  using	  diluted	  cDNA	  templates	  from	  human	  breast	  cancer	  
cells. The	  ½-­‐	  and	  ¼-­‐	  diluted	  cDNAs	  from	  human	  breast	  cancer	  cells	  were	  used	  in	  PCRs	  for	  amplicon	  VI.	  Two	  fragments	  were	  generated	  after	  PCRs:	  the	  upper	  strong	  band	  is	  the	  amplicon	  VI	  (357	  bp)	  as	  predicted;	  the	  lower	  weak	  band	  is	  an	  unknown	  fragment	  (about	  210-­‐220	  bp)	  indicated	  by	  an	  asterisk.	  The	   amplifications	   of	   GAPDH	   and	   β-­‐actin	   were	   experimental	   controls	   with	   the	   same	   template	  dilutions.	  	   
 
 
To further the investigation on alternative splicing of HNRPA3, cDNA templates from a broader 
scope were prepared. For rat brains, total RNAs were extracted at five important brain-developing 
stages (i.e. postnatal days P0, P5, P14, P21 and P49). The real-time PCR screenings on the 
correspondingly synthesized cDNAs would ultimately reveal the conditions of HNRPA3 splicing 
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during the brain maturation. For the samples of Homo sapiens, cDNA templates were synthesized 
from extracted RNAs of two origins: one is the human breast cancer MDA-MB-231 cell line, as 
mentioned before; the other is the brain tissue of a deceased Alzheimer’s disease patient (a kind gift 
from Dr. Peter Dodd). Altogether, there were eight types of cDNA templates over three species 
were screened with the real-time PCRs. Each template was amplified with the specific primers in 
duplicate using the automated cycles, and the resultant the end-point products were analyzed using 
gel electrophoresis. 
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Figure	  3-­‐19:	  Real-­‐time	  PCR	  screenings	  for	  alternative	  splicing	  on	  the	  HNRPA3	  cDNA. Panels	  A-­‐F	  are	  the	  agarose	  gel	  images	  of	  PCR	  products	  after	  screening	  reactions.	  In	  each	  panel,	  the	  same	  specific	  primers	  were	   used,	   and	   the	   targeting	   amplicon	   is	   indicated	   in	   the	   panel	   heading.	   Each	   template,	   as	  labeled	   on	   top	   of	   the	   gel	   lanes,	  was	   amplified	   in	   duplicate.	   Panel	   G	   shows	   the	   amplifications	   of	   the	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housekeeping	   genes	   (GAPDH	   and	   β-­‐actin)	   with	   the	   same	   automated	   cycles,	   serving	   as	   the	   internal	  controls.	  The	  sizes	  (bp)	  of	  the	  standard	  DNAs	  are	  indicated	  along	  with	  the	  DNA	  ladder	  lane.	  A	  possible	  splicing	  variation	  was	  found	  in	  panel	  F,	  indicated	  with	  an	  asterisk.	  	   
 
 
The high sensitivity of real-time PCRs allows the amplification of the templates at a very low level, 
therefore the minor forms of alternatively spliced transcripts would not be concealed due to the low 
efficiency of amplifications. The specific primers of the amplicons I-VI were used for all eight 
cDNA templates, and the panels A-F in Figure 3-19 individually corresponds to the reactions of 
each of the amplicons. The amplifications of two housekeeping gene, GAPDH and ACTB, are the 
internal controls, as shown in panel G. The intensities of these amplified housekeeping genes are 
uniform between the sample templates, which indicates the same amounts of templates were used in 
the screening reactions. 
 
As shown in the panels A-D, the PCR products in the same panel appear to be the identical 
fragments for all species, despite that the intensities of gel bands are different. All these products 
are shown in the single gel band with the matching sizes, suggesting that no splicing variations were 
detected with the primers of amplicons I-V. The major differences in amplifications between 
species are found in the panels E and F, where the amplicons V and VI are targeted.  In panel E, all 
templates from rat and mouse were consistently amplified into the amplicon V products, however, 
the amplification of mouse templates was much less efficient than for rat templates. At the same 
time, the amplifications of the both human templates are similar: no DNA bands are observed other 
than a very faint smear of fragments about 150 bp in size, which looks like the result of primer 
dimers.  
 
In panel F, the templates of rat and mouse were sufficiently amplified into just the amplicon VI 
product. The DNA bands of the PCR products from both human templates are shown to be much 
weaker. The templates of the Alzheimer’s disease patient (HAD) were amplified into the single 
amplicon VI product, while the amplification of templates from the breast cancer cells (HBC) gave 
rise to two products, one major product of the amplicon VI and one minor unknown product with 
the size range of 210-220 bp. This unknown product is consistent with the previous results obtained 
from the traditional PCRs (panel C Figure 3-17 and Figure 3-18). Therefore, it is believed to 
represent another alternatively spliced transcript.  However, this fragment is only observed from the 
amplifications of the HBC templates but not the HAD templates, so that this splicing variation is 
not a universal occurrence in Homo sapiens. This splicing variation of HNRPA3 might be 
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associated with the gene regulation in breast cancer, but more supporting evidence is needed to 
verify this hypothesis.  
 
Collecting all the screening results from traditional PCRs as well as real-time PCRs, other than the 
alternative splicing in the region of exon 1, no splicing variation was found in the HNRPA3 
transcript from rat and mouse brain. In more details, this unique alternative splicing of exon 1 
occurs at all five stages of the rat brain development. In contrast, there are two occurrences of 
alternative splicing on the HNRPA3 transcript from the human breast cancer cells: one is a 66-nt-
long fragment inside exon 1, the other is a fragment with the length of approximate 140-150 nt in 
the region of exon 7-10.  This alternative splicing of exon 1 is common for all HNRPA3 transcripts 
over species and cell types. However, this newly discovered alternative splicing, occurring in exon 
7-10, is restricted to the human breast cancer cells up to this point.   
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Chapter 4. Post-translational modifications  
of hnRNP A3 
4.1 Introduction 
 
In the previous chapter, proteomic mapping of the rat brain A2RE-binding proteins using 2-DE was 
described.  Among these 2-DE-separated proteins, a few protein spots were detected by hnRNP A2- 
and A3-specific antibodies in Western blots, which revealed that both hnRNPs A2 and A3 are 
present in multiple protein isoforms. The separation of the rat brain A2RE-binding proteins was 
also achieved by reverse-phase HPLC, and the masses of separated intact proteins were measured 
by ESI LC/MS. In addition to the anticipated masses of unmodified hnRNPs A2 and A3, a few 
novel masses were detected in close proximity to the unmodified masses of A2 and A3. Although 
the novel masses only accounted for the minority of the overall masses detected, their similarities to 
these unmodified masses strongly suggest the post-translational modifications (PTMs) of hnRNPs 
A2 and A3.  
 
In the post-transcriptional stage, alternative splicing of exons 2 and 9 of the HNRPA2 gene gives 
rise to four transcripts, resulting in four isoforms of hnRNP A2 (Kamma et al., 1999). These four 
isoforms are named in descending order of masses as B1, A2, B1b and A2b, which are also 
mentioned as hnRNP A2/B1 isoforms. The PTMs of these four isoforms further enlarge the 
diversity of the hnRNP A2/B1 proteome. For the HNRPA3 gene, its alternative splicing has been 
confirmed in Chapter 3 (Section 3.4): exon 1 of the rat HNRPA3 gene was identified to be the only 
alternative splicing site. The alternative splicing at exon 1 leads to the two isoforms hnRNP A3, 
A3a and A3b only. Like A2/B1, the A3 proteome presented from the 2-DE gel was more 
complicated than the two protein isoforms. This proteomic complexity of A3 suggests a 
consequence of the multiple PTMs of the isoforms A3a and A3b.  
  
After translation, one or more amino acid residues of eukaryotic proteins are covalently processed 
by cleaving or adding a modifying group. These processing events may dynamically modify one or 
multiple residues of a polypeptide chain in response to certain environmental stresses, which are 
generally classified as PTMs. More than 300 different types of PTMs have been reported, and most 
in vivo PTMs are site-specific for a given protein molecule. A single protein molecule is not only 
modified by a process on multiple residues, but also in combination of different PTMs. This creates 
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tremendous heterogeneity of protein properties, making it more difficult to structurally characterize 
PTMs so as to understand their functional impacts of protein modifications in living cells. Many 
vital cellular processes are regulated by the PTMs of protein, such as switching between functional 
states, subcellular localization, turnover, and interactions with other proteins (reviewed by (Mann & 
Jensen, 2003)).  
 
PTMs are commonly found from the members of hnRNP A/B family. According to annotations in 
Swiss-Prot protein database (UniProtKB/Swiss-Prot, http://www.uniprot.org), all three paralogs, A1 
(entry P04256 ROA1_RAT), A2/B1 (entry A7VJC2, ROA2_RAT), and A3 (entry Q6URK4, 
ROA3_RAT), contain multiple PTMs, which include acetylation, methylation and phosphorylation. 
Except for A1 whose protein modifications have been extensively reported, most annotations about 
the PTMs of A2 and A3 are predicted by amino acid sequence similarity, lacking the experimental 
identifications.  
 
When a group of proteins are separated by the denaturing 2-DE, each gel spot represents an 
individual protein molecules, whose gel position is featured by its unique combination of pI and 
MW. In the 2-DE profile of rat brain A2RE-binding proteins, a series of spots were detected to be 
A3 isoforms from the preliminary Western blotting (described in Section 3.3.3). Also, the LC/MS-
detected novel masses were larger than but closely related to the masses of unmodified A2 and A3 
isoforms (described in Section 3.2.4). Given the fact that A3a and A3b isoforms are the only 
HNRPA3 gene products in rat brain, this complex pattern of the A3 proteome of rat brain might be 
expanded by the PTMs of the basic A3a and A3b molecules.  So far, the research in the PTMs of 
hnRNP A3 is still a largely unexplored area. Only two large-scale phosphoproteomic reports on 
phosphorylation of A3 had been published at the time this project commenced: two phosphoserines 
(pS356 and pS376) of A3 were identified from rat renal cells (Hoffert, Pisitkun, Wang, Shen, & 
Knepper, 2006), and one phosphoserine (pS359) was identified in a Rous sarcoma virus-
transformed kidney cell line (Yamaoka et al., 2006). 
 
In this chapter, the overall aim was to investigate the protein modification of hnRNP A3 among the 
rat brain A2RE-binding proteins, with a particular focus on phosphorylation and Arg modifications. 
Thus, the experiments in this chapter were carried out from three aspects: protein identification of 
2-DE separated rat brain A2RE-binding proteins; phosphoproteomic studies of all A2RE-binding 
proteins; and peptide analysis in searching for phosphorylation and Arg modification sites of A3 
isoforms. 
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Protein identification of hnRNP A/B isoforms 
 
The bottom-up peptide mass fingerprinting (PMF) was used in the protein identification of gel-
separated A2RE-binding proteins. The MS-measured “fingerprints” of peptide masses, unique to 
each amino acid sequence of a particular protein, were searched against databases of in silico 
peptide masses of known proteins, After comparing all experimental masses with the theoretical 
ones, the computer program generated a statistical result for the best-matched protein, finally 
revealing the protein identity. 
 
Selected protein bands or spots from 1-DE and 2-DE-separated A2RE-binding proteins were 
digested in-gel with trypsin, and the peptides subsequently eluted from the gel slices and subjected 
to MALDI-TOF MS for PMF identification. In parallel, a double-digestion with trypsin and 
endopeptidase Asp-N was carried out to circumvent the limit of single typsin digestion, enlarging 
the overall peptide coverage for PMF. Endopeptidase Asp-N, only cleaving at the N-terminal of 
Asp residues, is a good complement to trypsin, which specifically cuts the peptide bonds at the 
carboxyl end of Arg and Lys. After analyzing PMF results of both tryptic and trypsin/Asp-N 
double-digested peptides, most rat brain A2RE-binding proteins were successfully identified. 
 
Phosphoproteomics of the A2RE-binding proteins 
 
Of the hnRNP A/B family members, only phosphorylation of hnRNP A1 has already been well 
studied. Some cellular processes, such as pre-mRNA splicing (Valcarcel & Green, 1996) and 
mRNA nucleo-cytoplasmic export (Tenenbaum & Aguirre-Ghiso, 2005), are closely coupled to 
phosphorylation of A1. Ser and Thr phosphorylations regulate RNA-binding activities of A1 
(Hamilton, Burns, Nichols, & Rigby, 1997): phosphorylated A1 specifically binds intronic 
sequences in the nucleus: whereas dephosphorylated A1 preferentially interacts with poly(A) RNA 
in the cytoplasm. In addition, the phosphorylation of A1 is inducible by stress stimuli such as 
osmotic shock or UV-C irradiation (van der Houven van Oordt et al., 2000), and the 
phosphorylation/dephosphorylation state of A1 determines the protein accumulation in the bi-
directional nucleo-cytoplasmic pathway (Allemand et al., 2005). 
 
The 2-DE profile of rat brain A2RE-binding proteins showed that the identified A3 spots were 
expanded into two horizontal trails. Inside each trail, these spots shared the same isoform identities, 
reflecting they came from the same origin of the protein isoform. However, multiple pI-changing 
PTMs converted them into a group of individual “charge isomers”, shown as a series of modified 
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versions of two alternatively spliced gene products. Very similar in molecular mass, these charge 
isomers differed from each other mainly by their pI values. Given the 71% homology of the protein 
sequence between hnRNPs A1 and A3, phosphorylation was assumed to be responsible for the pI-
varied charge isomers of A3 isoforms. 
 
Initially, the phosphorylation on Tyr residues was detected through 1-D Western blotting using a 
phosphor-Tyr antibody. Later, a comprehensive detection of Ser-, Thr- and Tyr- phosphorylation 
was achieved by Pro-Q Diamond fluorescent (Molecular Probes) staining of 2-DE-separated A2RE-
binding proteins. This commercially available Pro-Q Diamond stain specifically binds to the 
phosphate groups of Ser, Thr and Tyr residues, detecting as low as 4 ng of phosphorylated protein 
per spot. The overall phosphoproteome of the A2RE-binding proteins was clearly depicted on the 2-
DE gel after staining, and the phosphorylated A3 isoforms were carefully chosen for further 
characterization.  
 
Based on the reversible nature of protein phosphorylation, changes of the A2RE-binding proteins 
between phosphorylated and dephosphorylated states were observed. The endogenous 
phosphorylated A2RE-binding proteins were maintained by the addition of phosphatase inhibitor 
throughout the entire purification procedure, whereas the dephosphorylated proteins were obtained 
after incubation with phosphatase upon protein purification. The 2-DE proteomic profiles of the 
proteins in either phosphorylation state were subsequently compared. The shifting protein spots 
confirmed the Pro-Q Diamond stained phosphor-proteome. Also, the phosphorylated A3 isoforms 
were selected for the following identification of phosphorylation sites.  
 
Identification of Arg modifications of hnRNP A3  
 
The structure of the amino acid Arg includes a 3-carbon aliphatic straight chain capped by a 
complex guanidinium group in the distal end. Because the guanidinium group remains positively 
charged in most pH conditions, the free Arg is a strong basic amino acid. Methylation and 
citrullination (also called deimination) are the two major PTMs of Arg residue, and modifications 
always occur on the guanidinium group of the Arg residue.  
 
Arg methylation is a process (depicted in Figure 4-1) that mono-methyl or di-methyl groups are 
delivered to the nitrogen atom of the guanidino moiety (NG), resulting in three methylarginine 
forms in eukaryotes: ω-NG-monomethylarginine (MMA); asymmetric	  ω-NG,NG-dimethylarginine 
(aDMA); and symmetric	   ω-NG,N’G-dimethylarginine (sDMA) (Gary & Clarke, 1998). 
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Peptidylarginine methyltransferases (PRMTs) catalyze Arg methylation, whereas Arg deaminases 
(PADs) covert Arg residues to citrullines (Cit) (Y. Wang et al., 2004). Methylation does not alter 
the cationic property of Arg residue, but increases its hydrophobicity and introduces a 14 Da mass 
increase for each incorporated methyl group.  
	  
Figure	  4-­‐1:	  Methylation	  of	  arginine.	  Monomethylation	  is	  catalysed	  by	  type	  I	  and	  II	  PRMTs	  which	  add	  a	   methyl	   group	   to	   the	   guandino	   nitrogen	   atom	   of	   aginine.	   PRMT	   type	   II	   catalyses	   symmetrical	  dimethylation	   by	   adding	   a	   second	   methyl	   group	   to	   the	   opposite	   nitrogen	   atom,	   whereas	  asymmetrically	   dimethylated	   arginine	   is	   the	   result	  when	   two	  methyl	   groups	   are	   added	   to	   the	   same	  nitrogen	   by	   PRMT	   type	   I.	   S-­‐adenosylmethionine	   (SAM)	   is	   a	   methyl	   donor	   and	   is	   released	   as	   S-­‐adenosylhomocysteine	   (SAH)	   after	   methylation.	   Monomethylarginines	   can	   also	   be	   deimidated	   by	  PADs	  and	  becomes	  citrulline.	  (Cited	  from	  (Boisvert,	  Chenard,	  &	  Richard,	  2005)	  
 
Protein methylation typically takes place on Arg or Lys residues. For hnRNPs, methylations occur 
exclusively on Arg residues (Wilk, Werr, Friedrich, Kiltz, & Schafer, 1985). 12% of the total Arg 
residues of hnRNPs are methylated, which are commonly found in the regions with clustered Arg-
Gly-Gly motifs (RGG box) or Arg-Gly repeats (Boffa, Karn, Vidali, & Allfrey, 1977). These 
methylated Arg residues of hnRNPs are typically in form of aDMA, and the aDMA residues of 
hnRNPs account for about 65% of total methylarginines in the cell nucleus (Boffa et al., 1977). 
 
hnRNP A1 is highly methylated in vivo, containing 3.1-4.0 mol of aDMA per mol of the protein (S. 
Kim et al., 1997). However, researches on the methylations of its paralogs hnRNP A2 and A3 are 
far behind. Annotated in the Swiss-Prot database, the methylation sites of both hnRNPs are 
predicted, in absence of supporting experimental results. Here, the tandem MS (also known as 
MS/MS) approach was carried out to characterize the methylation of A3 isoforms, resulting to the 
unambiguous identification of aDMA residues in the protein C-terminal GRD (Friend et al., 2013). 
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The identified methylarginines A3 were analyzed in comparison with methylated Arg residues of 
A1 and A2.  
 
Citrullination, also known as deimination, is an Arg-exclusive modification which converts protein 
Arg residues into Cit residues by an enzyme family of PADs (Vossenaar, Zendman, van Venrooij, 
& Pruijn, 2003). This Arg-Cit conversion is accomplished by replacing the primary =NH group of 
Arg residue with a =O group, resulting in with a very small change in molecular mass (somewhat 
less than 1 Da) and one positive charge loss. Amino acid Cit is not among the twenty standard gene-
encoding amino acids, but a PTM product.     
 
At present, no Cit residue has been reported in hnRNPs. Myelin basic protein (MBP), synthesised 
by oligodendroglial cells, is among few proteins in the CNS containing Cit residues. The portion of 
citrullinated-MBP relative to total MBP closely correlates with the brain plasticity, and regulates 
myelin degeneration (Harauz & Musse, 2007). Nearly all MBP is deiminated in the child brain 
under the age of 2, but the ratio of citrullinated-MBP to total MBP decreases rapidly from almost 
100% to 18% between 2 and 4 years of age (Moscarello, Wood, Ackerley, & Boulias, 1994).  
 
In oligodendrocytes, the trafficking of MBP mRNAs depends on the roles played by hnRNP A/B 
proteins. It is worth mentioning that the A2RE sequence came from the 3’ UTR of MBP mRNA. 
Through the specific protein-RNA binding, the trans-factors A2 and A3 escort the cis-element 
A2RE-sequences (i.e. MBP transcripts) to the distal cytoplasmic locations in oligodendrocytes for 
local translation (Carson & Barbarese, 2005). In this chapter, the rat brain hnRNPs A/B proteins 
were purified by binding to the specific A2RE-sequence. With this close connection between 
hnRNP A/B proteins and the A2RE-containing MBP transcripts, citrullination was hypothesized to 
be another charge-related PTMs on hnRNP A/B isoforms. The putative Cit-containing peptides 
were analyzed by the tandem MS to identify Arg citrullination. 
 
Bottom-up proteomic strategy 
 
With the knowledge of the intact protein masses of the A2RE-binding proteins obtained from 
previous LC/MS method (described in Section 3.2.1.4), the bottom-up proteomic strategy 
(including PMF and MS/MS approaches) was used for the structure characterizations described in 
this Chapter. 
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There are three major advantages in this MS-based bottom-up strategy (Aebersold & Goodlett, 
2001). First, the small proteolytic peptides are better resolved in MS than large proteins. Second, 
MS of digested peptides greatly reduces the impact of unknown PTMs on protein identification. 
The parent protein can be identified if sufficient sequence information is accessible from 
unmodified peptides, regardless of any modification. Furthermore, the peptides containing unknown 
PTMs can be fragmented and analyzed in detail by the tandem MS. The first MS stage of the 
tandem MS provides the masses of the proteolytic peptides for selecting the precursor ions. In the 
next MS stage, the precursor ions were fragmented into a range of daughter ions, which reveals 
explicit information of the amino acid sequence. Short peptides have fewer components after 
fragmentation than do intact proteins. The third advantage is that complete MS/MS fragmentation 
spectra from the bottom-up approach are relatively easy to analyze. After MS/MS, not only the 
amino acid sequence of the selected peptide will be identified, but also the peptide PTMs will be 
precisely located on the backbone residues.  
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4.2 Protein identification 
4.2.1 Tryptic peptide analysis of 1-DE separated A2RE-binding proteins 
	  
The first step of bottom-up methodology in protein identification was separating proteins, either by 
denaturing 1-DE or 2-DE. The image of 1-DE gel (Figure 4-2) shows that rat brain A2RE-binding 
proteins were separated into a group of protein bands approximately ranging in size from 35 to 41 
kDa. Five major protein bands, as indicated by arrows in the figure, were postulated to contain 
isoforms of hnRNPs A2 and A3. These protein-containing gel bands were individually excised, in-
gel digested with trypsin, and the masses of tryptic peptides were then measured by MALDI-TOF 
MS. The final protein identification was achieved by PMF, matching the resultant peptide masses 
against the theoretical peptide masses of known proteins.  
 
 
	  
Figure	   4-­‐2:	   1-­‐DE	   separated	  
A2RE-­‐binding	  proteins	  for	  in-­‐gel	  
digestion.	  Rat	  brain	  A2RE-­‐binding	  proteins	   were	   isolated	   from	   pull-­‐down	   experiments	   and	  subsequently	   separated	   by	   1-­‐D	  SDS-­‐PAGE.	   The	   gel	   was	   stained	  with	   Coomassie	   blue.	   Five	   major	  protein	  bands,	  indicated	  by	  arrows,	  were	   excised	   and	   subject	   to	   in-­‐gel	  tryptic	  digestion.	  
 
 
In MALDI-TOF spectrometry, two conventional matrices for peptide analysis, α-cyano-4-
hydroxycinnamic acid (CHCA) and sinapinic acid (SA), were separately used in measuring the 
peptide masses. Thus, two independent sets of the peptide mass spectra were collected and analyzed 
in Figure 4-3. 
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bands	  
2-­‐5	  are
	  shown
	  in	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  I-­‐IV
.	  For	  co
mparis
on,	  eac
h	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l	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es	  two
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a	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  C
HCA-­‐	  a
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  SA-­‐
assiste
d	  MS)	  o
f	  the	  sa
me	  dig
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  p
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.	  Peptid
e	  
masses
	  were	  
labeled
	  on	  the
	  corres
pondin
g	  peak
s,	  and	  
the	  ma
tched	  p
eptides
	  were	  
highlig
hted	  w
ith	  red
	  and	  gr
een	  co
lours.	  T
he	  isof
orm-­‐sp
ecific	  p
eptides
	  
were	  in
dicated
	  with	  a
rrows	  
and	  the
	  peptid
e	  seque
nces.	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Each of the mass spectra was subject to MASCOT searching for the peptide primary sequences. 
The matched masses were evaluated by the molecular weight search (MOWSE) scoring algorithm 
(Pappin, Hojrup, & Bleasby, 1993), which is implemented inside the MASCOT search engine. The 
algorithm interprets the searching results into MOWSE scores, so that the searching results with the 
top MOWSE score will be designated by the system to be the protein identity. The CHCA- and SA-
assisted mass spectra were individually searched against the taxonomy of Rattus norvegicus in the 
NCBInr database. The conditions for peptide searching were set to allow one miscleavage with 
peptide tolerance of 0.5 Da, the fixed carbamidomethylation of cysteines and variable oxidation of 
methionines. No protein mass constraints were applied.  
 
For hnRNP A/B family members, the differences in protein sequence between isoforms encoded by 
a single-gene are originated from alternative splicing. Therefore, the tryptic peptides between the 
single gene encoded isoforms are almost in common, except for the alternative splicing region. 
When the matched peptides do not span over the alternative splicing sites, MASCOT searching will 
result in a list of isoforms all containing the matched peptides. Among the list of candidate 
isoforms, the smallest isoform, such as isoform A2b of hnRNP A2/B1 or isoform A3b of hnRNP 
A3, would normally designated by the system to be the protein identity due to the high MOWSE 
score together with the high percentage of matched peptides. For this reason, the MASCOT 
searching results have to be scrutinized to determine the correct isoform as the protein identity. The 
isoform-specific peptide masses indicated in the mass spectra unambiguously specified some 
protein isoforms (i.e. hnRNP A3a and A3b); whereas other isoforms without the signature peptides 
were determined by considering the molecular weights of their undigested parent proteins. The 
CHCA- and SA-assisted MS protein identification of bands 1-5 were summarized in Table 4-1. 
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Table	  4-­‐1:	  1-­‐D	  protein	  identification	  of	  gel-­‐separated	  A2RE-­‐binding	  proteins	  	  Protein	  identifications	  of	  bands	  1-­‐5	  were	  specified	  into	  isoforms,	  which	  were	  classified	  into	  methods	  of	  CHCA-­‐	   and	  SA-­‐assisted	  MALDI-­‐TOF	  mass	   spectrometry.	  The	   isoform	  determination	  was	  based	  on	  MASCOT	  searching	  results	  together	  with	  the	  previous	  Western	  blotting	  detections.	  The	  corrections	  of	  isoform	   identities	   are	   indicated	   with	   superscript	   numbers,	   and	   explained	   in	   the	   notes	   below.	   A	  MOWSE	  probability	   score	  was	   generated	   by	  MASCOT	   for	   every	   spectrum	   searching	   performed,	   and	  the	   MOWSE	   scores	   listed	   in	   the	   table	   showed	   the	   significance	   of	   the	   matches.	   The	   percentage	   of	  sequence	   coverage	   was	   individually	   calculated	   for	   the	   matched	   peptides	   in	   the	   entire	   protein	  sequence.	  	  
Gel	  
Band	  
CHCA-­‐assisted	  mass	  spectrometry	   SA-­‐assisted	  mass	  spectrometry	  
Matched	  
protein	  
Coverage	  
(%)	  
MOWSE	  
Score	  
Matched	  
protein	  
Coverage	  
(%)	  
MOWSE	  
Score	  
#1	  
hnRNP	  A2	  1 	  (gi|157059859)	   53	   126	   hnRNP	  A2	  1 	  (gi|157059859)	   48	   84	  
#2	  
Mixture	  of	  
	  	  	  hnRNP	  B1	  2 	  	  	  	  (gi|157265559)	  +	  
	  	  	  hnRNP	  A3b	  	  	  	  	  (gi|157277969)	  
	  	  49	  	  	   33	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Mixture	  of	  
	  	  	  hnRNP	  B1	  2 	  	  	  	  (gi|157265559)	  +	  
	  	  	  	  hnRNP	  A3b	  	  	  	  (gi|157277969)	  
	  	  56	  	  	   36	  
123	  
#3	  
Mixture	  of	  
	  	  	  hnRNP	  A3b	  	  	  	  (gi|157277969)	  +	  
	  	  	  hnRNP	  B1	  2 	  	  	  	  (gi|157265559)	  
	  	  45	  	  	  46	  
165	   hnRNP	  A3b	  (gi|157277969)	   36	   69	  
#4	  
hnRNP	  A3a	  (gi|31559916)	  	   37	   105	  
Mixture	  of	  
	  	  	  hnRNP	  B1	  2 	  	  	  	  (gi|157059859)	  +	  
	  	  	  hnRNP	  A3a	  	  	  	  (gi|31559916)	  
	  49	  	  	  29	   148	  
#5	  
Beta-­‐actin	  (gi|4501885)	  	   46	   82	  
Mixture	  of	  
	  	  	  Beta-­‐actin	  	  	  	  (gi|4501885)	  +	  
	  	  	  hnRNP	  A3a	  3 	  	  	  	  (gi|31559916)	  
	  	  48	  	  	  22	  
141	  
Notes: 
1 MASCOT searching result is hnRNP B0a (isoform A2b, gi|157059863, mass 32572). Considering the size of 
undigested parent protein shown on the SDS-PAGE gel as well as the previous Western blotting, the protein identity 
was corrected to the isoform A2 (gi|157059863, mass 36089).  
2 MASCOT searching result in the mixture is hnRNP B0a (isoform A2b, gi|157059863, mass 32572). With the same 
consideration as 1, the protein identity was corrected to be the isoform B1 (gi|157265559, mass 37512). 
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3 MASCOT searching result in the mixture is hnRNP A3b (gi|157277969, mass 37291). With the same consideration 
as 1, the protein identity was corrected to be the isoform A3a (gi|31559916, mass 39856). 
 
 
Although CHCA- and SA-assisted MS generated different mass spectra, the MASCOT results 
revealed that the protein identifications from both MS methods are consistent. The band 1 contained 
the single protein hnRNP A2 (theoretical mass 36054 Da), which was confirmed by both methods. 
hnRNP A3 isoforms were identified in bands 2-5, either as a single protein or in a protein mixture. 
In the gel image, protein bands 2 and 3 contained proteins of approximate 37-38 kDa, and bands 4 
and 5 contained proteins with sizes greater than 39 kDa. With the results of previous Western 
blotting, the short A3b isoform (theoretical mass 37086 Da) was detected in bands 2 and 3, and the 
full-length A3a isoform (theoretical mass 39652 Da) was found in bands 4 and 5. Here, the precise 
isoform identification of hnRNP A3 was achieved by both MS methods. In the CHCA- and SA-
assisted mass spectra, A3b-specific peptides were found in bands 2 and 3, and A3a-specific 
peptides were in the spectra of band 4. These isoform-specific peptides, as individually indicated in 
the mass spectrum (Figure 4-3) by arrows, stretch right over the alternative splicing site inside the 
exon 1, leading to the unambiguous isoform determination. However in band 5, hnRNP A3 was 
identified without any isoform-specific peptides, so that MASCOT searching result listed A3b as 
the potential identity. Supported by the previous Western blotting detection and the obvious 
molecular weight of more than 40 kDa, the identified hnRNP A3 in band 5 was corrected in Table 
4-1 to be the full-length A3a isoform. 
 
Other than hnRNP A3 isoforms, the matched peptides from bands 2-4 also pointed to proteins 
encoded by HNRPA2B1 gene. The protein size limitation in bands 2-4 were approximate 37-39 
kDa, it suggested that these HNRPA2B1 encoding proteins belong to the full-length isoform hnRNP 
B1 (theoretical mass 37478 Da). According to the molecular weights, hnRNP B1 with the 
theoretical mass should be in the gel position of band 2. Therefore, band 2-containing hnRNP B1 
was assumed to be the unmodified form. However, the proteins inside bands 3 and 4 were around 
38-40 kDa, which were larger than the theoretical mass of the B1 isoform. Hence, the identified 
hnRNP A2/B1 in bands 3 and 4 might be the B1 isoforms carrying a few extra masses from various 
modifications. The full-length B1 isoform is far less abundant than A2, which can be explained by 
the fact that the hnRNP B1 mRNAs account for 2-5% of overall hnRNP A2/B1 mRNA in cells 
(Kozu et al., 1995). Therefore, it was not surprising that the modified forms of hnRNP B1 were in 
an even lower abundance. Due to the low abundance, the amount of modified hnRNP B1 was not 
sufficient to be detected by both MS methods: the presence in band 3 was only detected by CHCA-
assisted MS, whereas the presence in band 4 was only detected by SA-assisted MS.  
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In band 5, the major protein was identified to be β-actin (theoretical mass 41737 Da) from the both 
MS methods, and the minor component was hnRNP A3a which was only detected by the SA-
assisted MS. However, two peptide masses of hnRNP A3, whose peaks were labeled with red 
masses in the CHCA-spectrum (Figure 4-3, Panel IV), were found among the pool of unmatched 
masses of the CHCA-assisted MS. Thus, hnRNP A3a was confirmed in association with β-actin in 
band 5. As mentioned in Section 3.2.1.1, a few non-hnRNP proteins, including β-actin, were 
usually pulled down by the A2RE-nucleotide sequence from the rat brain extracts as a consequence 
of non-specific protein interaction. The theoretical mass difference between hnRNP A3a and β-
actin is Δ2085 Da, which will make a noticeable distance on the gel after 1D SDS-PAGE 
separation. However, the protein compounds of band 5 included both β-actin and hnRNP A3a. The 
co-migration of the abundant β-actin and the inconsiderable hnRNP A3a in SDS-PAGE suggested 
that there might be an approximate 40 kDa protein form for A3a. This form might be present in a 
very small amount, with an approximate 2-kDa-difference to the theoretical mass of the A3a 
isoform. 
 
Coincidentally, the approximately 2 kDa mass discrepancy was also observed between protein 
bands 2 and 4, where hnRNP B1 isoforms were identified. Respectively encoded by HNRPA2B1 
and HNRPA3 genes, B1 and A3a both are the full-length translation product. The PMF-identified 
hnRNP A2/B1 isoform in band 4 and hnRNP A3 isoform in band 5 were observed carrying 2 kDa 
more than the theoretical masses of their full-length isoforms. Therefore, this extra mass of 2 kDa 
was expected to be introduced to the full-length isoforms only after translation, presumably caused 
by multiple processes of PTMs. On the other hand, the molecular weights of hnRNP B1 in band 2 
and hnRNP A3a in band 4 were very similar to their theoretical values, so that these proteins were 
considered to be the unmodified or less modified form of B1 and A3a. 
 
Since the PTM patterns of hnRNPs A2/B1 and A3 are largely unknown, the coincidence of extra 2-
kDa-mass associated with B1 and A3a brought up a few PTM-related questions: What (how many) 
types of PTMs together were attributed to the additional 2-kDa-mass to B1 or A3a? Do the same 
PTM patterns apply to the both full-length and alternatively spliced isoforms of each paralog? Is 
there any similarity in PTM patterns between the paralogs of hnRNP A2/B1 and A3?  
 
From another point of view, if common PTMs were not the major factor accounting for the extra 2-
kDa-mass, the identified B1 in band 4 and A3a in band 5 still contain all the structural information 
of other changeovers at the protein level. Under whatever circumstances, the extra-massed B1 and 
A3a should be target for the further structural investigation. However, in 1-D PMF analysis, co-
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migrations of two proteins always made the minor proteins overshadowed by their major partners, 
bringing difficulties in peptide analysis of the minorities. The structural characterizations of a 
specific protein form necessitated the availability of isolated and enriched protein sources. 
Therefore, PMF analysis of 2-DE separated A2RE-binding proteins, in particular the large B1 and 
A3a isoforms, were explored in the following section to overcome this limitation.  
 
4.2.2 Tryptic peptide analysis of 2-DE separated A2RE-binding proteins 
 
In the previous section, the isoform identifications of A2RE-binding proteins were limited by 1-DE 
separation followed with the PMF approach. The complexity of the mass spectra of the unseparated 
protein mixture would possibly interfere with the effective ionisation of certain peptides, leading to 
false-positive identifications. Thus, 2-DE was carried out to improve the separation of A2RE-
binding proteins, specifically targeting to the proteins around 37-40 kDa.  
 
 
Figure	  4-­‐4:	  2-­‐DE	  gel	  of	  rat	  brain	  A2RE-­‐binding	  proteins	  subject	  to	  PMF	  analysis.	  Rat	  brain	  A2RE-­‐binding	  proteins	  were	  separated	  by	  2-­‐DE	  and	  stained	  with	  Coomassie	  brilliant	  blue.	  The	  scanned	  gel	  image	  was	   cropped	  and	  presented	   in	  PhotoShop	  grids	   to	   indicate	   linear	  pH	  values	  on	   the	  7	   cm	   IPG	  strip	  (horizontal)	  and	  the	  molecular	  weights	  in	  kDa	  (vertical).	  The	  visible	  protein	  spots	  were	  labeled	  with	  numbers.	  The	  theoretical	  pI	  positions	  of	  hnRNP	  A/B	  protein	  isoforms	  were	  indicated	  by	  arrows	  at	  the	  bottom	  of	  image.	  The	  spots	  identified	  to	  be	  the	  same	  protein	  isoforms	  were	  grouped	  by	  the	  blue	  dotted	  lines.	  	  
 
Figure 4-4 shows the gel image of rat brain A2RE-binding proteins after 2-DE using 7 cm IPG strip 
pH 6-11. Compared with the 1-DE protein bands, 2-DE protein spots were much better separated 
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and more concentrated. In addition, the IPG strip of pH 6-11 clearly excluded most of the non-
specific cytoskeleton proteins, including β-actin (pI 5.29), from the hnRNP isoforms. All the visible 
2-DE protein spots were individually investigated by trypsin digestion followed with PMF protein 
identification. Due to the experimental limitations, the identifications of spots 17, 22, 23 and 27 
were not successful. The protein identities of all other spots appearing in Figure 4-4 were clarified 
in Table 4-2. The resultant PMF identities confirmed that each labeled 2-DE spot contained only 
one protein component.  
 
According to the PMF identification, the A2RE-binding protein spots can be easily sorted into 
isoform groups, as outlined by the dotted lines in Figure 4-4. These isoform groups include hnRNPs 
A1, A2/B1 and A3; and exhibited various distribution patterns on 2-DE gel. It implied that the 
hnRNP A1, A2/B1 and A3 isoforms might go through their isoform-specific modification 
processes.  
	  
	  
Table	  4-­‐2:	  Protein	  identifications	  of	  2-­‐DE	  separated	  A2RE-­‐binding	  proteins	  The	  labeled	  protein	  spots	  (Figure	  4-­‐4)	  were	  in-­‐gel	  digested	  with	  trypsin,	  followed	  by	  MALDI-­‐TOF	  mass	  spectrometry.	   MASCOT	   searching	   reports	   were	   summarized	   for	   the	   protein	   identifications,	   which	  were	  listed	  with	  MASCOT	  system-­‐generated	  data	  (i.e.	  sequence	  coverage,	  number	  of	  matched	  masses	  and	   MOWSE	   scores).	   The	   isoforms	   of	   identified	   proteins	   were	   manually	   specified	   based	   on	   the	  molecular	  weight	  of	  the	  undigested	  parent	  proteins	  as	  well	  as	  the	  previous	  Western	  blotting	  results.	  Swiss-­‐Prot	  database	  accession	  codes	  were	  given	  in	  the	  bracket	  along	  with	  the	  protein	  identities.	  Gel-­‐estimated	  values	  were	  deduced	  from	  Figure	  4-­‐4,	  while	  the	  theoretical	  values	  were	  summarized	  from	  Swiss-­‐Prot	  database.	  	  
	  
Gel	  
spot	  
Protein	  
identity	  
Gel-­‐estimated	   Theoretical	   Sequence	  
coverage	  
(%)	  
Number	  of	  
matched	  
masses	  
MOWSE	  
Score	  Mass	  
(kDa)	  
pI	  
Mass	  
(Da)	  
pI	  
#1	  
hnRNP	  A2	  
(A7VJC2)	  
36	   7.36	  
36054	   8.67	  
32	   15	   50	  
#2	   36	   7.78	   47	   21	   76	  
#3	   36	   8.09	   42	   19	   80	  
#4	   36	   8.28	   22	   9	   34	  
#5	   36	   8.43	   28	   9	   35	  
#6	   36	   8.59	   29	   13	   58	  
#7	   36	   8.74	   21	   7	   37	  
#8	   36.1	   8.93	   25	   8	   35	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Gel	  
spot	  
Protein	  
identity	  
Gel-­‐estimated	   Theoretical	   Sequence	  
coverage	  
(%)	  
Number	  of	  
matched	  
masses	  
MOWSE	  
Score	  Mass	  
(kDa)	  
pI	  
Mass	  
(Da)	  
pI	  
#9	  
hnRNP	  A1	  
(P04256)	  
35.5	   8.93	  
34212	   9.20	  
49	   16	   67	  
#10	   35.5	   9.05	   57	   18	   92	  
#11	   35	   9.05	   35	   11	   48	  
#12	   35	   9.16	   30	   15	   21	  
#13	  
hnRNP	  A3b 
(Q6URK4)	  
37	   7.28	  
37086	   8.46	  
49	   22	   118	  
#14	   37	   7.63	   45	   23	   84	  
#15	   37	   8.01	   35	   19	   82	  
#16	   37	   8.28 57	   27	   106	  
#18	   hnRNP	  B1	  
(A7VJC2) 
37.5	   8.78	   37478	   8.97	   51	   13	   103	  
#19	   37.5	   8.89	   61	   23	   96	  
#20	  
hnRNP	  A1b	  
(P09651)	  
39	   8.13 
38747	   9.17	  
47	   12	   80	  
#21	   39	   8.47 32	   7	   52	  
#24	   38.5	   8.97	   33	   12	   22	  
#25	   38	   9.08	   27	   12	   44	  
#26	   38	   9.20	   30	   11	   31	  
#28	  
hnRNP	  A3a	  
(Q6URK4)	  
40	   8.78	   39652	   9.10	   43	   22 100	  #29	   40	   8.93	   42	   19	   84	  
#30	   40	   9.01	   39	   15 81	  
 
 
Inside the A2RE-binding proteome, the overall level of hnRNP A3 is much lower than that of 
hnRNP A2/B1. However, among the 37-40 kDa A2RE-binding proteins, hnRNPs A3a and A3b 
were the most significant components. Of these two alternatively spliced isoforms, the truncated 
isoform A3b (theoretical mass 37086 pI 8.46) was far more abundant with more protein forms than 
the full-length isoform A3a (theoretical mass 39652, pI 9.10). Observed in the gel image, the 
difference in molecular weight was sufficient to vertically separate the isoforms A3b and A3a, and 
the process of isoelectric focusing unrolled these two isoforms into a ladder of spots along the 
horizontal pH gradient. Towards the anodic side, the isoform A3b spread over a broad gradient of 
pH 7.2-8.3 (spots 13-16); whereas the isoform A3a were clustered inside a narrow gradient of pH 
8.7-9.0 (spots 28-30) at the cathodic side. The identified protein spots of A3a and A3b confirmed 
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the antibody detection of the isoforms A3a and A3b from Western blotting in the previous chapter 
(Section 3.2.2.3). Considering protein pI, the corresponding pI values of A3a and A3b spots 
exhibiting in the gel were all lower than their theoretical pIs. This observation suggested a 
consequence of multiple PTMs, altogether introducing anionic charged groups to the modified 
forms of the same isoform.  
 
Being the most abundant component in the A2RE-binding proteins, hnRNP A2 (spots 1-8) spread 
over a broad pH gradient. Given the theoretical pI of A2 is 8.67, large amount of the isoform A2 
spots were localized to the anodic side of its theoretical pI position, reflecting the negative charges 
these protein molecules carried. Less than 10% of the isoform A2 (spot 8) appeared to carry the 
positive charge and migrate to the cathodic side. Besides the 36 kDa isoform A2, the full-length 
isoform B1 was identified from two adjacent spots 25 and 26, situated vertically between the A3a 
and A3b spots. Unlike A2 spots, both B1 spots were observed to carry moderate negative charges 
and localized to the anodic side of their theoretical pI position.  
	  
In addition to the isoforms of hnRNPs A2 and A3, the hnRNP A1 isoforms were also identified by 
2-D PMF. Although neither of the hnRNP A1 isoforms was detected from the 1-D PMF (Table 4-
1), the identification of hnRNP A1 from 2-DE spots confirmed the existence of A1 among the rat 
brain A2RE-binding proteins. It also confirmed the matched protein masses of hnRNP A1, which 
obtained from LC/MS (Table 3-2); however the identified A1 isoforms were in low abundance. 
Both encoded by HNRPA1 gene, A1a and A1b are the only two alternatively spliced isoforms. In 
HeLa cells, the full-length isoform A1b is only 5% the abundance of the truncated isoform A1a 
(Buvoli et al., 1990). As the dominant isoform of hnRNP A1, the truncated isoform A1a has been 
extensively investigated, and the isoform A1a is usually referred as hnRNP A1 if not specified. In 
contrast to the extensive studies on the protein structure and cellular functions of the isoform A1a, 
the knowledge of the full-length A1b isoform are very limited. In the Swiss-Prot database, both 
protein sequences of isoforms A1a and A1b are annotated under the entry of human hnRNP A1 
(ROA1_HUMAN, accession P09651), because the splicing alternations were first discovered in 
HeLa cells. However, under the hnRNP A1 entries of rat (ROA1_RAT, accession P04256) and 
mouse (ROA1_MOUSE, accession P49312), only the protein sequence of A1a is annotated to 
represent hnRNP A1. Till now, the full-length A1b has never been reported in rodents from the 
published research literature.  
  
In the previous section, the full-length hnRNP A1b was overlooked on the 1-D PMF analysis, 
probably because it mixed up with other similar-sized proteins. When separated by 2-DE, the 
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identified isoform A1b (spots 20, 21 and 24-26) was clearly resolved from isoelectric focusing. The 
identification of spots 22 and 23 was not successful, however, it is reasonable to predict both spots 
belong to the isoform A1b based on their gel positions. If each 2-DE gel spot indicates one PTM 
product, the A1b spots spreading over a large pH gradient (from pH 8.13 to 9.20) showed more 
varieties of possible PTMs than the isoform A1a (spots 9-12). Compared to A1b, the truncated 
isoform A1a appeared in fewer spots with less horizontal deviation from its theoretical pI. 	  
 
The 2-DE PMF results expand the previous 1D protein identifications (Table 4-1). Although 
lacking the protein identifications of spots 17, 22, 23 and 27, it is clear enough to understand the 
protein bands in the 1-DE image (Figure 4-2) of the A2RE-binding proteins: band 1 contained the 
isoform A2 only (equivalent to the spots 1-8 in Figure 4-4); bands 2 and 3 contained A3b and B1 
(equivalent to the spots 13-19 in Figure 4-4), which were stacked into two strong bands but not 
separated each other; the blurring region between bands 3 and 4 actually contained the isoform A1b 
(equivalent to the spots 20-26 in Figure 4-4), and the hazy shape reflected the variously modified 
A1b isoforms with tiny mass difference; band 4 contained A3a only; and band 5 contained the 
unspecifically bound β-actin which was co-migrated with A3a. 
 
Detailed identification of 2-DE protein spots clearly mapped the proteome of hnRNPs A1, A2/B1 
and A3 isoforms when they were pulled down by the A2RE cis-element. Inside the A2RE-binding 
context, the abundance of the individually bound isoforms was varied: 36 kDa A2 is the most 
abundant; then followed by 37 kDa A3b, 40 kDa A3a, 37 kDa B1, and the least abundant proteins 
were 34 kDa A1a and 39-40 kDa A1b. The overall amount of A1b among the A2RE-binding 
proteins was comparable to that of A1a, which was far more than the ratio of 5% when identified in 
HeLa cells. Whether it is due to the elevated expression of A1b in rat brain tissue, or the affinity to 
cis-element A2RE enriches the abundance of A1b, remains unknown. By virtue of the 2-D mass 
fingerprinting, the full-length isoform hnRNP A1b is for the first time identified amongst the A2RE 
proteome. The identification of A1a and A1b confirmed the involvement of hnRNP A1 in the 
A2RE-mechanism, along with its paralogs hnRNPs A2/B1 and A3. Especially, the multiple spots of 
the isoform A1b reveals the significance of A1b and its PTM processes when bound to the A2RE 
sequence, which have been overshadowed by the isoform A1a for many years.	  
 
The 2-D position of each gel spot indicates its final PTM state of each modified molecule. The gel-
estimated values of molecular weight and pI would later provide guidance for peptide 
characterization of PTMs. Although all three paralogs share the common “2×RRM-GRD” domain 
structure, the gel distribution pattern implied that the modifications of the paralogs were not 
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uniform. Negative-charged modifications dominated all A1, A2/B1 and A3 isoforms; except for the 
isoform A2 had some positively charged modification products. For the alternatively spliced 
isoform pairs A1a and A1b, A2 and B1, A3a and A3b, the negative-charged modifications were 
never parallelled between the isoform pairs. It implies that there is no direct connection between the 
sequence similarity and the modification pattern of a protein isoform.  
 
4.2.3 Peptide analysis of double-digested hnRNP A3 isoforms  
 
When the tryptic peptides retrieved from 2-D mass fingerprinting were analyzed between three 
paralogs hnRNPs A1, A2/B1 and A3, a similar pattern of sequence coverage was found: the N-
terminal sequences were better digested than the C-terminal parts. Large areas in the C-terminal 
GRD of hnRNPs A1 and A3 were skipped by trypsin. More specifically, a 98-residue-region 
(residues 258-355) situated inside the C-terminal GRD (position 211-379) of hnRNP A3 was 
skipped by trypsin. This region is particularly important for the PTM characterization of hnRNP A3, 
not only because it is rich in glycine residues, but also because it includes a few putative 
modification sites of arginine, serine and tyrosine.  
	  
In order to improve the peptide coverage in the C-terminal GRD of hnRNP A3, a sequential double-
digestion with trypsin and Asp-N endopeptidase was carried out. The 1-DE protein bands 
containing hnRNP A3 were first digested with trypsin. Upon the completion of the trypsin 
digestion, an aliquot of tryptic digestion solution was examined by MALDI-TOF MS before the 
following digestion with Asp-N endopeptidase. It assured that Asp-N proteolysis was initiated on 
the small tryptic peptides rather than the large intact protein molecules. When the second digestion 
with Asp-N endopeptidase was completed, the double-digested peptides were concentrated by C18 
zip-tip and undergone MALDI-TOF MS. Here, two MALDI-TOF mass spectra (Figure 4-6) were 
collected: a spectrum of the C18 zip-tip concentrated peptides, and a spectrum of content left in the 
flow-through solution after the C18 zip-tip purification. The purpose was to improve the signal 
intensity of the peptide masses, as well as to maximize the sequence coverage. MASCOT peptide 
search results of all the peptide masses matching to trypsin/Asp-N double-digested hnRNP A3 were 
listed in Table 4-3.  
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A.	  
	   RRM	  1	   RRM	  2	   GRD	   Overall	  	  Length	  (aa)	   Match	  (aa)	   Coverage	   Length	  (aa)	   Match	  (aa)	   Coverage	   Length	  (aa)	   Match	  (aa)	   Coverage	   Length	  (aa)	   Match	  (aa)	   Coverage	  
A1b	  
(P09651)	   84	   46	   54.8%	   80	   43	   53.8%	   178	   33	   18.5%	   372	   149	   40%	  
B1	  
(A7VJC2)	  
84	   62	   73.8%	   80	   56	   70%	   148	   93	   62.8%	   353	   242	   68.6%	  
A3a	  
(Q6URK4)	  
84	   67	   79.8%	   80	   69	   86.3%	   169	   69	   40.8%	   379	   231	   60.9%	  
	   	  
B.	   	  
	  	  
Figure	   4-­‐5:	   Sequence	   analysis	   of	   tryptic	   peptides	   in	   hnRNPs	   A1,	   A2/B1	   and	   A3.	   The	   identified	  tryptic	  peptides	  of	  hnRNPs	  A1,	  A2/B1	  and	  A3	  were	  summarized	   	   (Panel	  A)	  and	  compared	  with	  amino	  acid	  sequence	  alignments	  (Panel	  B).	  The	  tryptic	  peptides	  were	  searched	  against	  the	  full-­‐length	  sequence	  of	  A1,	  A2/B1	  and	  A3,	   i.e.	  A1b	  (P09651),	  B1	  (A7VJC2)	  and	  A3a	  (Q6URK4).	  The	  percentages	  of	  sequence	  coverage	  were	   also	   calculated	   based	   on	   the	   full-­‐length	   data.	   In	   Panel	   B,	   the	   protein	   sequences	   of	   A1b	  (ROA1_HUM),	  B1	  (ROA2_RAT),	  and	  A3a	  (ROA3_RAT)	  were	  aligned	  with	  their	  common	  protein	  domains	  RRM1,	   RRM2	   (both	   boxed	   in	   red	   shade)	   and	   GRD	   (boxed	   in	   green	   shade).	   All	   the	   identified	   tryptic	  peptides	   retrieved	   from	   2-­‐D	  mass	   fingerprinting	  were	   collectively	  marked	   in	   red	   fonts	   in	   the	   aligned	  sequences.	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  I. Spectra of trypsin/Asp-N digested peptides in band 2 
 
 
 
 
II. Spectra of trypsin/Asp-N digested peptides in band 3 
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IV. Spectra of trypsin/Asp-N digested peptides in band 5 
	  
Figure	  4-­‐6:	  MALDI-­‐TOF	  MS	  of	  double-­‐digested	  hnRNP	  A3.	  hnRNP	  A3-­‐included	  gel	  bands	  2-­‐5	  were	  sequentially	   digested	   with	   trypsin	   and	   Asp-­‐N	   endopeptidase,	   followed	   by	   C18	   zip-­‐tip	   purification.	  	  Both	  the	  C18	  zip-­‐tip	  concentrated	  peptides	  and	  the	  flow-­‐through	  samples	  were	  measured	  by	  MALDI-­‐TOF	  MS,	  as	  shown	  in	  panels	  I-­‐IV.	  In	  the	  spectra,	  peaks	  were	  labeled	  with	  corresponding	  masses,	  among	  which	  the	  identified	  hnRNP	  A3	  peptide	  masses	  were	  highlighted	  in	  red.	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Table	  4-­‐3:	  Matched	  masses	  of	  double-­‐digested	  hnRNP	  A3	  peptides	  	  MASCOT	   matched	   masses	   of	   double-­‐digested	   hnRNP	   A3	   peptides	   were	   summarized.	   The	   positions	   of	   the	  matched	  peptides	  were	  specified,	  in	  particular,	  the	  positions	  inside	  the	  glycine-­‐rich	  region	  were	  underlined.	  The	  peptide	  masses	  of	  Asp-­‐N	  endopeptidase	  only	  cleavage	  were	  shaded	  in	  grey.	  	  
	  
ZipTip	  purified	  peptides	   ZipTip	  flow-­‐through	  peptides	  
Observed	  
mass	  
Calculated	  
mass	  
Peptide	  
position	  	  
Observed	  
mass	  
Calculated	  
mass	  
Peptide	  
position	  	  
Ba
nd
	  2
	  
810.525 810.323 90-­‐96 944.343 944.396 175-­‐182 944.653 944.396 175-­‐182 944.343 944.499 167-­‐174 944.653 944.499 167-­‐174 1072.333 1072.594 166-­‐174 1072.747 1072.594 166-­‐174 1111.383 1111.574 27-­‐35 1312.878 1312.715 36-­‐47 1239.441 1239.669 27-­‐36 1334.859 1334.623 205-­‐216 1275.427 1275.596 48-­‐57 1737.127 1736.795 75-­‐89 1312.455 1312.715 36-­‐47 1771.085 1770.891 37-­‐52 1327.402 1327.645 149-­‐159 1799.080 1798.812 227-­‐246 1736.874 1736.795 75-­‐89 1883.122 1882.954 128-­‐143 1798.552 1798.812 227-­‐246 1911.210 1910.790 356-­‐377 1910.409 1910.790 356-­‐377 2008.218 2007.941 53-­‐68 1920.435 1920.818 332-­‐348 2011.228 2011.049 127-­‐143 1936.420 1936.813 332-­‐348 2398.517 2398.179 162-­‐182 2007.803 2007.941 53-­‐68 2569.457 2569.293 36-­‐57 2010.654 2011.049 127-­‐143 
   1039.284 1039.469 136-­‐143 
   1723.592 1723.892 13-­‐26 
Ba
nd
	  3
	  
829.251 829.369 176-­‐182 944.507 944.396 175-­‐182 829.251 829.514 181-­‐187 944.507 944.499 167-­‐174 944.513 944.396 175-­‐182 1111.580 1111.574 27-­‐35 944.513 944.499 167-­‐174 1234.826 1234.598 152-­‐161 1072.591 1072.594 166-­‐174 1239.665 1239.669 27-­‐36 1184.546 1184.620 37-­‐47 1493.727 1493.662 77-­‐89 1312.687 1312.715 36-­‐47 1798.874 1798.812 227-­‐246 1882.870 1882.954 128-­‐143 1882.940 1882.954 128-­‐143 1911.084 1910.790 356-­‐377 1910.776 1910.790 356-­‐377 1911.084 1910.954 183-­‐198 1920.793 1920.818 332-­‐348 2010.952 2011.049 127-­‐143 1936.795 1936.813 332-­‐348 2398.133 2398.179 162-­‐182 2011.039 2011.049 127-­‐143 2705.117 2705.420 90-­‐113 	   	   	  1993.896 1993.9463 144-­‐159 1723.609 1723.892 13-­‐26	  
Ba
nd
	  4
	  
944.520 944.396 175-­‐182 944.573 944.396 175-­‐182 944.520 944.499 167-­‐174 1111.638 1111.574 27-­‐35 1883.275 1882.954 128-­‐143 1239.752 1239.669 27-­‐36 2398.484 2398.179 162-­‐182	   1299.731 1299.647 37-­‐48 	   	   	   1427.826 1427.742 36-­‐48 	   	   	   1883.031 1882.954 128-­‐143 	   	   	   1910.841 1910.790 356-­‐377 
Ba
nd
	  5
	  
881.350 881.386 247-­‐257 944.571 944.396 175-­‐182 944.599 944.396 175-­‐182 944.571 944.499 167-­‐174 944.599 944.499 167-­‐174 1111.682 1111.574 27-­‐35 1251.789 1251.706 115-­‐126 1137.629 1137.495 205-­‐214 1883.018 1882.954 128-­‐143 1251.782 1251.706 115-­‐126 2270.918 2271.010 205-­‐226 1883.020 1882.954 128-­‐143 2398.112 2398.179 162-­‐182 1910.857 1910.790 356-­‐377 
  	   795.321 795.349 63-­‐68 1994.136 1993.946 144-­‐159	   1723.800 1723.892 13-­‐26 
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When the peptides retrieved from trypsin-only and trypsin/Asp-N digestions were mapped on the 
same hnRNP A3 sequence of (Panel A, Figure 4-7), the sequence coverages of both digestions were 
highly comparable. The combination of trypsin and Asp-N endopeptidase slightly improved the 
proteolysis, mostly in the N-terminal RRMs. Inside the trypsin-skipped C-terminal GRD region, 
only one fragment (residue 332-348) was obtained, which were cleaved by Asp-N endopeptidase at 
amino-terminus and trypsin at the carboxyl-terminus. In addition, a modified counterpart of this 
peptide containing methionine sulfoxide (MSO) at M347 was also identified from the double-
digestion. 
	  
According to the sequence mapping of peptides, a fragment (residue 259-331) inside the protein 
GRD resisted either trypsin or Asp-N endopeptidase cleavage. Analyzed in-depth, this indigestible 
segment was found to satisfy all the features of the “Gly-loop” motif (Steinert et al., 1991), which 
was first described in the GRD of hnRNP A1 to explain the protein configuration in the ssRNA 
binding and protein-protein interactions. The “Gly-loop” motif defines a repeating protein region 
with the Gly content around 40-50% and 10-15% aromatic residues. Each “Gly-loop” is made of an 
aromatic or long-chain aliphatic residues, i.e. Tyr (Y), Phe (F) or Met (M), directly followed with 
one or more Gly residues or variable polar residues, such as Ser (S), Asn (N), Arg (R) and Cys (C). 
The Gly-loops are usually indexed with the aromatic/aliphatic residues to make a virtual backbone 
chain, with the interval spacing of Gly residue loops (Steinert et al., 1991). In order to understand 
the possible configuration of the indigestible fragment of A3, a schematic diagram of Gly-loops was 
drawn from residues 259-355 (Panel B, Figure 4-7). As shown in the diagram, the Gly-loops were 
made of various Gly clusters, and these loops were stacked regularly on a virtual backbone chain 
consisting of residues Y, F and M. 
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Within the indigestible segment of residues 259-331, there are three cleavage sites for Asp-N 
endopeptidase and one for trypsin. In general, Asp-N endopeptidase cleaves the peptide bonds to 
the N-terminal side of Asp (D) residues. Two Asp residues (D265 and D274) subjected to Asp-N 
cleavage were flanked by multiple Gly residues, appearing in a “GGDGG” pattern. Moreover, both 
“GGDGG” patterns were at the apex of the Gly-loops (Panel B, Figure 4-8). This apex “GGDGG” 
pattern was only found in A3, not in A1 and A2. Usually, the hydrophilic residues at the apex 
position of Gly-loops are engaged in H-bonding interactions with similar residues on adjacent Gly-
loops or with other molecules (Steinert et al., 1991). Whether this A3-specific “GGDGG” pattern in 
Gly-loops or the hydrophilic Asp residues involved H-bonding interaction inhibit the Asp-N 
cleavage remains unclear. However, the resistance to Asp-N proteolysis might imply a more 
specific and complicated protein configuration of this region. 
 
Not at the apex of Gly-loop, the third Asp residue (D311) joined directly to the backbone Tyr 
residue (Y310). It has been reported that Asp-N digestion is inhibited when Asp residues are 
immediately adjacent to sulfated Tyr (sY) (Onnerfjord, Heathfield, & Heinegard, 2004). For this 
reason, residue Y310 might be the key for the resistance of Asp-N cleavage. Because sulfation is 
the most common PTM of Tyr residues (Baeuerle & Huttner, 1987), it normally occurs at Tyr 
residues located next to neutral or acidic residues (Bundgaard, Vuust, & Rehfeld, 1997). In this 
light, the sulfation of residue Y310 might be reason for the miscleavage of Asp-N endopeptidase at 
D311.  
     
Residue R286 is the only cleavage site for trypsin in the region of residues 259-331. As shown in 
the diagram, R286 was inside a RGG box right at the tip of its Gly-loop. When aligned with the 
protein sequence of hnRNP A2, the RGG box-containing residue R254 is the counterpart of the 
residue R286 of hnRNP A3. Similarly, both Arg residues are at the apex of the Gly-loops, and both 
Gly-loops were flanked by the two Tyr residues as the virtual backbone chain. However, the Gly-
loops harbouring these two counterpart Arg residues are different: R286 of A3a is in a five-residue-
loop of “SSRGG”; whereas the Gly-loop of R254 consists of “GGGRGG”. Interestingly, the 
residue R254 is the only methylated Arg residue in A2, modified by the process of asymmetric 
dimethylation (Friend et al., 2013), which directly resulting in the trypsin mis-cleavage at R254 
residue. With the knowledge of the asymmetrical dimethylated R254 of A2, the resistance to trypsin 
at the residue R286 of A3 implied an Arg modification.  
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A few PTMs of A3 had been postulated from the peptide analysis. In the following sections, the 
putative PTMs were investigated, mostly focusing on protein phosphorylation and Arg 
modifications.  
 
4.3 Phosphorylation analysis 
4.3.1 Reversible phosphorylation of the A2RE-binding proteins 
 
Reversible phosphorylation of proteins is an important regulatory mechanism, in which kinase and 
phosphatase are involved in phosphorylation and dephosphorylation, respectively. According to the 
annotations of Swiss-Prot database, all of the human hnRNP A/B proteins have been reported 
containing phosphorylated residues. However, no experimental evidence has been presented for the 
phosphorylation of their counterparts in rats. Based on the reversible nature of protein 
phosphorylation, comparative gel-based proteomics were used, in which the transition between 
phosphorylation states was observed by comparing 2-DE gels of the same proteins in either 
phosphorylated or dephosphorylated conditions.  
 
Purification of the rat brain A2RE-binding proteins was always carried out in the presence of 
protease inhibitors. To investigate the protein phosphorylation, the phosphatase inhibitor 
(Phosphatase Inhibitor Cocktails 2, Sigma Life Science) was specifically added to maintain the in 
vivo phosphorylation state of proteins. In contrast, the other batch of sample was processed under 
the condition free of phosphatase inhibitors, and was additionally treated with phosphatases 
(FastAP Thermosensitive Alkaline Phosphatase, Thermo Scientific). The dephosphorylation easily 
occurs when exposed to phosphatases without the protection of any phosphatase inhibitor. These 
two batches of A2RE-binding proteins were extracted from rat brains, purified, and simultaneously 
separated with 2-DE. The only difference between two batches was the inclusion of either 
phosphatase inhibitors or phosphatases during the extraction and purification procedures. The 2-D 
proteomic profiles of these two batches of protein samples were compared, as shown in Figure 4-8.  
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Figure	  4-­‐8:	  Gel	   comparison	  of	   the	  A2RE-­‐binding	  proteins	   in	  different	  phosphorylation	   states.	  Two	  batches	  of	  rat	  brain	  A2RE-­‐binding	  proteins	  were	  purified	  in	  parallel.	  First	  batch	  of	  proteins	  were	  purified	  in	  the	  presence	  of	  phosphatase	  inhibitors	  (panel	  A).	  The	  other	  batch	  of	  proteins	  (panel	  B)	  was	  purified	   free	   of	   phosphatase	   inhibitors,	   and	   subsequently	   treated	  with	   phosphatases.	   Each	   batch	   of	  A2RE-­‐binding	  protein	  sample	  was	   individually	  electrophoresed	   in	  both	  one-­‐	  and	  two-­‐dimensions	  on	  the	  same	  gel	  simultaneously,	  followed	  by	  Coomassie	  blue	  staining	  for	  visualization.	  Shown	  on	  the	  gel	  panel,	  the	  left-­‐sided	  area	  is	  the	  2-­‐DE	  mapping	  of	  A2RE-­‐binding	  proteins	  isoelectrically	  focused	  on	  the	  IPG	  strip	  (7cm,	  pH	  6-­‐11);	  whereas	   the	  right-­‐sided	   lane	   is	   the	  1-­‐DE	  of	  an	  aliquot	  of	   the	  same	  protein	  sample.	  The	  boundaries	  between	  1-­‐DE	  and	  2-­‐DE	  were	   indicated	  by	   short	  double	   lines	  on	   top	  of	   the	  gels.	   The	   positions	   of	   hnRNPs	  A2	   and	  A3	   are	   briefly	   indicated	   on	   the	   1-­‐D	   lane.	   Eight	   protein	   spots,	  labelled	  with	  number	  1-­‐8,	  are	  outlined	  by	  the	  red-­‐dotted	  circles	  in	  panels	  A	  and	  B.	  Pink-­‐coloured	  panel	  A	  image	  is	  merged	  with	  panel	  B	  image	  for	  comparison,	  as	  shown	  in	  panel	  C.	  The	  green	  arrow	  lines	  in	  panel	  C	  indicate	  the	  translocation	  directions	  of	  protein	  spots	  1-­‐8	  after	  dephosphorylations.	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The merged proteomic profile (Panel C, Figure 4-8) clearly showed the eight protein spots shifted 
horizontally. As identified from previous sections, the corresponding protein identities of this eight 
spots were: spots 1 and 2 were the less abundant A1b, spots 3-5 belong to A3b, and spots 6-8 were 
the abundant A2 isoforms.  
 
The phosphatases or inhibitors were the key in this comparative gel analysis. Therefore, the 
translocation of the same protein spots between the two 2-DE gels revealed the changes of the 
phosphorylation states. The general impacts of adding or removing a phosphate group to a protein 
molecule are illustrated in Figure 4-9, using an IPG strip to show the isoelectrical differences. 
During phosphorylation, the negative-charged phosphate group was delivered to the protein, so the 
phosphorylated molecules migrate towards the anode of the IPG strip. Conversely, 
dephosphorylation, catalyzed by protein phosphatase, reverses the phosphorylation process by 
removing the side-chain phosphate groups. Therefore, the dephosphorylated protein would shift 
back towards the cathode side.  
 
 
 
Figure	  4-­‐9:	  Effect	  of	  reversible	  phosphorylation	  on	  proteins.	  The	  diagram	  was	  drawn	  using	  Adobe	  Illustrator	  based	  on	  definitions	  of	  phosphorylation	  and	  dephosphorylation.	  	  	  
 
 
From the gel comparison in Panel C (Figure 4-8), the anode-to-cathode shifting was observed for all 
protein spots 1-8, which indicated the elimination of negative charges occurred on all eight 
molecules. The phosphatase treatment without the protection of phosphatase inhibitors was the only 
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reason accounting for the elimination of negative charges, which implied that the in vivo 
phosphorylated protein spots 1-8 were dephosphorylated when exposed to phosphatases.  
 
The number of negative charges being removed in dephosphorylation determines how far the 
affected protein molecules should shift during IEF. The more charges a molecule loses, the longer 
the distance it migrates. Spots 1-8 in Panel C all showed a common pattern in gel translocation: for 
the protein spots of the same isoform identity, the spots on the left (towards anode side) always 
shifted a longer distance than ones on their right (towards cathode side) after dephosphorylation. 
This implied that the left-sided protein spots contained more in vivo phosphorylated residues than 
their right-sided neighbours, so that more negative charges of the phosphate groups were possibly 
removed during the dephosphorylations. However, the phosphatase treatment did not make a trail of 
protein spots shrinking into one single spot. Instead, the different isoforms sharing a single protein 
identity were still scattered in a trail but with narrower intervals. Two possibilities could be deduced 
from this observation. First, the in vivo phosphorylated residues may not be fully dephosphorylated 
when treated with non-specific phosphatases in this experiment. Some phosphorylated residues 
might be relatively stable than other when confronting the phosphatases. Second, there might exist 
some types of protein modifications other than phosphorylation, which also brought negative 
charges to the modified molecule without being affected by phosphatases.  
 
4.3.2 Phospho-protein detection 
 
Comparative gel analysis indirectly identified that at least eight protein spots (i.e. A1b, A2 and 
A3b) among the A2RE-binding proteins containing the reversibly phosphorylated residues. 
However, the reversibility of each phosphorylated residue is not identical, and the comparative gel 
analysis only revealed the phospho-proteins easily being reversed due to the non-specific 
dephosphorylations. Therefore, some phospho-proteins less sensitive to the common phosphatases 
were overlooked from the above gel comparison.  
 
Aiming to sufficiently map the phospho-proteome of the A2RE-binding proteins, the specific 
fluorescent dye, Pro-Q Diamond reagent, was used to stain 2-DE separated proteins. In addition, 
Western blotting with the antibody specifically against the phospho-Tyr (pY) residues was carried 
out to detect the phospho-proteins bearing the rare occurrence of pY residues among the A2RE-
binding proteins.  
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Pro-Q Diamond reagent specifically binds to phosphate groups on modified Tyr, Ser or Thr 
residues, so that all the phospho-proteins can be directly revealed when a protein gel is stained with 
this fluorescent dye. Besides, the staining intensity correlated with the number of phosphate groups, 
so that the phospho-proteome were presented with their relative degree in phosphorylation 
according to the signal intensity of the fluorescent Pro-Q Diamond dye. With this preliminary 
information, the stained phospho-proteins were ready for further accurate analysis by MS-based 
proteomics. 
 
The phospho-proteomic detection of the rat brain A2RE-binding proteins was carried out under the 
protection of phosphatase inhibitors to maintain the in vivo phosphorylation state. After 2-DE, the 
gel containing separated proteins was firstly stained with Pro-Q Diamond dye (Panel A, Figure 4-
10) and subsequently with SYPRO Ruby dye (Panel B, Figure 4-10). The SYPRO Ruby dye was 
used for quantitatively staining overall proteome on gel. Only in conjunction with the staining of 
total proteins by SYPRO Ruby, Pro-Q Diamond phospho-protein staining became 
informative. When two gel images of staining was overlapped (Panel C, Figure 4-10), the stained 
phospho-proteins were easily recognized based on their 2-DE positions among the overall proteins 
stained by SYPRO Ruby. In addition, the ratio of fluorescence intensity between Pro-Q Diamond 
and SYPRO Ruby reflected the phosphorylation level in proportion to its protein amount. The 
merged image of two gels was particularly useful in distinguishing the lightly phosphorylated high-
abundance proteins (such as spots 3-5, Panel C, Figure 4-10) from the heavily phosphorylated but 
low-abundance proteins (such as spots 1 and 2, Panel C, Figure 4-10). 
 
Among the A2RE-binding proteins, three trails of protein spots were detected by the Pro-Q 
Diamond staining (Panel A, Figure 4-10), which ranged from 37 - 41 kDa in mass and from pH 6.0 
- 8.5 in pI values. The merged image (Panel C, Figure 4-10) revealed that these phosphoproteins 
were isoforms A1b, A3b and A2. However, other identified A2RE-binding proteins, A1a, A3a and 
B1, showed no sign of phospho-staining at all.  
 
	  
  169 
	  
Figure	   4-­‐10:	   Phospho-­‐protein	   detection	   of	   Pro-­‐Q	   Diamond	   staining.	   Rat	   brain	   A2RE-­‐binding	  proteins	  were	  purified	  in	  presence	  of	  phosphatase	  inhibitors,	  and	  separated	  with	  2-­‐DE	  (7cm	  IPG	  strip,	  pH	  6	  -­‐	  11).	  Pro-­‐Q	  Diamond	  staining	  was	  shown	  in	  Panel	  A,	  and	  the	  subsequent	  SYPRO	  Ruby	  staining	  of	  the	  same	  gel	  was	  shown	  in	  Panel	  B.	  Red-­‐coloured	  Panel	  A	  image	  is	  merged	  with	  blue-­‐coloured	  Panel	  B	  image	   for	   comparison,	   as	   shown	   in	  Panel	  C.	   PeppermintStick	  molecular	  weight	   standard	   (Molecular	  Probes)	  was	  shown	  in	  the	  right-­‐sided	  1-­‐D	   lane	  on	  gel,	  serving	  as	  both	  molecular	  weight	  marker	  and	  internal	  positive/negative	  controls	  for	  the	  specific	  phospho-­‐protein	  detection.	  The	  molecular	  weights	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23.6	  and	  45	  kDa	  of	  the	  phosphorylated	  proteins	  are	  indicated.	  Positions	  of	  A3b	  and	  A2	  are	  indicated	  on	  the	  left.	  Previously	  detected	  reversible	  phospho-­‐protein	  spots	  1-­‐8	  were	  also	  marked	  on	  the	  images	  of	  all	  panels.	  	  
 
 
In comparison of detected phospho-protein with total A2RE-binding proteins (Panel C, Figure 4-
10), the horizontal stretches of the phospho-protein spots exhibited a range of pH 6.0-8.5, whereas 
the visible total A2RE-binding proteins expanded to a different gradient range of pH 7.0-9.3. The 
detected phospho-protein spots (Panel A, Figure 4-10) were showed to scatter to the anodic side of 
gel: both trails of phosphorylated A3b and A2 expanded to the edge of IPG strip at pH 6.0; the trail 
of phosphorylated A1b spots spread to the position of pH 7.0. Among the detected phospho-protein 
spots, the A2 trail was the most abundant, followed by the A1b trail, whereas the A3b trail showed 
the least abundance. The patterns of phosphorylated A1b and A2 spots were much alike: most of 
isoforms were shown to be phosphorylated, at various phosphorylation levels; and the amount of 
phospho-proteins relatively lessens when phosphorylation getting heavier. Unlike A1b and A2 
phospho-proteins, only a small portion of A3b isoforms was phosphorylated. The phosphorylated 
A3b spots exhibited different level of phosphorylation. However, the abundance of phospho-
proteins at each phosphorylation level was relatively stable, although the overall protein staining 
showed the amount of A3b isoform greatly dropped towards the anodic side of the gel.  
  
Among the stained phospho-proteins, the spots with pI values below pH 7 had always been 
neglected in previous proteomic analyses, due to their low abundance. However, the failure in 
detection by the general protein dyes, such as Coomassie Brilliant Blue and SYPRO Ruby, was 
overcome by the Pro-Q Diamond staining. These low-pI phospho-proteins became evident through 
the fluorescent signals arising from their phosphorylated residues. Consistently, the eight 
phosphorylated protein spots, showing reversible phosphorylation from the comparative gel 
analysis (Section 4.2.2.1), were also detected among other phospho-proteins (Figure 4-10).  
 
The distribution of total A2RE-binding proteins on SYPRO Ruby-stained total protein gel (Panel B, 
Figure 4-10) was consistent with all the 2-DE gels in previous sections. As observed before, each 
pair of alternatively spliced hnRNP A/B isoforms differed in either the protein abundance or the 
arrangement of the isoform spots. Now, the phospho-protein staining provides the phosphorylation 
evidences in supporting this isoform-specific arrangement of spots. For hnRNP A1, the full-lengh 
A1b was heavily phosphorylated into multiple forms, but the truncated A1a was not 
phosphorylated; for hnRNP A2/B1 and A3, the full-length B1 and A3a was unphosphorylated, 
whereas the truncated A2 and A3b were phosphorylated at different degrees.  
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With the higher cellular abundances than their full-length counterparts, hnRNP A2 and A3b are 
considered as the major protein isoforms encoded by HNRPA2B1 and HNRPA3 genes, respectively. 
Interestingly, the phospho-protein detection reveals the phosphorylated protein spots exclusively 
belong to A2 and A3b isoforms. This observation supports the assumption that the A2 and A3b 
isoforms are more likely than the full-length B1 and A3a isoforms to participate in the 
phosphorylation-regulated mechanisms. 
 
For hnRNP A1, there was no obvious correlation between phosphorylation and protein cellular 
abundance. Differing in exon 8 near the C-terminus of the protein sequence, A1b and A1a were 
both pulled down by the A2RE-sequences from rat brain, in abundance far less than that of the A2 
and A3 isoforms. However, the 2-D phospho-protein staining brought out A1b among the most 
significantly phosphorylated proteins, distinguishing from the unphosphorylated A1a. This 
observation seems to contradict the universally phosphorylated A1a forms, which have been widely 
reported to participate into many cellular activities, and the protein phosphorylation sites on pTyr, 
pSer and pThr residues have all been identified. The unphosphorylated A1a isoforms found in the 
context of A2RE-binding proteins might imply that its association with A2RE-sequence is a 
phosphorylation-exclusive process. On the other hand, the heavily phosphorylated A1b isoforms 
were assumed to be the important candidates for some downstream mechanisms regulated by 
phosphorylation in the A2RE-pathway.  
 
The phospho-proteome of the A2RE-binding proteins was sufficiently mapped on the 2-DE gel, 
showing inclusively all types of phospho-proteins. On the other hand, the indiscriminate binding 
nature to the phosphate groups of pTyr, pSer and pThr residues made the Pro-Q Diamond dye 
unable to specify the phosphorylation types. Before using the MS-based proteomic approaches to 
locate the phosphorylated peptides, Western blotting was carried out to primitively blot the pTyr 
among the A2RE-binding proteins.     
 
Phosphorylation of Tyr is much less common than that of Ser and Thr. Large scale phospho-peptide 
analysis has shown that the pTyr, pThr and pSer residues account for 2.3%, 14% and 84% of 
overall cellular phosphorylations, respectively (Molina, Horn, Tang, Mathivanan, & Pandey, 2007). 
The pTyr residue tends to appear on less abundant proteins, and changes more dynamically in 
average than pSer and pThr (Olsen et al., 2006). Therefore, pTyr sites are usually underrepresented 
in the phospho-peptide analysis due to its instability. Here, detecting the pTyr-containing proteins 
was carried out by blotting 1-DE separated A2RE-binding proteins using the anti-pTyr antibody 
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before the MS-based phospho-proteomic analysis.  
 
The double-blotted A2RE-binding proteins were shown in Figure 4-10. To prevent the excess 
fluorescence in the blotting bands, the standard amount (45 µg) of purified proteins was loaded in 
gel along with its 1/3 aliquot (15 µg). The anti-pTyr antibody specifically blotted proteins 
containing pTyr residues; while the Y12 antibody quantitatively blotted the total A2RE-binding 
proteins, serving as the background for the Tyr phosphorylation detection.  
 
 
Figure	  4-­‐11:	  Western	  blotting	  of	  Tyr-­‐phosphorylated	  proteins.	  Rat	  brain	  A2RE-­‐binding	  proteins	  were	  purified	   in	  presence	  of	  phosphatase	   inhibitors	  to	  maintain	  their	   in	  vivo	  phosphorylation	  states.	  The	   purified	   proteins	   were	   separated	   1-­‐DE,	   followed	   by	  Western	   blotting.	   Two	   antibodies,	   anti-­‐sm	  (Y12)	   and	   anti-­‐pTyr	   antibodies,	   were	   used	   for	   double-­‐blottings,	   and	   blotted	   images	   were	   obtained	  through	   the	   Odyssey	   dual-­‐channel	   system.	   Three	   blotted	   images	   were	   aligned	   below	   (from	   left	   to	  right):	  the	  Y12	  blotting,	  the	  anti-­‐pTyr	  blotting,	  and	  the	  merged	  double-­‐blotting	  image	  (Y-­‐12	  blotted	  in	  green	   +	   anti-­‐pTyr	   blotted	   in	   red).	   For	   each	   blotting,	   two	   different	   amount	   of	   protein	   sample	   were	  loaded	   for	   clearer	   visibility:	   45	  µg	   purified	   protein	   lane	   labeled	   as	   “std”,	   and	   15	  µg	   lane	   labeled	   as	  “1/3”.	  The	  arrowheads	   in	   the	   images	  distinguished	  the	  positions	  of	  A3a	  and	  A1b	  protein	  bands.	  The	  37-­‐kDa	  molecular	  weight	  was	  labeled	  on	  the	  right	  side,	  and	  the	  identities	  of	  A/B	  isoforms	  were	  labeled	  on	  the	  left.	  	  	   
 
 
In human, the phosphorylated Tyr residues in hnRNPs A1, A2/B1 and A3 have been experimentally 
identified (summarised in Table 4-4), leaving a ratio 4:1:2 for the pTyr residues between paralogs. 
However, the pTyr residues of the rat paralogs in Table 4-4 were predicted by the sequence 
similarities due to lacking of the experimental evidences.  
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Here, Western blotting of the rat brain A2RE-binding proteins against pTyr residues (Figure 4-11) 
clearly indicated A1b, A2 and A3b isoforms all contain pTyr residues. The intensity of pTyr blots 
correlated with the number of pTyr residues. Considering the protein abundances revealed by the 
Y12-blotting (left panel in Figure 4-11), it is obvious that the numbers of pTyr residues in A1b and 
A3b are far more than the number of pTyr in A2, though A2 is the most abundant isoform among 
A2RE-binding proteins. This Western blotting image generally agrees with the previous 2-D 
phospho-protein mapping, and further pinpoints to the Tyr phosphorylation. pTyr residues together 
with pSer and pThr residues contribute to the complexity of the overall protein phosphorylation. 
Therefore, the relatively weak intensity of blotted pTyr in hnRNP A2 suggests pSer or pThr 
residues may also account for its overall phosphorylations.  
 
 
Table	  4-­‐4:	  pTyr	  phosphorylation	  sites1	  of	  human	  and	  rat	  hnRNPs	  A1,	  A2/B1	  and	  A3	  
	   hnRNP	  A1	  2	   hnRNP	  A2/B1	   hnRNP	  A3	  
Homo	  sapiens	  3	   pTyr167,	  pTyr341,	  pTyr347,	  pTyr357	   pTyr347	   pTyr360,	  pTyr364	  
Rattus	  norvegicus	   pTyr167,	  pTyr289,	  pTyr295,	  pTyr305	   pTyr347	   pTyr361,	  pTyr365	  
Note:  
1. The pTyr residues in the table were summarized from Swiss-Prot database annotations. The pTyr 
residues were numbered according to the protein sequences of the full-length isoform of each 
paralog.  
2. For Rattus norvegicus, the full-length hnRNP A1b is not annotated under the entry of hnRNP A1. 
Instead, the pTyr residues were numbered using the sequence of hnRNP A1a isoform.   
3. For Homo sapiens, all pTyr residues were experimentally identified by the large-scale MS-based 
phosphorylation analysis. In contrast, no experiment evidence supports the pTyr residues in Rattus 
norvegicus. The pTyr residue in Rattus norvegicus in this table were predicted based on sequence 
similarity to the human counterparts. 
 
 
4.4 Tandem MS proteomics for the identification of modified residues 
 
The phosphorylated isoforms among the rat brain A2RE-binding proteins were first mapped out by 
2-D A3protein staining, and were further revealed by blotting with pTyr antibody that hnRNPs 
A1b, A2, and A3b contain pTyr residues. However, the numbers of phosphorylated residues on a 
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per-protein basis as well as the location of each phosphorylated residue within the primary structure 
remain unknown. 
 
In addition to protein phosphorylation, methylation has been reported to occur on Arg residues in 
all human hnRNPs A1, A2 and A3. Also, Arg residues may be the modified by citrullination which 
converts Arg or monomethylarginine residues into Cit. As a result, citrullination is considered as an 
antagonizing reaction of Arg methylation (Gyorgy, Toth, Tarcsa, Falus, & Buzas, 2006). Therefore, 
the bottom-up proteomics coupled with MALDI-TOF/TOF MS were used to analyse the digested 
A3 peptides. The aim was to identify sites and modified residues of phosphorylation and Arg 
modifications of hnRNP A3 isoforms, in an effort to provide experimental evidences for its 
structural characterization. 
  
4.4.1 Peptide analysis for phosphorylation 
 
According to the 2-D phospho-protein mapping, both phosphorylated and unphosphorylated protein 
spots of hnRNP A3 were excised and subjected to MS-based peptide analysis. There were three 
phosphorylated protein spots of A3b (at the relative position of the spots 13-15 in Figure 4-4) and 
two unphosphorylated protein spots of hnRNP A3a (at the relative position of the spots 28 and 29 in 
Figure 4-4).  
 
In order to enrich the phospho-peptides, the tryptic peptides were additionally concentrated through 
titanium dioxide (TiO2) ZipTips prior to MS analysis. The first stage of MALDI-TOF MS was 
carried out in search of peptides containing phosphorylated residues. The MALDI-TOF spectra of 
A3b spots 13-15 were vertically aligned in Figure 4-12 for comparison. The peptide peaks of m/z 
1623, 1851, 2441, and 2693 were clearly observed in all three spectra. In addition, the MASCOT-
searching results also suggested these four peptides might contain phosphorylated residues (Table 
4-5).  
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Figure	  4-­‐12:	  MALDI-­‐TOF	  spectra	  of	  TiO2-­‐concentrated	  hnRNP	  A3b	  peptides.	  2-­‐DE	  separated	  A3b	  protein	  spots	  were	  in-­‐gel	  digested	  with	  trypsin,	  then	  concentrated	  by	  TiO2	  ZipTips.	  The	  concentrated	  peptides	  were	  spotted	  to	  a	  Bruker	  MALDI	  target	  plate	  with	  10	  mg/ml	  CHCA	  matrix.	  	  	  
 
	  
Table	  4-­‐5:	  MASCOT-­‐generated	  possible	  phospho-­‐peptides	  of	  hnRNP	  A3	  The	   peptide	   masses	   obtained	   from	   MALDI-­‐TOF	   MS	   were	   searched	   in	   MASCOT	   database	   included	  phosphorylation	  as	  a	  variable	  modification.	  	  	  
Mass Start-
End MC Peptide Observed Mr(expt) Mr(calc) Delta 
1623.9161 1622.9088 1622.6410 0.2679 217-232 1 R.GGGSGNFMGRGGNFGR.G + Oxidation 
(M); Phospho (ST) 
1851.0007 1849.9934 1849.8499 0.1435 37-52 0 K.LFIGGLSFETTDDSLR.E + Phospho (ST) 
2441.0629 2440.0556 2440.0753 -0.0197 146-165 1 
R.GFAFVTFDDHDTVDKIVVQK.Y + 2 Phospho 
(ST) 
2693.5558 2692.5485 2692.7502 -0.2017 294-317 2 R.SSGSPYGGGYGSGGGSGGYGSRRF.- +  
3 Phospho (ST); 3 Phospho (Y) 
	  
  176 
A.	  The	  product-­‐ion	  spectrum	  of	  the	  m/z	  2441	  peptide	  	  
	  
	  
	  
B.	  The	  product-­‐ion	  spectrum	  of	  the	  m/z	  2693	  peptide	  
 
	  
Figure	   4-­‐13:	  MALDI-­‐TOF/TOF	   spectra	   of	   predicted	   phosphorylated	   peptides.	  Peptide	   ions	  m/z	  2441	  and	  2693	  were	  selected	  for	  fragmentation.	  The	  spectra	  of	  the	  product	  ions	  were	  shown	  in	  panels	  A	  and	  B,	   respectively.	  The	  amino	  acid	   sequencing	   result	  of	  each	  peptide	  was	  displayed	   in	   the	  upper	  right	  corner	  of	  the	  spectrum.	  The	  confirmed	  residues	  were	  underlined	  inside	  the	  sequence,	  and	  their	  corresponding	  ion	  peaks	  were	  also	  individually	  labeled	  in	  the	  spectrum.	  	  	  
 
  177 
With the MASCOT-generated results, the corresponding ions of these possible phospho-peptides 
were selected for fragmentation, followed by the subsequent second stage of MS measurement. 
None of the above four possible phospho-peptides was confirmed to contain phosphorylated 
residues. The spectra of product ions generated by fragmentation revealed amino acid sequences of 
all four peptide ions, which matched to other region of A3 protein rather than MASCOT-estimated 
phospho-peptides. The product-ion spectra of peptide peaks m/z 2441 and 2693 were shown in 
Figure 4-13. The m/z 2441 peptide was the A3 sequence of L15-K35 (Panel A, Figure 4-13), 
containing 21 residues with one trypsin mis-cleavage. The m/z 2693 peptide was a 22-residue 
sequence of K105-K126 (Panel B, Figure 4-13), resulting from three mis-cleavages with trypsin. 
Both identified peptides were clearly unmodified.  
 
4.4.2 Peptide analysis for Arg methylation 
 
Arg residues attract special attention in studies of PTMs of hnRNPs because protein methylations 
exclusively occur on Arg residues in non-histone nuclear proteins and other RNA-binding proteins 
(Boffa et al., 1977). Besides, the methylarginine residues of hnRNPs constitute the majority of 
nuclear asymmetric dimethylarginine (aDMA) in HeLa cells. Further investigation revealed that the 
methylation usually occurs at an RGG motif that is inside the larger context of protein GRD (Gary 
& Clarke, 1998). Notably, all methylarginine residues inside RGG motifs are found in form of 
either monomethylarginine (MMA) or aDMA but not symmetric dimethylarginine (sDMA). Inside 
the RGG motif, the Arg-Gly structure is completely essential as the PRMT1 substrates, and final 
Gly residue distinguish the asymmetric methylation site from the myelin basic protein symmetric 
methylation consensus Arg-Gly-Leu (Gary & Clarke, 1998). 
 
The compositions and protein domain placement of Arg residues are similar between the hnRNP 
A1, A2 and A3 paralogs (summarized in Table 4-6). The Arg methylation of hnRNP A1 has been 
extensively studied, and the experimentally identified methylation sites have been reported many 
years before. In contrast, the methylation studies of hnRNPs A2 and A3 were quite limited, and 
their methylarginine residues annotated in Swiss-Prot database were predicted based on sequence 
similarities and the understanding of methylarginines of A1. Therefore, the methylation studies of 
hnRNP A/B paralogs (Friend et al., 2013) discussed in this chapter is the first time the individual 
methylation sites of A2 and A3 have been experimentally identified. In addition, the 
methylarginines of A2 and A3 in their protein GRDs are unambiguously identified to be 
asymmetrically dimethylated into aDMAs.  
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Table	  4-­‐6:	  Summary	  of	  Arg	  residues	  in	  hnRNPs	  A1,	  A2	  and	  A3	  The	  overall	  Arg	  residue	  contents,	  as	  well	  as	  the	  Arg	  contents	  of	  each	  protein	  domains,	  were	  compared	  between	   three	   paralogs.	   The	   methylarginine	   (mArg)	   residues	   included	   in	   this	   table	   are	   all	  experimentally	  identified	  with	  its	  sequence	  location.	  The	  tripeptide	  context	  (i.e.	  RGG	  and	  RGR	  boxes)	  of	  mArg	  residues	  was	  indicated	  in	  the	  parentheses	  with	  the	  modified	  residues	  underlined.	  	  
	  
Entire	  protein	  	   RRM1	  +	  RRM2	   GRD	  
Length	  
(aa)	  
Arg	  	   mArg	  
Length	  
(aa)	  
Arg	  	   mArg	  
Length	  
(aa)	  
Arg	  	  
RGG	  
motif	  
mArg	  
A1	   320	   24	   4	   84+80	   10+4	   0	   126	   10	   4	  
R194	  (RGR),	  R206	  (RGG),	  R218	  (RGG),	  R225	  (RGG)	  	  (S.	  Kim	  et	  al.,	  1997),	  	  R232	  (RGG)	  (Friend	  et	  al.,	  2013)	  
A2	   341	   25	   1	   84+80	   9+5	   0	   148	   9	   1	   R254	  (RGG)	  (Friend	  et	  al.,	  2013)	  
A3	   379	   29	   6	   84+80	   9+3	   0	   169	   10	   5	   R214	  and	  R216	  (RGR),	  R226	  (RGG),	  R239	  (RGG),	  R246	  (RGG),	  R286	  (RGG)	  (Friend	  et	  al.,	  2013)	  
 
 
Bottom-up MS proteomics were used in this study to search for peptides with the mass 
discrepancies of mono- (14 Da) or di-methyl (28 Da) group, particularly targeting the RGG repeats 
in C-terminus of the protein sequence. In order to overcome the trypsin-skipped region, 2-DE-
separated hnRNP A3 protein spots were digested in parallel with thermolysin, trypsin or 
chymotrypsin. Then, the digested peptides of A3 were examined by MALDI-TOF MS, and the 
peptides containing the putative methylated Arg residues were found a +28 Da mass discrepancy.  It 
is crucial to verify this extra 28 Da is the consequence of either symmetric or asymmetric 
dimethylation. To address this question, the MS/MS peptide fragmentations were applied to these 
targeting peptides, and the fragment ions generated from unmodified/modified Args were the key in 
unambiguous determination of unmodified Arg, MMA, sDMA or aDMA.  
 
When peptides containing unmodified or methylated Arg residues are subjected to tandem MS, 
fragment ions are usually generated with low mass, corresponding to the loss of the neutral side 
chains (amines, carbodiimide, and guanidine) of intact ions of Arg residue (Gehrig, Hunziker, 
Zahariev, & Pongor, 2004). These specific Arg-associated fragment ions have been reported in 
details (Gehrig et al., 2004), and their chemical structures are cited in Panel A, Figure 4-14.  
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A.	  Chemical	  structures	  of	  fragment	  ions	  arising	  from	  unmodified	  Arg	  or	  aDMA	  	  
	   	   	  
	  	  
1.	  m/z	  46.066	   2.	  m/z	  88.087	   3.	  m/z	  70.066	   4.	  m/z	  112.087	  
	   	   	   	  
	  
	   	  
	  
5.	  	  m/z	  87.092	   6.	  m/z	  60.056	   7.	  m/z	  115.087	   	  
	  
B.	  Tandem	  mass	  spectrum	  of	  m/z	  654.3	  ion	  fragmentation	  	  	  
 
Figure	   4-­‐14:	   Identification	   of	   aDMA	   ions	   from	   peptide	   fragmentation.	   In	   panel	   A,	   all	   chemical	  structures	  of	  Arg-­‐associated	  ions	  are	  cited	  from	  (Gehrig	  et	  al.,	  2004).	  In	  panel	  B,	  the	  region	  of	  m/z	  44-­‐
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150	  is	  zoomed	  from	  MALDI-­‐TOF/TOF	  spectrum	  of	  m/z	  654.3,	  corresponding	  to	  the	  modified	  peptide	  284-­‐SS-­‐aDMA-­‐GGY-­‐289	  of	  rat	  brain	  hnRNP	  A3.	  Structures	  of	  the	  matching	  ions	  were	  illustrated	  on	  top	  of	   the	   significant	   peaks.	   The	   aDMA-­‐specific	   fragment	   ions	   were	   highlighted	   in	   red,	   whereas	   other	  common	  fragment	  ions	  derived	  from	  Arg	  cleavage	  were	  highlighted	  in	  green.	  	  	  
 
 
Among these ions, dimethylammonium (m/z 46, Structure 1 of Panel A) is found exclusively from 
aDMA-containing peptides. Therefore, the dimethylammonium (m/z 46) peak is considered as a 
specific “reporter” ion for aDMA. Although dimethylated guanidinium (m/z 88, Structure 2 of 
Panel A) is usually arising from aDMA fragmentation, it alone does not distinguish the isomeric 
aDMA and sDMA forms. In contrast, guanidinium (m/z 60, Structure 6 of Panel A) is a diagnostic 
ion for unmodified Arg residue, as well as the peak of m/z 87 (Structure 5 of Panel A), which is 
also only found in low intensity from spectra of unmodified Arg residues. Other fragment ions at 
m/z 70, 112 and 115 (Structure 3, 4 and 7, respectively), whose cyclic ion structures are established 
from the cleavage of Arg side chains, are common for all Arg-related fragmentations. 
 
Examined via MALDI-TOF MS, a few digested peptides were found corresponding to Arg-
containing peptides of A3 in either unmodified or modified form.  When these Arg-containing 
peptides were fragmented by MS/MS, the Arg modification can be unambiguously determined by 
observing the “report” ions, i.e. m/z 46 for aDMA and m/z 60 for unmodified Arg. In Panel B 
(Figure 4-14), the peptide at m/z 654.3 of the initial MALDI-TOF MS was selected for further 
peptide fragmentation because it matched to the A3 peptide 284-SSRGGY-289 with an extra 28 Da 
mass. In the zoomed view of tandem MS spectrum, the dimethylammonium ion at m/z 45.99 
(diagnostic ion m/z 46) was clearly observed with another aDMA-specific ion at m/z 87.97 (m/z 
88). With the observation of these two significant aDMA-specific ion peaks, the R286 residue of 
this peptide was confirmed to be dimethylated into aDMA.     
 
Other MASCOT-estimated Arg-containing peptides of hnRNP A3 were analyzed through the same 
method by tandem MS fragmentation (data not shown). Finally, six aDMA residues were identified 
inside the A3 sequence (Friend et al., 2013). The MS/MS identified aDMAs as well as unmodified 
Arg residues are summarized in Table 4-7.  
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Table	  4-­‐7:	  Profile	  of	  Arg	  methylation	  in	  hnRNP	  A3	  	  2-­‐DE	  separated	  hnRNP	  A3	  spots	  were	  digested	  in	  parallel	  with	  trypsin,	  chymotrypsin	  and	  thermolysin.	  The	   digested	   peptides	   were	   screened	   by	   MALDI-­‐TOF	   MS,	   and	   MASCOT-­‐matched	   Arg-­‐containing	  peptides	  were	   selected	   for	   tandem	  MS	   fragmentation.	   The	   identified	   unmodified	   or	  methylated	  Arg	  residues	   are	   listed	   in	   the	   table.	   The	   observed	   fragment	   ions	   were	   listed	   in	   column	   “m/z[charge]”,	  compared	  with	  the	  expected	  masses	  of	  their	  corresponding	  peptides	  “Mr	  (expt)”.	  “MC”	  stands	  for	  mis-­‐cleavages	  of	  enzyme.	  The	  sequences	  of	  corresponding	  peptides	  are	  listed	  in	  the	  column	  “Modification	  status”,	  inside	  which	  the	  identified	  PTM	  residues	  were	  underlined.	  	  
Arg	  of	  
interest	  
Mass	   Peptide	  position	  
(Enzyme)	  
M
C	  
Modification	  Status	  
m/z[charge]	   Mr	  (expt)	  
R239	   318.2[2+] 634.3 237-­‐242 (thermolysin) 0 FGRGGN	  +	  Dimethyl	  (R) 
R226	   391.7[2+] 781.4 223-­‐229 (thermolysin) 1 FMGRGGN	   +	   Oxidation	   (M);	  Dimethyl	  (R)	  
R214	  
R216	  
455.2[3+] 1362.7 210-­‐223	   (thermolysin) 0 AGSQRGRGGGSGNF	   +	   2	  Dimethyl	  (R) 
R257	  
456.2[2+] 911.4[1+] 910.4 250-­‐260 (chymotrypsin) 0 GGGGGGSRGSY 
R246	  
R257	  
496.2[3+] 1485.6 244-­‐260 (chymotrypsin) 1 GGRGGYGGGGGGSRGSY	   +	  Dimethyl	  (R) 
R214	  
R216	  
546.3[3+] 2181.2 203-­‐223	   (chymotrypsin) 0 SKQEMQSAGSQRGRGGGSGNF	   +	  2	  Dimethyl	  (R) 
R214	  
R216	  
526.9[3+] 1577.7 208-­‐223	  (chymotrypsin) 0 QSAGSQRGRGGGSGNF	   +	   2	  Dimethyl	  (R) 
R239	  
591.2[2+] 1181.5	  [1+] 1180.5 231-­‐243 (chymotrypsin) 1 GGGGGNFGRGGNF	   +	   Dimethyl	  (R) 
R286	  
600.3[2+]	  1199.5	  [1+] 1198.5 284-­‐296 (chymotrypsin) 1 SSRGGYGGGGPGY	   +	   Dimethyl	  (R) 
R52	   633.7[3+] 1898.2 36-­‐52 (chymotrypsin) 1 KLFIGGLSFETTDDSLR 
R286	   654.3[1+] 653.2 284-­‐289 (chymotrypsin) 0 SSRGGY	  +	  Dimethyl	  (R) 
R226	   1328.4[1+] 1327.4 224-­‐236 (thermolysin) 1 MGRGGNFGGGGGNF	  +	  Oxidation	  (M);	  Dimethyl	  (R)	  
R286	   1832.6	  [1+]	   1831.6	   284-­‐303 (chymotrypsin) 2 SSRGGYGGGGPGYGNQGGGY	   +	  Dimethyl	  (R)	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Arg	  of	  
interest	  
Mass	   Peptide	  position	  
(Enzyme)	  
M
C	  
Modification	  Status	  
m/z[charge]	   Mr	  (expt)	  
R52	   1770.9[1+] 1769.9 37-­‐52 (chymotrypsin) 0 LFIGGLSFETTDDSLR	  
R377	   1910.9[1+] 1909.8 356-­‐377 (trypsin) 0 SSGSPYGGGYGSGGGSGGYGSR 
R246	  
R257	  
2368.4[1+] 2367.4 243-­‐269 (thermolysin) 0 FGGRGGYGGGGGGSRGSYGGGDGGYNG	  +	  Dimethyl	  (R)	  
R52	   2441.3[1+] 2440.2 37-­‐57 (trypsin) 1 LFIGGLSFETTDDSLREHFEK	  
R52	   2569.2[1+] 2568.2 36-­‐57 (trypsin) 2 KLFIGGLSFETTDDSLREHFEK	  
 
 
To summarize above table, there are six aDMA residues (i.e. R214, R216, R226, R239, R246 and 
R286) identified in hnRNP A3; whereas three Arg residues (i.e. R52, R257 and R377) were 
confirmed to be unmodified.   
 
Trypsin, chymotrypsin and thermolysin were individually used to digest A3 protein, which overall 
enlarged the coverage in search for Arg-containing peptides. As a result, the same 
unmodified/modified Arg residue was found in different-sized peptides due to the various cleavages 
of enzymes. However, the identified Arg residues were consistent cross these size-varied peptides, 
which further confirmed each other in the identification of Arg modification status. 
 
As listed in Table 4-6, there are ten Arg residues and five RGG motifs in the C-terminal GRD 
region of hnRNP A3. Six newly identified aDMA were all located in this region, taking up all the 
five RGG motifs (except for R214). In fact, R214 and R216 were inside the context of “RGRGG”, 
in which the essential structure Arg214-Gly215 is flanked by the RGG motif Arg216-Gly-Gly. This 
sequence structure fits in the PRMT1 recognition consensus for asymmetric dimethylation (Gary & 
Clarke, 1998), allowing the dimethylation of both residues R214 and R216. In opposite, the 
dipeptide Arg257-Gly258 is flanked by the Ser residue on both side, so that the Ser-Arg-Gly-Ser 
structure abolished the recognition of PRMT1, leaving the residue R257 unmodified. Because 
trypsin cleaves peptide chains at the carboxyl side of Arg residue, the unmodified R257 is the one 
and only cleavage site of trypsin in the GRD region residues 211-354. This is also the reason that 
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the R257-containing peptides can only be obtained from the chymotrypsin or thermolysine 
digestion, not trypsin.   
 
In Swiss-Prot database, the rat hnRNP A3 (Q6URK4) is still annotated the residues R52 (Omega-N-
methylarginine, MMA) and R246 (unspecified dimethylargine) as the predicted methylation sites. 
Here, the peptide fragmentation results clearly showed the residue R52 is unmodified, which is 
confirmed by three independent peptides digested by either trypsin or chymotrypsin (Table 4-7). In 
addition, the unmodified residue R377 was identified. 
 
4.4.3 Peptide analysis for Arg citrullination 
 
Citrullination, catalyzed by PAD enzymes, is another PTM of Arg residues. As a result, the 
positively charged Arg residues are converted into neutral citrulline residues. In term of molecular 
mass, citrullination causes an increase of 1 Da (actually 0.98 Da) per modified Arg residue (Kubota, 
Yoneyama-Takazawa, & Ichikawa, 2005). 
 
Till now, no citrullinated hnRNP has been reported. From the phospho-proteomic studies described 
in the previous section, some hnRNP A3 spots, located to the anodic side to their theoretical pI 
positions, were observed unaffected by the change of phosphorylation states. This observation 
suggests the possible PTMs of A3 would lead to the loss of positive charges of isoforms other than 
phosphorylation. Therefore, citrullination was under consideration due to its pI alteration effect 
without big mass change. Also, the citrullinated MBP provides another reason to assume the 
citrullination of Arg residues on hnRNP A3, which is a major trans-acting factor involved in 
trafficking A2RE-transcripts (i.e. MBP mRNAs).  
 
Using the same MALDI-TOF/TOF approach as the Arg methylation identification, the digested A3 
peptides were first screened by searching against the MASCOT database including citrullination as 
a variable modification. Then, MASCOT-generated peptidyl-citrulline-containing peptides were 
further fragmented for the amino acid sequence analysis. Since each citrullinated Arg residue only 
bring an extra 0.98 Da mass to the protein molecule, the identification of Cit residue requires 
careful analysis of the MS/MS spectra of each candidate peptides.  
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Figure	  4-­‐15:	  MALDI-­‐TOF	  spectra	  of	  digested	  peptides	  of	  A3a	  and	  A3b	  isoforms.	  2-­‐DE	  separated	  A3a	  and	  A3b	  spots	  were	  digested	  with	   trypsin	  and	   then	  spotted	   to	  a	  MALDI	   target	  plate	  with	  CHCA	  matrix.	  The	  spectra	  were	  collected	  from	  m/z	  0	  to	  3000,	  and	  then	  aligned	  for	  peptide	  analysis.	  The	  A3	  isoforms	  were	  indicated	  on	  the	  top	  right	  corner	  of	  each	  spectrum.	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All the 2-DE separated A3a and A3b spots were digested for MALDI-TOF analysis in searching for 
the citrullinated peptides. In Figure 4-15, the spectra of digested A3a and A3b peptides were 
alignment for comparison. Except for the isoform-specific ion peaks and the signal intensity, most 
peptide ion peaks were consistent between spectra. After searching in MASCOT database for the 
possible citrullinated peptides, the MASCOT results confirmed and protein identity of A3 and 
generated only three peptide ions (m/z 1735, 1751 and 1922) as the candidate peptides containing 
Cit residues. The MS/MS fragmentation spectra of m/z 1735, 1751 and 1922 are presented in Figure 
4-16, none of the product ion peak corresponds to the citrullinated Arg residue. 
 
If looking inside the amino acid sequences of the MASCOT-predicted Cit-containing peptides, it is 
not surprising that MS/MS fragmentation results eliminate the possibility that Cit residue were 
present in hnRNP A3. Two candidates for the Cit-containing peptides (m/z 1735 and 1751) 
correspond to the residue 201-216 of A3. Inside this region, the target Arg residues for citrullination 
is R214 and R216, both of which had been confirmed to be dimethylated into aDMA214 and 
aDMA216 (Section 4.2.3.2). The third candidate of Cit-peptide was the residue 110-127 of A3, 
which is located right in the region connecting two protein RRM domains. However, the resulting 
amino acid ions produced by fragmentation of m/z 1922 suggests a high Gly-residue content, 
referring this peptide to the protein Gly-rich region. With the exhaustive analysis of the Arg 
residues in the Gly-rich region (Secion 4.2.3.2), every Arg residue in the protein GRD domain has 
been identified either dimethylated or unmodified, which rules out the possibility that Arg residue 
in this region can be citrullinated.       
	  
	  
4.5 Discussion 
 
Following the previous chapter, where the complexity of hnRNP A3 isoforms in the A2RE-binding 
proteins had been revealed, further investigations were directed to find out what is the cause for the 
complexity of A3 isoforms. Therefore, all the experiments in this chapter were aimed to address the 
structural complexity of the isoforms binding to the A2RE-sequence, in particular focus on the 
structural characterization of A3 isoforms. 
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A.	  	  The	  product-­‐ion	  spectrum	  of	  the	  m/z	  1735	  peptide	  	  MASCOT	  predicted	  citrulline-­‐containing	  hnRNP	  A3	  peptide	  (201A	  -­‐	  216R):	  ALSKQEMQSAGSQRGR	  +	  2	  Citrulline	  (R)	  
 
	  
B.	  	  The	  product-­‐ion	  spectrum	  of	  the	  m/z	  1751	  peptide	  	  MASCOT	  predicted	  citrulline-­‐containing	  hnRNP	  A3	  peptide	  (201A	  -­‐	  216R):	  ALSKQEMQSAGSQRGR	  +	  2	  Citrulline	  (R);	  Oxidation	  (M)	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C.	  	  The	  product-­‐ion	  spectrum	  of	  the	  m/z	  1922	  peptide	  	  MASCOT	  predicted	  citrulline-­‐containing	  hnRNP	  A3	  peptide	  (110A	  -­‐	  127K):	  AVSREDSVKPGAHLTVKK	  +	  Citrulline	  (R)	  
 
Figure	  4-­‐16:	  MALDI-­‐TOF/TOF	   spectra	   of	   predicted	   citrulline-­‐containing	  peptides.	  Peptide	   ions	  m/z	  1735,	  1751	  and	  1922	  were	  observed	  in	  the	  MS	  spectra	  of	  both	  digested	  A3	  isoforms.	  They	  were	  predicted	   to	   contain	   Cit	   residue	   due	   to	   matching	   to	   the	   MASCOT-­‐calculated	   citrulline-­‐containing	  peptides.	  The	  spectra	  of	  the	  product	  ions	  were	  shown	  in	  panels	  A,	  B	  and	  C,	  respectively.	  The	  sequences	  of	   the	   putative	   Cit-­‐containing	   peptides	   were	   indicated	   in	   each	   panel,	   and	   the	   predicted	   modified	  residues	  were	  included	  in	  the	  bracket.	  	  
 
	  
Firstly, a picture profile of all proteins specifically binding to the A2RE-sequence from rat brain 
was depicted using 2-DE method. The protein identifications were critical to define the pattern of 
isoforms’ composition in two dimensions. Therefore, about 30 protein spots were successfully 
identified by MS-based PMF. With the knowledge of protein identities, the locations of 
corresponding isoform groups (isoforms of hnRNP A1, A2/B1 and A3) were determined on the 2-
DE gel with clarified isoform-specific range of pI and molecular weight. Among the identified rat 
brain A2RE-binding proteins, the full-length hnRNP A1b, as a minor binding component to the 
A2RE-sequence, was the first time identified. To date, the full-length A1b isoform has been only 
reported in human, although hnRNP A1 has attracted extensive research attentions for many 
decades.  
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On the other hand, the identified 2-DE protein spots directly provide pure and highly concentrated 
isoform materials, making it possible to carry out the isoform-specific structural analysis in the 
downstream investigations.  
 
From the 2-DE profile of the A2RE-binding proteins, the isoform-specific pI and molecular weights 
were found different to their theoretically calculated values. This deviation leaded to the assumption 
of the charge- or/and mass-altered protein modifications, such as phosphorylation and Arg 
modifications. In addition, the isoform pair encoded by the same hnRNP A/B gene (i.e. A1a and 
A1b, A2 and B1, A3a and A3b) exhibited different characteristics in isoelectrically focused isoform 
spots. This observation implied the consequences of multiple modifications, and each individual 
isoform spot carries its unique combination of different modification types as well as a certain 
degree of each modification type. The overall modification of the isoform molecule not only 
determines its specific coordinates (pI, MW) in the 2-D profile, but also ultimately decides its 
functional activities in the A2RE-RNA biogenesis.  
 
The phosphorylation studies were initiated by examining the impacts on the A2RE-binding proteins 
when treated with alkaline phosphatase or processed in presence of phosphatase inhibitors. There 
were eight spots, belong to A1b, A3b and A2, exhibiting obvious gel position shift between the 
changes of phosphorylation conditions. Then, the overall phospho-proteins among the 2-DE 
separated A2RE-binding proteins were mapped by staining with the phospho-specific fluorescent 
dye. The 2-D phospho-protein map confirmed that isoforms A1b, A3b and A2 were phosphorylated 
inside the A2RE-context. Together with the observation of their unphosphorylated counterpart 
isoforms A1a, A3a and B1, this 2-D phospho-protein mapping supports previous speculation that 
isoform pairs are not uniformly modified when bound to the A2RE-sequence. The isoforms A1b, 
A3b and A2 were further investigated by Western blotting. All three isoforms were clearly blotted 
by the antibody against the phosphorylated Tyr residues, indicating Tyr phosphorylation occurs 
among these three isoforms. However, the attempts using MS-based proteomic approaches in 
identifying phosphorylation sites of A3 were unsuccessful. Therefore, none of the in vivo 
phosphorylated residues has been located in A3.   
 
During the mapping and blotting of phospho-proteins, the full-length hnRNP A1b attracted 
attention again because it is the most prominent A2RE-binding protein being in vivo 
phosphorylated. Considering its low abundance among the A2RE-binding proteins, the presence of 
A1b has never been reported in the A2RE proteome before. Due to the reversibility and instability 
of the protein phosphorylation process, the heavily phosphorylated A1b inside the A2RE proteome 
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implied an important role triggered by the phosphorylation-related mechanism. The anti-pTyr 
blotting suggests that pTyr residues largely account for the phosphorylation of A3b; whereas A2 
might contain other phosphorylated residues in addition to pTyr. The gel spot shifting of A1b, A3b 
and A2 after phosphatase treatment revealed that these three isoforms were susceptible to the 
change of phosphorylation states, which also indicate their possible cellular roles could dynamically 
switch between changes of circumstance.   
 
Methylation and citrullination were the two PTMs of Arg residues investigated in this chapter. The 
Arg methylation of the other two paralogs A1 and A2/B1 has been reported for decades, while the 
few methylated Arg residues of A3 were identified through large-scale only proteomics without 
detailed analysis. The methylation status of A3 when bound to the A2RE-sequence was largely 
unknown. In contrast to the failure in identifying the phosphorylated residue, the identification of 
methylated Arg residues of A3 turned out to be a triumph—six methylated Arg residues (R214, 
R216, R226, R239, R246 and R286) were identified in the protein C-terminal GRD, and three other 
controversial Arg residues were identified being unmodified. The aDMA reporter ion m/z 46 
observed from MS/MS spectrum is a solid evidence for the aDMA identification, for all above six 
residues. The identification of six aDMA resiudes of A3 inside this project was published in 2013 
(Friend et al., 2013), which is the first time all the RGG-harbouring Arg residue in the A3 C-
terminus were confirmed to be asymmetric dimethylated. Moreover, the unambiguous identification 
came from the exhaustive analysis of all the RGG-harbouring Arg residues and their flanking 
region in C-terminus using the bottom-up approach coupled with MS/MS proteomics. The Gly-loop 
motif was introduced to understand the possible protein configuration where Arg residue located 
and the accessibility to modification/digestion enzymes.  
 
The same bottom-up proteomics were carried out in the citrullination investigations. According to 
the methylation analysis in the protein C-terminus, all the Arg residues in the Gly-rich region were 
identified either dimethylated or unmodified. The tandem MS spectra clearly invalidated the 
MASCOT-generated candidate Cit-containing peptides. Western blotting with anti-citrulline 
antibody (method described in Section 2.2.11, result data not shown) also confirmed the absence of 
citrulline in A3. Therefore, the conclusion can be reached that no citrullinated Arg residue in 
hnRNP A3 when bound to the A2RE sequence.  
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Chapter 5. Developmental and localization studies of 
hnRNP A3 isoforms 
 
5.1 Introduction 
 
Expression of the hnRNP A/B proteins has been reported to be tissue- (Kamma et al., 1999) and 
cell-type (Kamma, Portman, & Dreyfuss, 1995) specific. Moreover, the expression levels of these 
proteins fluctuate at the different stages of cell proliferation and development (J. Zhou et al., 2001). 
The changes in the level of these paralogs suggest a role associated with the cell cycle. On the other 
hand, it indicates that the expression of the A/B paralogs is tightly regulated by the specific 
mechanisms associated with the cell cycle. 
 
The expression of hnRNP A2/B1 isoforms has been extensively studied in rodent and human 
tissues, such as brain, testis, lung, skin, spleen, stomach, and ovary (Kamma et al., 1999) (Hatfield 
et al., 2002) (Ma et al., 2002). The alternative splicing of a 36-nucleotide exon in the HNRPA2B1 
gene gives rise to the two isoforms A2 and B1. However, these two isoforms exhibit quite different 
levels between tissues, with the A2 level approximately 20- to 50-fold higher than the B1 level in 
general. According to their protein abundances, A2 is considered to be the major isoform whereas 
the full-length isoform B1 is the minor form (Kozu et al., 1995) (Kamma et al., 1999). In addition, 
fluctuation of the overall expression level of hnRNP A2/B1 isoforms has been reported in rodent 
and human lung development: the hnRNP A2/B1 level increases at the early stages, including the 
embryonic and childhood periods (Montuenga et al., 1998), until the lung matures at adulthood 
which is indicated by a dramatic decrease of the overall hnRNP A2/B1 level. The hnRNP A2/B1 
level remains restrictedly low in adult lung, unless aberrantly over-expressed as observed during 
lung carcinogenesis (J. Zhou et al., 1998).  
 
In cultured cells, the levels of hnRNPs A1 and A2 are comparable during cell proliferation 
(LeStourgeon et al., 1978). However, the cellular concentration of A1 drops markedly at the time of 
confluency, whereas there is no obvious change in A2 between the proliferating and resting stages 
(Celis et al., 1986). RNAi suppression of A1 and A2 demonstrated both proteins are essential for 
cell proliferation (He, Brown, Rothnagel, Saunders, & Smith, 2005). Moreover, the siRNA-
mediated reduction in hnRNPs A1 and A2 directly triggers rapid apoptosis in cancer cells, whereas 
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the cellular reduction in A1 and A2 is unable to induce specific apoptosis in non-cancer cells (i.e. 
fibroblastic and epithelial cell lines) (Patry et al., 2003).  
 
Considering the cellular abundance, hnRNP A3 is not as prominent as its paralogs A1 and A2. 
Because of its low abundance, A3 is only clearly detected in brain, lung and testis, where A2 is also 
most abundant (Ma et al., 2002). In comparison with the immortalized, non-tumorigenic cell lines, 
the cellular level of hnRNP A3 is found moderately elevated in breast cancer, lung cancer, and 
squamous cell carcinoma, whereas overexpression of A1 and A2 is more significant in these cancer 
cells (He et al., 2005). In squamous carcinoma cells, the level of hnRNP A3 remains stable during 
the entire cell cycle, and suppression of A3 alone has no impact on cell proliferation (He et al., 
2005). 
 
There were two major aims in this chapter. The first aim was to quantify each alternative splice-
form of the HNRPA3 gene during brain development. The second aim was to observe the 
subcellular localization of hnRNP A3 isoforms. Observation of endogenous hnRNP A3 in cultured 
neurons was achieved by immunocytochemistry using isoform-specific antibodies. The localization 
of exogenous hnRNP A3 was investigated by delivering fluorescent GFP-tagged hnRNP A3 fusion 
protein into cultured neurons and HeLa cells by transfection.  
 
5.2 Real-time PCR quantification of the HNRPA3 splice-forms 
 
Alternative splicing at exon 1 of the HNRPA3 gene gives rise to A3a and A3b isoforms. However, 
levels of either the spliced HNRPA3 variants or the translated hnRNP A3 isoforms remain 
unknown. Since the abundance of hnRNP A3 protein has been shown to be higher in brain than in 
other tissues (Ma et al., 2002), the rat brain was chosen for the this quantification study. In 
particular, the HNRPA3 levels during postnatal brain development were a prime focus in this 
chapter. After birth, rats develop rapidly during infancy and usually their brains mature at the age of 
about 3 weeks. Therefore, rat brain tissue subjected to quantification studies was extracted at five 
developmental time points on postnatal days 0, 5, 14, 21, and 49 (abbreviated as P0, P5, P14, P21, 
and P49). Among these time points, the P21 is the generally accepted age for rat brain maturation. 
 
In order to distinguish the alternatively spliced HNRPA3 transcripts and quantify their specific 
cDNA levels by real-time PCR, two primer pairs were designed. As illustrated in Figure 5-1, the 
alternative splicing region of exon 1 was included in the A3a amplicon, but not in the A3b 
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amplicon. Apart for exon 1, the DNA sequences of both A3a and A3b transcripts are identical. 
Thus, the A3 amplicon (from exon 7-10) was designed to amplify the overall HNRPA3 gene, whose 
level should be the sum of A3a and A3b transcripts. The lengths of designed A3a, A3b and A3 
amplicons were similar, so that their amplifications in real-time PCR were carried out under the 
same PCR cycling conditions.  
 
The transcripts of housekeeping proteins GAPDH and β-actin were included as positive controls, 
which were amplified under the same cycling conditions as the HNRPA3 amplicons. The 
commercial primer pairs for housekeeping mRNAs have similar GC contents and annealing 
temperatures to the designed HNRPA3 primer pairs. The GAPDH amplicon is 240 bp long, 
amplified by the primers of 5’-TGATGACATCAAGAAGGTGGTGAAG-3’ (forward) and 5’-
TCCTTGGAGGCCATGTGGGCCAT-3’ (reverse); the β-actin amplicon is 285 bp long, amplified 
by the primer of 5’-TCATGAAGTGTGACGTTGACATCCGT-3’ (forward) and 5’-
CCTAGAAGCATTTGCGGTGCACGATG-3’ (reverse).  
 
 	  	  
 
	  
Figure	  5-­‐1:	  Strategy	  in	  real-­‐time	  PCR	  quantification.	  The	  alternatively	  spliced	  HNRPA3	  transcripts	  are	   drawn	   schematically	   as	   two	   series	   of	   connected	   exons	   (boxes),	   and	   the	   intron	   regions	   are	  simplified	  as	  connecters	  between	  exons.	  These	  two	  cDNA	  sequences	  are	  aligned	  by	  the	  identical	  exons,	  and	   the	   alternative	   splicing	   region	   is	   coloured	   in	   blue.	   The	   orange	   exons	   indicate	   the	   non-­‐coding	  regions.	  The	  lengths	  of	  exons	  (except	  for	  exon	  11)	  are	  proportional	  to	  the	  length	  of	  100bp	  bar	  shown	  underneath	  the	  sequences.	  The	  three	  HNRPA3	  amplicons	  subject	  to	  real-­‐time	  PCR	  quantifications	  are	  indicated	   as	   grey	   boxes	   with	   their	   relative	   positions	   on	   the	   cDNA	   sequences.	   The	   red	   arrowheads	  show	  the	  orientations	  of	  primer	  pair	  of	  each	  amplicon.	  Primer	  sequences	  are:	  A3a	  amplicon	  (365bp)	  Forward:	  CAGCCTGACTCCGGCCG	  	   Reverse:	  CCACCAACAAAAATCTTCTTCA	  A3b	  amplicon	  (340bp)	  Forward:	  CGGTCTCAAAATGGAGGGC	  	   Reverse:	  CCACCAACAAAAATCTTCTTCA	  A3	  amplicon	  (357bp)	   Forward:	  GTGGCAGCAGAGGCAGTTAT	  Reverse:	  CACCACTTCCACCTCCAGAT	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All the templates subjected to the real-time PCR quantification were prepared under the same 
experimental conditions. First, total RNA was extracted from rat brains at five different 
developmental stages (i.e. P0, P5, P14, P21, and P49). Then, the conventional RT-PCR was 
performed to synthesize cDNA, which was the template for the following real-time PCR 
amplification. In addition to the target cDNA amplifications (i.e. A3a, A3b, GAPDH or β-actin 
amplicon), non-template controls (NTC) were included to set the amplification baseline. For the 
purpose of repeatability and reproducibility, at least three replicate reactions were performed per 
amplification, and biological variants of the target were also included. Therefore, the real-time PCR 
results presented in this chapter are commensurate with the experimental and biological variations.  
 
SYBR Green was used as the fluorescent reporter for all real-time PCR reactions discussed in this 
chapter. The amplification curve was plotted with the cycle number versus the intensity of the 
continuous SYBR Green signals (ΔRn) emitted during the PCR at each time point. Because the ΔRn 
values during the exponential phase of PCR correlated with the initial amount of the target 
templates, an ΔRn threshold line is assigned where a sufficient number of amplicons have 
accumulated to the point that the initial template concentration can be accurately inferred from the 
detected fluorescence intensity. Thus, the threshold cycle (Ct) is derived at the intersection between 
the ΔRn threshold line and the amplification curve, and the Ct value inversely correlates to the 
logarithm of the initial copy number of the target template. Therefore, quantification of the level of 
target amplicon is achievable by measuring its Ct value of the real-time PCR amplification.  
 
Figure 5-2 showed the amplification plots of the four target amplicons. For each of the target 
amplicons, the amplification curves of replicate reactions were collectively plotted and aligned 
inside a single graph, so that the shape of aligned curves reflect the overall amplification pattern of 
the target amplicon.  
 
Among the four amplification curves, only the A3a curve showed a sigmoid shape in its log-linear 
exponential phase. The incompatibility between the primers and the fluorescent reporter dye might 
be the cause of this sigmoid-shaped amplification curve, since SYBR Green has been criticized 
responsible for such problem (Real-time PCR troubleshooting, Applied Biosystems). In contrast, 
the other three amplification curves showed a smooth increase in the exponential phase, reflecting a 
typical real-time amplification. The Ct values of the target amplicon also varied. The Ct ranges of 
the GAPDH and β-actin amplifications were lower than those of A3a and A3b amplicons. This 
implied the levels of A3a and A3b transcripts were much lower than the abundant housekeeping 
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transcripts when amplification initiated. Especially for the A3a amplicon, the sigmoid-shaped 
exponential phase of amplification together with its high Ct value indicated some difficulties in 
amplifying the A3a amplicon: incompatibility with the fluorescent dye and a fairly low starting 
level of the template. In this light, the follow-up analysis was required to further investigate the 
amplification specificities and efficiencies of the target amplicons before proceeding to 
quantifications. Therefore, the end-point analyses of the amplification products, i.e. the real-time 
PCR dissociation curves and agarose gel electrophoresis, were followed to evaluate the 
amplification specificity.  
  
 
Figure	  5-­‐2:	  Real-­‐time	  PCR	  amplification	  plots	  of	  HNRPA3	  and	  housekeeping	  amplicons.	  Panels	  A-­‐D	  respectively	  demonstrate	  the	  amplification	  plots	  of	  A3a,	  A3b,	  GAPDH	  and	  β-­‐actin	  amplicons.	  In	  each	  panel,	   the	   Y-­‐axis	   is	   the	   log	   scale	   of	   the	   fluorescence	   intensity	  ΔRn,	   and	   a	   thickened	   horizontal	   line	  indicates	   the	   individual	  ΔRn	  threshold.	  For	   the	  each	   target	  amplicon,	   the	  amplification	  curves	  of	   the	  cDNA	   templates	   from	  P0-­‐49	  old	   rat	  brains	   (triplicate	  amplifications	  at	   each	  age	  point)	  were	  aligned	  together	  into	  a	  single	  plot.	  The	  Ct	  values	  of	  each	  target	  amplicon	  were	  indicated	  as	  a	  range	  in	  brackets	  under	  the	  threshold	  line.	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5.2.1 Real-time PCR amplification specificity 
 
When SYBR Green-based PCR amplification finishes, the thermal cycler heats through over the 
melting temperature (Tm) of target amplicon, and the dsDNA PCR products are denatured by heat. 
The dsDNA-intercalating fluorogenic SYBR Green produces little fluorescence when it is free in 
solution, but emits a strong fluorescent signal upon binding to dsDNA. The dissociation of dsDNA 
product will result in a rapid release of free SYBR Green fluorescence, detected as a sudden loss in 
fluorescence intensity. Thus, a dissociation curve is normally plotted with the changes of 
fluorescence signals versus temperature, right after real-time PCR amplification. Usually, the rate of 
fluorescence change is designated by the negative first-derivative of fluorescence (i.e. -dF/dT) in 
the Y-axis, so that the dsDNA-melting event can be easily interpreted as a distinct dissociation peak 
in the plot. The shape and position of the dissociation peak are sequence-specific, which are 
determined by the sequence order, length and GC content of dsDNA.  
 
The real-time PCR dissociation curves of the four target amplicons were individually presented in 
Figure 5-3. The dissociation curves of the A3b, GAPDH and β-actin amplicons all clearly appeared 
to contain a single dissociation peak, indicating the homogeneous PCR products from these three 
amplifications. Due to the high repeatability of the real-time PCR, all the reactions of the same 
amplicon give the consistent Tm of each PCR product. The table in panel E (Figure 5-3) indicated 
the observed Tm of PCR products also match (≤±0.5°C) to the theoretical Tm of the A3b, GAPDH 
and β-actin amplicons. Intriguingly, the dissociation curve of A3a amplification showed a major 
peak followed by a shoulder peak 4 °C apart. The theoretical Tm of A3a amplicon is 83.8 °C, being 
the average of the two observed Tm. 
 
Normally, any primer dimers are much shorter than the target amplicon, so that they melt at lower 
temperatures and have broader dissociation peaks. In the A3a dissociation curve, the significant 
dissociation peak at 82 °C corresponded to the major PCR products. The minor shoulder peak 
implicated another dsDNA structure melting at 4 °C higher, which could not be the primer dimer. In 
addition, no peak was observed in the dissociation curves of negative controls in absence of DNA 
templates (the dissociation curves of NTC not shown), which eliminated the possibility of primer 
dimers during the A3a amplifications. Therefore, this irregular shape of the dissociation curve 
might also partially result from the same problem of incompatibility between the SYBR Green and 
the A3a primers, found in the amplification curves.    	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E.	  Comparison	  of	  observed	  and	  theoretical	  Tm	  
	   A3a	   A3b	   GAPDH	   β -­‐actin	  
Observed	  Tm	  	  (°C)	   82	  &	  86	   81.5	   83.6	   84.2	  
Theoretical	  Tm	  	  (°C)	   83.8	   82	   83.6	   84.6	  
 
Figure	   5-­‐3:	   Real-­‐time	   PCR	   dissociation	   curve	   analysis	   of	   the	   HNRPA3	   and	   housekeeping	  
amplicons. The	  real-­‐time	  PCR	  dissociation	  curves	  of	  the	  A3a,	  A3b,	  GAPDH	  and	  β-­‐actin	  amplicons	  are	  respectively	   displayed	   in	   panels	   A-­‐D.	   In	   each	   dissociation	   curve,	   the	   negative	   first-­‐derivative	   of	  fluorescence	  intensity	  (–dF/dT),	  noted	  on	  the	  Y-­‐axis,	  is	  plotted	  against	  temperature	  of	  the	  X-­‐axis.	  The	  Tm	  observed	   from	   the	  distinct	  dissociation	  peak	  was	   labeled	  on	   top	  of	   each	   corresponding	  peak.	   In	  panel	  E,	  both	  observed	  and	   theoretical	  Tm	  of	   four	   target	  amplicons	  were	   summarized	   in	  a	   table	   for	  comparison.	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In order to check the amplification specificity, conventional agarose gel electrophoresis was also 
used to observe the amplified products. The real-time PCR reaction mixtures of all four target 
amplicons were separated in 2% agarose gel (Figure 5-4). The real-time PCR products were 
consistent for all reactions from P0-49 rat brain DNA templates, and their sizes also match the 
theoretical size of the amplicon. The negative controls clearly show neither the amplification nor 
the primer dimer structure.  
 	  
	  
Figure	   5-­‐4:	   Agarose	   gel	   electrophoresis	   of	   real-­‐time	   PCR	   products.	  The	   real-­‐time	  PCR	   reaction	  mixtures	  of	  four	  target	  amplicons	  were	  loaded	  on	  2%	  agarose	  gel	  for	  electrophoresis.	  The	  gel	  lanes	  of	  reaction	  mixtures	   are	   grouped	  by	   amplicons,	   as	   shown	  on	   top	  of	   the	   gel,	   and	   the	   theoretical	   size	  of	  each	   amplicon	   is	   given	   in	   bracket.	   For	   each	   amplicon,	   the	   gel	   lanes	   of	   P0-­‐49	   are	   different	   reactions	  using	   the	   P0-­‐49	   rat	   brain	   cDNA	   templates.	   The	   negative	   controls,	   gel	   lane	   labeled	   as	   NTC,	   are	   the	  reactions	  without	  any	  DNA	  template.	  The	  molecular	  marker	  is	  positioned	  on	  the	  left	  and	  right	  edges,	  and	  sizes	  are	  indicated	  in	  bp.	  
 
 
The A3a amplicon showed a single DNA band of approximate 360-370 bp for all rat brain 
templates, which suggested that a specific A3a PCR product was amplified. Therefore, the two 
ambiguous dissociation peaks of the A3a amplification seen in the real-time PCR plot appeared to 
be a definitive PCR product shown in the gel. Sequence analysis of the A3a amplicon revealed that 
the GC nucleotides are unevenly distributed. In particular, a very high GC content is found at its 5’-
end, which might contribute to the two dissociation events of the single A3a amplicon during 
denaturing. Instead of all the A3a amplicon strands being evenly denatured at the theoretical 83.8 
°C, the majority of the double strands are dissociated at 82 °C, and the GC-rich 5’-ends lag behind 
until they eventually melt at a higher 86 °C. This two-step dissociation event is therefore interpreted 
as two joining peaks 4 °C apart in the dissociation curve of the A3a amplification.   
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The combined analyses of the real-time PCR dissociation curve and agarose gel electrophoresis 
validated the amplification specificities of all four target amplicons. The troubleshooting analysis of 
the amplification plots also revealed the possible incompatibility between SYBR Green 
fluorescence with the A3a primers. However, such complications were not found in amplifications 
of other target amplicons under the same reaction conditions, which implies that the incompatibility 
was from the primer sequence against the 5’-end. The 5’-end of the A3a amplicon begins at the 
alternative splicing region of the HNRPA3 gene (Figure 5-1), so that the amplicon is unique for the 
A3a transcripts only. The sequence analysis implies that this splicing region is not only GC-rich but 
also prone to form a large GC-paired loop in secondary structure (data not shown). This possible 
secondary structure might be the reason that alternatively spliced HNRPA3 gene is the majority: the 
replication of A3a transcripts has to be achieved by overcoming the steric hindrance brought by 
such secondary structure, which ultimately affect the protein expression the A3a isoform. 
 
5.2.2 Validation of real-time PCR amplification 
 
With the validated amplification specificities, the transcript quantification was carried out to 
investigate the levels of A3a and A3b in rat brain. A series of two-folds diluted P21 rat brain 
template (i.e. 1, ½, ¼, 1/8, 1/16 dilutions) were amplified using real-time PCR. The Ct values of 
replicate amplifications were collected, and plotted in the Ct value curve (Panel A, Figure 5-5). A 
standard curve (Panel B, Figure 5-5) was subsequently graphed on the basis of the Ct value curve, 
with the template dilution factors converted into log concentrations for the X-axis. The Y-axis of 
standard curve remained the same. The resultant standard curve of each amplicon was demonstrated 
by a linear equation, to evaluate the amplification efficiency. Here, four amplicons A3a, A3b, β-
actin and GAPDH were amplified in real-time PCR, and the coefficients derived from its standard 
curve were listed in Panel C, Figure 5-5.   
 
Although the equation of a real-time PCR standard curve was generated from a complicated 
mathematical algorithm, the amplification efficiency can be simply interpreted with the coefficients 
of the standard curve. For example, a theoretical 100% efficient amplification would have a slope of 
-3.32, a y-intercept between 33 and 37, and R2 of 1.00. The efficiency is calculated by the formula 
(Efficiency = 10-1/slope). When slope increases, the efficiency drops. Likewise, the amplification 
sensitivity decreases when y-intercept increases. The value of R2 indicates the precision of results: a 
high precision requires R2≥0.99.  
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A.	  Ct	  value	  curve	  	  
 
 
 
	  
	  
B.	  Real-­‐time	  PCR	  standard	  curve	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C.	  Table	  of	  real-­‐time	  PCR	  amplification	  coefficients	  	  	  
	   A3a	   A3b	   β-­‐actin	   GAPDH	  
Slope	   -­‐3.455	   -­‐3.361	   -­‐3.620	   -­‐3.719	  
Y-­‐intercept	   26.83	   22.59	   18.61	   17.88	  
R2	   0.966	   0.992	   0.999	   0.997	  
Efficiency	   94.74%	   98.41%	   88.92%	   85.72%	  
 
Figure	  5-­‐5:	   Calculation	  of	   amplification	  efficiencies.	  Panel	  A	  is	  the	  Ct	  value	  curve	  plotted	  against	  the	  amplifications	  of	  a	  serie	  of	  2-­‐folds	  diluted	  (i.e.	  1,	  ½,	  ¼,	  1/8	  and	  1/16)	  P21	  rat	  brain	  templates.	  The	  curves	   of	   A3a,	   A3b,	   β-­‐actin	   (BA)	   and	   GAPDH	   are	   individually	   labelled	   on	   the	   graph.	   Panel	   B	   is	   the	  standard	  curve	  plotted	  based	  on	  the	  Ct	  value	  curve	  in	  panel	  A.	  X-­‐axis	  denotes	  the	  log	  concentration	  of	  template	   (i.e.	   log1,	   log1/2,	   log1/4,	   log1/8	   and	   log1/16).	   For	   each	   amplicon,	   a	   standard	   curve	   is	  represented	   by	   a	   system-­‐generated	   linear	   formula	   and	   an	   R2	   value	   to	   evaluate	   the	   amplification	  efficiency.	  Panel	  C	  is	  the	  table	  of	  coefficient	  values.	  Values	  of	  slope,	  y-­‐intercept	  and	  R2	  were	  acquired	  from	  the	  system-­‐generated	  linear	  formula	  presented	  in	  Panel	  B,	  and	  the	  amplification	  efficiencies	  were	  calculated	  according	  to	  the	  formula	  (Efficiency	  =	  10-­‐1/slope).	  	  	  	  	  
 
From the above table, all the amplification efficiencies fell into the acceptable range. However, the 
amplification efficiencies of β-actin and GAPDH both were lower than the target A3a and A3b, 
suggesting the specifically designed A3a and A3b primers were more efficient than the commercial 
primers in amplifying β-actin and GAPDH under the same reaction conditions. However, 
coefficient R2 indicated that the amplification precision of A3a was slightly behind the other three, 
for its R2 was lower than the desired value of 0.99. This might also be the consequence of the same 
problem discussed earlier in amplifying the A3a amplicon (Panel A, Figure 5-3), possibly caused by 
either the incompatibility between SYBR Green and A3a primers or the putative GC clusters inside 
the amplified sequence.   
 
 
5.2.3 Reference gene selection and target gene quantification 
 
Prior to the target A3a and A3b genes, the housekeeping genes β-actin and GAPDH were amplified 
to validate their roles as a good reference gene for normalization in this developmental study 
(Figure 5-6).  
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A.	  Amplification	  chart	  of	  β-­‐actin	  gene	  through	  brain	  development	  (P0-­‐P49)	  
 
B.	  Amplification	  chart	  of	  	  GAPDH	  gene	  through	  brain	  development	  (P0-­‐P49)	  
 
Figure	  5-­‐6:	   Comparison	  of	   the	   amplification	   charts	  between	  β-­‐actin	   and	  GAPDH	  during	  brain	  
development.	  The	  templates	  subject	  to	  amplification	  were	  obtained	  from	  rat	  brain	  at	  the	  stages	  of	  P0,	  P5,	  P14,	  P21	  and	  P49.	  Five	  replicates	  of	  amplification	  were	  carried	  out	   for	  each	  sample,	  and	  β-­‐actin	  (Panel	   A)	   and	  GAPDH	   gene	   (Panel	   B)	  were	   amplified	   and	   analysed.	   Both	   charts	   are	   plotted	  with	   Ct	  values	   (Y-­‐axis)	   which	   are	   the	   mean	   of	   the	   five	   replicates.	   Detailed	   values	   and	   small	   black	   bars	   of	  standard	   deviations	   are	   presented	   on	   top	   of	   each	   Ct	   value	   bar.	   Values	   of	   Ct	   mean	   and	   standard	  deviation	   were	   calculated	   by	   the	   SDS	   2.3	   software	   (Applied	   Biosystems	   7900HT	   Real-­‐time	   PCR	  system).	  	  
 
The real-time PCR amplifications of A3-related genes, i.e. A3a, A3b and overall A3, were carried 
out using the rat brain templates at five significant stages of brain development. The absolute 
amplification chart (Panel A, Figure 5-7) was directly plotted with the experimental Ct values in Y-
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axis, so that this chart was reversely presented. The absolute quantification chart (Panels B, Figure 
5-7) was plotted with the template amounts, which were converted from the experimental Ct values; 
whereas the relative quantification chart (Panels C, Figure 5-7) was plotted with the GAPDH-
normalized value of target genes.  
 
In the absolute quantification chart (Panels B, Figure 5-7), the developmental changes of the A3a, 
A3b and overall A3 genes were correlated in a similar pattern. They all showed a very low level at 
P0, and gradually increased through P5 and P14, followed by a big rise at P21, and finally fell at 
P49.   
 
	  
A.	  Absolute	  amplification	  chart	  of	  A3a,	  A3b	  and	  A3	  transcripts	  	  
	  
	  
B.	  Absolute	  quantification	  chart	  of	  A3a,	  A3b	  and	  A3	  transcripts	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C.	  Relative	  (GAPDH-­‐normalized)	  quantification	  chart	  of	  A3a,	  A3b	  and	  A3	  transcripts	  	  
 
Figure	   5-­‐7:	   Quantification	   of	   A3a,	   A3b	   and	   A3	   transcripts	   during	   brain	   development.	  The	   rat	  brain	  templates	  at	  stages	  of	  P0,	  P5,	  P14,	  P21	  and	  P49	  were	  amplified	  by	  real-­‐time	  PCR.	  Five	  replicates	  were	  carried	  out	  for	  each	  sample,	  and	  three	  target	  genes,	  A3a,	  A3b	  and	  overall	  A3,	  were	  amplified	  and	  analyzed.	  In	  Panel	  A,	  the	  absolute	  amplification	  chart	  was	  drawn	  to	  show	  the	  Ct	  values	  (Y-­‐axis)	  of	  the	  each	  amplification.	  These	  Ct	  values	  were	  the	  mean	  of	  five	  replicates,	  and	  the	  small	  blak	  bars	  on	  top	  of	  the	   Ct	   value	   bars	   indicates	   the	   standard	   deviations.	   Both	   values	   of	   Ct	  mean	   and	   standard	   deviation	  were	  calculated	  by	  the	  SDS	  2.3	  software.	  The	  transcript	  levels	  of	  target	  genes	  were	  converted	  from	  Ct	  values	   in	  panel	  A,	  and	  then	  plotted	  as	  “Template	   level”	   (Y-­‐axis)	   in	  Panel	  B.	  The	  Panel	  C	   is	  a	  GAPDH-­‐normalized	   quantification	   chart.	   	   The	   normalization	  was	   calculated	   as	   the	   “GOI/GAPDH”	   ratio.	   GOI:	  Gene	  Of	  Interest.	  GAPDH	  is	  the	  selected	  reference	  gene.	  	  
 
 
When the absolute quantity was normalized with GAPDH (Panel C, Figure 5-7), the developmental 
changes of A3a, A3b and overall A3 genes were still consistently correlated, but slightly different to 
their absolute pattern. Due to the normalization with GAPDH, a decrease was observed in the A3b 
and the overall A3 genes at the stage of P14.  Other than P14, the other developmental changes of 
all three target genes were consistent to their absolute values.  
 
At the same time, the overall amount of the A3 transcripts was compared with the sum of the A3a 
and A3b amount. As shown in Figure 5-1, the A3 amplicon was designed to indiscriminately 
amplify the transcripts of both splice-forms of A3. Theoretically, the sum of the amplified A3a and 
A3b should be equal to the overall level of the A3. The quantification chart in Panel A (Figure 5-8) 
showed the sum of A3a and A3b was largely in agreement with the amount of A3, with tiny 
deviations at P5 and P21. It implied that the real-time PCR methods were highly reproducible with 
accuracy.  
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A.	  Comparison	  of	  the	  level	  of	  A3a+A3b	  and	  A3	  transcripts	  	  
 
	  
	  
B.	  The	  percentage	  of	  A3a	  and	  A3b	  during	  the	  brain	  development	  	  
 
 
	  
Figure	  5-­‐8:	   	  Comparison	  of	  A3a,	  A3b	  and	  A3	  transcripts	  during	  brain	  development.	  The	  sum	  of	  the	  expression	  level	  of	  A3a	  and	  A3b	  were	  plotted	  with	  the	  level	  of	  A3	  transcripts	  (Panel	  A),	  which	  was	  designed	   in	   the	   isoform-­‐identical	   sequence	   to	   amplify	   both	   A3a	   and	   A3b	   genes.	   The	   column	   of	   A3	  represented	  the	  overall	  A3	  level	  obtained	  through	  the	  amplification	  of	  the	  A3	  amplicon;	  whereas	  the	  column	   of	   A3a+A3b	   represented	   the	   sum	   of	   the	   amplification	   of	   A3a	   and	   A3b.	   The	   age-­‐specific	  percentages	  of	  A3a	  and	  A3b	  in	  the	  overall	  A3	  content	  were	  calculated	  and	  plotted	  side-­‐by-­‐side	  in	  Panel	  B.	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In addition, the percentages of A3a:A3 and A3b:A3 were compared side-by-side in Panel B (Figure 
5-8). The full-length A3a transcripts were always shown to be the less abundant form, no more than 
35% of the total A3 even at its highest level. The proportions of A3a and A3b in A3 showed an age-
related change but in a totally opposite side: the percentage of A3a steadily increased from P0 to 
P49, at the same time, A3b constantly lost its share to A3a. However, through the developmental 
stages P0-P49, the A3b’s share in A3 never fell below 65%.  Without any doubt, A3b is always the 
major splice-form of A3.  
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5.3 Subcellular localization of hnRNP A3 isoforms 
5.3.1 Culturing primary neural cells 
 
Brain tissue was dissected from newborn rat pups, following the procedures described in Chapter 2 
(Section 2.3.1). Tissues in the brain subventricular zones were dissected for establishing the 
primary oligodendrocyte (OL) culture, and the region of brain hippocampus was dissected for 
generating the primary neuron culture. Enzyme digestion was carried out to disaggregate the 
dissected tissues, followed by trituration to dissociate the viable stem cells. After calculating the 
concentration of isolated neural stem cells, these postnatal stem cells were plated with appropriate 
densities for the specific lineage differentiation. The cultured neural stem cells were firstly 
stimulated to proliferate, generating a sufficient population of the lineage-specific progenitor cells. 
Then, these distinct neural progenitor population were induced to differentiate into their mature 
phenotypes: the neuronal lineage progenitor cells differentiated into mature hippocampal neurons; 
the glial lineage progenitor cells differentiated into mature myelin-forming OLs. The stage-specific 
phenotypes of both cultured cell lineages are illustrated in Figure 5-9. At each stage, the plating 
density, growth factor composition and passage number of the primary culture were strictly 
monitored to facilitate lineage differentiations and also maintain the cell type homogeneity. 
 
Once the primary neural cell cultures were established, the transfection and immune-staining 
experiments were carried out on these primary cells at the immature stages. Prior to the transfection, 
Trypan Blue exclusion was always performed to calculate the number of viable cells. 
Lipofectamine transfections were ideally carried out at the density of 2-3 × 105 per plate.  
 
  
	  	  
Figure	   5-­‐9:	   Differentiation	   stages	   of	   primary	   neural	   cells.	  The	  postnatal	  neural	   stem	  cells	  were	  isolated	   from	  newborn	   rat	  brain.	  The	  primary	  neuron	  and	  OL	   cultures	  were	   initiated	  by	  plating	   the	  stem	   cells	   isolated	   from	   dissected	   tissues	   of	   the	   hippocampus	   region	   and	   the	   subventricular	   zone,	  respectively.	   Beginning	   with	   the	   multipotent	   stem	   cells,	   the	   progression	   stages	   of	   cultured	  hippocampal	  neurons	  (Panel	  A)	  and	  OLs	  (Panel	  B)	  are	  presented	   in	  six	  microscope	   images	  captured	  during	  their	  lineage-­‐specific	  differentiations.	  Underneath	  the	  microscope	  images,	  the	  graphic	  diagrams	  of	   cell	   phenotypes	   at	   each	   stage	  were	   drawn	  based	   on	   the	   reviews	   of	   neural	   lineage	   differentiation	  ((Conti	  &	  Cattaneo;	  Gage,	  2000)).	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5.3.2 Subcellular localization of exogenous hnRNP A3 
 
	  
As concluded in the previous section, the hnRNP A3b is a major isoform in rat brain during the 
stages P0-P49. Thus, A3b was selected as a reporter gene cloned into a GFP vector. In this project, 
two GFP-tagged A3b genes (pEGFP-N1-A3b and pEGFP-C1-A3b) were constructed for observing 
the subcellular localization of exogenous GFP-A3b fusion protein in vivo. When GFP is fused with 
report gene, the expression of reporter gene (i.e. A3b gene) will override the general GFP 
localization and direct the fusion proteins to the reporter’s specific subcellular localization. The N- 
and C-terminal GFP tags virtually have no difference in the expression and functionality of the 
reporter gene when fused with the A3b gene. Therefore, both GFP-tagged constructs should exhibit 
the same expression pattern of the reporter gene when transfected independently. 
 
The exogenous hnRNP A3b was delivered into cultured cells by transfection. Three types of 
cultured cells (i.e. HeLa cells, hippocampal neurons and oligodendrocytes) were transfected with 
the GFP-A3b constructs. At the same time, the GFP vectors without any reporter gene were also 
transfected, serving as negative controls.  
 
HeLa cells transfected with GFP-A3b constructs are shown in Figure 5-11. The images in the rows 
of GFP-N1 and GFP-C1 demonstrated the expression the GFP vectors without any reporter gene. 
As negative controls, the GFP proteins were localized evenly in the nucleus and cytoplasm. Images 
in the row of “GFP-N1-A3b” showed the localization of the exogenous A3b gene fused with GFP at 
N-terminus. It was clear the transfected HeLa cells were in the interphase. The expressed GFP-N1-
A3b fusion proteins were concentrated in the cell nucleus but were excluded from the nucleoli. 
Relatively higher concentration of GFP-N1-A3b was observed in the centre of the nucleus and 
along the boundary of nucleolus region. The concentration gradually declined outwards to the 
nuclear membrane as well as inwards to the nucleolus region.  
 
HeLa cells transfected with GFP-C1-A3b were at the different mitotic stages: one cell in the image 
just started a mitotic nuclear division, and the other cell almost finished a mitotic nuclear division. 
Therefore, the shape and number of nucleolus appeared differently in the same image. However, the 
localization of the GFP-C1-A3b fusion protein was also restricted inside the cell nucleus. However, 
the GFP-C1-A3b fusion proteins were also expressed in the nucleolus in a relatively low intensity, 
which was different to those interphase cells. 
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Figure	  5-­‐10:	  GFP-­‐A3b	  fusion	  proteins	   in	  HeLa	  cells.	  HeLa	  cells	  were	  transfected	  with	  GFP	  vectors	  (GFP-­‐N1	  and	  GFP-­‐C1)	  and	  two	  differently	  oriented	  constructs	  of	  GFP-­‐A3b	  (GFP-­‐N1-­‐A3b	  and	  GFP-­‐C1-­‐A3b).	   The	   images	   capturing	   the	   fluorescence	   emitted	   by	   GFP	   and	   GFP-­‐A3b	   fusion	   proteins	   were	  aligned	  in	  column	  “Green	  fluorescence”.	  The	  images	  aligned	  in	  column	  “DAPI”	  indicate	  the	  cell	  nucleus	  (counterstained	  by	   the	   fluorescent	  DNA	   staining,	  DAPI).	   In	   column	   “Merge”,	  DAPI	   staining	  was	  blue	  and	   the	   expressions	   of	   GFP	   constructs	   were	   green.	   Fluorescent images were taken with a ZEISS 
epifluorescence light microscope. Scale bar of 5 µm was indicated in the image. 	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Except that the transfected HeLa cells captured in images were in different cell cycle stages, the 
subcellular localizations of GFP-N1-A3b and GFP-C1-A3b were similar: both showed the nuclear 
localization leaving out the nucleolus region. The orientation of the GFP tag had no obvious impact 
in the expression of GFP-A3b fusion proteins in transfected HeLa cells.  
 
The same exogenous GFP-fusion proteins were delivered to the primary hippocampal neurons by 
transfection. The subcellular localizations of exogenous proteins are shown in Figure 5-11. The 
GFP vectors (GFP-N1 and GFP-C1) without the reporter gene were expressed evenly all over the 
neurons, presenting a clear neuronal morphology with the interweaving cell processes. The 
subcellular localization pattern of the fusion proteins GFP-N1-A3b and GFP-C1-A3b were very 
similar: they both restricted inside the nucleus of hippocampal neurons, and no cytoplasmic 
localization was observed. Relatively higher concentration of the GFP-A3b fusion protein was 
observed in the central area between nucleoli. In transfected hippocampal neurons, the GFP-A3b 
fusion proteins were also expressed inside nucleoli, but at a low level. The shapes of nucleoli were 
observed by the contrast of the fluorescent intensity in and out of the nucleoli. Based on the 
neuronal morphology described in the previous Section 5.2.2.1, it was obvious the hippocampal 
neurons presented here were at different stages in differentiation: the GFP-N1 transfected neurons 
were immature, whereas the GFP-C1 transfected neuron was at a fully matured stage.  
 
In Figure 5-12, the primary oligodendrocytes were transfected with the same exogenous GFP-A3b 
fusion proteins. The expression of the negative controls, the GFP vectors, was intense all over the 
transfected cell, which outlined the shape of the cell body with long and fine dendrites in the 
transfected oligodendrocyte. Based on the morphological description, both GFP-transfected primary 
cells were at the pre-OL stage.  
 
The expressions of the GFP-N1-A3b and GFP-C1-A3b fusion proteins were similar in each 
transfected oligodendrocytes. Both GFP-A3b fusion proteins were also restricted inside the nucleus 
of oligodendrocytes, without any sign of cytoplasmic localization. A few speckles of high 
concentration of the GFP-A3b proteins were observed in the nucleoplasm between nucleoli. The 
expression of the GFP-A3b fusion proteins was also observed in the nucleoli at a low level.  
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Figure	   5-­‐11:	   GFP-­‐A3b	   fusion	   proteins	   in	   hippocampal	   neurons.	   Hippocampal	   neurons	   were	  transfected	  with	  GFP	  vectors	  (GFP-­‐N1	  and	  GFP-­‐C1)	  and	  two	  differently	  oriented	  constructs	  of	  GFP-­‐A3b	  (GFP-­‐N1-­‐A3b	   and	   GFP-­‐C1-­‐A3b).	   The	   image	   alignments	   are	   the	   same	   as	   described	   in	   Figure	   5-­‐10.	  
Fluorescent images were taken with a ZEISS epifluorescence light microscope. Scale bar of 10 µm was 
indicated in the image. 	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Figure	   5-­‐12:	   GFP-­‐A3b	   fusion	   proteins	   in	   oligodendrocytes.	   Oligodendrocytes	   were	   transfected	  with	  GFP	  vectors	  (GFP-­‐N1	  and	  GFP-­‐C1)	  and	  two	  differently	  oriented	  constructs	  of	  GFP-­‐A3b	  (GFP-­‐N1-­‐A3b	   and	   GFP-­‐C1-­‐A3b).	   The	   image	   alignments	   are	   the	   same	   as	   described	   in	   Figure	   5-­‐10.	  Fluorescent 
images were taken with a ZEISS epifluorescence light microscope. Scale bar of 10 µm was indicated in the 
image.  
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5.3.3 Subcellular localization of endogeous hnRNP A3 
 
In parallel to transfecting the exogenous hnRNP A3b into different cell types, the subcellular 
localization of endogenous hnRNP A3b were investigated in cultured HeLa and primary neural 
cells.    
 
 
 
Figure	  5-­‐13:	  Subcellular	   localization	  of	  endogenous	  hnRNPs	  A2	  and	  A3	   in	  HeLa	  cells.	  Cultured	  HeLa	  cells	  were	  immunostained	  with	  the	  rabbit	  polyclonal	  A3b	  (labeled	  as	  anti-­‐A3)	  and	  A2	  (labeled	  as	  anti-­‐A2)	  antibodies	  separately.	  Image	  in	  the	  left	  panel	  is	  the	  nuclear	  stained	  with	  DAPI	  in	  HeLa	  cells.	  It	  served	  as	  non-­‐specific	   control.	   Images were taken with a Zeiss	   confocal	   system.	  Scale bar of 5 µm was 
indicated in the image. 	  
 
The immunostained images clearly showed the localization patterns of endogenous hnRNPs A2 and 
A3b in the cultured HeLa cells (Figure 5-13). Comparing the stainings for the endogenous A2 and 
A3b, the fluorescent intensity of the A2 staining was much higher than that of the A3b, indicating 
that A2 was expressed at a much higher level than A3b. The A2 were largely expressed in the 
nucleus, but unevenly. Few sparsely distributed A2 speckles were observed in cytoplasm. The 
staining of A2 showed low fluorescent intensity inside the nucleoli. Some A2 proteins were 
gathering into tiny bright speckles concentrated at the inner nucleoplasm or between nucleoli, and 
the A2 concentration decreased outward to the nuclear envelope. 
 
Unlike A2, the endogenous A3b proteins were exclusively expressed in the nucleus. The nucleolar 
staining of A3b was observed, but in a low intensity. A few speckles of high concentration of A3 
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were located on the periphery of nucleoli, clearly outlining the shapes of nucleoli. No cytoplasmic 
speckles of A3b were observed. 
 
 
 
Figure	   5-­‐14:	   Subcellular	   localization	   of	   endogenous	   hnRNPs	   A2	   and	   A3	   in	   hippocampal	  
neurons.	  The	  primary	  hippocampal	  neurons	  were	  immunostained	  with	  the	  rabbit	  polyclonal	  A3	  and	  A2	   antibodies	   separately. Image of neuron stained with DAPI in the right panel served as non-specific 
control, also indicated the neucleus. All images were taken with a Zeiss	  confocal	  system.	  Scale bar of 5 µm 
was indicated in the image.  
	  
 
In the hippocampal neurons, endogenous A2 demonstrated an uneven localization pattern inside the 
nucleus. Higher level was observed in the inner nucleoplasm and between nucleoli. The A2 level 
gradually decrease outward to the nuclear envelope. A few faint A2 speckles were noticed in the 
cytoplasm, vaguely outlining the shape of cell processes (as arrow indicated). 
 
The endogenous A3 were limited inside the nucleus only. Less high concentration speckles of A3 
were observed. These bright A3 speckles distributed in the proximity to the regions of nucleoli, 
however, low level of A3 protein was observed inside nucleoli.  
 
5.4 Discussion 
 
Following the structural investigation, the developmental studies of the hnRNP A3 isoforms in rat 
brain were carried out. The real-time PCR was used to quantify alternatively spliced A3 transcripts  
at the different developmental stages.  
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By normalizing the amplification data with the selected reference gene GAPDH (Panel C, Figure 5-
7), the expression levels of A3a, A3b and overall A3 transcripts showed a similar trend during the 
brain development: a comparative low level was observed at P0 and P5, followed by a small decline 
at P14, then increased to the highest level at P21, and decreased to the lowest level at P49.  
 
It has been reported the expression of hnRNP A2/B1 in mammalian lungs is strictly regulated in a 
pattern that higher levels are only found during late fetal and neonatal stages whereas 
downregulation is found in normal adult (Montuenga et al., 1998). Now it is well accepted the 
upregulation or overexpression of hnRNP A2/B1 in adulthood is a biomarker for early detection of 
lung cancer (Tauler & Mulshine, 2009; Wright & Gruidl, 2000). Our observation of hnRNP A3 is 
not quite alike because the expression level of A3 is fairly low at the neonatal stage from P0 to P5. 
But the low level of A3 at P49 after the peak stage of P21 suggests a sharp downregulation of A3 
during and after brain maturation. With the knowledge of the A2 expression pattern, it will not be 
surprised to find the expression of A3 remains low during the entire adulthood. So far, hnRNP A3 
has not been reported evidently involved in cancer regulation, but our results imply a mechanism 
strictly regulates the expression of the HNRNPA3 gene from fetal to adult stages.  
 
Although the test samples were obtained from rat brain at five significant stages in the brain 
development, it will be arbitrary to draw a conclusion of brain development barely on the 
quantification data of these five time points. The expression patterns between the sharp increase at 
P14 and P21 and between the huge downregulation at P21 and P49 are still unknown. Therefore, rat 
brain samples between P14 and P21 (or P21-49) with shorter intervals are suggested to provide 
relatively continuous information to track the changes of the A3 splice-forms in the brain 
development.  
 
As the only splice-forms of HNRPA3 gene, the percent ratios of A3a and A3b to the overall 
HNRPA3 gene are also changing along the brain development (Panel B, Figure 5-8). In general, 
A3a gradually gained its abundance from P0 to P49; whereas A3b maintained its dominance in 
expression with small decreases along with age. Therefore, A3b is always the dominant form, and 
its expression level reflects a high cellular demand for A3b in the brain. 
 
As the trans-factors of the A2RE-mRNA, all the binding proteins (i.e. hnRNP A1, A2 and A3) had 
been reported capable to travel between nucleus and cytoplasm. However, the subcellular 
localization of exogenous and endogenous A3 showed the opposite. Either the exogenous GFP-A3b 
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fusion proteins or the immunostained endogenous A3b demonstrated a nuclear exclusive 
localization. Localization details of exogenous and endogenous proteins in different cell types were 
briefly summarized in Table 5-1.   
 
Table	  5-­‐1:	  Comparison	  of	  subcellular	  localization	  of	  the	  exogenous	  and	  endogenous	  
proteins	  
	  
	   Cell	  type	  
Observed	  
protein	  
Subcellular	  Localization	  
Nucleus	  
Cytoplasm	  
Nucleolus	   Nucleoplasm	  
Ex
og
en
ou
s	  
HeLa	  
GFP-­‐N1-­‐A3b	   Very	  low,	  uneven	   High,	  uneven	   No	  GFP-­‐C1-­‐A3b	   Low,	  even	   High,	  uneven	   No	  
Hippocampal	  
neuron	  
GFP-­‐N1-­‐A3b	   Low,	  even	   High,	  uneven	   No	  GFP-­‐C1-­‐A3b	   Low,	  even	   High,	  uneven	   No	  
Oligodendrocyte	  
GFP-­‐N1-­‐A3b	   Low,	  even	   High,	  uneven	   No	  GFP-­‐C1-­‐A3b	   Very	  low,	  uneven	   High,	  uneven	   No	  
En
do
ge
no
us
	  
HeLa	  
A3b	   Low,	  uneven	   Moderate,	  uneven,	  a	  few	  bright	  speckles	   No	  
A2	   Low,	  even	   High,	  uneven,	  many	  bright	  speckles	   Few	  speckles	  
Hippocampal	  
neuron	  
A3b	   Low,	  uneven	   Moderate,	  uneven,	  many	  bright	  speckles	   No	  
A2	   Moderate,	  uneven	   High,	  uneven,	  many	  bright	  speckles	   Very	  low	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A few conclusions can be reached according to the above table. First, almost all the observed 
exogenous and endogenous proteins showed no sign in cytoplasmic localization. Second, all these 
proteins restricted in the nucleus with an uneven distribution pattern. High intensity of localized 
proteins was observed in the middle of nucleoplasm and between nucleoli. However, no or low 
expression were observed in the nucleolus, some were evenly distributed, while others were not. 
The periphery of nucleoli was always surrounded by a few concentrated protein speckles, which 
clearly delineated the shapes of the nucleoli. The exogenous GFP-A3b fusion proteins were all 
localized in the nucleoplasm with high intensity, while their endogenous counterparts were 
localized in the same subcellular region with very moderate intensity. In terms of protein 
abundance, hnRNP A3 is never comparable with hnRNP A2 in vivo. Therefore, the high intense 
fluorescence detected from the exogenous GFP-A3b fusion proteins might be the accumulation of 
overexpressed fusion proteins. Lastly, even the transfection and immune-staining were conducted 
on different types of cell (i.e. HeLa cells, hippocampal neuron and oligodendrocytes). All the tested 
cell types showed the similar nuclear localization. Therefore, the nuclear localizaiton of A3b and 
A2 is not cell-type specific.  
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Chapter 6. General Discussion 
 
 
At the time this project started, the “A2RE-mRNA trafficking pathway” attracted a lot of attention, 
because it represents a mechanism that selectively transports mRNAs to a subcellular location for 
local translation.  The cis-trans determinants of this pathway have been identified: the cis-element 
is a 11-nucleotide sequence of “A2 response element (A2RE)” (i.e. GCCAAGGAGCC) (Munro et 
al., 1999), whereas the trans-acting factor is the well-characterized hnRNP A2 (Hoek et al., 1998). 
However, hnRNP A2 was not the only protein binding to the A2RE-sequence. HnRNP A3 with its 
four isoforms (Ma et al., 2002) emerged from the A2RE pull-down experiments, in addition to 
hnRNP A2.  
 
At that stage, the studies of hnRNP A3 were very limited due to its low abundance in most tissues 
and cells. Because hnRNP A3 is the second abundant protein pulled down by the A2RE-sequence 
(Ma et al., 2002), the A2RE pull-down experiment was used to purify protein A3 along with A2 and 
the other hnRNP proteins. Thus, the A2RE pull-down experiments provided a platform where 
enriched A3 can be obtained inside a relatively simple context. This is the background when the 
investigation of A3 was commenced.  
 
The emerging of hnRNP A3 as a novel key component binding to the A2RE-sequence raised a lot 
of structural and functional questions awaiting answers. A comprehensive characterization of 
hnRNP A3 became essential in order to further understand the story of “A2RE-mRNA trafficking” 
as well as its biochemical and biological relationship to its well-characterized paralogs hnRNP A1 
and A2. To achieve this aim, this projects was designed inside a scope of the A2RE-bindng proteins 
to address three general questions: 
 
• What are they in the A2RE-binding proteins? 
• Why are they getting involved in the A2RE-binding? 
• How do they perform? 
 
In the following sections, the major outcomes presented in the previous chapters will be concluded 
and the possible future directions will be discussed from the aspects of structure and biological 
implications of A2RE-related cellular mechanism. 
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6.1 What are they in the A2RE-binding proteins? 
—Protein identification of the A2RE-binding proteins 
 
This project was initiated to extend the previous work of discovering hnRNP A3 from an A2RE 
pull-down assay (Ma et al., 2002). According to the data collected from the previous work, four 
alternatively spliced isoforms in rat brain were hypothesized, awaiting experimental evidence. This 
was where I started this project.  
 
Targeting to the alternatively spliced isoforms of hnRNP A3, structural characterizations were 
carried out from both genomic and protein level. From the genomic aspect, six different primers 
were designed to screen the entire cDNA sequence of the HNRNPA3 gene. The screening results 
exclusively confirmed there are only two splice-forms of the HNRNPA3 gene in rat, individually 
encoding the protein isoforms A3a and A3b (Chapter 3). At the protein level, although there were 
still four protein bands of A3 observed from 1-DE gels, the LC/MS methods had yielded a few new 
masses close to unmodified A3 isoforms. When 2-DE was used in separating the A2RE-binding 
proteins, a full profile of the specific A2RE-binding proteins was unveiled. Western blotting using 
A2 and A3 isoform-specific antibodies individually demonstrated the distribution pattern of each 
protein. The A3 isoforms presented in two dimensions were much more complicated than the 
previously hypothesized four isoforms, however, these 2-D spots of A3 isoforms were scattered into 
two trails, suggesting these isoforms were all from the two coding products (A3a and A3b) of the 
HNRNPA3 gene.  
 
The establishment of the 2-DE separation made it possible to individually identify and investigate 
all the specific A2RE-binding proteins. As a result, 26 out of overall 30 protein spots were 
successfully identified (Chapter 4). The entire specific A2RE-proteome included A1a, A1b, A2, B1, 
A3a and A3b, supporting the previous finding (Ma et al., 2002). 
 
A ~140-150 nt long segment in the region of exon 7-10 of the HNRNPA3 gene was discovered to be 
a second splice site in the human breast cancer cell line MDA-MB-231 (Chapter 1). However, all 
other splice-form screenings on rat and mouse brain samples reinforced the conclusion that exon 1 
is the only splicing site of the HNRNPA3 gene.  
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6.1.1 Future directions 
 
In the structural characterization, the Y12 antibody was extensively used in Western blotting. 
Because it was observed to blot all the hnRNP A/B proteins bound to the A2RE-sequence, the Y12 
antibody was always used in the sequential double-blottings (Chapter 3 and 4) to mark the entire 
A2RE-proteome as a background image for the isoform-specific detection.  
 
Although the commercial specification stated the Y12 monoclonal antibody recognizes cross-
reactive epitopes on the B’ / B and D polypeptides of Sm (Lerner et al., 1981), it is considered as a 
methyl-specific antibody that only recognizes the symmetrical methylarginine (Brahms et al., 2000) 
for 20 years. This so-called “methyl-specific” antibody Y12 was first used in the project to detect 
the existence of sDMA residues in the A2RE-binding proteins. Due to the unmodified nature, the 
recombinant A2 and A3 proteins were used in our Western blotting experiments as negative 
controls when the rat brain A2RE-binding proteins were blotted against the Y12 antibody. Our 
observation of Y12-blotted recombinant A2 and A3 proteins (data not shown) greatly challenged its 
specificity of blotting sDMA: it successfully blotted hnRNP A/B proteins not the sDMA residues. 
Under such circumstance, the Y12 antibody was used in this project to present hnRNP A/B proteins 
only. The specificity of this controversy of the Y12 antibody turned into a very interesting topic 
(Friend LR, manuscript in preparation). The epitope of the Y12 antibody needs further 
characterization. The studies of the Y12’s epitope and its specificity in detecting hnRNP A/B 
proteins independent to their methylation status need a profound understanding of protein domains 
and configurations of hnRNP A/B proteins and the pre-mRNA splicing factors. It will open a totally 
different scenario where hnRNP A/B proteins get involved. 
 
6.2 Why are they getting involved in the A2RE-binding? 
—Investigation of PTMs of hnRNP A3 isoforms 
 
After translation, the modification of amino acid expands protein functions by attaching some 
functional groups (e.g. acetate and phosphate), changing the chemical nature of a residue (e.g. 
citrullination), or making structural changes (e.g. forming disulfide bridges), etc. Therefore, PTM is 
a common mechanism that controls the behavior of a protein to meet the cellular requirement. In the 
A2RE-binding proteins, the complexity of the hnRNP A/B isoforms suggested all the A/B isoforms 
were modified by different types at different extent. On the other hand, the specific protein 
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modifications of the A/B isoforms not only allowed them bind to the A2RE-sequence, but also 
make each modified isoform unique for its specific tasks. Therefore, the question “why are they 
getting involved” leads to the characterization of PTMs of the A2RE-binding proteins.  
  
Using the Pro-Q Diamond dye, a profile of the A2RE-binding proteins was successfully mapped on 
the 2-DE image. In comparison with the total proteins bound to the A2RE, three major 
phosphorylated isoforms were detected (i.e. A1b, A2 and A3b). When treated with the phosphatase, 
these three isoforms were all affected, showing more or less relocations on the 2-DE gel (Chapter 
4). In Western blots, these three isoforms were further detected to possess the phosphorylated Tyr 
residues. All this results indicated A1b, A2 and A3b were phosphorylated when they bound to the 
A2RE-sequence, whereas A1a, B1 and A3a were not. Considering the discrimination of 
phosphorylation between the isoform pairs of A/B proteins, various types of phosphorylated 
residues, different degrees in phosphorylation, a conclusion can be reached that the binding of 
hnRNP A/B proteins to the A2RE-sequence is phosphorylation-specific.  
 
In the mouse liver cell, the specific binding of hnRNP A3 to the AIE (age-related increase element) 
RNA was also regulated by its phosphorylation status (Hamada et al., 2010). When hnRNP A3 
bound to the AIE, the Ser359 is unphosphorylated. However, a mixture of phosphorylated and 
unphosphorylated S359 residues were found in A3 from the mouse liver nuclear extracts. This 
finding provides evidence in supporting the above conclusion.  
 
Using the bottom-up strategy coupled with MS/MS proteomics, the results in methylation studies 
were very productive. Six methyl-Arg residues were identified in the C-terminal Gly-rich region of 
A3. Except for R214, the other five methyl-Arg residues were all inside the RGG motifs. The 
aDMA “reporter” product ion m/z 46 was found in all six MS/MS spectra, which unambiguously 
proved that all six methyl-Arg residues were aDMAs. The identification of six aDMA residues of 
A3 in this project has been published last year (Friend et al., 2013).  
  
The critical role of arginine residues in regulating specific protein-RNA interactions through the 
protein GRD has been studied for more than two decades (Calnan, Tidor, Biancalana, Hudson, & 
Frankel, 1991). In the specific binding of protein-RNA, one positively-charged guanidine group in 
the Arg side chain is capable of donating five hydrogen bonds (H-bonds) with the negatively-
charged specific RNA phosphates, resulting in an H-bond network between the protein GRD and 
ssRNA backbone (Borders et al., 1994). One or more Gly residues flanking the Arg residues 
provide the necessary flexibility in protein conformation to facilitate establishment of the H-bond 
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network. The interspersed aromatic residues, i.e. Phe and Tyr, between the Arg-Gly clusters 
potentially interact with the bases of the nucleic acid through their hydrophobic ring structure. 
Together, the specificity of protein-RNA interaction is achieved through the established network of 
Arg-dependent H-bonds. However, the methylation of Arg residue brings one or two extra methyl 
groups to the side chain, resulting in the increased hydrophobicity of protein. Thus, the Arg-
dependent H-bond networks could not maintained after methylation, which is essential for specific 
protein-RNA interactions. Therefore, the methylarginine-containing Gly-rich domains would lose 
their binding capacity and specificity towards nucleic acids because of the disrupted Arg-dependent 
H-bonds. 
 
In vivo, five out of ten Arg residues in the GRD of hnRNP A1 and six out of ten Arg residues in the 
GRD of hnRNP A3 are methylated. The methylation would inevitably interfere the Arg-dependent 
H-bond network between the protein GRD and the specific nucleotide sequence. In contrast, the 
R254 residue is the only methylated Arg residue in hnRNP A2, so that the H-bond networks are 
established and still maintained by the other eight unmethylated Arg residues in the protein GRD. 
The Arg-dependent H-bond network might help to explain the binding specificity of A2 is much 
higher than its paralogs A1 and A3.  
 
In addition, three Arg residues were identified to be unmethylated, including the R52 residue in the 
protein N-terminus which was previously predicted as a monomethylated Arg residue. The results 
of MS/MS together with Western blotting have invalidated the existence of the citrullinated Arg 
residue in hnRNP A3.   
  
6.2.1 Future directions  
 
The 2-DE profile of the A2RE-proteome showed each alternatively spliced isoform of the hnRNP 
A/B proteins was spread into a trail of charged isomers. The complexity of each A/B isoform 
displayed on the 2-DE gel reflected the variety of the protein modifications on the different isoform 
molecules which made them distinct with each other with slightly different pI and molecular 
weight. The investigations of phosphorylation, methylation and citrullination had been carried out 
in the project. However, there must be many more types of protein modifications need to be 
explored to give a better understanding of the isoform complexity of the hnRNP A/B paraologs 
inside the A2RE-context.  
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A protein modification catalyzed by small ubiquitin-related modifier (SUMO), called 
SUMOylation, has been identified in hnRNPs C and M (Vassileva & Matunis, 2004). The SUMO 
enzymes are located inside the nuclear pore complexes, which indicates the protein molecules are 
modified when they travel between the nucleus and the cytoplasm. In many cases, SUMOylation of 
target proteins results in altered localization and binding partners: the SUMO modification of 
hNinein leads to its localization from the centrosome to the nucleus (Cheng et al., 2006); and the 
SUMO-modified RanGAP1 results in its movement from cytosol to nuclear pore complex (R. 
Mahajan, Delphin, Guan, Gerace, & Melchior, 1997). Since SUMOylated proteins are always 
involved in nuclear-cytoplasmic transport, transcriptional regulation, protein stability and apoptosis, 
it will be very interesting to find out whether SUMOylation would occur on the hnRNP A/B 
proteins when they are transported through the nuclear pore complexes.    
 
The protein material subject to investigation in this project was purified from rat brain tissue by the 
A2RE pull-down experiment. Therefore, the protein composition was a mixture which came from 
the different neural cells at their different cell cycle stages. Our results in phosphorylation and 
methylation reflect the modification status of proteins originated from a diverse population of brain 
cells. Therefore, a relatively uniformed system is suggested for the investigation of protein 
modification. This is extremely important for the phosphorylation, which is well known as a cell-
cycle regulated modification.  
 
For the in vitro protein characterization, a fast-growing mouse neuroblastoma cell line Neuro-2a 
(N2a) and a human bone marrow derived cell line SH-SY5Y are proposed to provide two different 
uniformed cellular environments. Both cell lines are able to differentiate cells along the neuronal 
lineage: the N2a cells have a neuronal morphology with neurofilaments (being used to study 
Alzheimer’s Disease); whereas SH-SY5Y cells have short spiny neurite-like processes (being used 
to study Parkinson’s Disease). Though both cell lines are not originated from brain, the consistency 
of their neuroblast-like cultured cells will be more practical in cell synchronization at different cell-
cycle stages than the cultured primary neurons or oligodendrocytes. Then A2RE-binding proteins 
purified at different cell-cycle stages will be characterised still using 2-D proteomics methodology 
(as described in Chapter 4). With this proposed strategy, the investigation of protein modification 
could be focused on one cell type at one cell-cycle stage. Thus, the collection of cell-cycle-specific 
protein modification results will conclude the full story of the protein dynamics in an entire cell 
cycle.  
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Furthermore, advanced proteomic methods such as the differential analysis tool 2D-DIGE 
(described in Section 1.5.2) are suggested to overcome the technical limitations of our established 
MS/MS proteomics in the project. 
 
6.3 How do they perform? 
—Studies of developmental changes and subcellular localization of hnRNP 
A3 isoform 
 
The real-time PCR results indicated the expression level of the HNRNPA3 genes (both alternative 
splice-forms A3a and A3b) in rat brain change along the developmental stages. The HNRNPA3 
gene started at a very level at the time of birth (P0 stage) and increased slowly through P5 and P14 
stages. A huge increase was observed at P21, where both A3a and A3b reached to its top levels. At 
P49, the level of HNRNPA3 gene decrease to its lowest. The trends during the brain development 
between A3a and A3b are consistent in general (Figure 5-7), however the percent ratio of individual 
splice-form to the overall HNRNPA3 gene varies along brain development (Panel B, Figure 5-8). 
The percentage of A3a increased steadily through P0-P49, whereas the percentage of A3b showed a 
fluctuating pattern: the starting level was similar at both P0 and P5, followed by the gradual 
decreases at P14 and P21, and the level was maintained at P49.  
 
Between the two splice-forms of the HNRNPA3 gene, the truncated A3b form is an absolute major 
form. Especially in the early stage of the brain development, the A3b level is around four times 
more than the full-length form. However, the difference is getting smaller in later stages, when the 
level of A3a constantly increases. At P21 and P49, the A3b level is about only two fold of the A3a 
level (Panel B, Figure 5-8).   
 
In order to establish a real-time PCR system to quantify our target A3 genes, the amplification 
efficiency, sensitivity and precision were all optimized for both target A3 genes and the reference 
genes β-actin and GAPDH. However, due to the inherent GC-cluster-prone nature of the A3a 
sequence, or possibly incompatibility between the SYBR Green and the A3a primers, the 
amplification of A3a was somewhat affected, as reflected in the atypical amplification curves and 
dissociation curve. Although the following agarose gel electrophoresis supported its amplification 
specificity, the collected data of the A3a amplification were considered underrated?. This could be 
observed in Panel A (Figure 5-8), which demonstrated that the level of A3 gene was always slightly 
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higher than the sum level of A3a and A3b. Theoretically speaking, both values in comparison 
should be identical.  
 
Aimed to investigate the biological function of hnRNP A3, the primary oligodendrocyte culture and 
hippocampal neuron cultures had been established for the localization studies. Two A3b gene 
constructs were designed to individually fuse with GFP-tag at the C- or N-termini, as the exogenous 
source of A3 in the investigation. 
 
Transfected GFP-tagged A3b primary culture cells and HeLa cells showed the GFP-fusion proteins 
were mostly restricted into the cell nucleus. Immune-staining indicated the endogenous A3 is also 
restricted inside the cell nucleus. From our observation, both exogenous and endogenous A3 
proteins showed a nuclear rather than a cytoplasmic distribution pattern.  
 
6.3.1 Future directions 
 
The subcellular localization of hnRNP A2 has been proved to be independent to its methylation 
status (Friend et al., 2013). The point mutation of its only methylated Arg residue 254 (R254A) 
resulted in an unmodified form of hnRNP A2. Both naturally methylated hnRNP A2 and point-
mutated unmethylated hnRNP A2 are exclusively located inside the nucleus, with no sign of 
cytoplasmic localization.   
 
Although the methylation profile of hnRNP A3 is quite different to that of A2, the exclusive nuclear 
distribution of hnRNP A3 observed in vivo mirrors the nuclear localization of hnRNP A2. As 
discussed in the previous section, the methylation in RGG motifs of the protein Gly-rich region 
critically affects the specific RNA-protein binding by abolishing the H-bonds, which can be 
established only with unmodified Arg residues. So far, none of work has been carried out to 
investigate the distribution pattern of hnRNP A3 if its methylation profile has been changed. 
According to the H-bond theory, the affinity and binding specificity to the RNA molecules will be 
diminished as the consequence of Arg methylation in the protein Gly-rich region. Except for the 
R257 residue, the Arg residues in the Gly-rich region have been exhaustively methylated. An 
incompatibility to the methylation consensus was considered as the reason for this unmethylated 
R257 residue of hnRNP A3. The mutation experiments are suggested to convert this R257-flanking 
region to a methylation-friendly consensus, resulting to in a methylated R257 residue inside hnRNP 
A3. The cellular distribution pattern of hnRNP A3 carrying methylated R257 will be a good 
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comparison to that of hnRNP A2-carrying unmethylated R254 (Friend et al., 2013). Likewise, the 
unmethylated R194 residue of hnRNP A1 is also a suggested target residue for mutation. Therefore, 
the comparison between A1 with methylated R194 residue, A2 with unmethylated R254 residue and 
A3 with methylated R257 residue, would provide more comprehensive information in regards to 
protein localization and protein-RNA binding. 
 
As mentioned in the previous section 6.2.1, uniformed neuronal cell cultures are preferred in in vivo 
studies of hnRNP A3 isoforms. Mouse N2a cell line and human SH-SY5Y cell lines are suggested. 
Likewise, the localization of endogenous hnRNP A/B isoforms will be observed in a cell-cycle-
specific manner. Moreover, the limitation of mixed population of cells in real-time PCR 
quantifications will be also overcome. At each cell-cycle phase, the activities of individual hnRNP 
isoforms take part in will be clearly depicted from transcriptional (real-time PCR quantifications), 
structural (protein modifications) and spatial (subcellular localisation) changes collected at the same 
synchronised phase.  
 
Phylogenetic studies revealed that gene duplication has given rise to the ancestors of the 
HNRNPA1, HNRNPA2B1 and HNRNPA3 genes, but HNRNPA2B1 appears to have separated first 
(Akindahunsi et al., 2005). It suggests that A3 is evolutionarily closer to A1, rather than A2. In 
terms of Arg methylation profile, A1 and A3 are more common. Although all three paralogs are 
actively involved with the A2RE-mRNA, A1 and A3 are present in the A2RE-proteomes in much 
lower abundance than A2. This protein composition of hnRNP A/B paralogs in the A2RE-proteome 
might imply a supporting role from both A1 and A3, whereas A2 plays more dominantly. Neither 
the individual tasks of each paralog nor the relationship between A1, A2 and A3 has not been 
clarified in the A2RE-proteome. Therefore, a suppression experiment is suggested to examine 
whether there is a compensation mechanism between paralogs, especially between the low abundant 
A1 and A3, in the A2RE-proteome. 
 
6.4 Summary  
 
At the time when this project was commenced, few literature resources of hnRNP A3 were 
available except that the global proteomic studies documented hnRNP A3 among other hundreds of 
proteins yielded. By the time when this project had been completed, a few more research reports 
stated the important roles hnRNP A3 played in many biological mechanisms, among which the 
methylation studies of hnRNP A3 described in chapter 4 has been published in 2013 (Friend et al., 
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2013). Up to date, none of the published results overlapped with the researches presented in this 
thesis. No doubt that hnRNP A3 has become more significant with more and more experimental 
data supporting its indispensable roles of many cellular activities.  
 
The experiments in the project were carried out from aspects of genomics, proteomics and cellular 
location, but all inside the scope of A2RE-binding proteins. Recently, hnRNP A3 was found to be a 
major protein specifically binding to the AIE (age-related increase element), a 102 bp RNA 
sequence, and the ASE (age-related stability element), ~50 bp RNA sequence in mouse liver cells 
(Hamada et al., 2010). The binding specificities of A3 to AIE and ASE as well as A2RE might 
indicate a more generalized model that this protein participates in the downstream cellular 
metabolism. It will be a very sophisticated mechanism that tightly regulates proteins to first 
distinguish the specific sequences for binding at the certain stage in a certain cell type, and then take 
the downstream tasks after binding with the specific RNA molecules. The specific binding is just a 
very beginning for these proteins (including hnRNPs) to take part in the processes of the mRNA 
biogenesis.  
 
From my understanding of this project, the “A2RE-mRNA trafficking pathway” is a journey for the 
mRNA molecules. All the identified A2RE-binding components together built a special cargo to 
accommodate the A2RE-mRNA molecules for this journey. hnRNP A/B proteins are the building 
blocks of the cargo. The characterization of hnRNP A3 revealed that A3 was fitted in this cargo 
with multiple modified forms of A3a and A3b. The comparison studies with A1 and A2 indicated 
that the sequence and domain similarity might be required to be built into this special cargo aiming 
to be recognized by the A2RE-sequence. However, in a living cell, a more dynamic circumstance 
requires the multiple functional complexes tailor-made to fulfill their assigned tasks. Therefore, it is 
quite likely the trafficking-mRNA cargo, built with A1a, A1b, A2, B1, A3a and A3b, is also a 
dynamic structure, ready for changes to deal with different conditions along the trafficking journey. 
Although the 2-DE profile of all the A2RE-binding proteins has been pictured with their 
abundances. It will be interesting to know what happened inside this A2RE-cargo (in terms of 
protein composition, abundance, configuration) through the whole journey until arrived at the 
subcellular destination. This important piece is needed to string together the entire story about the 
journey of the A2RE-mRNA trafficking pathway.  
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Appendix 
Appendix	  1:	  List	  of	  primers	  designed	  for	  this	  project	  
	   Primer	   Sequence	  	  
Amplified	  Region	  of	  	  
The	  Target	  Gene	  	  
Product	  
Size	  (bp)	  
Sp
lic
in
g	  
Va
ri
at
io
n	  
Sc
re
en
in
g	  
X234A3F	   Forward:	  CACGATCCAAAGGAACCAGA	  
HNRPA3	  coding	  region	  76-­‐395	   320	  
X234A3R	   Reverse:	  CCACCAACAAAAATCTTCTTCA	  
X456A3F	   Forward:	  TAAAGCCTGGTGCCCATTTA	  
HNRPA3	  coding	  region	  350-­‐650	   301	  
X456A3R	   Reverse:	  CCACGACCTCTCTGTGATCC	  
X5678A3F	   Forward:	  TGGGCATAATTGTGAAGTGAA	  
HNRPA3	  coding	  region	  576-­‐879	   304	  
X5678A3R	   Reverse:	  TCCACCACCTCCATAACCTC	  
X7890A3F	   Forward:	  GTGGCAGCAGAGGCAGTTAT	  
HNRPA3	  coding	  region	  761-­‐1117	   357	  
X7890A3R	   Reverse:	  CACCACTTCCACCTCCAGAT	  
X1bA3F	   Forward:	  CAGCCTGACTCCGGCCG	   HNRPA3	  coding	  region	  31-­‐395	  	  (paired	  with	  X234A3R)	   365	  
X12A3F	   Forward:	  CGGTCTCAAAATGGAGGGC	   HNRPA3	   5’-­‐upstream	   10	   to	   coding	  region	  395	  (spanning	  over	  the	  slicing	  site)	   340	  
Re
al
-­‐t
im
e	  
PC
R	  
X1A3F	   Forward:	  CGGTCTCAAAATGGAGGTAAAAC	   HNRPA3	   5’-­‐upstream	   10	   to	   coding	  region	  314	   324	  X3A3R	   Reverse:	  ACCACACGTCCATCAACCTT	  
GAPDH-­‐F	  	   Forward:	  TGATGACATCAAGAAGGTGGTGAAG	  
GAPDH	  coding	  region	  867-­‐1106	   240	  
GAPDH-­‐R	   Reverse:	  TCCTTGGAGGCCATGTGGGCCAT	  
ActinF	   Forward:	  TCATGAAGTGTGACGTTGACATCCGT	  
ACTB	  coding	  region	  916-­‐1200	   285	  
ActinR	   Reverse:	  CTTAGAAGCATTTGCGGTGCACGATG	  
Cl
on
in
g	  
	   A3NcoI-­‐
Forward	  
Forward:	  AATATCCATGGAGGGCCACGATCC	   Entire	   coding	   region	   of	   rat	   HNRPA3	  (short	   variant)	   with	   flanking	  restriction	  sites	   1088	  A3BamHI-­‐
Reverse	  
Reverse:	  ATGGATCCTCAGAACCTTCTGCTACC	  
Se
qu
en
g	  
Re
ac
ti
on
	   pET-­‐SeqF	   Forward:	  GAATTCCATGGAGAGAGAAAAG	   Entire	  region	  of	  multiple	  cloning	  sites	  (MCS)	  of	  pET	  vector	   	  pET-­‐SeqR	   Reverse:	  GTCGACTCAGTATCGGCTCCTCCC	  
M13-­‐	  
22merF	  
Forward:	  TCACACAGGAAACAGCTATGA	  C	   Entire	   region	   of	   MCS	   of	   pGEM-­‐T	  vector	   	  M13-­‐
24merR	  
Reverse:	  CGCCAGGGTTTTCCCAGTCACGAC	  
 
